{"meta":{"query_hash":"c2894d613fe8","filters":{"venue":"OncoImmunology"},"cohort_total":218,"direct_labels_cover":1,"predictions_cover":218,"exported":218,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/c2894d613fe8","api":"https://metacan.xera.ac/api/v1/cohort?venue=OncoImmunology"},"results":[{"id":"W1495108757","doi":"10.1080/2162402x.2015.1016709","title":"The antitumor immune response generated by fractionated radiation therapy may be limited by tumor cell adaptive resistance and can be circumvented by PD-L1 blockade","year":2015,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":93,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Blockade; Immune system; Cancer research; CD8; PD-L1; Tumor microenvironment; Immunotherapy; T cell; Medicine; Cell; Radiation therapy; Acquired immune system; Immunology; Biology; Receptor; Internal medicine","score_opus":0.02045912337141762,"score_gpt":0.26386041447586994,"score_spread":0.24340129110445233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1495108757","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87428325,0.10100233,0.000022842716,0.022792844,0.0004294193,0.0006868028,0.00035899208,0.00012052113,0.00030297408],"genre_scores_gemma":[0.97165835,0.010716082,0.00005859001,0.0027091613,0.000053556534,0.00011815899,0.0007261371,0.00006870729,0.013891271],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99733955,0.0007448097,0.0005719063,0.00050247525,0.0003262479,0.00051504106],"domain_scores_gemma":[0.9982063,0.00040042607,0.00042260732,0.0005446596,0.00029165213,0.00013436185],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00086817594,0.00035292265,0.00048520992,0.00013008721,0.00040893766,0.000058322094,0.00022538159,0.0002624533,0.000074909156],"category_scores_gemma":[0.00018591543,0.000278185,0.00009674377,0.000549802,0.0005587483,0.00011153614,0.000037846752,0.00047897466,0.000007364537],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04858776,0.00026964044,0.00029154756,0.0000053790664,0.0003611323,0.000025060413,0.00046917735,6.854534e-7,0.8021436,0.0000075661987,0.145607,0.0022314873],"study_design_scores_gemma":[0.012005011,0.0016114447,0.009158619,0.000034653498,0.00006236624,0.00009285307,0.0011229104,0.000108962384,0.25236097,0.000010734525,0.72311014,0.00032134846],"about_ca_topic_score_codex":0.0014328791,"about_ca_topic_score_gemma":0.00009062776,"teacher_disagreement_score":0.57750314,"about_ca_system_score_codex":0.0005386617,"about_ca_system_score_gemma":0.00051268464,"threshold_uncertainty_score":0.99996704},"labels":[],"label_agreement":null},{"id":"W1556179571","doi":"10.1080/2162402x.2015.1008354","title":"T cell receptor-therapy in HBV-related hepatocellularcarcinoma","year":2015,"lang":"en","type":"article","venue":"OncoImmunology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Wellcome Trust","keywords":"T-cell receptor; Chimeric antigen receptor; Adoptive cell transfer; Medicine; Antigen; Immunology; Hepatitis B virus; T cell; Receptor; Cell therapy; Hepatitis B; Cancer research; Virology; Cell; Virus; Immune system; Biology; Internal medicine","score_opus":0.05337410790290423,"score_gpt":0.30603250749086675,"score_spread":0.25265839958796255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1556179571","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9340681,0.007418521,0.000006030007,0.0015163433,0.00040744865,0.0006454285,0.0000021896815,0.000104575505,0.055831406],"genre_scores_gemma":[0.9605528,0.0010990975,0.0002580195,0.0002900656,0.00008662848,0.00006314611,0.000060559698,0.00006382135,0.037525866],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979258,0.00029317808,0.00042904873,0.0004139415,0.00032406964,0.0006139188],"domain_scores_gemma":[0.9987847,0.00009489284,0.00007914228,0.0006774038,0.00017257011,0.00019125202],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0006939629,0.00022120918,0.0005253332,0.00040094933,0.000034651035,0.000013387108,0.00025395153,0.00038894502,0.006198713],"category_scores_gemma":[0.00008852966,0.00020545357,0.00011809725,0.000598741,0.00024267998,0.00006579756,0.000097663054,0.00078433583,0.0015429812],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002732539,0.00081177964,0.14542793,0.000020215955,0.00010122258,0.00045150428,0.002139681,0.000004269587,0.7926689,0.00021709783,0.005142124,0.05028277],"study_design_scores_gemma":[0.04198354,0.0087474175,0.05807793,0.000102574704,0.00003118841,0.0006586135,0.0017654487,0.00056330254,0.17710131,0.0014024888,0.7088002,0.00076600135],"about_ca_topic_score_codex":0.0006333554,"about_ca_topic_score_gemma":0.0000236069,"teacher_disagreement_score":0.70365804,"about_ca_system_score_codex":0.00048255431,"about_ca_system_score_gemma":0.0005099124,"threshold_uncertainty_score":0.99923444},"labels":[],"label_agreement":null},{"id":"W1574165260","doi":"10.1080/2162402x.2014.999536","title":"CD20<sup>+</sup>T cells have a predominantly Tc1 effector memory phenotype and are expanded in the ascites of patients with ovarian cancer","year":2015,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek","keywords":"CD20; CD8; Immunology; Cytotoxic T cell; Medicine; Biology; Cancer research; Antigen; In vitro","score_opus":0.010496928941660568,"score_gpt":0.22431096020262825,"score_spread":0.21381403126096768,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1574165260","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99385464,0.0030348226,0.000023466651,0.00021439046,0.0010566363,0.0004924973,0.000020325431,0.00002449137,0.0012787101],"genre_scores_gemma":[0.997166,0.00009142237,0.000027712531,0.00022722557,0.000021901766,0.00008893449,0.0000843904,0.000018885508,0.0022735249],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984491,0.00056449574,0.00033462248,0.00028996536,0.000055878372,0.00030598056],"domain_scores_gemma":[0.9989462,0.00024804295,0.0002690096,0.00034331408,0.0001776142,0.000015851865],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031651344,0.00021548192,0.00042746292,0.00016790714,0.000092481736,0.000013341451,0.00020121908,0.00027095233,0.00034172548],"category_scores_gemma":[0.00010478667,0.00014127168,0.000049533923,0.00014385594,0.00035338788,0.00014154054,0.00007448111,0.0004053293,0.00009632103],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03066766,0.0035923158,0.5371427,0.00025919516,0.0018484339,0.00003612355,0.060379773,0.000486427,0.30318356,0.0004368911,0.029657591,0.032309342],"study_design_scores_gemma":[0.027599093,0.0045940066,0.7839231,0.00035441582,0.00028615416,0.00007671886,0.02150029,0.00009949235,0.07999916,0.00009778079,0.080698624,0.0007711605],"about_ca_topic_score_codex":0.0010939916,"about_ca_topic_score_gemma":0.00022374939,"teacher_disagreement_score":0.24678041,"about_ca_system_score_codex":0.00008045607,"about_ca_system_score_gemma":0.00009388787,"threshold_uncertainty_score":0.5760892},"labels":[],"label_agreement":null},{"id":"W1601735325","doi":"10.1080/2162402x.2015.1016707","title":"Deficient regulatory B cells in human chronic graft-versus-host disease","year":2015,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institut National Du Cancer; Institute of Cancer Research; Société Française de Dermatologie et de Pathologie Sexuellement Transmissible","keywords":"Regulatory B cells; Graft-versus-host disease; Immunology; Hematopoietic stem cell transplantation; Disease; Immune system; Medicine; Stem cell; Haematopoiesis; Transplantation; Innate immune system; Downregulation and upregulation; Cancer research; Biology; Interleukin 10; Gene; Internal medicine; Cell biology; Genetics","score_opus":0.03451271174651163,"score_gpt":0.2981925151773277,"score_spread":0.2636798034308161,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1601735325","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9877626,0.0019184178,0.00007887875,0.00045221506,0.00070255535,0.00037346393,0.0000072120424,0.00008080349,0.0086238785],"genre_scores_gemma":[0.99860793,0.00006386026,0.00012970773,0.0001035438,0.00007280094,0.000036600275,0.000066838875,0.000027393384,0.00089132786],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.998642,0.00009530581,0.00032812328,0.00029968028,0.00022555112,0.00040931525],"domain_scores_gemma":[0.9991156,0.000061539016,0.00007052021,0.00047192423,0.00006341131,0.00021702633],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030526335,0.00015505549,0.0002994422,0.00019375545,0.000040096224,0.0000067936044,0.00011517348,0.0001408614,0.00017269107],"category_scores_gemma":[0.000040332772,0.00015182451,0.00006496525,0.00019269656,0.0001704223,0.00004926809,0.000033136297,0.00022073662,0.00036832027],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006059014,0.0022222635,0.078490965,0.0010306456,0.000290563,0.0027548461,0.0064523853,0.00030769667,0.877382,0.01865025,0.0029456238,0.0034137894],"study_design_scores_gemma":[0.044959214,0.0038414877,0.8212118,0.00094930053,0.0005508049,0.00023091896,0.0022452604,0.00039173933,0.076949656,0.00061487034,0.047071487,0.0009834261],"about_ca_topic_score_codex":0.00010724141,"about_ca_topic_score_gemma":0.000099938705,"teacher_disagreement_score":0.8004323,"about_ca_system_score_codex":0.00071430317,"about_ca_system_score_gemma":0.0005486488,"threshold_uncertainty_score":0.6191224},"labels":[],"label_agreement":null},{"id":"W1602732985","doi":"10.1080/2162402x.2015.1026529","title":"Survivin-targeted immunotherapy drives robust polyfunctional T cell generation and differentiation in advanced ovarian cancer patients","year":2015,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":99,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nova Scotia Health Authority; Princess Margaret Cancer Centre; University Health Network; Immunovaccine (Canada); Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Immune system; CD8; Survivin; Immunotherapy; Antigen; Immunology; Medicine; Cancer research; Cytotoxic T cell; Ovarian cancer; Cancer immunotherapy; T cell; Tumor antigen; Cancer; Biology; Internal medicine","score_opus":0.01658068134635127,"score_gpt":0.23476289167382006,"score_spread":0.2181822103274688,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1602732985","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9602453,0.035770625,0.00025250978,0.0003546018,0.0025952011,0.00037138467,0.00003866723,0.000070526345,0.00030116417],"genre_scores_gemma":[0.99358433,0.0023066914,0.00014690105,0.00023241865,0.000044291544,0.00012435755,0.00059113064,0.000040590603,0.0029293129],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9977857,0.0007100379,0.0005117158,0.00044312023,0.00006951714,0.0004799251],"domain_scores_gemma":[0.9991256,0.00012747306,0.00024551988,0.00030101562,0.0001764995,0.000023892613],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00029303448,0.00031411715,0.00043596848,0.00032940315,0.00020797638,0.00002944585,0.00020601397,0.00043183845,0.0006024867],"category_scores_gemma":[0.00007634897,0.00029781627,0.00006973285,0.00023739162,0.00023428579,0.00031748446,0.0000773462,0.00039338018,0.000106095904],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023279095,0.0006353032,0.093611926,0.000007297488,0.00019822376,0.0000012589917,0.0020013792,0.00015347132,0.86895543,0.00023394058,0.00048994384,0.031383935],"study_design_scores_gemma":[0.015276938,0.0010021,0.8718798,0.000032266387,0.000027210584,0.000016021586,0.0005093907,0.000080399004,0.09378722,0.00012387567,0.016765608,0.00049914356],"about_ca_topic_score_codex":0.0008898664,"about_ca_topic_score_gemma":0.00028099003,"teacher_disagreement_score":0.7782679,"about_ca_system_score_codex":0.00021172,"about_ca_system_score_gemma":0.00020202548,"threshold_uncertainty_score":0.99994737},"labels":[],"label_agreement":null},{"id":"W1626602876","doi":"10.1080/2162402x.2015.1074375","title":"Autoantibodies specific to estrogen receptor alpha act as estrogen agonists and their levels correlate with breast cancer cell proliferation","year":2015,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Lethbridge","keywords":"Breast cancer; Estrogen receptor; Cancer; Autoantibody; Medicine; Cancer research; Estrogen; Receptor; Cell growth; Estrogen receptor alpha; Internal medicine; Endocrinology; Cancer cell; Immunology; Antibody; Biology","score_opus":0.010404165211724417,"score_gpt":0.24315693716277084,"score_spread":0.23275277195104643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1626602876","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98292184,0.0141201615,0.00012849252,0.0006362178,0.00032329976,0.00044247683,0.0000992169,0.000043481905,0.0012847896],"genre_scores_gemma":[0.9960007,0.001530072,0.00058834977,0.00019264116,0.00019398228,0.0000793961,0.00018461011,0.000052742704,0.0011775163],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986398,0.0001286113,0.00021133058,0.0005021261,0.0001046945,0.00041342218],"domain_scores_gemma":[0.99916166,0.000013881258,0.000115936164,0.00035429283,0.00016099103,0.00019324053],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015605942,0.00031494192,0.00029151776,0.000049965034,0.0001334651,0.000049151,0.00019214358,0.00035528484,0.00004689092],"category_scores_gemma":[0.000014896481,0.00023250403,0.000058818223,0.000106574545,0.00017581313,0.000016132497,0.00014657006,0.00020236269,0.000096691685],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019194869,0.000175264,0.0077960854,0.000017493641,0.00042393594,0.000022644314,0.0011101317,0.000110782144,0.96587414,0.00028191647,0.0033762131,0.018891923],"study_design_scores_gemma":[0.004269816,0.0050399024,0.009224271,0.00009305142,0.00010038788,0.0015285724,0.0011762502,0.00006773559,0.8567708,0.00009486209,0.12063962,0.0009946912],"about_ca_topic_score_codex":0.00017072358,"about_ca_topic_score_gemma":0.00003234006,"teacher_disagreement_score":0.11726341,"about_ca_system_score_codex":0.000077946795,"about_ca_system_score_gemma":0.00033330006,"threshold_uncertainty_score":0.94812393},"labels":[],"label_agreement":null},{"id":"W1658471897","doi":"10.1080/2162402x.2015.1030561","title":"Characterization of T cell repertoire of blood, tumor, and ascites in ovarian cancer patients using next generation sequencing","year":2015,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Saskatchewan","keywords":"Ascites; Ovarian cancer; T-cell receptor; Immune system; CD8; Biology; Tumor microenvironment; T cell; Cancer research; Cancer; Cytotoxic T cell; Cell; Immunology; Medicine; Internal medicine; Genetics; In vitro","score_opus":0.044810602246881416,"score_gpt":0.24254404966384677,"score_spread":0.19773344741696536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1658471897","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964588,0.0014027212,0.00006842606,0.000023852688,0.001665527,0.00014189823,0.0000061690203,0.000009853128,0.00022272301],"genre_scores_gemma":[0.99903786,0.000175903,0.00008255886,0.00005413322,0.000017237913,0.000008661441,0.00017490875,0.000010990993,0.00043773907],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999019,0.00019097695,0.00043326154,0.00018128203,0.00002752409,0.00014792936],"domain_scores_gemma":[0.9992663,0.00002462989,0.00036035484,0.00013917376,0.00020050787,0.0000090298145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015667378,0.000109808396,0.0002636797,0.00020158007,0.00004522339,0.0000056150056,0.00006453451,0.00016843453,0.00013561954],"category_scores_gemma":[0.00007071015,0.00010821835,0.000028829287,0.00014255129,0.000112166075,0.00024305204,0.000046667334,0.00015368627,0.0000065653153],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013569332,0.00013759558,0.01864541,0.000018072029,0.000040969262,7.1315884e-7,0.0010960719,0.000017092232,0.97909826,0.000041631396,0.000016782795,0.00075170427],"study_design_scores_gemma":[0.0019746083,0.0003237685,0.014505436,0.000056143817,0.000043537635,0.000020922369,0.0004226026,0.00026244242,0.9816021,0.0000073785063,0.0006781431,0.0001029628],"about_ca_topic_score_codex":0.0017248759,"about_ca_topic_score_gemma":0.000065262895,"teacher_disagreement_score":0.0041399733,"about_ca_system_score_codex":0.00009379267,"about_ca_system_score_gemma":0.00013146098,"threshold_uncertainty_score":0.44130164},"labels":[],"label_agreement":null},{"id":"W1781387617","doi":"10.1080/2162402x.2015.1050575","title":"B7-H4 is a positive regulator of antitumor immunity","year":2015,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Regulator; Negative regulator; Cancer research; Immunity; Medicine; Immune system; T cell; Immunology; Biology; Signal transduction; Cell biology; Genetics; Gene","score_opus":0.030064290279245134,"score_gpt":0.3041757713370558,"score_spread":0.2741114810578107,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1781387617","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97935116,0.0054612705,0.000032348744,0.0021090284,0.00038229994,0.00024438032,0.00002768625,0.000045621626,0.012346213],"genre_scores_gemma":[0.9959428,0.00025278475,0.0004873986,0.0009570785,0.000054354317,0.000009683284,0.000028337325,0.000019358662,0.0022482232],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99901885,0.000087639055,0.0003173492,0.00018226416,0.00016154977,0.00023235379],"domain_scores_gemma":[0.99899393,0.00004364024,0.00015803725,0.0005023751,0.00023683727,0.00006518457],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028443598,0.00014008688,0.00042980496,0.00013433932,0.00004324354,0.0000048903535,0.00014377123,0.0001592575,0.00031684394],"category_scores_gemma":[0.00006574925,0.000120579185,0.00014352037,0.00026462908,0.00041017245,0.00006318849,0.00006452556,0.00019720031,0.00005626175],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02146277,0.0012523668,0.030349132,0.00011208507,0.0019118905,0.00014458924,0.007708407,5.142786e-7,0.8570412,0.0015647227,0.021067716,0.05738465],"study_design_scores_gemma":[0.014919581,0.00570629,0.5427169,0.00034253014,0.0002480826,0.0010609746,0.003133779,0.000025537849,0.32902032,0.0006568443,0.10174999,0.00041912522],"about_ca_topic_score_codex":0.0011858105,"about_ca_topic_score_gemma":0.000019313038,"teacher_disagreement_score":0.5280208,"about_ca_system_score_codex":0.0001493531,"about_ca_system_score_gemma":0.00033167127,"threshold_uncertainty_score":0.49170762},"labels":[],"label_agreement":null},{"id":"W1860654126","doi":"10.1080/2162402x.2015.1008342","title":"Accumulation of tolerogenic human 6-sulfo LacNAc dendritic cells in renal cell carcinoma is associated with poor prognosis","year":2015,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"Technische Universität Dresden","keywords":"Clear cell renal cell carcinoma; Cancer research; Acquired immune system; Immune system; Medicine; Dendritic cell; Immunotherapy; T cell; Tumor progression; Primary tumor; Cell; Immunology; Renal cell carcinoma; Metastasis; Biology; Cancer; Pathology; Internal medicine","score_opus":0.04511338071340423,"score_gpt":0.28320222357011393,"score_spread":0.2380888428567097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1860654126","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906142,0.0074161543,0.000015990392,0.00013718024,0.00032261485,0.00048094193,0.000037071364,0.000060830484,0.0009150617],"genre_scores_gemma":[0.9962974,0.000057225803,0.000056325858,0.00013555087,0.000010454133,0.00007089091,0.00016885319,0.000044304987,0.0031589791],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99733645,0.00084851054,0.0006955758,0.00041523157,0.00008386687,0.00062036846],"domain_scores_gemma":[0.99865717,0.00025018785,0.00041895025,0.00041592005,0.00023401376,0.000023788958],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005576577,0.00032057767,0.0007137884,0.00038104976,0.00013140804,0.000012957925,0.00041116052,0.0006053388,0.00036647252],"category_scores_gemma":[0.00008350255,0.00029167483,0.00013097117,0.00044372238,0.0004740309,0.00016647567,0.000101980535,0.00049113977,0.00017779731],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001439857,0.0007540494,0.038920004,0.00001527164,0.00030210847,0.000022102438,0.001965254,0.000023819975,0.9550701,0.00008851401,0.00066547253,0.00073348684],"study_design_scores_gemma":[0.007521106,0.002165352,0.15119763,0.00008833115,0.00009851647,0.000060276543,0.0006290937,0.0000075136168,0.835299,0.000073935786,0.0025177435,0.00034150903],"about_ca_topic_score_codex":0.0008993353,"about_ca_topic_score_gemma":0.00013349821,"teacher_disagreement_score":0.11977107,"about_ca_system_score_codex":0.00022371604,"about_ca_system_score_gemma":0.00031514917,"threshold_uncertainty_score":0.99995357},"labels":[],"label_agreement":null},{"id":"W1890562348","doi":"10.1080/2162402x.2014.1001232","title":"Mast cell/MDSC a liaison immunosuppressive for tumor microenvironment","year":2015,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Nautical Research Society","funders":"","keywords":"Tumor microenvironment; Myeloid-derived Suppressor Cell; Crosstalk; Cancer research; Immunosuppression; Suppressor; Medicine; Immunology; Cancer; Tumor cells","score_opus":0.019150018419893697,"score_gpt":0.24441366908194395,"score_spread":0.22526365066205026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1890562348","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.809644,0.14316759,0.0025996983,0.0017584594,0.016862903,0.0027576608,0.0003176666,0.00047512364,0.022416903],"genre_scores_gemma":[0.95370436,0.00041156117,0.0025523473,0.0009573236,0.00014808608,0.000804684,0.00044183354,0.00013935668,0.04084043],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974007,0.00027890867,0.00059792673,0.00065812387,0.000060459537,0.0010038689],"domain_scores_gemma":[0.9982788,0.00025006008,0.00036194656,0.00092727947,0.00013693114,0.00004501436],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00033114938,0.00043709765,0.0006548511,0.00016222878,0.0002441402,0.000024052464,0.0007904758,0.00048376626,0.00095526903],"category_scores_gemma":[0.00012527267,0.00042466825,0.00022936886,0.0001241986,0.0006931656,0.00013619044,0.00039825833,0.00057289505,0.0036533857],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012418902,0.00042944227,0.0006441211,0.000036267636,0.0002863881,0.000018898652,0.0013128505,0.00002669528,0.9200202,0.00028233865,0.07136878,0.0043321247],"study_design_scores_gemma":[0.005351062,0.0009113938,0.0007622334,0.000028433018,0.00007868442,0.00020120197,0.0013633452,0.0000030473382,0.38148943,0.00026593535,0.6091705,0.0003747382],"about_ca_topic_score_codex":0.00013681198,"about_ca_topic_score_gemma":0.000010039193,"teacher_disagreement_score":0.53853077,"about_ca_system_score_codex":0.00043623353,"about_ca_system_score_gemma":0.00026971978,"threshold_uncertainty_score":0.999958},"labels":[],"label_agreement":null},{"id":"W1899263436","doi":"10.1080/2162402x.2015.1021537","title":"Identification of characteristic TRB V usage in HBV-associated HCC by using differential expression profiling analysis","year":2015,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Hepatocellular carcinoma; Liver cancer; T-cell receptor; Antigen; Cancer; clone (Java method); Biology; Immune system; Cancer research; Immunology; T cell; Medicine; Gene; Genetics","score_opus":0.03060118265010576,"score_gpt":0.312870143548007,"score_spread":0.28226896089790127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1899263436","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977719,0.00077617634,0.00083507964,0.000065787804,0.00023701397,0.00020365282,0.000028779423,0.000022597722,0.000059019538],"genre_scores_gemma":[0.9992744,0.00007058188,0.000060418908,0.000024033436,0.000020351787,0.000013260659,0.00026289863,0.000012409543,0.000261675],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9987147,0.00015989534,0.0005540539,0.00021666905,0.00016423264,0.00019046161],"domain_scores_gemma":[0.999207,0.000037435548,0.00037067867,0.0002532412,0.000098332705,0.000033289216],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003628798,0.00011427004,0.0004882965,0.0003192486,0.000030692703,0.000009528445,0.00009358288,0.00017749428,0.00009550242],"category_scores_gemma":[0.00013110833,0.000103177495,0.00011583783,0.0005987357,0.00009807893,0.000068807814,0.000031677595,0.00014298921,0.0000036873491],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011451748,0.0002877467,0.05095821,0.000016517894,0.00035708322,0.000004507207,0.00041386692,0.0000039533443,0.9448192,0.000002245437,0.000031385767,0.001960085],"study_design_scores_gemma":[0.0064709997,0.00041084937,0.50885314,0.00018178191,0.000838683,0.000011803748,0.0007196285,0.004659045,0.47743058,0.00002612007,0.00016297154,0.00023442633],"about_ca_topic_score_codex":0.00041878244,"about_ca_topic_score_gemma":0.000030422947,"teacher_disagreement_score":0.46738863,"about_ca_system_score_codex":0.00029091473,"about_ca_system_score_gemma":0.000106966785,"threshold_uncertainty_score":0.4207456},"labels":[],"label_agreement":null},{"id":"W1962016368","doi":"10.1080/2162402x.2015.1085146","title":"PD-1 expression on dendritic cells suppresses CD8<sup>+</sup>T cell function and antitumor immunity","year":2015,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":181,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Lethbridge","keywords":"Granzyme B; Cytotoxic T cell; Adoptive cell transfer; CD8; Perforin; Cancer research; Granzyme; Dendritic cell; CD11c; Immune system; T cell; Immunology; Biology; In vitro; Phenotype","score_opus":0.022566461775047106,"score_gpt":0.26425986540270396,"score_spread":0.24169340362765684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1962016368","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98545253,0.005736531,0.00008021285,0.0005245144,0.00070038147,0.000335095,0.000014497189,0.00011171335,0.007044507],"genre_scores_gemma":[0.9955295,0.00085583446,0.00024783573,0.0007632352,0.00013280104,0.000029374673,0.000052688425,0.00003546143,0.0023532996],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99857044,0.0001923732,0.00031059107,0.0003519919,0.00020979643,0.0003648225],"domain_scores_gemma":[0.9989746,0.0001401891,0.000107342625,0.00054255006,0.000113976515,0.00012131498],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028648562,0.00024546846,0.00040269483,0.0001830569,0.00014890844,0.000029862937,0.00013509976,0.0002481672,0.0003306379],"category_scores_gemma":[0.00005933562,0.00020651451,0.0000897126,0.00016872295,0.00028595194,0.00013239236,0.00009260649,0.00040107607,0.00015101433],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009109458,0.0006699347,0.0030011053,0.00011993756,0.000113503615,0.0000670373,0.00086488837,0.000021146632,0.96898884,0.0000607351,0.010568068,0.006415325],"study_design_scores_gemma":[0.019948145,0.008937595,0.042086765,0.00055026513,0.00028882225,0.00043880244,0.005253101,0.00019056382,0.7480464,0.00043581723,0.17311476,0.00070897327],"about_ca_topic_score_codex":0.0002803741,"about_ca_topic_score_gemma":0.000007459559,"teacher_disagreement_score":0.22094247,"about_ca_system_score_codex":0.00014287248,"about_ca_system_score_gemma":0.00017791189,"threshold_uncertainty_score":0.84214175},"labels":[],"label_agreement":null},{"id":"W1968645192","doi":"10.4161/21624011.2014.946361","title":"The potential impact of mouse model selection in preclinical evaluation of cancer immunotherapy","year":2014,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Medicine; Immunotherapy; Cancer; Cancer research; Cancer immunotherapy; Human disease; Disease; Immunology; Pathology; Internal medicine","score_opus":0.030266896491353553,"score_gpt":0.41854889522530525,"score_spread":0.3882819987339517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968645192","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99675685,0.0025422098,0.0003245913,0.000042240972,0.000034115896,0.00017923213,0.000010793295,0.000002762375,0.000107181535],"genre_scores_gemma":[0.9977131,0.0019867264,0.000048145474,0.000005859285,0.000024703319,0.000066505556,0.000016017006,0.00001098714,0.00012794354],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99915606,0.00022581982,0.0002023948,0.00013335007,0.00013190029,0.00015048771],"domain_scores_gemma":[0.99951744,0.000019232224,0.00010776967,0.0001720012,0.00017051645,0.000013037699],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052677724,0.000066074484,0.00012299429,0.0000344376,0.000026533306,0.000003436311,0.00011769573,0.00010374649,0.00001379215],"category_scores_gemma":[0.00008965695,0.00004625799,0.00009357232,0.000059041475,0.00011086337,0.0000026146117,0.00003184725,0.00007264702,6.1514646e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010520804,0.00013069398,0.012338336,0.0000022823488,0.00021267381,2.8552128e-8,0.000021128646,0.020390393,0.90122014,0.000022468534,0.00004532049,0.06456448],"study_design_scores_gemma":[0.0091491565,0.0038368488,0.26484302,0.000018971585,0.00007042211,0.0000046739106,0.000030642783,0.13732612,0.5826859,0.0013633893,0.00048752886,0.0001833264],"about_ca_topic_score_codex":0.0025572858,"about_ca_topic_score_gemma":0.0023493608,"teacher_disagreement_score":0.3185342,"about_ca_system_score_codex":0.00007873399,"about_ca_system_score_gemma":0.00036194574,"threshold_uncertainty_score":0.38658682},"labels":[],"label_agreement":null},{"id":"W1968823017","doi":"10.4161/onci.28441","title":"Macrophages in the liver prevent metastasis by efficiently eliminating circulating tumor cells after monoclonal antibody immunotherapy","year":2014,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Monoclonal antibody; Immunotherapy; Metastasis; Antibody; Monoclonal antibody therapy; Immune system; Medicine; Cancer research; Immunology; Effector; Monoclonal; Cancer; Phagocytosis; Cancer immunotherapy; Internal medicine","score_opus":0.01103759606715744,"score_gpt":0.2993532819969469,"score_spread":0.28831568592978946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968823017","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9851918,0.010170808,0.00022536344,0.001617736,0.00015150552,0.00050331716,0.000033746088,0.000030879353,0.0020748351],"genre_scores_gemma":[0.9955202,0.00062496983,0.0010246168,0.0016125193,0.00012118019,0.00009530803,0.000071188,0.00003608534,0.0008939862],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99732006,0.00060511444,0.00049703143,0.0004306053,0.00046517432,0.0006820214],"domain_scores_gemma":[0.99868274,0.0005809851,0.00014209855,0.00044443694,0.00008794226,0.00006181623],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010900699,0.00028309468,0.00050480425,0.00018031003,0.00017769949,0.000045139044,0.0003733186,0.00011401149,0.0005739114],"category_scores_gemma":[0.000095674535,0.0001910073,0.00020485313,0.00031953768,0.00028982744,0.000068516194,0.00013635012,0.0006539428,0.00016751981],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012026852,0.0012920434,0.009629998,0.0002114434,0.0002899857,0.0007116509,0.0030582943,0.00003571314,0.8620595,0.000518219,0.0008202734,0.1201702],"study_design_scores_gemma":[0.008107223,0.0048097284,0.65813804,0.0007030564,0.0002729191,0.0025098857,0.0024482023,0.011102744,0.13665204,0.0004133081,0.1734626,0.0013802492],"about_ca_topic_score_codex":0.000542322,"about_ca_topic_score_gemma":0.000017452232,"teacher_disagreement_score":0.7254075,"about_ca_system_score_codex":0.00008472758,"about_ca_system_score_gemma":0.00006847492,"threshold_uncertainty_score":0.7789052},"labels":[],"label_agreement":null},{"id":"W1971136482","doi":"10.4161/onci.21205","title":"Targeting the MHC Class II antigen presentation pathway in cancer immunotherapy","year":2012,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":161,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Institute for Research in Immunology and Cancer; Hôpital Notre-Dame; Université de Montréal","funders":"Canadian Institutes of Health Research","keywords":"Immunotherapy; Immune system; Cancer immunotherapy; MHC class I; Immunology; Antigen presentation; Major histocompatibility complex; Cancer; Medicine; Antigen processing; Antigen; Cancer research; T cell; Internal medicine","score_opus":0.018448110644944202,"score_gpt":0.2858585649095042,"score_spread":0.26741045426455995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971136482","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8246865,0.16931309,0.000062960156,0.0015839724,0.0027973736,0.0004743334,0.000013109274,0.00015122935,0.00091737934],"genre_scores_gemma":[0.98622996,0.0076770205,0.000030186064,0.00076290977,0.00011579933,0.00026516375,0.00007291708,0.00007277497,0.004773281],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969192,0.0009938701,0.00062900694,0.00031101913,0.000062761355,0.0010841402],"domain_scores_gemma":[0.9986384,0.00042644376,0.00028237948,0.00056671415,0.000071208175,0.00001484234],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010089283,0.00033721395,0.00045940705,0.00022248727,0.0005986452,0.000021597198,0.0006102271,0.0004813943,0.0013886053],"category_scores_gemma":[0.00010922714,0.0002461721,0.00015164919,0.0003890733,0.0005226617,0.00038128562,0.00018852821,0.0007884476,0.00032488414],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00095235737,0.00039597214,0.017755572,0.0000058299815,0.00032270537,0.0000020102327,0.0071703573,0.000022024176,0.9304379,0.0011501736,0.0016957398,0.040089354],"study_design_scores_gemma":[0.0024911445,0.00027733104,0.10458852,0.000037117567,0.000011370079,0.00006819191,0.0019357547,0.0000048211814,0.18854037,0.00008548143,0.70161253,0.00034736868],"about_ca_topic_score_codex":0.0013820421,"about_ca_topic_score_gemma":0.00005481609,"teacher_disagreement_score":0.7418975,"about_ca_system_score_codex":0.00017194393,"about_ca_system_score_gemma":0.00016598175,"threshold_uncertainty_score":0.99999905},"labels":[],"label_agreement":null},{"id":"W1971374789","doi":"10.4161/onci.20735","title":"Stromal CEACAM1 expression regulates colorectal cancer metastasis","year":2012,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Peptidase Inhibition and Analysis","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Occupational Cancer Research Centre; McGill University Health Centre","funders":"","keywords":"Stromal cell; Colorectal cancer; Metastasis; Medicine; Cancer research; Chemokine; Infiltration (HVAC); Adoptive cell transfer; Immune system; Bone marrow; Pathology; Cancer; T cell; Immunology; Internal medicine","score_opus":0.019980594437794104,"score_gpt":0.3082504443025227,"score_spread":0.2882698498647286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971374789","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99300647,0.0022004147,0.000035841567,0.0010333837,0.000118664975,0.00009252268,0.000019655274,0.00009015955,0.003402878],"genre_scores_gemma":[0.9963082,0.00011401504,0.00082260394,0.00033004742,0.00023488096,0.000042654712,0.00006874409,0.000017093935,0.0020617277],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990385,0.00007943529,0.00020703695,0.0001689918,0.00013437713,0.0003716704],"domain_scores_gemma":[0.9995049,0.000041293104,0.00008685166,0.00019122778,0.000059614787,0.000116092415],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00012568217,0.0001340492,0.00032956785,0.00014392422,0.00008853055,0.0000067746623,0.000060125443,0.0001432303,0.003813137],"category_scores_gemma":[0.00004829664,0.00010672338,0.00015603284,0.00017932814,0.00012560304,0.0001233105,0.000056471672,0.00019819936,0.00020254072],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019512256,0.00027652903,0.03505345,0.000015285115,0.00020683682,0.000013201027,0.0002732957,0.0000011512635,0.9539961,0.00032336527,0.002725148,0.006920492],"study_design_scores_gemma":[0.0015157056,0.00023512995,0.25840193,0.00020427619,0.0002588701,0.00018727042,0.000549551,0.00003120488,0.7144666,0.000041013398,0.023914149,0.0001943316],"about_ca_topic_score_codex":0.00008377996,"about_ca_topic_score_gemma":0.000008418059,"teacher_disagreement_score":0.23952956,"about_ca_system_score_codex":0.00009926818,"about_ca_system_score_gemma":0.00005419897,"threshold_uncertainty_score":0.9970975},"labels":[],"label_agreement":null},{"id":"W1972406166","doi":"10.4161/onci.27156","title":"An allogeneic NK cell line engineered to express chimeric antigen receptors","year":2013,"lang":"en","type":"article","venue":"OncoImmunology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research; Labex Immuno-Oncology; Institut National Du Cancer; Ligue Contre le Cancer; Agence Nationale de la Recherche","keywords":"Cytotoxic T cell; Chimeric antigen receptor; Antigen; Interleukin 21; NK-92; Biology; Antibody; Antibody-dependent cell-mediated cytotoxicity; Adoptive cell transfer; Immunology; Natural killer T cell; Immunotherapy; Cancer research; T cell; Monoclonal antibody; Immune system; CD8; In vitro","score_opus":0.019229888736515183,"score_gpt":0.29912613956505857,"score_spread":0.2798962508285434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972406166","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902543,0.0014437936,0.00034080783,0.0014877439,0.000501277,0.0009762394,0.000004683691,0.00018225868,0.004808906],"genre_scores_gemma":[0.96759254,0.00092753005,0.004300886,0.0010406718,0.00039377136,0.00021773537,0.000107982705,0.00010429723,0.025314609],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981476,0.00014635644,0.0003209213,0.00046470008,0.00024050864,0.0006799087],"domain_scores_gemma":[0.99846256,0.00007787259,0.000053956875,0.00096049934,0.00015772217,0.00028737372],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00020172998,0.0002465083,0.00048689847,0.00032340435,0.000069574155,0.000026916396,0.00039244955,0.00025459132,0.018964006],"category_scores_gemma":[0.00005814652,0.00022265481,0.00010518918,0.00042291151,0.00011547064,0.00009854436,0.0001154558,0.00041178227,0.0023307533],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019812396,0.00030821958,0.001612153,0.000020953283,0.000088550805,0.000019055371,0.0005558314,0.000034936988,0.94113696,0.000008708781,0.003298184,0.05271833],"study_design_scores_gemma":[0.0027199571,0.0044209664,0.04387355,0.000042566633,0.000036346202,0.00010592069,0.00043256115,0.0002761055,0.6132514,0.00003724426,0.33434367,0.00045971043],"about_ca_topic_score_codex":0.0007395365,"about_ca_topic_score_gemma":0.000011594039,"teacher_disagreement_score":0.3310455,"about_ca_system_score_codex":0.00013001445,"about_ca_system_score_gemma":0.00012502073,"threshold_uncertainty_score":0.99844605},"labels":[],"label_agreement":null},{"id":"W1972729597","doi":"10.4161/onci.19534","title":"Combined vaccination and immunostimulatory antibodies provides durable cure of murine melanoma and induces transcriptional changes associated with positive outcome in human melanoma patients","year":2012,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Canadian Institutes of Health Research; Terry Fox Foundation; McMaster University","keywords":"Melanoma; Immune system; Vaccination; Medicine; Immunotherapy; Tumor microenvironment; Immunology; Antibody; Cancer research; Cytokine; Immunity","score_opus":0.014010005627188704,"score_gpt":0.24953616600434272,"score_spread":0.23552616037715401,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972729597","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9801889,0.01861855,0.0000026230407,0.00022430219,0.00022518306,0.00045845975,0.00006067764,0.000036139867,0.00018518457],"genre_scores_gemma":[0.9985682,0.000499268,0.0000191707,0.000058835223,0.0000071186932,0.000038013757,0.0003253332,0.000026146674,0.00045792066],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99824923,0.0005232428,0.0004593208,0.0002548607,0.000055897835,0.00045743943],"domain_scores_gemma":[0.9989963,0.0003465938,0.00032372176,0.00017767466,0.00013966885,0.000016027749],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039189964,0.0002900469,0.00062153395,0.00035946342,0.0002441322,0.000012201761,0.00013978743,0.00038399926,0.00011403896],"category_scores_gemma":[0.00010223403,0.00024382131,0.00004199264,0.0001615988,0.00042311876,0.00033886373,0.0000725687,0.0003521845,0.0000043905056],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014084011,0.0006243617,0.5574852,0.000031840405,0.0004323753,0.0000016157587,0.0026222803,3.989956e-7,0.43440515,0.0009643013,0.000008018214,0.0020160617],"study_design_scores_gemma":[0.00658879,0.0022711926,0.93807435,0.00012226029,0.00006539689,0.000026548114,0.00058568025,7.2827703e-7,0.05171414,0.0000641402,0.00023326045,0.00025349413],"about_ca_topic_score_codex":0.00030349963,"about_ca_topic_score_gemma":0.00009939639,"teacher_disagreement_score":0.382691,"about_ca_system_score_codex":0.00007749999,"about_ca_system_score_gemma":0.000037441412,"threshold_uncertainty_score":0.9942745},"labels":[],"label_agreement":null},{"id":"W1973832362","doi":"10.4161/onci.27384","title":"Immunopathogenesis of paraneoplastic neurological syndromes associated with anti-Hu antibodies","year":2013,"lang":"en","type":"review","venue":"OncoImmunology","topic":"Autoimmune Neurological Disorders and Treatments","field":"Medicine","cited_by":91,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Nautical Research Society","funders":"Conseil Régional Midi-Pyrénées; Institut National de la Santé et de la Recherche Médicale","keywords":"Medicine; Immune system; Cancer; Antibody; Immunology; Central nervous system; Immunotherapy; Antigen; Nervous system; Paraneoplastic cerebellar degeneration; Neuroscience; Cancer research; Autoantibody; Biology; Internal medicine","score_opus":0.05387051741663455,"score_gpt":0.31133909519088276,"score_spread":0.2574685777742482,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973832362","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.059535753,0.9378884,0.0000060284174,0.000044753477,0.00020330271,0.0013274099,0.00006668391,0.00014742535,0.00078028406],"genre_scores_gemma":[0.021104096,0.97734135,0.000085963045,0.00006911067,0.000013592835,0.00022740227,0.00043757402,0.00009362507,0.0006272753],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966077,0.00053956365,0.0011157192,0.00077197066,0.00028899388,0.0006760615],"domain_scores_gemma":[0.9970299,0.00092994707,0.0010308191,0.00077779527,0.00015384621,0.00007766377],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00013010149,0.00085213414,0.0059274402,0.00032453117,0.000118827506,0.000015956868,0.000336678,0.0010757493,0.00036041657],"category_scores_gemma":[0.00048591234,0.00049295573,0.0007567212,0.0005047776,0.0007756964,0.0000519768,0.00021638264,0.00081202696,0.00025570986],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036071305,0.0041328412,0.010596599,0.007519177,0.007188222,0.0040293825,0.00004703487,0.000003022389,0.00009156722,0.00014919224,0.00015838126,0.9657239],"study_design_scores_gemma":[0.008538634,0.03402942,0.36186063,0.022087889,0.024124607,0.011486412,0.00004814776,0.0000239868,0.000011618043,0.00015500066,0.5354128,0.0022208383],"about_ca_topic_score_codex":0.00003136349,"about_ca_topic_score_gemma":0.0000017580498,"teacher_disagreement_score":0.963503,"about_ca_system_score_codex":0.0000533335,"about_ca_system_score_gemma":0.00029587824,"threshold_uncertainty_score":0.9997522},"labels":[],"label_agreement":null},{"id":"W1973901905","doi":"10.4161/onci.26013","title":"Oncolytic vesicular stomatitis virus quantitatively and qualitatively improves primary CD8<sup>+</sup>T-cell responses to anticancer vaccines","year":2013,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; McMaster University Medical Centre; University of Guelph","funders":"Canadian Institutes of Health Research","keywords":"Vesicular stomatitis virus; Cytotoxic T cell; Adoptive cell transfer; CD8; Immunology; Biology; Priming (agriculture); Virology; Granzyme; Granzyme B; T cell; Vaccination; Viral vector; Immune system; Virus; Perforin; Recombinant DNA; In vitro","score_opus":0.017907814448584348,"score_gpt":0.31237317765651385,"score_spread":0.2944653632079295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973901905","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904942,0.006025329,0.0002739846,0.001334566,0.00008014087,0.0008692391,0.00005840493,0.000043354587,0.0008208002],"genre_scores_gemma":[0.989689,0.0015420677,0.0031145292,0.001830971,0.00011630385,0.00036494798,0.00006016075,0.00008074629,0.0032012917],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99716556,0.0007563956,0.0004323193,0.0007423314,0.00023902941,0.0006643743],"domain_scores_gemma":[0.9984921,0.00026857,0.00013887743,0.00061823905,0.00030770214,0.00017446511],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005430731,0.00036549216,0.00047915822,0.00022780958,0.00019341116,0.00007777015,0.00043870558,0.0002696521,0.00015813393],"category_scores_gemma":[0.0003650771,0.00034410186,0.00010295659,0.00026363862,0.00034231614,0.000027953067,0.00035044376,0.00023579162,0.00032521374],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023325572,0.00017212954,0.0005767457,0.000053650656,0.00018236476,0.000011327538,0.00096598774,0.000022219388,0.97917455,0.000070775146,0.0023718635,0.014065829],"study_design_scores_gemma":[0.0041557727,0.021979779,0.0774358,0.000072744246,0.000062923835,0.00006263521,0.0027421904,0.00021249801,0.8649091,0.0005666984,0.026646473,0.001153369],"about_ca_topic_score_codex":0.00050113344,"about_ca_topic_score_gemma":0.0001385493,"teacher_disagreement_score":0.11426543,"about_ca_system_score_codex":0.00009021556,"about_ca_system_score_gemma":0.00038600975,"threshold_uncertainty_score":0.9999011},"labels":[],"label_agreement":null},{"id":"W1976716096","doi":"10.4161/onci.26618","title":"Preventing surgery-induced NK cell dysfunction and cancer metastases with influenza vaccination","year":2013,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Cancer, Stress, Anesthesia, and Immune Response","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"","keywords":"Medicine; Vaccination; Cancer; Immunology; Immunotherapy; Cancer research; Cell; Natural killer cell; Immune system; Internal medicine; Cytotoxic T cell; Biology; In vitro","score_opus":0.020681078058053238,"score_gpt":0.2711012058860209,"score_spread":0.25042012782796763,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976716096","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9871281,0.010920219,0.000026606385,0.00057673786,0.00021004996,0.00042168912,0.000002086088,0.00006625539,0.00064830366],"genre_scores_gemma":[0.9958629,0.0018416849,0.000116460724,0.0003618492,0.00014489685,0.00020436783,0.000018898878,0.000030483614,0.0014184357],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9989231,0.00013254462,0.0002730299,0.0002632768,0.00012345743,0.00028456267],"domain_scores_gemma":[0.9991349,0.00021400281,0.00019276609,0.00025050982,0.00015684342,0.000050986666],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018962854,0.00017532869,0.0004044519,0.00019701343,0.00011362484,0.000029797608,0.000046385187,0.00012250978,0.00064640614],"category_scores_gemma":[0.000082244595,0.00013973108,0.000061987455,0.00018636229,0.000053379525,0.00023531685,0.00002813126,0.0001907624,0.000042264135],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026639958,0.00039406793,0.11026625,0.00046645664,0.0004312927,0.00003809555,0.0008757947,0.000011585796,0.20123829,0.000039396844,0.002857922,0.6807169],"study_design_scores_gemma":[0.0033897667,0.00095150736,0.89526093,0.0002815115,0.0003428198,0.0003929468,0.00092763855,0.00007877346,0.051348,0.000030107922,0.046671398,0.00032457343],"about_ca_topic_score_codex":0.002668507,"about_ca_topic_score_gemma":0.00010583816,"teacher_disagreement_score":0.7849947,"about_ca_system_score_codex":0.00010952077,"about_ca_system_score_gemma":0.00022647581,"threshold_uncertainty_score":0.7077694},"labels":[],"label_agreement":null},{"id":"W1977957999","doi":"10.4161/onci.20696","title":"Trial Watch","year":2012,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Immune Response and Inflammation","field":"Immunology and Microbiology","cited_by":192,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research; Institut National Du Cancer; American Society of Clinical Oncology","keywords":"Innate immune system; Immune system; TLR2; Toll-like receptor; Pattern recognition receptor; TLR4; Immunology; Biology; Acquired immune system; TLR7; TLR3; Medicine; Cancer research","score_opus":0.016659581501656043,"score_gpt":0.25980436783370914,"score_spread":0.2431447863320531,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977957999","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9688093,0.0072712675,0.000100993944,0.00090011786,0.0047887685,0.00028686022,0.0000017394051,0.00014685474,0.017694103],"genre_scores_gemma":[0.9850359,0.0001317831,0.000050826595,0.00016262999,0.00015769848,0.00006023527,0.00008477236,0.00001632016,0.014299812],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985914,0.00035104196,0.00030736384,0.00014121884,0.000023440263,0.00058552664],"domain_scores_gemma":[0.99934435,0.00014938726,0.00010602725,0.00034761892,0.00003810223,0.0000145402755],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00046012923,0.00014699336,0.0002540487,0.00007916349,0.00016320038,0.000006968587,0.00019883507,0.00038130314,0.0025628188],"category_scores_gemma":[0.00013381579,0.00012745324,0.00009956503,0.00011114306,0.00016978136,0.00023319115,0.000085439424,0.00029900655,0.011182051],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024080902,0.0004273512,0.0011792104,0.000005892608,0.00027567687,0.0000020622613,0.0013601638,3.1782886e-7,0.90397817,0.013034016,0.015377298,0.04027891],"study_design_scores_gemma":[0.02255705,0.00042291067,0.005267748,0.000005691449,0.000029858873,0.0001271461,0.0002082935,1.9836662e-7,0.18113546,0.000103160644,0.7899635,0.00017899385],"about_ca_topic_score_codex":0.00004728949,"about_ca_topic_score_gemma":0.0000016388483,"teacher_disagreement_score":0.7745862,"about_ca_system_score_codex":0.000054051307,"about_ca_system_score_gemma":0.000048409336,"threshold_uncertainty_score":0.99834895},"labels":[],"label_agreement":null},{"id":"W1978074643","doi":"10.4161/onci.28541","title":"Smac mimetics combined with innate immune stimuli create the perfect cytokine storm to kill tumor cells","year":2014,"lang":"en","type":"article","venue":"OncoImmunology","topic":"RNA Interference and Gene Delivery","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Children's Hospital of Eastern Ontario","funders":"","keywords":"Innate immune system; Immunotherapy; Immune system; Cytokine storm; Cytokine; Medicine; Immunology; Cancer research; Neuroscience; Biology; Disease; Internal medicine","score_opus":0.00722489540134074,"score_gpt":0.22468664850088546,"score_spread":0.2174617530995447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978074643","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954474,0.00048215294,0.000747868,0.00068148796,0.00037979629,0.00029462378,0.00003423558,0.000027253727,0.0019051937],"genre_scores_gemma":[0.996013,0.000120141456,0.000375473,0.0014468067,0.0001365114,0.000046712496,0.000129232,0.000040839153,0.0016913094],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99855137,0.0001807088,0.00028297745,0.00042976503,0.00011456725,0.00044058345],"domain_scores_gemma":[0.9987358,0.00004934165,0.00012576501,0.0008456517,0.00017442994,0.00006905037],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028165468,0.00028193757,0.0003330696,0.000069531816,0.00016347373,0.000033287706,0.00057916075,0.0001498029,0.000057211902],"category_scores_gemma":[0.00007470116,0.00018898112,0.000100046185,0.0001463451,0.0002295868,0.0000045893576,0.0002737403,0.0002244602,0.0002193636],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010107225,0.00008597057,0.0009576627,0.0000075199127,0.00017279189,0.00000949054,0.00015565779,0.00022223989,0.99290353,0.000093043214,0.0013981883,0.0029831822],"study_design_scores_gemma":[0.0016645138,0.009296279,0.01787868,0.000030140465,0.00007433906,0.00006440782,0.0001908909,0.00012150402,0.87110823,0.00004115426,0.09910145,0.00042839127],"about_ca_topic_score_codex":0.00025270897,"about_ca_topic_score_gemma":0.00020802344,"teacher_disagreement_score":0.121795274,"about_ca_system_score_codex":0.000027245705,"about_ca_system_score_gemma":0.00007425148,"threshold_uncertainty_score":0.77064264},"labels":[],"label_agreement":null},{"id":"W1978261324","doi":"10.4161/21624011.2014.958952","title":"Co-blockade of immune checkpoints and adenosine A<sub>2A</sub>receptor suppresses metastasis","year":2014,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"National Evidence-based Healthcare Collaborating Agency","keywords":"Blockade; Immune checkpoint; Immune system; Tumor microenvironment; Cancer research; CD8; Adenosine; Immunotherapy; Metastasis; Medicine; T cell; Receptor; CTLA-4; Immunology; Cancer; Internal medicine","score_opus":0.006129508302185307,"score_gpt":0.23196646970393464,"score_spread":0.22583696140174933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978261324","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98134506,0.016504075,0.00068843254,0.0003361783,0.00017210683,0.00011587402,0.000034844994,0.00001862634,0.0007848278],"genre_scores_gemma":[0.99725306,0.0013839237,0.00056701363,0.000102527265,0.00020528531,0.000018359027,0.0001999026,0.000033796256,0.00023616129],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986593,0.00015405074,0.00040075654,0.0003695095,0.00010278053,0.00031358318],"domain_scores_gemma":[0.99914783,0.00005987381,0.00020863059,0.00043008072,0.000096756296,0.000056814708],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025368074,0.000226305,0.0004040014,0.00008356567,0.000080685124,0.000012084508,0.00024261544,0.000257485,0.00009965243],"category_scores_gemma":[0.0001885792,0.00021485156,0.000112584275,0.0000953182,0.000293841,0.000006825681,0.00014447657,0.00014535853,0.000025410623],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015599001,0.000088641056,0.00095996633,0.00003807338,0.0001965098,0.00000161057,0.000060389168,0.000010728791,0.9907011,0.00013149912,0.0041301544,0.003525338],"study_design_scores_gemma":[0.0009613152,0.0005722508,0.003176884,0.000022682221,0.000059498645,0.000045964676,0.00008173451,0.000010674009,0.9538775,0.00006110016,0.040914748,0.00021565366],"about_ca_topic_score_codex":0.000049694903,"about_ca_topic_score_gemma":0.0000036293175,"teacher_disagreement_score":0.036823604,"about_ca_system_score_codex":0.000008385753,"about_ca_system_score_gemma":0.00004803,"threshold_uncertainty_score":0.8761393},"labels":[],"label_agreement":null},{"id":"W1984152314","doi":"10.4161/onci.21424","title":"Surviving host innate immunity","year":2012,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Autocrine signalling; Crosstalk; Tumor necrosis factor alpha; Innate immune system; Cancer research; Apoptosis; Immunology; Biology; Medicine; Immune system; Receptor; Internal medicine","score_opus":0.033818690060529004,"score_gpt":0.3090216571003404,"score_spread":0.2752029670398114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984152314","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9522538,0.0012895999,0.00016246962,0.0006848297,0.0010801723,0.00009734435,0.0000047733683,0.00010456958,0.044322398],"genre_scores_gemma":[0.99767023,0.00008336301,0.00030959112,0.00039146727,0.00024233962,0.000011475524,0.00002583687,0.00001868797,0.0012470111],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9992369,0.00007187078,0.00018877794,0.00009793644,0.000073316114,0.00033123107],"domain_scores_gemma":[0.99938756,0.00009770578,0.0000636425,0.00031735728,0.0000657782,0.000067973735],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00025248507,0.0001032514,0.00022139763,0.00011186127,0.00011585972,0.0000075264625,0.000072722134,0.0001011466,0.0012832398],"category_scores_gemma":[0.00018075747,0.00009081837,0.000083967905,0.0001458833,0.00007620228,0.0001273029,0.00007241695,0.00038940075,0.0005319708],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010968009,0.00045959195,0.068091646,0.000017170685,0.00014517098,0.000009768,0.000996243,4.053357e-7,0.9197848,0.0023995282,0.0011263733,0.0068596476],"study_design_scores_gemma":[0.0009452591,0.0004002938,0.65980715,0.000076316435,0.00007550874,0.00067784707,0.0006348261,0.000021187709,0.06529852,0.000036894224,0.27184552,0.00018069375],"about_ca_topic_score_codex":0.00040247862,"about_ca_topic_score_gemma":0.000014146801,"teacher_disagreement_score":0.8544862,"about_ca_system_score_codex":0.000081358456,"about_ca_system_score_gemma":0.00005218854,"threshold_uncertainty_score":0.99962974},"labels":[],"label_agreement":null},{"id":"W1984454936","doi":"10.4161/onci.1.2.18231","title":"Anti-leukemia activity of human gamma delta T cells","year":2012,"lang":"en","type":"article","venue":"OncoImmunology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials; University of Toronto; Western University","funders":"","keywords":"Leukemia; Chronic lymphocytic leukemia; Cancer research; Adoptive cell transfer; Medicine; Immunology; T cell; Immune system","score_opus":0.040782841344297514,"score_gpt":0.3459616183447385,"score_spread":0.305178777000441,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984454936","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97364604,0.00073190965,0.000027732185,0.00016523368,0.0002799604,0.0002579389,0.0000063371576,0.00004679775,0.024838071],"genre_scores_gemma":[0.99001634,0.0001871799,0.00013502927,0.000067145906,0.00019247936,0.000013069412,0.000013953824,0.000032820277,0.009341995],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986719,0.0001420346,0.00022560456,0.00018904076,0.0002218876,0.0005495208],"domain_scores_gemma":[0.9989552,0.00011430894,0.000104616054,0.0006228285,0.00009827424,0.00010479808],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00041160965,0.00014459982,0.0005053406,0.00017494176,0.00006207512,0.0000042723464,0.00017546098,0.00023770983,0.004876762],"category_scores_gemma":[0.000043174765,0.00013175062,0.0001278641,0.00020495088,0.00032386306,0.000089548426,0.00013076644,0.00044612866,0.00019512585],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002425633,0.0003161167,0.016559305,0.000047809364,0.00013682613,0.000012795913,0.00034673847,3.7524723e-7,0.9518203,0.00024272787,0.00064750545,0.029626919],"study_design_scores_gemma":[0.0015176068,0.000616768,0.16543971,0.000026011947,0.00004315063,0.00007938955,0.00008195684,0.000007508131,0.80476505,0.000028780569,0.02728456,0.00010950679],"about_ca_topic_score_codex":0.00051576487,"about_ca_topic_score_gemma":0.000017358478,"teacher_disagreement_score":0.1488804,"about_ca_system_score_codex":0.00029015998,"about_ca_system_score_gemma":0.00017846338,"threshold_uncertainty_score":0.9960329},"labels":[],"label_agreement":null},{"id":"W1986380014","doi":"10.4161/onci.20499","title":"Hunting for clues","year":2012,"lang":"en","type":"article","venue":"OncoImmunology","topic":"T-cell and B-cell Immunology","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Medicine; Biology","score_opus":0.020343398721294103,"score_gpt":0.2591857794699303,"score_spread":0.23884238074863623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986380014","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9383102,0.035562422,0.0009883972,0.0008375316,0.0077843782,0.00058611465,0.00003565607,0.0004263396,0.015468965],"genre_scores_gemma":[0.9841997,0.00018072464,0.00073954655,0.00044272855,0.00022331558,0.00015828777,0.0001900116,0.00004762646,0.013818077],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976599,0.00021763326,0.00045425806,0.00035064953,0.000024501162,0.0012930341],"domain_scores_gemma":[0.99872625,0.00045266483,0.00020655985,0.00049166795,0.00009469899,0.000028153672],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00048071507,0.00030000065,0.0005140103,0.00017883957,0.0004467812,0.000012776886,0.00043265225,0.0006907932,0.0011587681],"category_scores_gemma":[0.00018206856,0.00027318552,0.0002106739,0.0001442481,0.0004839491,0.0002143015,0.0002041822,0.00044592508,0.0033386599],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018366847,0.0002963412,0.0061117047,0.000016240936,0.00028611466,9.146237e-7,0.00056835805,4.1317196e-7,0.9585889,0.012780325,0.005448652,0.01571839],"study_design_scores_gemma":[0.0019227412,0.00032874267,0.003159587,0.0000124929,0.00007008003,0.00020376816,0.0005620049,0.0000010155555,0.3386603,0.00049865386,0.65426487,0.00031577214],"about_ca_topic_score_codex":0.00011436075,"about_ca_topic_score_gemma":0.000014861122,"teacher_disagreement_score":0.6488162,"about_ca_system_score_codex":0.00006861507,"about_ca_system_score_gemma":0.000058354104,"threshold_uncertainty_score":0.99997205},"labels":[],"label_agreement":null},{"id":"W1987682745","doi":"10.4161/onci.26384","title":"Crucial role of inflammatory monocytes in antitumor immunity","year":2013,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Nautical Research Society","funders":"","keywords":"Myeloid cells; Inflammation; Cancer research; Immunity; Immunology; Myeloid; Carcinogenesis; Monocyte; Immune system; Myeloid-derived Suppressor Cell; Macrophage; Medicine; Biology; Cancer; In vitro; Suppressor","score_opus":0.005448230770923328,"score_gpt":0.21340089871955212,"score_spread":0.2079526679486288,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987682745","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9674824,0.020732792,0.000005679961,0.000089533,0.0010796323,0.0003604307,0.0000065606073,0.00006271441,0.010180288],"genre_scores_gemma":[0.997786,0.00046233248,0.00011983082,0.00006748594,0.000021368272,0.000109599016,0.000030467552,0.000026908414,0.0013760322],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99813896,0.00036860094,0.0006507913,0.00027523687,0.00003348726,0.00053289614],"domain_scores_gemma":[0.99876773,0.00020973705,0.00025926725,0.000629836,0.00012198743,0.000011441923],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00022669359,0.00022775984,0.0005514241,0.00029784016,0.00008813204,0.00000813548,0.000602945,0.00047409185,0.0033300226],"category_scores_gemma":[0.00012634031,0.00022700547,0.000106364576,0.00021537924,0.0007571517,0.00019740213,0.00031168654,0.0006632552,0.002096006],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012328116,0.00017841256,0.036302656,0.000018645722,0.00010811217,0.0000031864572,0.00080895773,0.000007509338,0.94118106,0.0011066739,0.0005147903,0.019646691],"study_design_scores_gemma":[0.0022146152,0.0002586898,0.41240397,0.0000651366,0.000018050485,0.000060729428,0.0017966649,0.000005641967,0.55429345,0.0019789254,0.026591802,0.0003123108],"about_ca_topic_score_codex":0.0034210978,"about_ca_topic_score_gemma":0.00015055585,"teacher_disagreement_score":0.3868876,"about_ca_system_score_codex":0.00012016573,"about_ca_system_score_gemma":0.00017153777,"threshold_uncertainty_score":0.99868095},"labels":[],"label_agreement":null},{"id":"W1988726471","doi":"10.4161/onci.1.2.18458","title":"FIST, a sword and shield fusokine for cancer immunotherapy","year":2012,"lang":"en","type":"article","venue":"OncoImmunology","topic":"TGF-β signaling in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Occupational Cancer Research Centre","funders":"","keywords":"Fist; Ectodomain; Cancer research; Immunotherapy; Cancer immunotherapy; Angiogenesis; Immune system; Medicine; Receptor; Fusion protein; Immunology; Biology; Internal medicine; Recombinant DNA; Gene","score_opus":0.014381532727476675,"score_gpt":0.2964366606507601,"score_spread":0.2820551279232834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988726471","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9437261,0.053920347,0.0011027228,0.00030761224,0.00039429805,0.00020237887,0.000030518135,0.000031170435,0.0002848078],"genre_scores_gemma":[0.9957009,0.0009814278,0.0009433532,0.0006218389,0.00045526435,0.00021074178,0.00006648006,0.00004461191,0.0009753673],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992362,0.0000355187,0.00014785898,0.00020492302,0.000040219882,0.0003352522],"domain_scores_gemma":[0.9995481,0.0000339076,0.00006644593,0.00026366353,0.000037546466,0.000050374856],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010912808,0.00013692565,0.000153538,0.000031277275,0.00007114709,0.000010053262,0.00013881143,0.00017772726,0.000062354455],"category_scores_gemma":[0.000053054664,0.00013058435,0.00006144534,0.000035225177,0.000121372585,0.0000045053885,0.00006938264,0.00006354532,0.0000044493718],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047939023,0.00013612157,0.015385802,0.000023658778,0.0001975924,4.674612e-7,0.00021862931,0.00000332632,0.95049065,0.0002675416,0.0024288057,0.030368019],"study_design_scores_gemma":[0.0012318005,0.00031476124,0.023985494,0.000013909577,0.000028613853,0.00001672046,0.00007902293,0.0000050651115,0.18820156,0.00007997478,0.7858049,0.00023816679],"about_ca_topic_score_codex":0.000041783638,"about_ca_topic_score_gemma":0.00003090438,"teacher_disagreement_score":0.7833761,"about_ca_system_score_codex":0.000014806002,"about_ca_system_score_gemma":0.000059185077,"threshold_uncertainty_score":0.5325075},"labels":[],"label_agreement":null},{"id":"W1990584931","doi":"10.4161/onci.20238","title":"Turning the tumor microenvironment into a self vaccine site","year":2012,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Bentley (Canada)","funders":"","keywords":"Tumor microenvironment; Infiltration (HVAC); Effector; Innate immune system; Medicine; Cancer research; Tumor cells; Immunology; Immune system","score_opus":0.005435569502497045,"score_gpt":0.21868467715843848,"score_spread":0.21324910765594143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990584931","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91165537,0.0805289,0.00008251428,0.0011166098,0.0038692248,0.0003211228,0.000005310518,0.00016796174,0.0022529815],"genre_scores_gemma":[0.9928124,0.00059756724,0.0004390139,0.0015224434,0.00015031424,0.00010521062,0.000053795964,0.000047664074,0.004271581],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99788177,0.00044143345,0.00040679958,0.00030859042,0.00004084402,0.00092055224],"domain_scores_gemma":[0.9986205,0.00030048538,0.00022039542,0.00080818345,0.000028236134,0.000022187343],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00046016177,0.00030014862,0.00037756393,0.00009022571,0.0004489433,0.000012833475,0.0005544749,0.0002722894,0.0025116364],"category_scores_gemma":[0.0000637565,0.00021503713,0.0001313813,0.00014610744,0.0002945233,0.0001434013,0.0004689075,0.0008128197,0.008813277],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014234401,0.00025966257,0.01988423,0.000014660039,0.00039672284,0.000004981626,0.0055960924,0.000005104311,0.9574072,0.00034481936,0.010388699,0.0055555063],"study_design_scores_gemma":[0.0013202854,0.00017117542,0.06321849,0.000019074314,0.00009892329,0.0005377806,0.00065341237,0.0000011155435,0.11355589,0.0000583205,0.82009465,0.00027087264],"about_ca_topic_score_codex":0.00018404862,"about_ca_topic_score_gemma":0.000019109342,"teacher_disagreement_score":0.84385127,"about_ca_system_score_codex":0.00028530994,"about_ca_system_score_gemma":0.00005110521,"threshold_uncertainty_score":0.9984002},"labels":[],"label_agreement":null},{"id":"W1996126071","doi":"10.4161/onci.21175","title":"A new dynamic model of three cell interactions for CTL responses","year":2012,"lang":"en","type":"article","venue":"OncoImmunology","topic":"T-cell and B-cell Immunology","field":"Immunology and Microbiology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saskatoon Medical Imaging; Saskatchewan Cancer Agency","funders":"","keywords":"Cytotoxic T cell; Priming (agriculture); CTL*; CD8; T cell; Cell biology; Dendritic cell; Immunology; Cd4 t cell; Antigen-presenting cell; Biology; Chemistry; Immune system; In vitro; Genetics","score_opus":0.028656930243499478,"score_gpt":0.2756263314810068,"score_spread":0.24696940123750732,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996126071","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92541564,0.01960525,0.04435611,0.0007645478,0.0038752386,0.00065431866,0.00015696899,0.00018907024,0.004982867],"genre_scores_gemma":[0.9524636,0.00019647989,0.0042033265,0.00011374748,0.000043800694,0.0000858514,0.00012788891,0.000045557972,0.042719726],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979964,0.00018501241,0.0005876888,0.0003420931,0.000030323574,0.000858466],"domain_scores_gemma":[0.99823713,0.00062015734,0.000341777,0.00064467906,0.000118003445,0.00003827723],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002837351,0.00031082617,0.0006093874,0.00030863023,0.00021978997,0.0000063376574,0.0004927463,0.0005486847,0.000816297],"category_scores_gemma":[0.00011579276,0.00028962258,0.00027050654,0.00015596629,0.00039091587,0.00020662334,0.00020848631,0.0004986303,0.0007146818],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012521154,0.00047715454,0.00075128925,0.000024532654,0.00028221615,5.0965997e-7,0.00067390385,0.000024575638,0.98047686,0.0034431978,0.004036797,0.008556868],"study_design_scores_gemma":[0.006297194,0.001278183,0.0020502063,0.000046373443,0.00034473938,0.00026158386,0.000768239,0.00037863906,0.8268046,0.0041394117,0.15693837,0.0006924838],"about_ca_topic_score_codex":0.00024071707,"about_ca_topic_score_gemma":0.000165338,"teacher_disagreement_score":0.15367228,"about_ca_system_score_codex":0.000102077625,"about_ca_system_score_gemma":0.00027403043,"threshold_uncertainty_score":0.9999556},"labels":[],"label_agreement":null},{"id":"W1996316168","doi":"10.4161/onci.24889","title":"IgG4 antibodies and cancer-associated inflammation","year":2013,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"Medical Research Council; Cancer Research UK","keywords":"Antibody; Inflammation; Cancer; Immunology; Immune system; Medicine; Cytotoxic T cell; Melanoma; Immunotherapy; Subclass; Cancer immunotherapy; Cancer research; Biology; Internal medicine","score_opus":0.020335001030632422,"score_gpt":0.3109879214035046,"score_spread":0.2906529203728722,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996316168","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9779124,0.0030350275,0.0000019502513,0.011063119,0.00010327843,0.00023425986,0.0000058243063,0.000048342965,0.007595752],"genre_scores_gemma":[0.9847332,0.0039916346,0.00013654449,0.0002824872,0.00010083825,0.00005458478,0.000038541246,0.000010877875,0.010651269],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99924535,0.000046668818,0.00016675462,0.00015458076,0.00012219674,0.00026443167],"domain_scores_gemma":[0.9995475,0.00007964748,0.00005127292,0.00011326523,0.00014687367,0.00006143285],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00008055639,0.00010034075,0.00023942921,0.00009011513,0.00010025715,0.00001809145,0.000054046897,0.00011477684,0.0009657141],"category_scores_gemma":[0.00009617366,0.00007727815,0.00003656521,0.00009812713,0.00021107306,0.00008958656,0.0000772935,0.00019816025,0.00027000913],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020435956,0.00012318252,0.3615694,0.00011478568,0.00039281062,0.000038946917,0.00080326473,0.0000010922332,0.30482906,0.0022191573,0.005552308,0.3241516],"study_design_scores_gemma":[0.00083812315,0.00033224604,0.96449107,0.00006940625,0.00002671426,0.000062554675,0.00015805695,0.00023641696,0.005085654,0.0006127397,0.027977156,0.0001098818],"about_ca_topic_score_codex":0.0025327723,"about_ca_topic_score_gemma":0.00007483523,"teacher_disagreement_score":0.60292166,"about_ca_system_score_codex":0.00004824157,"about_ca_system_score_gemma":0.00006597576,"threshold_uncertainty_score":0.99994755},"labels":[],"label_agreement":null},{"id":"W1998048839","doi":"10.4161/21624011.2014.958951","title":"Unleashing antitumor T-cell activation without ensuing autoimmunity: the case for A20-deletion in adoptive CD8<sup>+</sup>T-cell therapy","year":2014,"lang":"en","type":"article","venue":"OncoImmunology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Nautical Research Society","funders":"","keywords":"Autoimmunity; Cytotoxic T cell; Adoptive cell transfer; Immune system; CD8; Immunology; T cell; Inflammation; Cancer research; Immunotherapy; Immunity; Immune checkpoint; Biology; Medicine; In vitro; Biochemistry","score_opus":0.03481339900123783,"score_gpt":0.3126402239680923,"score_spread":0.2778268249668545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998048839","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9867139,0.00061300554,0.0027538363,0.0018222032,0.00014580648,0.0017569977,0.000005446185,0.00011129306,0.0060775173],"genre_scores_gemma":[0.99394715,0.0004398004,0.0009538763,0.00067363353,0.00022032345,0.00025471277,0.00007018322,0.000091496346,0.0033487973],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99733686,0.00074297946,0.0004945144,0.00047992019,0.00025442353,0.0006913082],"domain_scores_gemma":[0.9974782,0.0011141433,0.00022548795,0.0008415685,0.00027408762,0.00006650184],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0018764785,0.00031874847,0.0005861981,0.00038856192,0.00037908804,0.0000608128,0.00031254793,0.00031530732,0.00031019392],"category_scores_gemma":[0.00035758023,0.00024845728,0.00017247467,0.0004637239,0.0003319263,0.00019062618,0.00010740773,0.0011074999,0.00004924282],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032189996,0.00074505527,0.0029622212,0.000121125835,0.00012260649,0.00013158687,0.0071977335,0.00048705412,0.84712446,0.0005880867,0.00016787752,0.13713318],"study_design_scores_gemma":[0.058656704,0.011041819,0.018679153,0.00079036236,0.00025200768,0.0038524326,0.03276428,0.10542565,0.55991083,0.00213858,0.20468578,0.0018024361],"about_ca_topic_score_codex":0.0012862238,"about_ca_topic_score_gemma":0.000065818356,"teacher_disagreement_score":0.28721368,"about_ca_system_score_codex":0.0004145517,"about_ca_system_score_gemma":0.00024868015,"threshold_uncertainty_score":0.9999968},"labels":[],"label_agreement":null},{"id":"W1999014052","doi":"10.4161/onci.28047","title":"The battle for the brain","year":2014,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Neuroinflammation and Neurodegeneration Mechanisms","field":"Neuroscience","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Glioma; Microglia; In vivo; Cancer research; In vitro; Medicine; Brain tumor; Immunology; Inflammation; Chemistry; Biology; Pathology; Biotechnology","score_opus":0.030764460746479833,"score_gpt":0.2762381161020951,"score_spread":0.24547365535561524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999014052","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.29219517,0.00040997006,0.20853707,0.44886366,0.030084105,0.0022071805,0.000024785812,0.0008437006,0.01683437],"genre_scores_gemma":[0.9787779,0.0001512061,0.00014994625,0.010411821,0.00031353813,0.00020454887,0.0000015976613,0.000029003331,0.009960451],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99912906,0.00025352722,0.00014636075,0.00018888373,0.00008732834,0.00019481633],"domain_scores_gemma":[0.9887379,0.010765415,0.000072339884,0.00038531108,0.000023241379,0.000015838496],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003489655,0.000073536685,0.00006653715,0.000019531357,0.00081424275,0.000068246634,0.000396191,0.00003584301,0.00004609535],"category_scores_gemma":[0.005161808,0.000039525028,0.000049460854,0.0000854547,0.0001489079,0.000045080196,0.00005192399,0.00010917837,0.00021723639],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001766931,0.000005364789,7.945765e-7,6.368024e-7,0.0000010933564,2.0629216e-7,0.000031440486,0.000023584425,0.676693,0.29953024,0.006560526,0.017135428],"study_design_scores_gemma":[0.00021478333,0.000082536644,0.0000703119,4.7114966e-7,0.000001951294,0.000013465387,0.000011300146,0.0030819813,0.40313408,0.002128953,0.5912236,0.00003660463],"about_ca_topic_score_codex":0.000001183982,"about_ca_topic_score_gemma":0.000009726439,"teacher_disagreement_score":0.68658274,"about_ca_system_score_codex":0.000007707855,"about_ca_system_score_gemma":0.000019310464,"threshold_uncertainty_score":0.6262579},"labels":[],"label_agreement":null},{"id":"W2005988914","doi":"10.4161/2162402x.2014.994370","title":"CD4<sup>+</sup>T cell plasticity engenders robust immunity in response to cytokine therapy","year":2015,"lang":"en","type":"article","venue":"OncoImmunology","topic":"T-cell and B-cell Immunology","field":"Immunology and Microbiology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Effector; Immune system; Cytokine; Population; Immunology; Immunity; Acquired immune system; Immunotherapy; Biology; Medicine","score_opus":0.03580790354298228,"score_gpt":0.2485230319113967,"score_spread":0.21271512836841444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005988914","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9855334,0.0060669216,0.0002844484,0.0013936806,0.0012421376,0.00069581415,0.000062620275,0.0002806387,0.0044403407],"genre_scores_gemma":[0.9910569,0.00042605208,0.00036597223,0.00089973,0.000056236062,0.00013823784,0.0001358247,0.00008254246,0.006838505],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9937471,0.002742033,0.00094127626,0.00092458224,0.00010644173,0.0015385281],"domain_scores_gemma":[0.99728173,0.0010198758,0.00024835469,0.0010836504,0.0002449418,0.00012142151],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0015116793,0.00068298494,0.0010901821,0.0008561336,0.000310998,0.00003133601,0.0012572078,0.0012597685,0.0010295017],"category_scores_gemma":[0.00063440995,0.0006446186,0.00020141731,0.00079689245,0.00079262914,0.00019391684,0.0006070352,0.0017555289,0.004963175],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014236574,0.0012367344,0.0015909809,0.000009012531,0.00022102681,0.000098958,0.006005324,0.0018466794,0.96656126,0.00015263431,0.0050273137,0.0030135214],"study_design_scores_gemma":[0.02389084,0.006447171,0.0121940635,0.00006341865,0.00006685735,0.0005523025,0.011628932,0.00007256174,0.49838722,0.00040100823,0.444729,0.0015666316],"about_ca_topic_score_codex":0.0016584867,"about_ca_topic_score_gemma":0.00020175656,"teacher_disagreement_score":0.468174,"about_ca_system_score_codex":0.00050815416,"about_ca_system_score_gemma":0.0006193173,"threshold_uncertainty_score":0.9998837},"labels":[],"label_agreement":null},{"id":"W2010813474","doi":"10.4161/21624011.2014.948705","title":"IFNα signaling through PKC-θ is essential for antitumor NK cell function","year":2014,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Nautical Research Society","funders":"","keywords":"Degranulation; Protein kinase C; Cell biology; CXCL10; Signal transduction; Biology; Cancer research; Chemokine; Chemistry; Immunology; Immune system; Receptor; Biochemistry","score_opus":0.01164085981488639,"score_gpt":0.24208964567579766,"score_spread":0.23044878586091128,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010813474","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.65459037,0.00851458,0.22304842,0.0019252991,0.055254556,0.0013014772,0.000030453295,0.000756229,0.054578613],"genre_scores_gemma":[0.9603995,0.00015439308,0.0003797169,0.001765925,0.0002346568,0.00008116812,0.00035532343,0.00004550137,0.03658378],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99825877,0.00023037218,0.0004685722,0.00048288464,0.000036695244,0.00052267645],"domain_scores_gemma":[0.9988752,0.00024643014,0.00027309597,0.00041551705,0.00017629823,0.000013486131],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0002770898,0.0002711237,0.0004043639,0.00013556752,0.00046307707,0.000030528827,0.00022879223,0.00048146004,0.004348593],"category_scores_gemma":[0.00008605765,0.0002639202,0.00024203543,0.00013040709,0.00019768941,0.0002667827,0.00007230566,0.0004277941,0.0032565775],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008828647,0.00019550891,0.00008711917,0.000036962167,0.0001693429,5.149219e-7,0.00042244923,0.000010896274,0.94910204,0.0034281663,0.041894935,0.003769212],"study_design_scores_gemma":[0.0019099773,0.0007919782,0.00019374027,0.000016936567,0.00008093049,0.000037515576,0.00032202876,0.000031618874,0.4337939,0.0005035256,0.5621169,0.0002009241],"about_ca_topic_score_codex":0.00013071744,"about_ca_topic_score_gemma":0.0000062239565,"teacher_disagreement_score":0.520222,"about_ca_system_score_codex":0.00006778049,"about_ca_system_score_gemma":0.000055536548,"threshold_uncertainty_score":0.9999813},"labels":[],"label_agreement":null},{"id":"W2011945701","doi":"10.4161/2162402x.2014.991613","title":"Human NK cells activated by EBV<sup>+</sup>lymphoblastoid cells overcome anti-apoptotic mechanisms of drug resistance in haematological cancer cells","year":2015,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"K562 cells; Cancer research; Cytotoxic T cell; Biology; Cancer cell; Interleukin 12; Lymphoblast; Interleukin 21; NK-92; Leukemia; Apoptosis; Cancer; Immunology; Cell culture; In vitro; Immune system; T cell","score_opus":0.013473782813572874,"score_gpt":0.24417292361582346,"score_spread":0.2306991408022506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011945701","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98839974,0.003891407,0.0002486037,0.0003570847,0.0041088494,0.0004912217,0.0000775709,0.00015435375,0.0022711589],"genre_scores_gemma":[0.9673982,0.0003254293,0.00013823339,0.00035522337,0.000020797845,0.00006979131,0.00019521141,0.000057625748,0.031439476],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9962591,0.00091646233,0.0010934463,0.0007493421,0.000120700264,0.0008609827],"domain_scores_gemma":[0.99820036,0.00021344615,0.00060727895,0.00068434374,0.00023541498,0.000059180646],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000503909,0.0005183811,0.0011993516,0.0003987948,0.00019766505,0.000021847989,0.00060878746,0.0008822365,0.002419018],"category_scores_gemma":[0.000055609933,0.0004924418,0.00020822443,0.0004492072,0.0005308353,0.00026483453,0.00023039743,0.00096862135,0.0009781932],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006699715,0.0006803035,0.00010118134,0.000053483498,0.00017408207,0.000018033188,0.0010714555,0.00018993631,0.9545996,0.0007934306,0.04154468,0.000103793944],"study_design_scores_gemma":[0.0039287657,0.00038467467,0.00026045734,0.00012872633,0.000052687723,0.000034678505,0.0015539511,0.00001976742,0.9422909,0.00037693486,0.050505985,0.0004624863],"about_ca_topic_score_codex":0.0012963099,"about_ca_topic_score_gemma":0.00012674819,"teacher_disagreement_score":0.029168317,"about_ca_system_score_codex":0.00050860917,"about_ca_system_score_gemma":0.00021054069,"threshold_uncertainty_score":0.99979967},"labels":[],"label_agreement":null},{"id":"W2012028285","doi":"10.4161/onci.23793","title":"Enhanced immunity in slowly aging mutant mice with high mitochondrial oxidative stress","year":2013,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Mitochondrial Function and Pathology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Oxidative stress; Reactive oxygen species; Immune system; Mitochondrion; Mutant; Carcinogenesis; Lipopolysaccharide; Immunity; Cell biology; Biology; Cancer research; Immunology; Cancer; Biochemistry; Genetics","score_opus":0.006693063568824412,"score_gpt":0.22614816449124095,"score_spread":0.21945510092241655,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012028285","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904638,0.00026619318,0.0048926556,0.00029509826,0.0010403777,0.00044029093,0.000018692892,0.000027954746,0.0025549415],"genre_scores_gemma":[0.99433327,0.00013435693,0.003010597,0.00035045424,0.0002867113,0.00017378645,0.0002515517,0.000031916967,0.0014273581],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99833536,0.00033018444,0.00031118965,0.00049181364,0.00009026126,0.00044117135],"domain_scores_gemma":[0.9990885,0.00005148188,0.00014643437,0.0005088058,0.00014695502,0.000057805595],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008414225,0.00024989797,0.00031669746,0.00011841927,0.00009661716,0.000025430323,0.00030730825,0.00034354714,0.00045563883],"category_scores_gemma":[0.00011258898,0.00021877913,0.00006089147,0.0001817917,0.00022637995,0.000013868351,0.00015147946,0.00035297606,0.00017792692],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043100584,0.00013134055,0.0006778728,0.0000071123413,0.00006509424,0.000012298581,0.00026370215,0.000038043407,0.9959193,0.00021357332,0.00022053438,0.0020201288],"study_design_scores_gemma":[0.0030514896,0.0012670816,0.00979207,0.00003700974,0.000017688286,0.000071291455,0.0007412948,0.000009653599,0.979477,0.00018019235,0.0049789534,0.00037630097],"about_ca_topic_score_codex":0.0013161055,"about_ca_topic_score_gemma":0.0010932673,"teacher_disagreement_score":0.01644232,"about_ca_system_score_codex":0.00004033676,"about_ca_system_score_gemma":0.00011868503,"threshold_uncertainty_score":0.89215535},"labels":[],"label_agreement":null},{"id":"W2014111919","doi":"10.4161/onci.27616","title":"Immunosurveillance of senescent cancer cells by natural killer cells","year":2014,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Allergy and Infectious Diseases; Canadian Institutes of Health Research; National Institutes of Health","keywords":"Immunosurveillance; Senescence; Chemokine; Cancer cell; Cell biology; Natural killer cell; CCL2; Biology; NKG2D; Cell; Cancer research; Cancer; Immunology; Chemistry; Cytotoxicity; Tumor cells; Inflammation; In vitro; Biochemistry","score_opus":0.004553497089941164,"score_gpt":0.2188645361097816,"score_spread":0.21431103901984044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014111919","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86378056,0.03192221,0.00065186067,0.00077242224,0.094816685,0.00045510684,0.000022880833,0.00024312673,0.0073351604],"genre_scores_gemma":[0.9396957,0.0011108827,0.000031923515,0.0004309144,0.00004325633,0.000027529795,0.00013544425,0.000030113732,0.058494203],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99815524,0.00042531634,0.00053765863,0.00036887993,0.00004766102,0.00046525622],"domain_scores_gemma":[0.9987687,0.00019777921,0.0003556695,0.00048804915,0.00017483928,0.000014991382],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00025157753,0.00027009402,0.0005188931,0.00012541724,0.00014697257,0.0000098110495,0.00032869866,0.0003713561,0.003300778],"category_scores_gemma":[0.00004072454,0.00024360522,0.00017004392,0.00015316982,0.00032998915,0.000102655584,0.000108421715,0.00053518073,0.001284859],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029868542,0.00015256183,0.0003047869,0.000016396794,0.00019496246,3.6878433e-7,0.00015557052,0.000010544439,0.8856688,0.00013667012,0.102357,0.010703609],"study_design_scores_gemma":[0.0009527069,0.0001784942,0.0013447115,0.00002124968,0.000017176655,0.000017751065,0.0000950886,0.000013692082,0.5345443,0.0000065275876,0.46264616,0.00016213681],"about_ca_topic_score_codex":0.0008631529,"about_ca_topic_score_gemma":0.000030356337,"teacher_disagreement_score":0.36028916,"about_ca_system_score_codex":0.000111339825,"about_ca_system_score_gemma":0.00005550947,"threshold_uncertainty_score":0.99949276},"labels":[],"label_agreement":null},{"id":"W2020518300","doi":"10.4161/onci.27138","title":"Rewiring cancer cell death to enhance oncolytic viro-immunotherapy","year":2013,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; McMaster University Medical Centre","funders":"","keywords":"Oncolytic virus; Virotherapy; Immunotherapy; Cancer immunotherapy; Cancer; Immune system; Medicine; Cancer research; Immunogenic cell death; Cancer therapy; Immunology; Internal medicine","score_opus":0.014043599230312384,"score_gpt":0.3248581717362995,"score_spread":0.3108145725059871,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020518300","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9816456,0.010418974,0.00031865662,0.0010093575,0.0002711268,0.0006146895,0.000007839339,0.000037320366,0.005676444],"genre_scores_gemma":[0.9797198,0.0038789941,0.0008385763,0.0029944093,0.0002492989,0.0006702477,0.000024231422,0.00008113176,0.01154332],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99819976,0.00012678013,0.00027781655,0.00056351506,0.00016212504,0.00066999247],"domain_scores_gemma":[0.9987226,0.000022785829,0.00008215826,0.00085943495,0.00019954983,0.00011347046],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00019820826,0.00025467548,0.00026452457,0.0000701632,0.00013558727,0.00004055908,0.00061273423,0.00025463157,0.0014942181],"category_scores_gemma":[0.00003134618,0.0002507265,0.000102063066,0.0001462805,0.00009170757,0.000010461036,0.00021649487,0.0002116089,0.0006771254],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006260722,0.00009701072,0.0005800519,0.000008365143,0.0000906469,0.0000024843557,0.000117320946,0.00007140167,0.9531636,0.000009484064,0.002592486,0.04264104],"study_design_scores_gemma":[0.0006340004,0.0032524546,0.0026757924,0.000016992077,0.000006982698,0.0000073646647,0.00008551945,0.00003164224,0.9359538,0.00005090265,0.0569545,0.0003300785],"about_ca_topic_score_codex":0.0012476223,"about_ca_topic_score_gemma":0.0008355009,"teacher_disagreement_score":0.054362014,"about_ca_system_score_codex":0.00016602784,"about_ca_system_score_gemma":0.00023967602,"threshold_uncertainty_score":0.9999945},"labels":[],"label_agreement":null},{"id":"W2020650741","doi":"10.4161/onci.21650","title":"Tumor-infiltrating B cells and T cells","year":2012,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":83,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Immunity; CD8; Cancer research; Antigen-presenting cell; Cytotoxic T cell; Immunology; Ovarian cancer; Antigen; Medicine; Immune system; Biology; Cancer; T cell; In vitro; Internal medicine","score_opus":0.010793764532306668,"score_gpt":0.2256077316471736,"score_spread":0.21481396711486694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020650741","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94800955,0.008876096,0.00021422903,0.00018359271,0.01584946,0.00019473286,0.0000043747127,0.00018730223,0.026480688],"genre_scores_gemma":[0.98211485,0.0001724117,0.00014763311,0.0005836221,0.000081863436,0.000016706897,0.000030454237,0.000020982023,0.016831499],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987602,0.00020200503,0.00028964828,0.00020754013,0.00002037474,0.00052021455],"domain_scores_gemma":[0.99939775,0.00015139508,0.00014021691,0.0002451757,0.000041104144,0.000024363986],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00023997034,0.00018502855,0.00025260376,0.00011362636,0.00023555395,0.000015442234,0.00011283832,0.0002259775,0.002819697],"category_scores_gemma":[0.00003506319,0.00017240271,0.00006388041,0.00008564872,0.00021350522,0.0002665475,0.0000915447,0.00044045848,0.003997247],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000073176634,0.00010148307,0.0010291332,0.000007335223,0.00007687507,0.0000012097744,0.00053623127,6.388064e-7,0.9803885,0.00090410415,0.011617021,0.0052642524],"study_design_scores_gemma":[0.00055969064,0.00015051401,0.004298469,0.000009726315,0.000023324408,0.00025515954,0.00074001605,0.0000022366526,0.55068594,0.00001351323,0.4431025,0.00015887085],"about_ca_topic_score_codex":0.00010532195,"about_ca_topic_score_gemma":0.0000031018892,"teacher_disagreement_score":0.4314855,"about_ca_system_score_codex":0.000046082714,"about_ca_system_score_gemma":0.000023459595,"threshold_uncertainty_score":0.9980919},"labels":[],"label_agreement":null},{"id":"W2022364340","doi":"10.4161/2162402x.2014.990803","title":"miR-23a blockade enhances adoptive T cell transfer therapy by preserving immune-competence in the tumor microenvironment","year":2015,"lang":"en","type":"article","venue":"OncoImmunology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Immunosuppression; Tumor microenvironment; Adoptive cell transfer; Blockade; Medicine; CD8; Cytotoxic T cell; Immune system; T cell; Immunology; Cancer research; Tumor-infiltrating lymphocytes; Biology; Internal medicine; Receptor","score_opus":0.028752533743026068,"score_gpt":0.28106612261061253,"score_spread":0.2523135888675865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2022364340","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9649888,0.022552421,0.0000440793,0.0026190968,0.00014867651,0.0009952107,0.000011441342,0.000034551354,0.008605704],"genre_scores_gemma":[0.99012125,0.0028213488,0.00021238443,0.0008262793,0.00008099109,0.00022270952,0.000037679427,0.000046017212,0.0056313486],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99750715,0.00050935167,0.00041726808,0.00044770862,0.00045572364,0.00066278543],"domain_scores_gemma":[0.9988028,0.00022355132,0.00005918497,0.00077612343,0.000050685336,0.000087691784],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008002925,0.00027625103,0.00048676218,0.00012506392,0.000081761704,0.000028290715,0.00072331756,0.00014959536,0.0017691571],"category_scores_gemma":[0.000027453185,0.00019468534,0.00012911318,0.00027360144,0.00043702414,0.00009270578,0.000096917014,0.00078544667,0.00014511695],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013175604,0.0007076594,0.0016950296,0.000015774902,0.000073600444,0.0000943091,0.0067822407,0.0000048938127,0.98506135,0.000010999453,0.0009595964,0.0032769833],"study_design_scores_gemma":[0.0065034754,0.0021690421,0.017613862,0.00005786355,0.000026173051,0.00018427805,0.0050281235,0.000040590752,0.7525325,0.00008425111,0.21548451,0.00027536752],"about_ca_topic_score_codex":0.0010114746,"about_ca_topic_score_gemma":0.00006701023,"teacher_disagreement_score":0.2325289,"about_ca_system_score_codex":0.00025147782,"about_ca_system_score_gemma":0.00019074895,"threshold_uncertainty_score":0.99914336},"labels":[],"label_agreement":null},{"id":"W2025291611","doi":"10.4161/onci.1.1.17962","title":"Targeting platelet function to improve drug delivery","year":2012,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Inflammatory Biomarkers in Disease Prognosis","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Heart, Lung, and Blood Institute; National Institutes of Health; Kom op tegen Kanker; Terry Fox Foundation","keywords":"Drug; Medicine; Drug delivery; Platelet; Cancer; Pharmacology; Cancer drugs; Intensive care medicine; Internal medicine; Nanotechnology","score_opus":0.008943299060013734,"score_gpt":0.24522583524272215,"score_spread":0.23628253618270842,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025291611","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906115,0.0025301648,0.0001367181,0.00043726145,0.0018651763,0.00043223455,0.00000634336,0.00021293077,0.0037676594],"genre_scores_gemma":[0.99554586,0.000044092038,0.0017149041,0.0013432808,0.00049559213,0.00010678895,0.000040247527,0.00003402766,0.0006751789],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99869764,0.0000731333,0.00026722485,0.00022915442,0.00013791547,0.0005949147],"domain_scores_gemma":[0.99925774,0.00006359976,0.00007934476,0.0003100874,0.00009922762,0.00019001242],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000404008,0.00016179676,0.00024756434,0.00015383767,0.00010249417,0.000008721019,0.00009478741,0.00015069343,0.0005278587],"category_scores_gemma":[0.00014702011,0.0001530872,0.000088607354,0.00015819218,0.00007174942,0.00014778956,0.00012872163,0.00020898067,0.0013250216],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002889308,0.00041575867,0.34651896,0.00011369821,0.000545222,0.000051175983,0.0009734246,0.0000017124173,0.48730275,0.00026228782,0.025797777,0.1351279],"study_design_scores_gemma":[0.0032800464,0.0006663401,0.57828087,0.0001032891,0.0003606231,0.00015125064,0.0013065856,0.00005977544,0.044147648,0.000115685856,0.37093762,0.0005902363],"about_ca_topic_score_codex":0.000031304353,"about_ca_topic_score_gemma":0.0000018724741,"teacher_disagreement_score":0.4431551,"about_ca_system_score_codex":0.00020625476,"about_ca_system_score_gemma":0.000080730984,"threshold_uncertainty_score":0.9994526},"labels":[],"label_agreement":null},{"id":"W2031719011","doi":"10.4161/onci.27668","title":"Location, location, location","year":2014,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Victoria; BC Cancer Agency","funders":"","keywords":"Phenotype; Tumor-infiltrating lymphocytes; Serous fluid; Pathology; Ovarian cancer; Disease; Biology; Cancer research; Medicine; Cancer; Immunology; Antigen; Gene; Internal medicine; CD8; Genetics","score_opus":0.00854983309411879,"score_gpt":0.22865939567008706,"score_spread":0.22010956257596825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031719011","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.28410247,0.042105045,0.42710656,0.014347112,0.07449846,0.0021376316,0.00000467757,0.0027684355,0.15292963],"genre_scores_gemma":[0.96099395,0.000089359426,0.000088050234,0.0010383358,0.00010262347,0.000063927095,0.00029591488,0.000028242934,0.03729962],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983065,0.00039704412,0.00048734256,0.00039316423,0.00004143139,0.00037450154],"domain_scores_gemma":[0.99819714,0.00016787439,0.00024470707,0.00060845143,0.0007639051,0.000017925919],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0003902303,0.00022198251,0.00028099236,0.00022762034,0.0003387243,0.00002447627,0.0002825177,0.000413901,0.0018842698],"category_scores_gemma":[0.00051091553,0.00022034398,0.000059005008,0.00051550096,0.00026558148,0.00024614864,0.00006303287,0.0004072959,0.014503935],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00082627457,0.0009915271,0.0043691383,0.00016517918,0.00063854427,0.0000015324002,0.0020945817,0.0009379792,0.6182363,0.08643517,0.17433515,0.1109686],"study_design_scores_gemma":[0.0016109798,0.00045846374,0.030403938,0.00006565654,0.000050814604,0.00015929325,0.0005221815,0.00015624924,0.03725205,0.00052971276,0.9284497,0.00034094937],"about_ca_topic_score_codex":0.0002563916,"about_ca_topic_score_gemma":0.0000389596,"teacher_disagreement_score":0.75411457,"about_ca_system_score_codex":0.00014740515,"about_ca_system_score_gemma":0.00013183166,"threshold_uncertainty_score":0.99902815},"labels":[],"label_agreement":null},{"id":"W2042681245","doi":"10.4161/onci.1.1.18312","title":"NK cells sense tumors, course of disease and treatments","year":2012,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Nautical Research Society","funders":"Ligue Contre le Cancer; Société Française de Dermatologie et de Pathologie Sexuellement Transmissible; Institut National de la Santé et de la Recherche Médicale","keywords":"Disease; Cancer research; Medicine; Immunology; Interleukin 12; Cell; Lymphokine-activated killer cell; Janus kinase 3; NK-92; Interleukin 21; Biology; Pathology; T cell; Immune system; Cytotoxic T cell; In vitro","score_opus":0.009935568665127206,"score_gpt":0.24097433833419996,"score_spread":0.23103876966907275,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2042681245","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9777877,0.016195599,0.000029498575,0.00012638084,0.0034418518,0.00015429046,0.000015615286,0.000049392223,0.0021996945],"genre_scores_gemma":[0.9850637,0.0006093528,0.000023065566,0.00012726033,0.000028247317,0.000013874334,0.000103599865,0.000014719992,0.014016183],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99905485,0.00018628335,0.00025436017,0.000160738,0.000017333849,0.00032645784],"domain_scores_gemma":[0.9994159,0.00009304105,0.0001488744,0.00026299836,0.00004643108,0.000032770713],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00011260032,0.00016075445,0.0002680826,0.000084018975,0.00009983941,0.0000035963726,0.000058683243,0.00015520345,0.0012154231],"category_scores_gemma":[0.000024011833,0.0001369016,0.0000739041,0.00006183478,0.00027406804,0.0001459371,0.000063047286,0.0001824648,0.0006467203],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007456505,0.0007027268,0.009524797,0.00002213968,0.00041835665,0.000003240474,0.0006114439,5.838371e-7,0.975835,0.0008375852,0.0061802682,0.0051182085],"study_design_scores_gemma":[0.003467935,0.00084756495,0.20950423,0.00006885856,0.00035152293,0.00028764855,0.0014486092,0.000004057958,0.5443983,0.000068400244,0.23917536,0.00037750136],"about_ca_topic_score_codex":0.00008032937,"about_ca_topic_score_gemma":0.0000015524198,"teacher_disagreement_score":0.4314367,"about_ca_system_score_codex":0.000036160756,"about_ca_system_score_gemma":0.000038612514,"threshold_uncertainty_score":0.9996976},"labels":[],"label_agreement":null},{"id":"W2047167261","doi":"10.4161/onci.24272","title":"High endothelial venules","year":2013,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"High endothelial venules; Immune system; Medicine; Endothelium; Pathology; Cancer research; Biology; Immunology; Internal medicine","score_opus":0.007380598495121902,"score_gpt":0.23030742454405434,"score_spread":0.22292682604893244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047167261","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993293,0.0027123024,0.00025338773,0.00036096884,0.00048455878,0.00010093362,0.000012534345,0.000015738418,0.002766595],"genre_scores_gemma":[0.9950887,0.00039428248,0.0006531585,0.0005056658,0.000421863,0.00007364012,0.00005181651,0.000018524992,0.0027923284],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994095,0.00003300695,0.00011323947,0.000196862,0.000042499367,0.00020491607],"domain_scores_gemma":[0.9996077,0.0000066143534,0.000043481617,0.00026816202,0.00004738423,0.000026684189],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00003934956,0.000096035066,0.000108711654,0.00002168157,0.000052889925,0.0000112334765,0.00016266886,0.00014712138,0.0005796169],"category_scores_gemma":[0.000019641508,0.00008647899,0.00007022864,0.0000316181,0.00009781729,0.0000022813865,0.00008077939,0.00004772423,0.00055426895],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023393362,0.000030606174,0.0016446428,0.000002404386,0.00005504907,0.0000013532269,0.0000146589,0.0000052058263,0.96718526,0.00085626973,0.010387391,0.019793773],"study_design_scores_gemma":[0.00073532015,0.0004262235,0.034656536,0.000005970895,0.0000138658725,0.000037422655,0.000070404865,0.0000045667175,0.3759868,0.0006335527,0.58717954,0.00024979425],"about_ca_topic_score_codex":0.00017895081,"about_ca_topic_score_gemma":0.000014287077,"teacher_disagreement_score":0.59119844,"about_ca_system_score_codex":0.000010926951,"about_ca_system_score_gemma":0.000039335948,"threshold_uncertainty_score":0.7124191},"labels":[],"label_agreement":null},{"id":"W2047682874","doi":"10.4161/21624011.2014.945378","title":"Anti-melanoma vaccines engineered to simultaneously modulate cytokine priming and silence PD-L1 characterized using<i>ex vivo</i>myeloid-derived suppressor cells as a readout of therapeutic efficacy","year":2014,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Ex vivo; Cancer research; Interleukin 12; Priming (agriculture); Gene silencing; Cytokine; Interleukin 10; Small hairpin RNA; Melanoma; T cell; Immunology; Immunotherapy; Cancer immunotherapy; FOXP3; Immune system; Biology; In vivo; Medicine; Cytotoxic T cell; Cell culture; In vitro; Gene knockdown","score_opus":0.011704032580891824,"score_gpt":0.2438292344512137,"score_spread":0.23212520187032187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047682874","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99325573,0.0029192667,0.00064290065,0.0002497826,0.0017223217,0.00075629744,0.000056255572,0.00015208083,0.0002453694],"genre_scores_gemma":[0.996747,0.00045940198,0.00083445245,0.0004689805,0.000077834935,0.00002820938,0.00004905642,0.00009533043,0.0012397082],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99687237,0.0004960701,0.000858236,0.0007904439,0.00007869192,0.000904215],"domain_scores_gemma":[0.9973324,0.0008993873,0.00045753358,0.0010365417,0.00022296338,0.00005116245],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00034799642,0.0005674459,0.0013970628,0.0003172529,0.0001883068,0.000027094404,0.0007068902,0.00064729014,0.0005438964],"category_scores_gemma":[0.000298965,0.000540831,0.0001554024,0.000268014,0.00042055736,0.00012409528,0.00041003615,0.0005404761,0.00024839825],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015500382,0.0002109076,0.00023172903,0.00008422085,0.00046356177,0.000014588288,0.0019141794,0.0004251786,0.98749405,0.00006582523,0.000038903334,0.0075068404],"study_design_scores_gemma":[0.004877353,0.0010234148,0.01256702,0.00017317534,0.00019802205,0.0003393407,0.00017645801,0.0003477676,0.9616135,0.000035227353,0.018058555,0.0005901668],"about_ca_topic_score_codex":0.00029883784,"about_ca_topic_score_gemma":0.0000061031687,"teacher_disagreement_score":0.025880527,"about_ca_system_score_codex":0.000088764085,"about_ca_system_score_gemma":0.00011113143,"threshold_uncertainty_score":0.9997043},"labels":[],"label_agreement":null},{"id":"W2047928035","doi":"10.4161/onci.27589","title":"Dasatinib promotes the expansion of a therapeutically superior T-cell repertoire in response to dendritic cell vaccination against melanoma","year":2014,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Center for Advancing Translational Sciences; National Cancer Institute; National Institutes of Health; Cancer Institute, University of Pittsburgh; Atomic Energy of Canada Limited; University of Pittsburgh","keywords":"Tumor microenvironment; Cancer research; Dasatinib; Immunotherapy; Melanoma; Medicine; Dendritic cell; CD8; T cell; Immunology; Antigen; Immune system; Imatinib; Myeloid leukemia","score_opus":0.00939459129431934,"score_gpt":0.24049565005159484,"score_spread":0.2311010587572755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047928035","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98779964,0.007255251,0.00017126379,0.0020267495,0.0004983163,0.0006915541,0.000009076075,0.00006083786,0.0014873105],"genre_scores_gemma":[0.9957561,0.00029599995,0.00019022971,0.00079859846,0.000013882951,0.00012369656,0.000028663615,0.000043825068,0.002749002],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9951817,0.0029555499,0.0007672628,0.00044209554,0.00007267823,0.00058074313],"domain_scores_gemma":[0.99694824,0.0017812217,0.00020953506,0.0009016383,0.00014123628,0.000018116292],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016281558,0.0003126388,0.00057207985,0.00036161038,0.0002522707,0.000019338962,0.00067325286,0.00047388943,0.00031151724],"category_scores_gemma":[0.0005890676,0.00023142842,0.00014911137,0.00039702762,0.00027427915,0.00010801718,0.00016109475,0.00052060233,0.00029848123],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0066804416,0.0003770307,0.0006544252,0.0000234914,0.000052823358,0.0000046277964,0.0040374524,0.000006520161,0.9430391,0.00018735391,0.000070924485,0.04486577],"study_design_scores_gemma":[0.0050025354,0.0032429884,0.09620023,0.00010380155,0.000032261705,0.00007452336,0.0017036428,0.00002481222,0.8476081,0.00011922243,0.045514077,0.0003738279],"about_ca_topic_score_codex":0.000111778325,"about_ca_topic_score_gemma":0.00003500993,"teacher_disagreement_score":0.095545806,"about_ca_system_score_codex":0.00009691213,"about_ca_system_score_gemma":0.00022170423,"threshold_uncertainty_score":0.9437377},"labels":[],"label_agreement":null},{"id":"W2048856583","doi":"10.4161/onci.29243","title":"Tumor-associated autoantibodies correlate with poor outcome in prostate cancer patients treated with androgen deprivation and external beam radiation therapy","year":2014,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency; University of Victoria","funders":"BC Cancer Agency; Canadian Institutes of Health Research","keywords":"Medicine; Prostate cancer; Autoantibody; Androgen deprivation therapy; Cancer; Oncology; Radiation therapy; Prostate-specific antigen; Internal medicine; Androgen; Immune system; Androgen suppression; Immunology; Antibody; Hormone","score_opus":0.012896353262131238,"score_gpt":0.2829936209693502,"score_spread":0.270097267707219,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048856583","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969594,0.00170139,0.0000055555824,0.00034048923,0.00004174438,0.0007556799,0.000013717517,0.000050795526,0.00013125938],"genre_scores_gemma":[0.9972938,0.0015468566,0.00003728849,0.00015031935,0.000013486488,0.00013322299,0.00015463209,0.000027330416,0.0006431191],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989367,0.00008401497,0.0002226345,0.00027101487,0.0001732955,0.0003123421],"domain_scores_gemma":[0.99948853,0.000050109415,0.0001519437,0.00012423424,0.00013604717,0.00004911037],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001332635,0.00017623471,0.00034743853,0.00017626717,0.00008304443,0.000018691311,0.000046926325,0.000073719224,0.000021694348],"category_scores_gemma":[0.000030494672,0.00010924207,0.00001921759,0.00022603368,0.00015284799,0.00011329048,0.000019211788,0.00019991623,0.000004654243],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031455231,0.00027311782,0.97065693,0.000016187425,0.00017207892,0.000031686068,0.00046640207,0.000009817745,0.0021830413,0.000008248437,0.000008666427,0.023028312],"study_design_scores_gemma":[0.016651247,0.0031054243,0.9760092,0.00015401751,0.000046622044,0.000018839411,0.00003617771,0.0002494923,0.003349625,0.000017323284,0.00023152254,0.00013051134],"about_ca_topic_score_codex":0.000972837,"about_ca_topic_score_gemma":0.0001801141,"teacher_disagreement_score":0.022897802,"about_ca_system_score_codex":0.00026498444,"about_ca_system_score_gemma":0.00010266987,"threshold_uncertainty_score":0.44547623},"labels":[],"label_agreement":null},{"id":"W2049898667","doi":"10.4161/21624011.2014.953407","title":"Metronomic cyclophosphamide enhances HPV16E7 peptide vaccine induced antigen-specific and cytotoxic T-cell mediated antitumor immune response","year":2014,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Public Health; Queen Elizabeth II Health Sciences Centre; Ontario Institute for Cancer Research; Immunovaccine (Canada); Dalhousie University","funders":"Dalhousie University","keywords":"Cytotoxic T cell; Medicine; Immune system; Immunology; Peptide vaccine; Vaccination; Antigen; CD8; Vaccine therapy; Immunization; Cancer vaccine; Context (archaeology); Immunotherapy; Cancer research; Epitope; Biology; In vitro","score_opus":0.008748838181144787,"score_gpt":0.22656435147671586,"score_spread":0.21781551329557108,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049898667","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.921584,0.07430657,0.00015843973,0.0005939753,0.001718571,0.00051373953,0.00002397515,0.0002798195,0.000820926],"genre_scores_gemma":[0.98097944,0.013932481,0.00022578181,0.0003081086,0.000057558056,0.00008637832,0.00014157452,0.00010508533,0.0041635837],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9942659,0.0023213518,0.0011638482,0.00095410866,0.000083817744,0.001210985],"domain_scores_gemma":[0.99598455,0.0020377429,0.0005910644,0.0011993031,0.00013244899,0.00005488769],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0019384372,0.00072747143,0.0013145203,0.00065773603,0.0006845816,0.000066365974,0.00083594484,0.00080117944,0.001267895],"category_scores_gemma":[0.00048745595,0.00068099477,0.00025044815,0.0004793372,0.00061663624,0.00031875636,0.0003318323,0.0010049177,0.0022984843],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010576654,0.00031658314,0.0011261972,0.000015164473,0.00036781974,0.000016216347,0.00069889374,0.0000014015359,0.9778087,0.00028831986,0.0005274544,0.0082565835],"study_design_scores_gemma":[0.005456343,0.0015495301,0.17553398,0.000050612878,0.000026408243,0.00022318127,0.00046020956,0.0000033661793,0.6163909,0.000060454135,0.19966368,0.00058134523],"about_ca_topic_score_codex":0.0003147814,"about_ca_topic_score_gemma":0.000020981628,"teacher_disagreement_score":0.36141783,"about_ca_system_score_codex":0.00015895041,"about_ca_system_score_gemma":0.00020990889,"threshold_uncertainty_score":0.99964505},"labels":[],"label_agreement":null},{"id":"W2052590920","doi":"10.4161/onci.1.1.17824","title":"PD-L1 co-stimulation, ligand-induced TCR down-modulation and anti-tumor immunotherapy","year":2012,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Versus Arthritis; Rosetrees Trust","keywords":"Cytotoxic T cell; Immunotherapy; T-cell receptor; Effector; Ligand (biochemistry); Downregulation and upregulation; Stimulation; Cancer research; Co-stimulation; Function (biology); Antigen presentation; Cell biology; Chemistry; Receptor; T cell; Immunology; Medicine; Immune system; Biology; Neuroscience; Biochemistry; CD28; In vitro","score_opus":0.022328723385317426,"score_gpt":0.30892876758755883,"score_spread":0.2866000442022414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052590920","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989368,0.0061749625,0.00020345517,0.00086125755,0.000804335,0.00047026877,0.000007892023,0.00012922054,0.0019805573],"genre_scores_gemma":[0.99680835,0.000731682,0.00034246422,0.0012234211,0.00034623823,0.00003098618,0.00007736438,0.000043171265,0.00039632802],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99858904,0.000089276036,0.00041723214,0.00027225926,0.00017166948,0.000460521],"domain_scores_gemma":[0.9991033,0.00009840874,0.0001847653,0.00041943154,0.00011210947,0.00008199405],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003814331,0.00024179695,0.0004478425,0.00019651295,0.00018453164,0.00002426094,0.000090285204,0.00022614932,0.00036698626],"category_scores_gemma":[0.00005348016,0.00021224169,0.00010942794,0.0002285558,0.00017719688,0.00024438972,0.000026943866,0.00023828453,0.000092667375],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017699817,0.00021663978,0.119402125,0.000023821307,0.00026971122,0.0000056417234,0.0008144709,0.0000013088829,0.83074844,0.00015727508,0.00052474614,0.046065833],"study_design_scores_gemma":[0.0051669786,0.0005039189,0.91377896,0.000054307497,0.00005232298,0.00029222507,0.00016247037,0.0000942138,0.03663148,0.00004997075,0.042963933,0.00024921307],"about_ca_topic_score_codex":0.0002173588,"about_ca_topic_score_gemma":0.0000052788378,"teacher_disagreement_score":0.79437685,"about_ca_system_score_codex":0.00014907774,"about_ca_system_score_gemma":0.000098260476,"threshold_uncertainty_score":0.86549646},"labels":[],"label_agreement":null},{"id":"W2055332350","doi":"10.4161/onci.23081","title":"Targeting SIRPα in cancer","year":2013,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Phagocytosis and Immune Regulation","field":"Immunology and Microbiology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; SickKids Foundation; Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Cancer; Adoptive cell transfer; Blockade; Immune system; Cancer research; Cancer immunotherapy; Leukemia; Cancer cell; Medicine; Immune checkpoint; Immunotherapy; Immunology; T cell; Receptor; Internal medicine","score_opus":0.01407830196796735,"score_gpt":0.2593188735469524,"score_spread":0.24524057157898502,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055332350","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9738415,0.020653166,0.000037005495,0.001008899,0.0009889199,0.00026614234,0.0000031245195,0.00006984344,0.0031314173],"genre_scores_gemma":[0.995714,0.0005420794,0.000053455948,0.0002006402,0.000025551237,0.00018178902,0.000057588553,0.000016093374,0.003208776],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9987933,0.00016787916,0.00034056578,0.00024365546,0.0000183844,0.00043620626],"domain_scores_gemma":[0.9995371,0.00007484262,0.000108146756,0.0002159715,0.000055395245,0.000008529038],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00013761171,0.00014590465,0.00028375766,0.00014704543,0.00009326918,0.0000120074665,0.00020501287,0.00028647238,0.0052359006],"category_scores_gemma":[0.000053449505,0.00013118607,0.00005202431,0.00016848854,0.00015141012,0.00020086236,0.00009037724,0.00030408087,0.0025316614],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021980095,0.00009680796,0.014733263,0.0000047231833,0.00005357307,0.0000011225711,0.0002860196,0.000034461453,0.94217247,0.00063310494,0.0041301646,0.037832316],"study_design_scores_gemma":[0.0035210778,0.00025405342,0.7424102,0.000076421275,0.000022957609,0.000045626904,0.00080177933,0.00013127572,0.10627252,0.0012926642,0.14463729,0.0005341595],"about_ca_topic_score_codex":0.0028160533,"about_ca_topic_score_gemma":0.000055072327,"teacher_disagreement_score":0.83589995,"about_ca_system_score_codex":0.000105431674,"about_ca_system_score_gemma":0.000052530228,"threshold_uncertainty_score":0.998245},"labels":[],"label_agreement":null},{"id":"W2056373410","doi":"10.4161/onci.1.2.18100","title":"Tumor immune escape in acute myeloid leukemia","year":2012,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Research in Immunology and Cancer","funders":"","keywords":"Myeloid leukemia; Medicine; Leukemia; Immune system; Cancer research; Myeloid; Human leukocyte antigen; Immunology; Myeloid cells; Immune escape; Antigen","score_opus":0.009594060998956773,"score_gpt":0.2445719505498521,"score_spread":0.23497788955089532,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056373410","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90254223,0.088312775,0.00003941576,0.00029283873,0.003038122,0.00033403322,0.000015437663,0.00018313431,0.005242005],"genre_scores_gemma":[0.9866938,0.0016387905,0.00014418566,0.00052140676,0.00005762716,0.00011701502,0.00010967759,0.000065115055,0.010652366],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.996469,0.0007713376,0.000797298,0.0003928328,0.000052730586,0.0015167705],"domain_scores_gemma":[0.9985043,0.00033312515,0.00025353112,0.0008238172,0.000055053024,0.000030167967],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0008113474,0.0004446969,0.00079715915,0.00047527175,0.0002579048,0.000018593519,0.00067480013,0.00056720135,0.0029959378],"category_scores_gemma":[0.0001261103,0.00041563963,0.000233864,0.00045971616,0.0005630819,0.00044664025,0.00024913633,0.0010187298,0.0055875434],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017477798,0.0003664372,0.00702015,0.000009792006,0.0005287006,0.000027800832,0.0016064409,0.0000018566291,0.9601051,0.0023378183,0.0008065247,0.02544155],"study_design_scores_gemma":[0.0051024845,0.0005325349,0.33164692,0.00006549664,0.00007787627,0.0015299494,0.0009306325,0.0000016951935,0.31857723,0.00013426974,0.34071,0.0006908987],"about_ca_topic_score_codex":0.000493726,"about_ca_topic_score_gemma":0.000018240682,"teacher_disagreement_score":0.64152795,"about_ca_system_score_codex":0.0004103737,"about_ca_system_score_gemma":0.00025528882,"threshold_uncertainty_score":0.99982953},"labels":[],"label_agreement":null},{"id":"W2057270791","doi":"10.4161/onci.23687","title":"Victories and deceptions in tumor immunology","year":2013,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Tumor immunology; Medicine; Immunology; Immune system; Immunotherapy","score_opus":0.00815938468256729,"score_gpt":0.252433483791686,"score_spread":0.2442740991091187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057270791","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98620456,0.0065987976,0.000013182636,0.0032502583,0.00027962684,0.0002914874,0.0000016980273,0.00005164564,0.003308763],"genre_scores_gemma":[0.9961334,0.001441005,0.00044197615,0.00087294116,0.000036538477,0.000113215356,0.000009964572,0.000014206425,0.0009367863],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9992118,0.000046811325,0.00023824572,0.00019218301,0.000047805286,0.00026318044],"domain_scores_gemma":[0.999588,0.000060087434,0.00004901873,0.00022739584,0.000046462977,0.000029010616],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000057511494,0.00011612445,0.00026863517,0.00017300817,0.000043618522,0.000012317499,0.00006605349,0.00012010623,0.0013384135],"category_scores_gemma":[0.000039513114,0.000100620295,0.000041828618,0.0001890959,0.0003725584,0.00009112234,0.000047607853,0.00020630386,0.00016632618],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001187432,0.00031540822,0.1372533,0.00003693511,0.0003156477,0.00006170953,0.0023100993,2.2202893e-7,0.75345045,0.0022640235,0.0013655293,0.10143923],"study_design_scores_gemma":[0.002805798,0.0005372149,0.9278499,0.000041351464,0.000015556918,0.0004929772,0.0009278508,0.000009015614,0.0018035852,0.00061231566,0.064777985,0.00012646859],"about_ca_topic_score_codex":0.0012322653,"about_ca_topic_score_gemma":0.00020116253,"teacher_disagreement_score":0.7905966,"about_ca_system_score_codex":0.00009779379,"about_ca_system_score_gemma":0.00008172184,"threshold_uncertainty_score":0.9995745},"labels":[],"label_agreement":null},{"id":"W2058840851","doi":"10.4161/21624011.2014.963409","title":"Immunotherapy of metastatic and autochthonous liver cancer with IL-15/IL-15Rα fusion protein","year":2014,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Institute of Allergy and Infectious Diseases","keywords":"Immunotherapy; Medicine; Cancer research; Liver cancer; CD8; Cancer immunotherapy; Interleukin 15; Fusion protein; Cancer; Chimeric antigen receptor; Immunology; Immune system; Interleukin; Cytokine; Biology; Internal medicine; Recombinant DNA; Hepatocellular carcinoma; Gene","score_opus":0.010247891093694499,"score_gpt":0.233088115341293,"score_spread":0.2228402242475985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058840851","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9829497,0.009849961,0.001980682,0.0004909506,0.0014175328,0.0005934119,0.000012959744,0.00011316452,0.0025916551],"genre_scores_gemma":[0.9847414,0.001014212,0.00043768674,0.00026816298,0.00002269029,0.00013691305,0.000052789088,0.000037294474,0.0132888695],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99848366,0.00039923142,0.00039128587,0.00034087728,0.00004562575,0.00033932223],"domain_scores_gemma":[0.9990047,0.00013015767,0.0003244008,0.00038126513,0.00014457651,0.000014888164],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00026539303,0.00025196327,0.00049828226,0.00018946482,0.00018120062,0.000012106287,0.00017275687,0.00022753792,0.0023189143],"category_scores_gemma":[0.00004528757,0.00019591114,0.0000748986,0.00014285705,0.00044265066,0.00014572352,0.000070807335,0.00039380748,0.0002250409],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013723703,0.00019188382,0.00029524008,0.000039982322,0.0003872326,0.0000025598808,0.0006525152,0.000006418213,0.9338632,0.0015359367,0.000648484,0.06100414],"study_design_scores_gemma":[0.006141589,0.0042581125,0.018511385,0.00022608507,0.00015222657,0.00045026978,0.0006365827,0.000089245215,0.43476835,0.00020464188,0.53403735,0.0005241526],"about_ca_topic_score_codex":0.0011404215,"about_ca_topic_score_gemma":0.00009660965,"teacher_disagreement_score":0.53338885,"about_ca_system_score_codex":0.000055743025,"about_ca_system_score_gemma":0.00007897749,"threshold_uncertainty_score":0.9985931},"labels":[],"label_agreement":null},{"id":"W2059388136","doi":"10.4161/onci.28782","title":"Transplantation-induced cancers: Emerging evidence that clonal CMV-specific NK cells are causal immunogenic factors","year":2014,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Nautical Research Society","funders":"","keywords":"Cytomegalovirus; Immunology; Transplantation; Repertoire; Biology; Liver transplantation; Cancer research; Medicine; Virus; Herpesviridae; Viral disease; Internal medicine","score_opus":0.04018371493190794,"score_gpt":0.2628070945618559,"score_spread":0.22262337962994797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059388136","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9690692,0.009359011,0.0017577037,0.00036594932,0.017370785,0.00029061578,0.000013718106,0.00024237484,0.001530643],"genre_scores_gemma":[0.9900117,0.0039982214,0.000034791552,0.0002921558,0.00010640456,0.00004751127,0.00023471657,0.00004989068,0.0052246316],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973205,0.0006379775,0.0005839731,0.00064352725,0.00009330364,0.0007207728],"domain_scores_gemma":[0.9980581,0.00058407936,0.0005622988,0.00060983293,0.0001520735,0.000033629043],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0003534795,0.000437645,0.00056772487,0.00029784843,0.000549021,0.00004212643,0.00047379627,0.0005780819,0.004751597],"category_scores_gemma":[0.00008725378,0.00041388572,0.00025952648,0.00023492082,0.00030839964,0.00045204788,0.000071826216,0.00091974897,0.0023787944],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00066188304,0.0000806681,0.0026438483,0.000031271244,0.00028083927,0.000006981493,0.0016895203,0.000026983435,0.98510236,0.00030668936,0.0039826646,0.005186272],"study_design_scores_gemma":[0.001973004,0.0006543001,0.044493042,0.00025944406,0.00011591371,0.00023791812,0.003363666,0.000015529613,0.72136945,0.000038600894,0.22683977,0.000639346],"about_ca_topic_score_codex":0.0010215961,"about_ca_topic_score_gemma":0.00016418121,"teacher_disagreement_score":0.2637329,"about_ca_system_score_codex":0.00038811128,"about_ca_system_score_gemma":0.00012986148,"threshold_uncertainty_score":0.9998313},"labels":[],"label_agreement":null},{"id":"W2063193285","doi":"10.4161/onci.28329","title":"Natural killer T cell strategies to combat Epstein–Barr virus infection","year":2014,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Child and Family Research Institute; University of British Columbia","funders":"","keywords":"Natural killer T cell; Virus; Immune system; Epstein–Barr virus; CD1D; Immunology; Biology; Effector; Virology; Cell; Natural killer cell; T cell; Cytotoxic T cell; In vitro","score_opus":0.007527886998474594,"score_gpt":0.23421357835513607,"score_spread":0.22668569135666147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063193285","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8922425,0.0021268656,0.0035247903,0.00084756286,0.04222386,0.00038250317,0.0000018781644,0.00044548712,0.05820454],"genre_scores_gemma":[0.9467779,0.0001489636,0.000057331144,0.0010251272,0.00008206463,0.000043832493,0.00013768565,0.00003016166,0.051696934],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99826247,0.0004129855,0.00039052957,0.00040197553,0.00003876116,0.0004932763],"domain_scores_gemma":[0.99910605,0.00015228822,0.0001535447,0.00045201046,0.000111406946,0.000024684414],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00022954827,0.00028033796,0.00036928602,0.00027904566,0.0003188783,0.000048702932,0.00021955531,0.00041648743,0.002961842],"category_scores_gemma":[0.00008492939,0.000259091,0.0001395412,0.00020318027,0.00016075691,0.00028905994,0.00012615361,0.00069155806,0.01306036],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036927598,0.00017731907,0.0003612585,0.000011602932,0.00010566718,0.0000013024887,0.00048280598,0.00006175593,0.9503095,0.0032124026,0.037026327,0.007880741],"study_design_scores_gemma":[0.001348739,0.0009235576,0.016273707,0.000017642773,0.000032431737,0.00009817509,0.00035985434,0.000016230964,0.13274753,0.00015998595,0.847707,0.00031519498],"about_ca_topic_score_codex":0.0012818979,"about_ca_topic_score_gemma":0.00025152732,"teacher_disagreement_score":0.817562,"about_ca_system_score_codex":0.00012196234,"about_ca_system_score_gemma":0.000056334036,"threshold_uncertainty_score":0.9999861},"labels":[],"label_agreement":null},{"id":"W2064415726","doi":"10.4161/2162402x.2014.974374","title":"High endothelial venules are rare in colorectal cancers but accumulate in extra-tumoral areas with disease progression","year":2015,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Medical Research Council; Wellcome Trust","keywords":"Medicine; Colorectal cancer; Disease; High endothelial venules; Cancer research; Pathology; Cancer; Endothelium; Internal medicine","score_opus":0.018742191533093807,"score_gpt":0.2794869923474949,"score_spread":0.2607448008144011,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064415726","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937422,0.0053291623,0.000015261416,0.00018786656,0.00025211513,0.00024337483,0.000072471936,0.000012726558,0.00014477072],"genre_scores_gemma":[0.9989049,0.00020724467,0.00016204471,0.0000979552,0.00016405713,0.0001626267,0.00013614468,0.000028790997,0.00013622688],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988671,0.00010583302,0.00019497373,0.0003759388,0.0001101339,0.00034600726],"domain_scores_gemma":[0.9994927,0.000008969169,0.00011655579,0.00022650378,0.000059753114,0.00009550453],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010862548,0.00018679407,0.0002427974,0.00007412655,0.000033521177,0.000012259351,0.00018915774,0.00016501265,0.00001731482],"category_scores_gemma":[0.000046411365,0.00015639156,0.00005018494,0.000117178104,0.00017448966,0.000007783869,0.000092558,0.00012174276,0.000007931765],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01047394,0.00031077748,0.8360198,0.000036021465,0.00008466461,0.00070482027,0.00029268424,0.0015289236,0.13954459,0.00013845798,0.0006133011,0.010252],"study_design_scores_gemma":[0.009700665,0.0020088155,0.86705154,0.00035332155,0.00004298271,0.000094075214,0.0011693347,0.00013415137,0.097580336,0.00025657602,0.020744609,0.00086360675],"about_ca_topic_score_codex":0.00045434135,"about_ca_topic_score_gemma":0.0017228035,"teacher_disagreement_score":0.041964255,"about_ca_system_score_codex":0.00017258796,"about_ca_system_score_gemma":0.00049852696,"threshold_uncertainty_score":0.6377463},"labels":[],"label_agreement":null},{"id":"W2071355800","doi":"10.4161/21624011.2014.944056","title":"Transcriptional profiling of whole blood: a rich source of immune biomarkers in cancer","year":2014,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"","keywords":"Medicine; Tremelimumab; Immunotherapy; Cancer immunotherapy; Peripheral blood; Immune system; Cancer; Immunology; Whole blood; Gene expression profiling; Immune Dysfunction; Oncology; Internal medicine; Gene expression; Gene; Biology; Ipilimumab","score_opus":0.015273027825085274,"score_gpt":0.2774577912047784,"score_spread":0.26218476337969315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071355800","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9857,0.011481425,0.00019060924,0.00080464536,0.00022287041,0.0002626704,0.000012907956,0.00001981509,0.0013050513],"genre_scores_gemma":[0.9980815,0.0005180187,0.00079473446,0.0001091126,0.000034016546,0.000042074167,0.000024434645,0.000019670992,0.00037644582],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987032,0.00009743151,0.0006061692,0.00020459673,0.00015210552,0.0002365183],"domain_scores_gemma":[0.99931145,0.00007970281,0.00022077264,0.00027629576,0.0000891535,0.000022604241],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043737344,0.00013456955,0.0005046515,0.00026117163,0.000023538545,0.000001962341,0.00013234882,0.00016983117,0.00021373658],"category_scores_gemma":[0.000046271995,0.00012174543,0.00015605216,0.0003810008,0.00033256656,0.000040333518,0.00002113211,0.00017276563,0.0000031442692],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024760112,0.00037870897,0.03870962,0.00016057932,0.00056995865,0.000002280864,0.00051453593,0.000011124597,0.93141025,0.000206993,0.000021768836,0.025538163],"study_design_scores_gemma":[0.014067553,0.0016959412,0.46345177,0.0006455321,0.000251339,0.000081404214,0.0008161857,0.00021673669,0.5043589,0.00011127081,0.014054544,0.00024883132],"about_ca_topic_score_codex":0.0018997836,"about_ca_topic_score_gemma":0.00011180415,"teacher_disagreement_score":0.42705137,"about_ca_system_score_codex":0.00006587752,"about_ca_system_score_gemma":0.00018875784,"threshold_uncertainty_score":0.49646342},"labels":[],"label_agreement":null},{"id":"W2071754795","doi":"10.4161/onci.26770","title":"TCR/CD3 activation and co-stimulation combined in one T cell retargeting system improve anti-tumor immunity","year":2013,"lang":"en","type":"article","venue":"OncoImmunology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Retargeting; T cell; T-cell receptor; Cancer research; Antigen; CD3; Bispecific antibody; Immunity; Co-stimulation; Cell; Chimeric antigen receptor; Medicine; Stimulation; Antibody; Immunology; Immune system; CD28; CD8; Biology; Computer science; Monoclonal antibody; Internal medicine","score_opus":0.023860766809999833,"score_gpt":0.2860688319584116,"score_spread":0.2622080651484118,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071754795","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99076766,0.00025384614,0.00008906206,0.00047999984,0.00011093191,0.001209744,0.000002286991,0.00009069082,0.006995792],"genre_scores_gemma":[0.99802434,0.00005945354,0.00031722494,0.00008341161,0.000054690572,0.00007662476,0.00008105123,0.000034676286,0.0012685138],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99843,0.00028978457,0.00040408643,0.0002915514,0.00019884633,0.0003857378],"domain_scores_gemma":[0.99888825,0.00028489745,0.00016692365,0.0004165346,0.00018080206,0.00006259157],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000563177,0.00016637027,0.00047542033,0.0002822023,0.00011017974,0.000031174724,0.00010740659,0.00019869943,0.00064985483],"category_scores_gemma":[0.00015060412,0.00016469293,0.000045192413,0.0002509974,0.00013822953,0.00018184174,0.00008473029,0.0006069714,0.00012226198],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004181992,0.00022094318,0.028084848,0.00020661703,0.00004280087,0.000009446971,0.0004254834,0.000006567857,0.9624259,0.000081594495,0.000030736406,0.0080468925],"study_design_scores_gemma":[0.007872058,0.0013621016,0.7036634,0.00024088156,0.000030989184,0.000043978765,0.0016513573,0.006917732,0.2773582,0.00008635218,0.0005302672,0.00024268313],"about_ca_topic_score_codex":0.0021970554,"about_ca_topic_score_gemma":0.000011690557,"teacher_disagreement_score":0.68506765,"about_ca_system_score_codex":0.00038641092,"about_ca_system_score_gemma":0.00010587547,"threshold_uncertainty_score":0.71154547},"labels":[],"label_agreement":null},{"id":"W2071932221","doi":"10.4161/2162402x.2014.994441","title":"Tregs activated by bispecific antibodies","year":2015,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Bispecific antibody; Tumor microenvironment; Cancer research; Antibody; CD3; Medicine; Immunology; Chemistry; Tumor cells; Immune system; Monoclonal antibody; CD8","score_opus":0.05954470185408708,"score_gpt":0.33956369655357954,"score_spread":0.2800189946994925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071932221","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8934566,0.0055309706,0.000014030098,0.00634301,0.00028375618,0.00017525464,0.000021985876,0.00010783336,0.0940666],"genre_scores_gemma":[0.93499863,0.0009717388,0.0003333673,0.00040874636,0.0001611998,0.000015676302,0.00017585303,0.00002764617,0.06290713],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99872965,0.000079904545,0.0002174829,0.00026826398,0.00027089557,0.00043379478],"domain_scores_gemma":[0.99921894,0.00007950766,0.000051621097,0.00029188063,0.00016933425,0.00018871286],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00016103263,0.00016723442,0.0003982106,0.00013746701,0.000078925754,0.000015110287,0.0001536918,0.00016261141,0.00047552958],"category_scores_gemma":[0.000112069116,0.00012684982,0.00008474389,0.0002297657,0.00034253346,0.00007018711,0.00010863199,0.00035365773,0.0009976692],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021757435,0.00047658436,0.018183602,0.000037193753,0.0002987104,0.00023394461,0.00057051145,4.845324e-7,0.71197474,0.0016045764,0.23310821,0.031335704],"study_design_scores_gemma":[0.0021177807,0.0011167522,0.016334426,0.00003557982,0.000026328806,0.00040064377,0.00076258724,0.000017280348,0.07670859,0.00032165396,0.9019669,0.00019141944],"about_ca_topic_score_codex":0.0003730402,"about_ca_topic_score_gemma":0.000009612102,"teacher_disagreement_score":0.66885877,"about_ca_system_score_codex":0.0000989252,"about_ca_system_score_gemma":0.00018396154,"threshold_uncertainty_score":0.9997802},"labels":[],"label_agreement":null},{"id":"W2075737968","doi":"10.4161/21624011.2014.970025","title":"Ectopic expression of embryonic stem cell and other developmental genes in cutaneous T-cell lymphoma","year":2014,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health; University of British Columbia; Université Laval; Quest University Canada; McGill University Health Centre","funders":"National Cancer Institute; Novo Nordisk Fonden","keywords":"SOX2; Homeobox protein NANOG; Biology; Cancer research; Stem cell; Carcinogenesis; Ectopic expression; Embryonic stem cell; KLF4; Phenotype; Gene; Cutaneous T-cell lymphoma; Cancer stem cell; Stem cell marker; Cancer; Lymphoma; Genetics; Immunology; Induced pluripotent stem cell; Mycosis fungoides","score_opus":0.015121044678659688,"score_gpt":0.2631689459095448,"score_spread":0.24804790123088513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075737968","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9817533,0.0031033535,0.000035803016,0.000099034514,0.000056957644,0.00031560694,0.0000032073515,0.000022564105,0.014610172],"genre_scores_gemma":[0.9950346,0.00031508305,0.0005484157,0.00013508768,0.000018698576,0.0000240081,0.0000051514266,0.000030590963,0.0038884026],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99873674,0.00016257324,0.00028670987,0.00030982547,0.0001725827,0.00033155738],"domain_scores_gemma":[0.99941576,0.00015513666,0.00008453036,0.00023366627,0.000055544417,0.000055389555],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013161142,0.00016760419,0.00041924007,0.00022027666,0.00005053281,0.0000071157538,0.00012395704,0.00018161858,0.00015517976],"category_scores_gemma":[0.000025699212,0.00014687603,0.00004197558,0.00014323035,0.00021089982,0.000024893605,0.00013117705,0.000116362935,0.000050308387],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051078334,0.0005031825,0.16183415,0.00019736317,0.000017748833,0.00010273758,0.0010476534,0.0000028293784,0.79243463,0.00004673269,0.00006155602,0.043240603],"study_design_scores_gemma":[0.012151032,0.0018901468,0.029201549,0.00021561833,0.000031383533,0.004729452,0.0027732477,0.0004467716,0.92738223,0.00014311745,0.020633679,0.00040174933],"about_ca_topic_score_codex":0.00015486308,"about_ca_topic_score_gemma":0.000080009646,"teacher_disagreement_score":0.1349476,"about_ca_system_score_codex":0.00017204706,"about_ca_system_score_gemma":0.00024236176,"threshold_uncertainty_score":0.59894305},"labels":[],"label_agreement":null},{"id":"W2077023409","doi":"10.4161/onci.24754","title":"Myeloid-derived suppressor cells, age and cancer","year":2013,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; McMaster University Medical Centre","funders":"","keywords":"Suppressor; Myeloid-derived Suppressor Cell; Cancer; Cancer research; Myeloid; Myeloid cells; Immunology; Medicine; Biology; Internal medicine","score_opus":0.010878609211907208,"score_gpt":0.2350063358891916,"score_spread":0.2241277266772844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077023409","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9412182,0.047392234,0.000027319229,0.0010623136,0.003822778,0.0004836508,0.000025842499,0.00017829555,0.0057893577],"genre_scores_gemma":[0.9680427,0.0042055324,0.00023997613,0.0008312134,0.000058387886,0.00038217878,0.000053582648,0.000053113086,0.026133321],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99820846,0.0002255346,0.00035342269,0.00048364993,0.000031547428,0.0006973554],"domain_scores_gemma":[0.9990291,0.00017297253,0.00014555782,0.0005357749,0.00009115241,0.000025458667],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00009195604,0.0003002609,0.0004767276,0.00011998962,0.00022398982,0.00003278866,0.000404738,0.0005462602,0.010072612],"category_scores_gemma":[0.00003295489,0.00027431652,0.000077657314,0.00011167876,0.0009402913,0.00016654881,0.00032868973,0.00056710123,0.003257214],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000529417,0.00006192189,0.00047955554,0.000018312918,0.00022742523,0.000013335617,0.0005901393,0.0000019589402,0.94940734,0.00018249598,0.019006724,0.029957838],"study_design_scores_gemma":[0.0019109532,0.00017915407,0.032444168,0.000031776366,0.00005369557,0.00008372348,0.00042793303,0.0000020145171,0.6074911,0.00034677915,0.35663354,0.00039518008],"about_ca_topic_score_codex":0.0025121863,"about_ca_topic_score_gemma":0.00007326279,"teacher_disagreement_score":0.34191626,"about_ca_system_score_codex":0.00009459617,"about_ca_system_score_gemma":0.000081757586,"threshold_uncertainty_score":0.9999709},"labels":[],"label_agreement":null},{"id":"W2080254064","doi":"10.4161/onci.26705","title":"A<sub>2A</sub>blockade enhances anti-metastatic immune responses","year":2013,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"National Health and Medical Research Council; Medical Research Council; National Evidence-based Healthcare Collaborating Agency","keywords":"Blockade; Immunosuppression; Medicine; Adenosine; Immune system; Metastatic melanoma; Adenosine receptor; Metastatic breast cancer; Cancer research; Immunotherapy; Receptor; Cancer; Immune checkpoint; Immunology; Melanoma; Breast cancer; Internal medicine; Agonist","score_opus":0.009144183630438738,"score_gpt":0.24564945300201316,"score_spread":0.23650526937157443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080254064","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.979439,0.018000431,0.00049412245,0.0005644092,0.000309086,0.00020828845,0.000007735059,0.00003710523,0.0009398065],"genre_scores_gemma":[0.9953921,0.0018439193,0.00049118826,0.0002992498,0.00021727555,0.00008134969,0.00008723029,0.000035331363,0.0015523459],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99847937,0.00019657296,0.00037053938,0.00040243386,0.00010433829,0.00044675145],"domain_scores_gemma":[0.9991071,0.00007125838,0.000155476,0.0004978479,0.000112104724,0.000056164852],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001759982,0.00023879857,0.00031124405,0.000092860064,0.00013655964,0.00003406963,0.0003336567,0.00019400808,0.00021576785],"category_scores_gemma":[0.0001705147,0.00021889672,0.00012679181,0.00013577587,0.0002168856,0.000010824002,0.00018351377,0.00018082446,0.00043021535],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007708438,0.00007761952,0.0006371448,0.000011088404,0.00013449279,0.000013392558,0.000052663443,0.00001576057,0.99169886,0.000051243987,0.00436523,0.0028653964],"study_design_scores_gemma":[0.00060589425,0.00040977422,0.011958417,0.000018897443,0.000029690384,0.00012721251,0.00017150023,0.000014192408,0.9701593,0.00019303415,0.016029961,0.00028212077],"about_ca_topic_score_codex":0.00016231935,"about_ca_topic_score_gemma":0.000006008552,"teacher_disagreement_score":0.021539576,"about_ca_system_score_codex":0.000014071419,"about_ca_system_score_gemma":0.00011257292,"threshold_uncertainty_score":0.8926349},"labels":[],"label_agreement":null},{"id":"W2080830471","doi":"10.4161/onci.1.2.18101","title":"The double-edge sword effect of anti-CD73 cancer therapy","year":2012,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"SWORD; Medicine; Cancer; Immune system; Cancer research; Blockade; Targeted therapy; Cancer cell; Immunology; Internal medicine; Receptor; Computer science","score_opus":0.013532766654919433,"score_gpt":0.29495619015776603,"score_spread":0.2814234235028466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080830471","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8993057,0.09833412,0.000037449812,0.00016940506,0.0005214014,0.00012391822,0.0000027519436,0.000007900172,0.0014973509],"genre_scores_gemma":[0.9921952,0.006213121,0.000015415439,0.00008779798,0.00041229135,0.00004626675,0.000016446467,0.000017403483,0.0009960777],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992233,0.00011179224,0.00016252307,0.00013364851,0.000059192596,0.00030953166],"domain_scores_gemma":[0.999451,0.00006045864,0.00009975296,0.00031960427,0.000041003346,0.000028218557],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027645187,0.00012849853,0.00017663608,0.000019784728,0.00010693839,0.000006127203,0.00022907527,0.00015548992,0.000050349987],"category_scores_gemma":[0.000018481533,0.00007943775,0.00008958024,0.00007001282,0.00015329817,0.000003348969,0.00008246488,0.00010035446,0.00001176821],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006929166,0.000049778846,0.036607645,0.000008508708,0.00022335256,7.0158876e-7,0.000083561165,0.000013082478,0.94295156,0.00032462055,0.0065195607,0.012524711],"study_design_scores_gemma":[0.0012667376,0.0004150096,0.010816017,0.000006535717,0.000016785982,0.000013656663,0.000024420722,0.0000013961626,0.69553846,0.000006855457,0.2917942,0.000099925805],"about_ca_topic_score_codex":0.000112204456,"about_ca_topic_score_gemma":0.000004283303,"teacher_disagreement_score":0.28527465,"about_ca_system_score_codex":0.000008287217,"about_ca_system_score_gemma":0.00003961926,"threshold_uncertainty_score":0.32393774},"labels":[],"label_agreement":null},{"id":"W2087198431","doi":"10.4161/onci.27988","title":"NKp44L","year":2014,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Nautical Research Society","funders":"","keywords":"Cytotoxicity; Ligand (biochemistry); Cancer research; Cancer; Immunotherapy; Receptor; Computational biology; Biology; Immunology; Medicine; Immune system; In vitro; Biochemistry; Genetics","score_opus":0.00795300873703434,"score_gpt":0.22066106657538942,"score_spread":0.21270805783835509,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2087198431","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.43570107,0.0039383615,0.006762842,0.0021888255,0.03229756,0.00028179184,0.000002020388,0.00079975196,0.5180278],"genre_scores_gemma":[0.9277229,0.000045471188,0.000055643737,0.0008124552,0.00004877227,0.000016416034,0.0000717277,0.000015261925,0.07121137],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99902964,0.00022599175,0.00022114605,0.00021726808,0.000015507387,0.00029044598],"domain_scores_gemma":[0.99940574,0.000117552925,0.00008496331,0.00032906196,0.000054131317,0.000008576822],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00018686459,0.0001287086,0.00020104615,0.000111705296,0.0001635694,0.000009600134,0.00017402184,0.0002489439,0.0063025896],"category_scores_gemma":[0.00012476942,0.000117038806,0.00008186537,0.00008868587,0.00015423758,0.00008937953,0.000057718084,0.00032437712,0.017417965],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017025042,0.0001208015,0.00074437197,0.0000043541013,0.00011638094,8.804411e-7,0.00018053933,0.0000030047925,0.86445886,0.019316802,0.05931927,0.05556451],"study_design_scores_gemma":[0.000877573,0.00029429203,0.0060676914,0.0000064299593,0.000013400968,0.000131169,0.00011378163,0.000007989529,0.051120274,0.00026895964,0.94096637,0.0001320694],"about_ca_topic_score_codex":0.00007005402,"about_ca_topic_score_gemma":0.000006334164,"teacher_disagreement_score":0.8816471,"about_ca_system_score_codex":0.00003901723,"about_ca_system_score_gemma":0.000018803754,"threshold_uncertainty_score":0.9946058},"labels":[],"label_agreement":null},{"id":"W2092063434","doi":"10.4161/onci.23472","title":"Analysis of NKp30/NCR3 isoforms in untreated HIV-1-infected patients from the ANRS SEROCO cohort","year":2013,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research; Institut National Du Cancer; Ligue Contre le Cancer; Agence Nationale de la Recherche","keywords":"CD16; Cohort; Immunology; Medicine; Downregulation and upregulation; Disease; Immune system; Innate immune system; CD8; Cancer research; Biology; Internal medicine; CD3; Gene","score_opus":0.0048941428281209015,"score_gpt":0.20144396618921967,"score_spread":0.19654982336109877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092063434","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945992,0.00054640905,0.00004127562,0.0002520925,0.0013730479,0.00043412042,0.00003116078,0.00006032361,0.0026623306],"genre_scores_gemma":[0.9925723,0.0001387746,0.000008358368,0.00028618416,0.000009115934,0.00007477796,0.0025899694,0.000015521953,0.004305016],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982663,0.00037322438,0.0006321205,0.00032358934,0.000042073974,0.0003626999],"domain_scores_gemma":[0.9985455,0.00035681776,0.00032101944,0.00053438905,0.00023109415,0.000011171021],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00014077655,0.00021832506,0.00058397016,0.00039453714,0.00012262889,0.000013952897,0.00030596563,0.00040427665,0.011450097],"category_scores_gemma":[0.00013996214,0.00015140088,0.00019678322,0.0008878491,0.00025366168,0.00019558745,0.00010635031,0.00045121778,0.002204111],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023168563,0.0003315627,0.9066037,0.0000017595908,0.0024932455,5.571561e-7,0.0005512777,0.000030293244,0.08071837,0.000048284022,0.0053854752,0.0036037792],"study_design_scores_gemma":[0.0017530808,0.00019807108,0.975969,0.000014256048,0.0004087652,0.0000021631788,0.00048453978,0.00008116761,0.007667093,0.000025602047,0.013243098,0.00015311786],"about_ca_topic_score_codex":0.012206327,"about_ca_topic_score_gemma":0.0006376813,"teacher_disagreement_score":0.073051274,"about_ca_system_score_codex":0.0001221725,"about_ca_system_score_gemma":0.0000381082,"threshold_uncertainty_score":0.99857277},"labels":[],"label_agreement":null},{"id":"W2106492804","doi":"10.4161/onci.27622","title":"Two is better than one: Complementing oncolytic virotherapy with gemcitabine to potentiate antitumor immune responses","year":2014,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Izaak Walton Killam Health Centre; Dalhousie University","funders":"","keywords":"Oncolytic virus; Virotherapy; Immune system; Immunosuppression; Gemcitabine; Cancer research; Cancer; Immunology; Biology; Medicine; Internal medicine","score_opus":0.018314062069322037,"score_gpt":0.3078933072238697,"score_spread":0.2895792451545477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106492804","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925549,0.00076423836,0.0020042511,0.0030570237,0.00011144284,0.0005007095,0.000025230584,0.000040553958,0.00094166904],"genre_scores_gemma":[0.9910817,0.00013824369,0.0028396628,0.0033472246,0.00023929501,0.00009894491,0.00008388291,0.00008943028,0.0020816163],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99755806,0.00042399095,0.00037005608,0.00063856156,0.00026003167,0.0007492999],"domain_scores_gemma":[0.9985516,0.00004768073,0.00013985604,0.0010040703,0.00015515405,0.00010165635],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007039542,0.0003043206,0.00039865842,0.00019118637,0.00023867792,0.00005537455,0.0005776081,0.00012757309,0.0003484464],"category_scores_gemma":[0.000053439653,0.00027911615,0.00011335319,0.0002363407,0.00022642908,0.00000847003,0.00026210063,0.0002326932,0.00021589229],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006692484,0.00015461922,0.0044621457,0.000010719329,0.0003095432,0.000008429465,0.00010577558,0.000020081148,0.97508955,0.000057624096,0.00021781719,0.012871233],"study_design_scores_gemma":[0.004783581,0.0132167125,0.031277426,0.000051280702,0.000035800207,0.000053998367,0.00009331297,0.000053920252,0.8995399,0.000097947195,0.0502639,0.0005322556],"about_ca_topic_score_codex":0.00017399967,"about_ca_topic_score_gemma":0.00042547385,"teacher_disagreement_score":0.07554966,"about_ca_system_score_codex":0.000048263508,"about_ca_system_score_gemma":0.00013438624,"threshold_uncertainty_score":0.9999661},"labels":[],"label_agreement":null},{"id":"W2123262599","doi":"10.1080/2162402x.2015.1008791","title":"Understanding high endothelial venules: Lessons for cancer immunology","year":2015,"lang":"en","type":"review","venue":"OncoImmunology","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":92,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"National Heart, Lung, and Blood Institute; Medical Research Council; Wellcome Trust","keywords":"High endothelial venules; Lymphotoxin; Immunology; Lymphotoxin beta receptor; Biology; Lymphatic system; Lymphangiogenesis; CD11c; Inflammation; Immune system; Tumor microenvironment; Cancer research; Medicine; Cancer; Metastasis","score_opus":0.20970323727528145,"score_gpt":0.3848510287832197,"score_spread":0.17514779150793824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123262599","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00001696502,0.98338634,0.0006078282,0.0003964269,0.010704549,0.002048669,0.002007239,0.00030993085,0.0005220731],"genre_scores_gemma":[0.00012949198,0.9841571,0.00010041464,0.00010339464,0.00029358212,0.0022033984,0.0018961177,0.0003092111,0.010807289],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99381924,0.0016761912,0.0015370866,0.001185936,0.00008712217,0.0016944106],"domain_scores_gemma":[0.9954837,0.0016203781,0.001247521,0.0013757902,0.00022935569,0.000043260377],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","insufficient_payload"],"category_scores_codex":[0.0009805006,0.0013022317,0.0047762687,0.00087976456,0.00071439194,0.00005924201,0.001609164,0.0032762054,0.0011097661],"category_scores_gemma":[0.00029885728,0.0011403329,0.0012723558,0.0004777213,0.0013223267,0.000166132,0.0003876058,0.0017695375,0.0014638474],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012494145,0.00030069592,6.548191e-7,0.0019581472,0.006923697,0.000020476948,0.0004950697,0.0000011616744,0.0026319392,0.02901642,0.009303896,0.9480984],"study_design_scores_gemma":[0.0035163695,0.000878522,0.0000023694777,0.0031638579,0.0016069012,0.000560033,0.00034186913,1.868245e-7,0.00028292168,0.0013785693,0.98716754,0.0011008788],"about_ca_topic_score_codex":0.0003289203,"about_ca_topic_score_gemma":0.000054464337,"teacher_disagreement_score":0.9778636,"about_ca_system_score_codex":0.001856285,"about_ca_system_score_gemma":0.0026084331,"threshold_uncertainty_score":0.99997294},"labels":[],"label_agreement":null},{"id":"W2130024935","doi":"10.4161/onci.23621","title":"Lessons learned from a highly-active CD22-specific chimeric antigen receptor","year":2013,"lang":"en","type":"article","venue":"OncoImmunology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"","keywords":"CD22; Chimeric antigen receptor; Epitope; Antigen; Bispecific antibody; Receptor; Antibody; Immunology; Computational biology; Cancer research; Medicine; Immunotherapy; Biology; Monoclonal antibody; Internal medicine; Immune system","score_opus":0.07570445915132859,"score_gpt":0.34021376943611,"score_spread":0.2645093102847814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2130024935","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95011336,0.003029833,0.000060161317,0.017706066,0.00064165716,0.00079978304,0.000033065535,0.00018908705,0.027426977],"genre_scores_gemma":[0.9395764,0.011949884,0.0020254282,0.0006733328,0.00068734935,0.00030273138,0.00037497297,0.00013937803,0.044270534],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978806,0.00023773138,0.00032349356,0.0006039998,0.00029155938,0.00066263275],"domain_scores_gemma":[0.99837637,0.00025535666,0.00011388836,0.00090513314,0.00019315637,0.00015608434],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00014229605,0.000261017,0.0006329252,0.00023177815,0.00013693584,0.00004066458,0.00032665516,0.00031927926,0.06862086],"category_scores_gemma":[0.00008388387,0.00023347214,0.00016948339,0.00041042204,0.00041136472,0.00013572704,0.00017083657,0.00076978194,0.010004231],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005264676,0.00019588784,0.00069523987,0.0000037929121,0.00028032454,0.000020136433,0.00063192745,2.3237746e-7,0.6595682,0.00016079453,0.0060649,0.3318521],"study_design_scores_gemma":[0.003156278,0.0008753847,0.13641529,0.000045468038,0.000026354965,0.0000440548,0.0010936243,0.000022918552,0.07344133,0.00085274887,0.7837338,0.00029278666],"about_ca_topic_score_codex":0.002648021,"about_ca_topic_score_gemma":0.000022133627,"teacher_disagreement_score":0.7776689,"about_ca_system_score_codex":0.00029415928,"about_ca_system_score_gemma":0.00020120834,"threshold_uncertainty_score":0.9907666},"labels":[],"label_agreement":null},{"id":"W2159829076","doi":"10.4161/onci.27897","title":"Role of the complement system in NK cell-mediated antitumor T-cell responses","year":2014,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Armand Frappier Museum; Institut National de la Recherche Scientifique; Université du Québec à Montréal","funders":"","keywords":"Complement system; Complement (music); Immunology; Complement receptor; Cancer research; Carcinogenesis; CD8; Cell; Biology; Immune system; Cancer; Phenotype; Gene","score_opus":0.009471826718366015,"score_gpt":0.2281227994439035,"score_spread":0.2186509727255375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2159829076","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.984084,0.0048892475,0.00001492083,0.00012423795,0.0008484194,0.0005917492,0.00011495282,0.00007752328,0.009254921],"genre_scores_gemma":[0.99878037,0.000024179697,0.000026157279,0.000064497086,0.000016768963,0.00007722925,0.00007398568,0.000021095691,0.00091569085],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.996875,0.0015125993,0.0007302844,0.00033485633,0.00006578231,0.00048149607],"domain_scores_gemma":[0.9980124,0.00065852545,0.00041010295,0.0008279745,0.00007518163,0.00001577613],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005835117,0.00022336931,0.00053551217,0.00020382444,0.00014513903,0.000006891513,0.0007471215,0.00017343102,0.00048820194],"category_scores_gemma":[0.00013223109,0.00017212548,0.00013429529,0.0002459241,0.0003210871,0.00003727996,0.0003764928,0.00025258333,0.00057380646],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029713695,0.00035231208,0.0688336,0.00014366332,0.000055847177,0.000002262224,0.00035394132,0.000010028133,0.9254991,0.0029068831,0.0012308089,0.00031441535],"study_design_scores_gemma":[0.0076770284,0.00073925604,0.40222585,0.0003997771,0.00010250406,0.00007857756,0.0067524104,0.00006715823,0.42499653,0.00015086812,0.15632224,0.00048778378],"about_ca_topic_score_codex":0.0005995382,"about_ca_topic_score_gemma":0.00019175206,"teacher_disagreement_score":0.5005026,"about_ca_system_score_codex":0.00013669288,"about_ca_system_score_gemma":0.00012993994,"threshold_uncertainty_score":0.73753124},"labels":[],"label_agreement":null},{"id":"W2163252162","doi":"10.4161/21624011.2014.955691","title":"Consensus guidelines for the detection of immunogenic cell death","year":2014,"lang":"en","type":"review","venue":"OncoImmunology","topic":"Phagocytosis and Immune Regulation","field":"Immunology and Microbiology","cited_by":824,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal; McMaster University; BC Cancer Agency; Institute of Cancer Research; McMaster University Medical Centre; Pancreas Centre (Canada)","funders":"National Institute of Neurological Disorders and Stroke; National Cancer Institute; Cancer Research UK","keywords":"Immunogenic cell death; Calreticulin; Immune system; Programmed cell death; Autophagy; Acquired immune system; Immunology; Endoplasmic reticulum; Antigen; Medicine; Cancer research; Biology; Apoptosis; Immunotherapy; Cell biology","score_opus":0.10494768991068182,"score_gpt":0.3646024099074481,"score_spread":0.25965471999676626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2163252162","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000672221,0.9936241,0.001664637,0.000078501624,0.002765546,0.0014142325,0.00009729014,0.000061475905,0.00022700235],"genre_scores_gemma":[0.0018787298,0.9944531,0.00012025868,0.000042555188,0.00011675833,0.00040558277,0.0003479286,0.0000794739,0.0025556427],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99667245,0.0006403004,0.0016695369,0.00047517827,0.000043545602,0.00049897545],"domain_scores_gemma":[0.9948765,0.0019555734,0.0015763021,0.0010662915,0.00051495776,0.000010384288],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008941085,0.0005437882,0.0023541597,0.00024049211,0.00034170155,0.0000124658145,0.0007608947,0.001283405,0.00009451782],"category_scores_gemma":[0.0004969642,0.00034981922,0.0012137269,0.00021277157,0.00042227737,0.000027017491,0.00018265066,0.00054063,0.00026067352],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008661229,0.00006737345,7.120563e-7,0.0018651861,0.0010954611,2.4402718e-7,0.000023442604,0.0000023717655,0.026535813,0.00030004175,0.0011034389,0.9689193],"study_design_scores_gemma":[0.0009856567,0.00041731415,0.000020935488,0.0009998796,0.0018770976,0.00020546379,0.000036089226,0.0000087688495,0.005191081,0.0000646785,0.9898671,0.00032596439],"about_ca_topic_score_codex":0.00014817371,"about_ca_topic_score_gemma":0.0000139911945,"teacher_disagreement_score":0.98876363,"about_ca_system_score_codex":0.000121916186,"about_ca_system_score_gemma":0.00031839032,"threshold_uncertainty_score":0.9998954},"labels":[],"label_agreement":null},{"id":"W2165582666","doi":"10.1080/2162402x.2015.1046675","title":"CD73: A potential biomarker for anti-PD-1 therapy","year":2015,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Biomarker; Blockade; Concomitant; Disease; Clinical trial; Oncology; Pharmacology; Internal medicine; Receptor; Biology","score_opus":0.04289721207157496,"score_gpt":0.29771285353848065,"score_spread":0.2548156414669057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2165582666","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9741157,0.0142962,0.008817331,0.0005281002,0.0005830276,0.00021108627,0.000014581966,0.000025008341,0.0014089427],"genre_scores_gemma":[0.99611515,0.00034564006,0.0009782648,0.0004563307,0.00037638366,0.000043315733,0.00017954127,0.000026700012,0.0014786547],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992038,0.000051714513,0.00015898062,0.000262831,0.000060275717,0.00026242225],"domain_scores_gemma":[0.99948776,0.000010285785,0.000064692,0.00026987476,0.000115884555,0.000051479405],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016832369,0.00013326407,0.00015736357,0.000042281175,0.000059173064,0.000013336809,0.00019061116,0.00021333233,0.0000319099],"category_scores_gemma":[0.000052021125,0.00011843453,0.000099355035,0.00005747038,0.00008444237,0.0000030251545,0.00007211006,0.00005562723,0.000023334742],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00066061463,0.000111706024,0.0009105902,0.000004181787,0.00018821385,0.000009744703,0.000063791354,0.000050980023,0.9164473,0.0001938348,0.0748141,0.006544973],"study_design_scores_gemma":[0.0043504736,0.0012678911,0.0034170852,0.0000059915938,0.000023761546,0.00015125956,0.00020851768,0.00012212494,0.156766,0.0005196961,0.8328289,0.00033834868],"about_ca_topic_score_codex":0.000037093963,"about_ca_topic_score_gemma":0.0000014850054,"teacher_disagreement_score":0.7596813,"about_ca_system_score_codex":0.000010052161,"about_ca_system_score_gemma":0.00011840805,"threshold_uncertainty_score":0.482962},"labels":[],"label_agreement":null},{"id":"W2165986055","doi":"10.4161/onci.24501","title":"Synchronous apoptosis in established tumors leads to the induction of adaptive immunity","year":2013,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Phagocytosis and Immune Regulation","field":"Immunology and Microbiology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; Health Sciences Centre","funders":"Cancer Research UK","keywords":"Immune system; Apoptosis; Immunogenic cell death; Acquired immune system; Programmed cell death; Cancer research; Immunity; Immunology; Caspase; Medicine; Biology; Immunotherapy","score_opus":0.01443459588058328,"score_gpt":0.23468555433767838,"score_spread":0.2202509584570951,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2165986055","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936488,0.0020777746,0.00014622399,0.0011279839,0.0007369414,0.0006500138,0.000007317034,0.00004041161,0.001564494],"genre_scores_gemma":[0.9988496,0.0000723466,0.000101461716,0.0001208353,0.00002048923,0.00019183526,0.000051724637,0.000018836321,0.0005728715],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9980925,0.0005735724,0.00056890864,0.00027946796,0.00004362541,0.00044193197],"domain_scores_gemma":[0.9987854,0.00018696593,0.00024058687,0.00060869555,0.00016370951,0.00001466334],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00040906377,0.00020900746,0.00047311155,0.00031033912,0.00016900824,0.000014515725,0.0004843474,0.0003244165,0.00073278096],"category_scores_gemma":[0.00016873959,0.00015794813,0.000096857555,0.0005443731,0.0003547995,0.0002809075,0.0002131335,0.00052158016,0.00084361515],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017752257,0.00025030645,0.0031948667,0.0000070132523,0.000103285514,2.8149617e-7,0.0017271301,0.00011919499,0.9483538,0.0010453045,0.0013171862,0.043704066],"study_design_scores_gemma":[0.0014367352,0.0009677133,0.62933403,0.00008094062,0.000031288586,0.000048072125,0.0028261063,0.000022662494,0.36056036,0.00036915884,0.0040453062,0.00027764018],"about_ca_topic_score_codex":0.0057911705,"about_ca_topic_score_gemma":0.00019379721,"teacher_disagreement_score":0.62613916,"about_ca_system_score_codex":0.0001728271,"about_ca_system_score_gemma":0.00010432642,"threshold_uncertainty_score":0.9999343},"labels":[],"label_agreement":null},{"id":"W2180740294","doi":"10.1080/2162402x.2015.1048955","title":"Carving out its niche: A role for carbonic anhydrase IX in pre-metastatic niche development","year":2015,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Canadian Centre for Applied Research in Cancer Control; BC Cancer Agency","funders":"","keywords":"Niche; Cancer research; Metastasis; Hypoxia (environmental); Bone marrow; Medicine; Carbonic anhydrase; Biology; Immunology; Enzyme; Chemistry; Cancer; Internal medicine; Biochemistry","score_opus":0.0379765576497468,"score_gpt":0.29800849841749366,"score_spread":0.2600319407677469,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2180740294","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92513424,0.06598113,0.0002528698,0.00033553474,0.0037321642,0.0011414988,0.000025065103,0.00014627243,0.0032512404],"genre_scores_gemma":[0.9849969,0.0001704953,0.0011976355,0.0003280213,0.000039871284,0.0007035656,0.0001748907,0.00007302757,0.0123156],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970779,0.0004120357,0.00077843195,0.00062493596,0.0000646029,0.0010421324],"domain_scores_gemma":[0.9984987,0.00036256103,0.00026934844,0.00063610764,0.00019231476,0.000040970473],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008116753,0.00039095283,0.00073007244,0.00029801248,0.00013890819,0.000018236451,0.00066539354,0.00049033784,0.00016309519],"category_scores_gemma":[0.000543556,0.00039400553,0.00011519457,0.00022368286,0.0002453666,0.0001349685,0.00036028383,0.0006788347,0.00084188057],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026206996,0.0011284557,0.014594206,0.00021759582,0.0013968329,0.000069884816,0.03826779,0.00034413452,0.88530624,0.00089261914,0.008028482,0.04713308],"study_design_scores_gemma":[0.014712143,0.001077086,0.010594232,0.00019143087,0.00016888825,0.0002419472,0.0036218048,0.00012529554,0.31313035,0.00078021776,0.6541801,0.0011764902],"about_ca_topic_score_codex":0.000320331,"about_ca_topic_score_gemma":0.0009834121,"teacher_disagreement_score":0.6461516,"about_ca_system_score_codex":0.00075419986,"about_ca_system_score_gemma":0.0012046711,"threshold_uncertainty_score":0.9999361},"labels":[],"label_agreement":null},{"id":"W2233686346","doi":"10.1080/2162402x.2015.1061176","title":"Biological network-driven gene selection identifies a stromal immune module as a key determinant of triple-negative breast carcinoma prognosis","year":2015,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Bioinformatics and Genomic Networks","field":"Biochemistry, Genetics and Molecular Biology","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Response Biomedical (Canada)","funders":"Agence Nationale de la Recherche","keywords":"Triple-negative breast cancer; Gene signature; Breast cancer; Stromal cell; Gene; Computational biology; Cancer research; Gene expression; Medicine; Biology; Cancer; Genetics","score_opus":0.015666360082826656,"score_gpt":0.23930737659338697,"score_spread":0.22364101651056031,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2233686346","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995663,0.0014337689,0.0012544729,0.00008178308,0.0004685432,0.0003665785,0.0000379034,0.000020123556,0.00067381747],"genre_scores_gemma":[0.99604213,0.00016783981,0.0027717494,0.000049391692,0.0002993825,0.00006940841,0.00017216083,0.000021043425,0.00040689445],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99840826,0.00016002406,0.0005294376,0.00033371084,0.00010833908,0.00046025668],"domain_scores_gemma":[0.999002,0.000019202549,0.00034182527,0.0003112032,0.00023996152,0.0000858306],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030271395,0.00023948913,0.0004080392,0.00006304178,0.00011027222,0.000021763197,0.0003105071,0.000427102,0.000022648741],"category_scores_gemma":[0.00006613479,0.00020848952,0.00015892462,0.00017214479,0.00029617336,0.000010929391,0.00030857688,0.00019116409,0.00002226336],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00299698,0.0005440797,0.06309933,0.000045650475,0.00083924783,0.000026476368,0.0010336468,0.0013041879,0.90429336,0.00092658424,0.0040875124,0.020802928],"study_design_scores_gemma":[0.012149733,0.016591853,0.37839156,0.00014367788,0.00032731213,0.0037921418,0.0021450808,0.012862921,0.55675143,0.006495229,0.008306563,0.0020425061],"about_ca_topic_score_codex":0.00024252318,"about_ca_topic_score_gemma":0.00007630702,"teacher_disagreement_score":0.34754196,"about_ca_system_score_codex":0.000046722835,"about_ca_system_score_gemma":0.00020143868,"threshold_uncertainty_score":0.85019565},"labels":[],"label_agreement":null},{"id":"W2240026571","doi":"10.1080/2162402x.2015.1057674","title":"All that glitters is not gold: the need to consider desirable and undesirable immune aspects of oncolytic virus therapy","year":2015,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Izaak Walton Killam Health Centre; Dalhousie University","funders":"","keywords":"Oncolytic virus; Immunosuppression; Medicine; Immune system; Immunology; Cancer; Virus; Cancer therapy; Internal medicine","score_opus":0.08400600607620658,"score_gpt":0.333954609591915,"score_spread":0.2499486035157084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2240026571","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9831208,0.008974861,0.00005389822,0.004455081,0.00016181686,0.0005275752,0.000017352031,0.000017061318,0.0026715372],"genre_scores_gemma":[0.9912684,0.0013983186,0.00018998372,0.0056367335,0.000056336343,0.000051345072,0.000016689035,0.000045712288,0.0013364656],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982376,0.0003204982,0.00028513765,0.0004178202,0.00023091586,0.0005080285],"domain_scores_gemma":[0.9986188,0.000092782764,0.00012413452,0.0008723027,0.00016741295,0.00012456268],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007382669,0.00024165992,0.000354972,0.00010042737,0.00007841688,0.000035219495,0.00048859086,0.00023268406,0.000069679016],"category_scores_gemma":[0.00010097917,0.00018583375,0.00009040329,0.00017689231,0.0004306371,0.000008523954,0.0002473836,0.00020528669,0.000053341275],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004140825,0.00010185388,0.00025895966,0.000006477236,0.00031001036,0.0000066947537,0.0006525653,0.000035465302,0.9864351,0.0002276519,0.0036025166,0.0042218906],"study_design_scores_gemma":[0.0023824235,0.0047508455,0.0013603877,0.000011304829,0.000018841547,0.000042374966,0.0006624181,0.00001554816,0.93854105,0.0005518463,0.05143917,0.00022376714],"about_ca_topic_score_codex":0.0007085374,"about_ca_topic_score_gemma":0.000273318,"teacher_disagreement_score":0.047894016,"about_ca_system_score_codex":0.00006761736,"about_ca_system_score_gemma":0.00039954315,"threshold_uncertainty_score":0.757808},"labels":[],"label_agreement":null},{"id":"W2265669938","doi":"10.1080/2162402x.2014.995562","title":"Natural killer T cell activation overcomes immunosuppression to enhance clearance of postsurgical breast cancer metastasis in mice","year":2015,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Beatrice Hunter Cancer Research Institute; Dalhousie University","funders":"","keywords":"Natural killer T cell; Immunotherapy; Cancer research; Medicine; Cytotoxic T cell; Metastasis; Immunology; CD8; Cancer; Metastatic breast cancer; T cell; Dendritic cell; Myeloid-derived Suppressor Cell; Breast cancer; Immune system; Biology; Internal medicine; In vitro; Suppressor","score_opus":0.010811134840289772,"score_gpt":0.281672839730135,"score_spread":0.27086170488984523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2265669938","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9834968,0.0051083984,0.000064351734,0.0017442416,0.007030715,0.00027873748,0.0000103417,0.000052087165,0.0022143298],"genre_scores_gemma":[0.9888369,0.00025134665,0.000081220496,0.00035268013,0.000025998925,0.000049873554,0.00007085035,0.00002258932,0.010308541],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99822944,0.00039411892,0.00053397863,0.00037884217,0.0000699122,0.0003937141],"domain_scores_gemma":[0.9990498,0.00014274337,0.0002574582,0.0003119169,0.00021203455,0.000026056889],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002727142,0.0002342381,0.0004807413,0.00031220238,0.000070201095,0.000009768676,0.0002799036,0.0003147146,0.001181176],"category_scores_gemma":[0.0000861177,0.0002086211,0.00010897393,0.00037419822,0.00013540192,0.00031535912,0.00014904303,0.0005878075,0.00053293345],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004059562,0.00032601386,0.0010365349,0.0000151136655,0.00008755669,0.000002044911,0.0009644193,0.000100055324,0.97598237,0.000070760354,0.007969388,0.009386184],"study_design_scores_gemma":[0.0020512256,0.0003363512,0.055727065,0.00014690348,0.000025005902,0.000087235756,0.00097407534,0.000012733337,0.8486411,0.000020716923,0.0916949,0.0002827009],"about_ca_topic_score_codex":0.0018449541,"about_ca_topic_score_gemma":0.00005341527,"teacher_disagreement_score":0.12734129,"about_ca_system_score_codex":0.00026091444,"about_ca_system_score_gemma":0.000119968005,"threshold_uncertainty_score":0.9997319},"labels":[],"label_agreement":null},{"id":"W2270967011","doi":"10.1080/2162402x.2015.1090077","title":"Pharmacological DNA demethylation: Implications for cancer immunotherapy","year":2015,"lang":"en","type":"article","venue":"OncoImmunology","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"DNA demethylation; Stimulator of interferon genes; IRF7; Interferon; MDA5; Viral infection; TLR7; Demethylation; Downregulation and upregulation; Cancer immunotherapy; Cancer research; Biology; DNA; Immunotherapy; Cancer; Interferon regulatory factors; DNA methylation; Virology; Innate immune system; Gene; Immunology; RNA; Immune system; Virus; Genetics; Gene expression; Toll-like receptor; RNA interference","score_opus":0.07756765969573012,"score_gpt":0.37292225307251653,"score_spread":0.2953545933767864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2270967011","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87452185,0.08348273,0.0070727714,0.019223064,0.0068568485,0.0016011132,0.00019156301,0.00093164167,0.006118392],"genre_scores_gemma":[0.9875291,0.0008901242,0.0004491415,0.0014003848,0.00010350307,0.0009432216,0.00014620236,0.000054504282,0.008483842],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984471,0.00031146087,0.0003882951,0.00033340466,0.000022024898,0.00049772346],"domain_scores_gemma":[0.9988598,0.0003451051,0.00015443622,0.00031857335,0.0002928787,0.000029190967],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036707794,0.00021956013,0.00037550682,0.00013502686,0.00019137283,0.000016068383,0.0004082251,0.00039352974,0.00074584805],"category_scores_gemma":[0.00016201814,0.0001892302,0.00015347466,0.0001568337,0.0003456706,0.00010469333,0.000082961924,0.00027280036,0.00037305948],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016912767,0.00019697691,0.0010181345,0.00000326619,0.00049976644,5.8392385e-7,0.00039838077,0.00000612971,0.91305816,0.0077214167,0.023247445,0.05215849],"study_design_scores_gemma":[0.0039085452,0.0007933241,0.0135867335,0.000007674825,0.00006286254,0.00007843195,0.00024110381,0.0000036950105,0.1544737,0.0015151472,0.8250824,0.0002463706],"about_ca_topic_score_codex":0.00008140022,"about_ca_topic_score_gemma":0.000017896804,"teacher_disagreement_score":0.80183494,"about_ca_system_score_codex":0.00017255313,"about_ca_system_score_gemma":0.00029505434,"threshold_uncertainty_score":0.8166513},"labels":[],"label_agreement":null},{"id":"W2300857522","doi":"10.1080/2162402x.2015.1025194","title":"Effective combination treatment of GD2-expressing neuroblastoma and Ewing's sarcoma using anti-GD2 ch14.18/CHO antibody with Vγ9Vδ2+ γδT cells","year":2015,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Cancer Research UK","keywords":"Antibody-dependent cell-mediated cytotoxicity; Neuroblastoma; Cancer research; Antibody; Immunotherapy; Cytotoxicity; Cancer; Medicine; Cell culture; In vitro; Biology; Immunology; Monoclonal antibody; Internal medicine; Biochemistry","score_opus":0.03790087040618048,"score_gpt":0.3386236049533383,"score_spread":0.3007227345471578,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2300857522","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966014,0.0006737415,0.00021396996,0.00013659909,0.0001495736,0.0012081938,0.000012523202,0.000064144915,0.00093982654],"genre_scores_gemma":[0.9986165,0.0001505058,0.00086160126,0.000032387143,0.000039353756,0.000039131744,0.000034154644,0.00005121335,0.0001751156],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981749,0.00028214097,0.00028161693,0.0004607483,0.00031182647,0.00048873335],"domain_scores_gemma":[0.9987701,0.00019221233,0.00019917791,0.0004011796,0.00023370693,0.00020357595],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012037273,0.00031401805,0.0006985695,0.00032152625,0.00012506262,0.000028424227,0.000085354484,0.00013411834,0.000017363744],"category_scores_gemma":[0.000055131353,0.00023804234,0.0000743529,0.00027993947,0.00042527783,0.00017803753,0.000084495274,0.00018485519,0.000017806293],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026741624,0.0024428095,0.05569771,0.000093073875,0.0005374138,0.0010803598,0.0008379865,0.000041174142,0.9132437,0.000042265874,0.000033071035,0.023276253],"study_design_scores_gemma":[0.031018259,0.033257782,0.3069279,0.00045207248,0.0004535381,0.0019045549,0.00034075152,0.0019176942,0.6221902,0.00008819551,0.0010868856,0.00036218684],"about_ca_topic_score_codex":0.0003946142,"about_ca_topic_score_gemma":0.000011017952,"teacher_disagreement_score":0.29105353,"about_ca_system_score_codex":0.00031494474,"about_ca_system_score_gemma":0.00023751055,"threshold_uncertainty_score":0.9707085},"labels":[],"label_agreement":null},{"id":"W2305268165","doi":"10.1080/2162402x.2015.1093276","title":"NKG2D- and T-cell receptor-dependent lysis of malignant glioma cell lines by human γδ T cells: Modulation by temozolomide and A disintegrin and metalloproteases 10 and 17 inhibitors","year":2015,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Cytotoxic T cell; NKG2D; Temozolomide; Cancer research; Glioma; T cell; Cell culture; Biology; Chemistry; Immunology; Immune system; In vitro","score_opus":0.011495009953035758,"score_gpt":0.22518120723283402,"score_spread":0.21368619727979826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2305268165","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97049284,0.027620044,0.00006136672,0.00019690064,0.0006379567,0.00029253386,0.000036889873,0.00004499968,0.0006164958],"genre_scores_gemma":[0.97860175,0.0015877222,0.00008225263,0.000045286517,0.000019626457,0.000027338721,0.00024818623,0.000026618101,0.01936124],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982928,0.00032563918,0.00053592736,0.00050581875,0.00005420734,0.00028557572],"domain_scores_gemma":[0.9990977,0.000117841366,0.0003597399,0.00024233508,0.00013120846,0.00005115853],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00032560714,0.00030691046,0.0005329669,0.00021368176,0.00019283827,0.00003575057,0.000093979594,0.00043768613,0.0002657893],"category_scores_gemma":[0.000057831272,0.00026999632,0.00005210732,0.00010121757,0.0005233245,0.00022435669,0.00018888422,0.00029155798,0.00003133739],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044232138,0.00021671336,0.00071855064,0.00004219521,0.0001256866,0.0000016955404,0.00047461528,0.000001537716,0.9728249,0.000022050788,0.022516724,0.0026130497],"study_design_scores_gemma":[0.0028877263,0.0012237055,0.00049140287,0.000039566392,0.00012349528,0.00010800787,0.0018616816,0.000024971629,0.9379299,0.000053350454,0.054959793,0.00029635782],"about_ca_topic_score_codex":0.0010175889,"about_ca_topic_score_gemma":0.00003253504,"teacher_disagreement_score":0.034894917,"about_ca_system_score_codex":0.00004867436,"about_ca_system_score_gemma":0.000028446182,"threshold_uncertainty_score":0.9999752},"labels":[],"label_agreement":null},{"id":"W2307546987","doi":"10.1080/2162402x.2015.1084463","title":"The presence of CXCR4<sup>+</sup>CD1a<sup>+</sup>cells at onset of Langerhans cell histiocytosis is associated with a less favorable outcome","year":2015,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Histiocytic Disorders and Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Leids Universitair Medisch Centrum; Stichting Kinderen Kankervrij; Universiteit Leiden; Deutsches Krebsforschungszentrum","keywords":"Langerhans cell histiocytosis; Histiocyte; CXCR4; Histiocytosis; Pathology; Medicine; Cancer research; Bone marrow; Chemokine; Biology; Molecular biology; Immunology; Inflammation","score_opus":0.03356550537872877,"score_gpt":0.2673946211698069,"score_spread":0.23382911579107812,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2307546987","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98369396,0.002032614,0.00004526682,0.00092361815,0.00009806162,0.00058631995,0.00025539025,0.000055744786,0.012309022],"genre_scores_gemma":[0.9704898,0.00021838101,0.00029150033,0.00018924974,0.000016009195,0.000066203225,0.00011723013,0.000049340528,0.028562296],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976349,0.00023297459,0.0006572189,0.00041860584,0.00049375417,0.00056257425],"domain_scores_gemma":[0.9975862,0.00050641433,0.0004575291,0.0008831556,0.00042151564,0.00014518738],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043584587,0.0003337573,0.00096547446,0.00014271426,0.00017824917,0.000012582487,0.00036029873,0.00028465927,0.00017477243],"category_scores_gemma":[0.00032695846,0.00022615124,0.00017181406,0.0003991405,0.00067792984,0.00006938871,0.00015705227,0.000283399,0.00013583354],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009898449,0.010803901,0.798808,0.00077507837,0.006909055,0.00092409155,0.041151963,0.0044113696,0.007615266,0.0005746723,0.10746566,0.010662511],"study_design_scores_gemma":[0.1622008,0.04290899,0.08791689,0.0037755866,0.013236809,0.0012304429,0.084872894,0.037416577,0.16507223,0.0018513938,0.39428416,0.0052332254],"about_ca_topic_score_codex":0.0022597925,"about_ca_topic_score_gemma":0.00025611496,"teacher_disagreement_score":0.71089107,"about_ca_system_score_codex":0.0006116715,"about_ca_system_score_gemma":0.00054903934,"threshold_uncertainty_score":0.92221797},"labels":[],"label_agreement":null},{"id":"W2313718437","doi":"10.1080/2162402x.2016.1164364","title":"Tertiary lymphoid structures are confined to patients presenting with unifocal Langerhans Cell Histiocytosis","year":2016,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Histiocytic Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Leids Universitair Medisch Centrum; Universiteit Leiden","keywords":"High endothelial venules; Follicular dendritic cells; Pathology; Histiocyte; CXCL13; Lymphatic system; Immune system; Langerhans cell histiocytosis; Medicine; Myeloid; Lymph node; Chemokine; Lymph; Dendritic cell; Immunophenotyping; Lymphocyte; T cell; Immunology; Antigen-presenting cell; Antigen; Chemokine receptor","score_opus":0.007150763855680321,"score_gpt":0.22313640149611075,"score_spread":0.21598563764043044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2313718437","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98934937,0.00015123874,0.00024109293,0.0011202937,0.00015715025,0.00036330507,0.000039653452,0.00007502127,0.008502867],"genre_scores_gemma":[0.99346334,0.000022883054,0.00056164566,0.00046593774,0.000035817473,0.000045023506,0.00004292904,0.000030627045,0.005331809],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989636,0.00003832112,0.00019311329,0.00031236716,0.00015950053,0.00033309916],"domain_scores_gemma":[0.99929494,0.00005692995,0.000100882295,0.0003310821,0.000111015914,0.00010512914],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000027742633,0.00018799197,0.0003125418,0.0001156541,0.00008518955,0.000008394097,0.00010188415,0.00011083862,0.00034843665],"category_scores_gemma":[0.000057297573,0.000110303605,0.00004949742,0.00010382707,0.000113672606,0.0000412541,0.00005602611,0.00006367778,0.00018353522],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000686461,0.0005419628,0.9705745,0.000037461472,0.00021707924,0.00014772321,0.00031987394,0.0000011738014,0.006075487,0.00011746431,0.002012637,0.019268151],"study_design_scores_gemma":[0.009928498,0.0009877244,0.9542764,0.00010495846,0.00018252246,0.00005991867,0.00013040124,0.0000037453385,0.0077624624,0.000083594794,0.026242802,0.00023700268],"about_ca_topic_score_codex":0.0002993339,"about_ca_topic_score_gemma":0.00009698409,"teacher_disagreement_score":0.024230165,"about_ca_system_score_codex":0.000218606,"about_ca_system_score_gemma":0.000108145345,"threshold_uncertainty_score":0.44980502},"labels":[],"label_agreement":null},{"id":"W2317889432","doi":"10.1080/2162402x.2016.1151593","title":"NLRC5 elicits antitumor immunity by enhancing processing and presentation of tumor antigens to CD8<sup>+</sup> T lymphocytes","year":2016,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":79,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"CD80; Antigen; Cytotoxic T cell; CD8; Biology; Antigen presentation; MHC class I; Cancer research; Antigen-presenting cell; Major histocompatibility complex; Immunology; T cell; Immune system; CD40; In vitro","score_opus":0.009731550120782162,"score_gpt":0.25617748532565743,"score_spread":0.24644593520487526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2317889432","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9694193,0.027765045,0.0011154648,0.00048770744,0.0002652524,0.00042605028,0.00006524573,0.00011013972,0.00034580095],"genre_scores_gemma":[0.9947163,0.0014166788,0.00024972862,0.0002641718,0.000020833288,0.000052729545,0.00004027523,0.00004786585,0.0031914148],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973875,0.0006267685,0.00073913776,0.0004851675,0.000069317764,0.0006920593],"domain_scores_gemma":[0.9983128,0.0005624814,0.00035143143,0.000528698,0.00021222036,0.000032417414],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00051663956,0.00036335955,0.00069525663,0.0003270761,0.00039685777,0.000025254196,0.0004356059,0.00029300526,0.0003847172],"category_scores_gemma":[0.00043807516,0.0002791564,0.000103951075,0.00031119146,0.0007203669,0.00033836628,0.0002362688,0.00023208007,0.00023149043],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014159986,0.0001727906,0.0021294402,0.0000468984,0.00019037064,0.000004469705,0.0020478007,0.0000023093612,0.9317738,0.00010706406,0.0005314461,0.06157766],"study_design_scores_gemma":[0.0030652059,0.0008697292,0.014388646,0.00033191452,0.000044138225,0.00027451932,0.0013613724,0.0000049273094,0.95290184,0.000059528134,0.02632443,0.00037372482],"about_ca_topic_score_codex":0.00054496137,"about_ca_topic_score_gemma":0.000017860322,"teacher_disagreement_score":0.061203934,"about_ca_system_score_codex":0.0001155548,"about_ca_system_score_gemma":0.00025664695,"threshold_uncertainty_score":0.9999661},"labels":[],"label_agreement":null},{"id":"W2323614958","doi":"10.4161/onci.28272","title":"Tumor vascularity in ovarian cancer","year":2014,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria; BC Cancer Agency","funders":"","keywords":"Ovarian cancer; Medicine; Vascularity; Tumor-infiltrating lymphocytes; Cancer research; Immune system; Cancer immunology; Immunotherapy; Cancer; Oncology; Immunology; Pathology; Internal medicine","score_opus":0.00989348837308657,"score_gpt":0.24238396542768137,"score_spread":0.2324904770545948,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2323614958","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92482144,0.00589991,0.0013701743,0.001989314,0.017743723,0.00034980534,0.0000033866277,0.00020800256,0.047614228],"genre_scores_gemma":[0.9883605,0.000115250674,0.000038037393,0.00093317626,0.00004263262,0.00006318114,0.00004509777,0.000016322869,0.0103858],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99865115,0.00038240667,0.00029982554,0.0002852737,0.000020628155,0.00036073668],"domain_scores_gemma":[0.9994186,0.00009388043,0.00009860731,0.00032985798,0.000049464925,0.000009601682],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000316599,0.00015189439,0.00029402165,0.00018432508,0.00010860978,0.000009461576,0.00019158909,0.00024397967,0.005300302],"category_scores_gemma":[0.00012236432,0.00014476985,0.000089529254,0.00015970893,0.00013624755,0.00010697845,0.00006901044,0.000539576,0.002239196],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045572824,0.00037350683,0.018647864,0.000016381971,0.00021773049,0.000007132614,0.0004994301,0.000029316321,0.923376,0.011651135,0.009057486,0.035668273],"study_design_scores_gemma":[0.0026737417,0.00020907697,0.16977969,0.000031935895,0.000022007183,0.00010850874,0.00017692219,0.000028811066,0.046226244,0.00031651164,0.78019404,0.00023252421],"about_ca_topic_score_codex":0.0021314994,"about_ca_topic_score_gemma":0.0003556955,"teacher_disagreement_score":0.87714976,"about_ca_system_score_codex":0.00011632269,"about_ca_system_score_gemma":0.000051110514,"threshold_uncertainty_score":0.99853766},"labels":[],"label_agreement":null},{"id":"W2328903599","doi":"10.1080/2162402x.2016.1151591","title":"Ranitidine modifies myeloid cell populations and inhibits breast tumor development and spread in mice","year":2016,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Izaak Walton Killam Health Centre; Dalhousie University","funders":"","keywords":"Ranitidine; Medicine; Myeloid; Cancer research; Histamine H2 receptor; Breast cancer; Population; Cancer; Internal medicine; Immunology; Pharmacology; Receptor; Antagonist","score_opus":0.015340402216365132,"score_gpt":0.2255058756578487,"score_spread":0.21016547344148356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2328903599","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98292124,0.013781717,0.00005694208,0.00078148633,0.0005609275,0.00021406586,0.000026176604,0.000054363732,0.0016030635],"genre_scores_gemma":[0.99489737,0.00048220882,0.0004838805,0.00016234828,0.00001495847,0.000053240645,0.000027652562,0.000024334475,0.0038540263],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985838,0.00016128809,0.0004025438,0.00038548693,0.000025251707,0.000441638],"domain_scores_gemma":[0.9994192,0.00017773459,0.0001235592,0.00021102748,0.00005142345,0.00001701546],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017588846,0.00022969833,0.00035289882,0.00021300677,0.00016086057,0.000010158854,0.00014850592,0.00024533283,0.00022054353],"category_scores_gemma":[0.000039380135,0.00018033128,0.00002452291,0.00010665065,0.0005088163,0.00017395978,0.0002352772,0.00023769062,0.00024495166],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023089878,0.00010586814,0.011627882,0.000025952437,0.00004721075,0.000011104325,0.00087020703,5.60685e-7,0.9530412,0.0012376468,0.00026795725,0.03253352],"study_design_scores_gemma":[0.007230985,0.00018973762,0.28824094,0.0002526954,0.000036386165,0.0013697994,0.00074529485,9.670524e-7,0.63952047,0.00055719155,0.06124443,0.00061111996],"about_ca_topic_score_codex":0.00024377712,"about_ca_topic_score_gemma":0.00026539204,"teacher_disagreement_score":0.31352076,"about_ca_system_score_codex":0.000116811796,"about_ca_system_score_gemma":0.000109255445,"threshold_uncertainty_score":0.7353696},"labels":[],"label_agreement":null},{"id":"W2336703042","doi":"10.1080/2162402x.2015.1129484","title":"Linking cancer-induced Nlrp3 inflammasome activation to efficient NK cell-mediated immunosurveillance","year":2016,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Inflammasome and immune disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Inflammasome; Immunosurveillance; Colorectal cancer; Cancer research; NKG2D; Apoptosis; Immunology; Cancer; Medicine; Biology; Inflammation; Immune system; Cytotoxicity; In vitro; Internal medicine","score_opus":0.00773803632410453,"score_gpt":0.2384469418959819,"score_spread":0.23070890557187737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2336703042","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99485475,0.0008259119,0.0006401318,0.0011885046,0.0006540038,0.00032667303,0.000016757136,0.00005192076,0.0014413291],"genre_scores_gemma":[0.9975097,0.0005425762,0.000073315314,0.00046767908,0.00018422258,0.00013467328,0.00010149812,0.000046785368,0.0009395421],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982836,0.00012375084,0.0003764188,0.00050300005,0.0001409668,0.0005722189],"domain_scores_gemma":[0.99890584,0.000054822704,0.00018368193,0.00061369454,0.00018188599,0.00006006152],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023022295,0.0002691896,0.00026530848,0.00013640265,0.00015526018,0.000020346568,0.0003990151,0.00034323556,0.000088005436],"category_scores_gemma":[0.00018878118,0.00021767081,0.00010764464,0.000229691,0.000082872524,0.000008378131,0.00024287203,0.00013759884,0.00026867696],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027961287,0.00005869052,0.0031247055,0.000011088089,0.000061042316,0.0000019747301,0.00013205718,0.00006872883,0.9748766,0.00004282923,0.0002226654,0.021120049],"study_design_scores_gemma":[0.0016296516,0.0004980655,0.02478422,0.0000676536,0.000008197731,0.0000041869866,0.00007819291,0.000008539148,0.8888875,0.000014883284,0.08363313,0.00038573844],"about_ca_topic_score_codex":0.00011619234,"about_ca_topic_score_gemma":0.000056358265,"teacher_disagreement_score":0.08598902,"about_ca_system_score_codex":0.00010030093,"about_ca_system_score_gemma":0.00019947652,"threshold_uncertainty_score":0.88763577},"labels":[],"label_agreement":null},{"id":"W2339252122","doi":"10.1080/2162402x.2016.1160979","title":"CXCL16-positive dendritic cells enhance invariant natural killer T cell-dependent IFNγ production and tumor control","year":2016,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Beatrice Hunter Cancer Research Institute; Dalhousie University","funders":"","keywords":"CXCL16; Natural killer T cell; Interleukin 12; Dendritic cell; Immune system; Immunology; Medicine; Cancer research; Biology; Cell biology; Cytotoxic T cell; Chemokine; T cell; In vitro; Chemokine receptor; Genetics","score_opus":0.00416152982155571,"score_gpt":0.2064445161738855,"score_spread":0.2022829863523298,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2339252122","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93761563,0.008920856,0.001365687,0.0052535306,0.041876566,0.00091205206,0.000017374257,0.00022685561,0.00381143],"genre_scores_gemma":[0.9392238,0.00038905785,0.000036472386,0.0005641682,0.00008889005,0.0000667433,0.00003362194,0.000027673444,0.059569538],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99790204,0.00046673982,0.00044035734,0.0006148072,0.00004924976,0.00052680256],"domain_scores_gemma":[0.9989063,0.0002875388,0.00024735136,0.000376106,0.00015751232,0.000025181209],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00025230885,0.00030204793,0.00040833498,0.00017784606,0.0003017284,0.000025167315,0.00018262422,0.00027863562,0.0019841897],"category_scores_gemma":[0.00018801307,0.00021986815,0.00009709536,0.00009156152,0.00041821264,0.00035549543,0.00009491572,0.0005509568,0.0021830492],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00084164,0.00018048432,0.00016146086,0.000011145299,0.0001825582,0.000015345939,0.00023888076,8.9231764e-7,0.98662925,0.00045011533,0.00842694,0.0028612658],"study_design_scores_gemma":[0.0027462065,0.00058434537,0.003958735,0.000105826046,0.000085955544,0.000751503,0.00030350042,0.0000029502678,0.94875515,0.00006699303,0.04228077,0.00035809612],"about_ca_topic_score_codex":0.0001659337,"about_ca_topic_score_gemma":0.000044364602,"teacher_disagreement_score":0.055758107,"about_ca_system_score_codex":0.00018019296,"about_ca_system_score_gemma":0.00007635144,"threshold_uncertainty_score":0.9989281},"labels":[],"label_agreement":null},{"id":"W2339862396","doi":"10.1080/2162402x.2015.1127493","title":"Identification of CD245 as myosin 18A, a receptor for surfactant A: A novel pathway for activating human NK lymphocytes","year":2016,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research; Institut National Du Cancer","keywords":"CD137; Myosin; Monoclonal antibody; Receptor; Cell biology; Biology; Cancer immunotherapy; Cytotoxicity; Antibody; Immunology; Immunotherapy; Immune system; Biochemistry","score_opus":0.020812556988940092,"score_gpt":0.27163881353149205,"score_spread":0.250826256542552,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2339862396","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9649528,0.001317081,0.024439279,0.0008704069,0.0061671394,0.0012190149,0.0002423577,0.00014998134,0.00064193015],"genre_scores_gemma":[0.9726477,0.00009160926,0.00030835878,0.000097987664,0.000056411078,0.00035304812,0.00031462198,0.000042488373,0.026087772],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99829775,0.00011038981,0.0007623658,0.00040048573,0.0000328285,0.00039617575],"domain_scores_gemma":[0.99779516,0.0007510795,0.00068585895,0.00038518215,0.0003699004,0.000012809246],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004545951,0.0002180574,0.00041629485,0.00018848146,0.00032559366,0.000012911806,0.00024261334,0.0004090443,0.00067331875],"category_scores_gemma":[0.0007322275,0.00017110899,0.00022226849,0.00010228207,0.00023741025,0.00022231432,0.000055825858,0.00012023712,0.00027271287],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011824316,0.0002636173,0.000080945225,0.00003837259,0.00025185835,7.272089e-8,0.0003132726,5.7298087e-7,0.96701187,0.0067796204,0.0018704272,0.02220693],"study_design_scores_gemma":[0.0038813024,0.00086155673,0.0006781732,0.000084447,0.00002679568,0.000023711584,0.000439957,0.0000039496117,0.8018198,0.00027072895,0.19173285,0.00017674114],"about_ca_topic_score_codex":0.00010330298,"about_ca_topic_score_gemma":0.000011464199,"teacher_disagreement_score":0.18986242,"about_ca_system_score_codex":0.00024423216,"about_ca_system_score_gemma":0.0001519345,"threshold_uncertainty_score":0.7372368},"labels":[],"label_agreement":null},{"id":"W2342335890","doi":"10.1080/2162402x.2016.1170264","title":"Extracellular HSP110 skews macrophage polarization in colorectal cancer","year":2016,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Heat shock proteins research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research; Institut National Du Cancer; Agence Nationale de la Recherche","keywords":"Extracellular; Cytotoxic T cell; Cancer research; Colorectal cancer; Macrophage polarization; Macrophage; Biology; Immunology; In vitro; Cancer; Cell biology; Genetics","score_opus":0.010368544051871327,"score_gpt":0.28553872900251714,"score_spread":0.2751701849506458,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2342335890","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99105734,0.005307035,0.0015352311,0.0007800518,0.00015956852,0.00028756273,0.00002223492,0.000015500435,0.0008355009],"genre_scores_gemma":[0.9922668,0.0007933012,0.00022016144,0.000039878716,0.000106511194,0.00013723996,0.000032327822,0.000029010356,0.006374772],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99865896,0.00020466185,0.00022272552,0.0003700404,0.00010731271,0.00043633164],"domain_scores_gemma":[0.9995382,0.000020721247,0.000046132736,0.00027539034,0.00006831667,0.000051269013],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024139715,0.00013504298,0.00015896885,0.00010506182,0.000053804044,0.000009583682,0.00025674782,0.00034738466,0.00036884472],"category_scores_gemma":[0.00019550814,0.00010567608,0.00004785053,0.00014850465,0.0001575567,0.0000061082887,0.0001767379,0.00014650628,0.00011793702],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016394696,0.000060188675,0.016521486,0.0000054050324,0.000022862167,0.00002230968,0.000026771531,0.000002716697,0.9465905,0.00023128017,0.000104633116,0.03624791],"study_design_scores_gemma":[0.0011313435,0.00033621918,0.034746923,0.000021081984,0.000002912047,0.000021464055,0.000017822362,0.000010557126,0.899384,0.000058558006,0.064101376,0.00016772919],"about_ca_topic_score_codex":0.0003839809,"about_ca_topic_score_gemma":0.00057498866,"teacher_disagreement_score":0.06399674,"about_ca_system_score_codex":0.00010566795,"about_ca_system_score_gemma":0.00027271127,"threshold_uncertainty_score":0.43093458},"labels":[],"label_agreement":null},{"id":"W2345395916","doi":"10.1080/2162402x.2016.1178438","title":"No evidence for TSLP pathway activity in human breast cancer","year":2016,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada Research Chairs; University of Toronto","funders":"Agence Nationale de la Recherche","keywords":"Thymic stromal lymphopoietin; Breast cancer; Stromal cell; Tumor microenvironment; Cancer research; Cytokine; Medicine; Immunology; Cancer; Biology; Internal medicine; Tumor cells","score_opus":0.043099836321001735,"score_gpt":0.35643586287957113,"score_spread":0.3133360265585694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2345395916","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98937666,0.0017109571,0.00008031407,0.0065189227,0.0003342791,0.0003304481,0.000050203485,0.000052898522,0.0015453275],"genre_scores_gemma":[0.9951215,0.00026502847,0.000035063258,0.00040312595,0.000093024835,0.00022240733,0.0000031501143,0.00001315416,0.0038435762],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9991733,0.00007273199,0.00015880971,0.00024570918,0.0000574281,0.0002920321],"domain_scores_gemma":[0.9991807,0.0003355674,0.00006592336,0.0002842103,0.00008784604,0.00004575751],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011212124,0.00011178044,0.0003073712,0.00008690057,0.00005914594,0.0000028931636,0.00011031882,0.00016995917,0.000546399],"category_scores_gemma":[0.0002179221,0.00007526432,0.00007626142,0.000067702575,0.00021844442,0.00012695348,0.0000434023,0.00010572647,0.00009795769],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034429003,0.00046193588,0.43045688,0.00012043907,0.00010676442,0.00012745759,0.000079830716,1.4722637e-7,0.49174094,0.000691507,0.008267912,0.06450328],"study_design_scores_gemma":[0.0030882414,0.00021972539,0.96976423,0.0005856439,0.000038742903,0.00020904491,0.000011600166,0.0000041955745,0.009953928,0.00043609785,0.015555341,0.00013321945],"about_ca_topic_score_codex":0.00018344432,"about_ca_topic_score_gemma":0.00014935531,"teacher_disagreement_score":0.53930736,"about_ca_system_score_codex":0.00012440926,"about_ca_system_score_gemma":0.00021267698,"threshold_uncertainty_score":0.59826857},"labels":[],"label_agreement":null},{"id":"W2403976714","doi":"10.1080/2162402x.2016.1150398","title":"Maraviroc decreases CCL8-mediated migration of CCR5<sup>+</sup>regulatory T cells and reduces metastatic tumor growth in the lungs","year":2016,"lang":"en","type":"article","venue":"OncoImmunology","topic":"T-cell and B-cell Immunology","field":"Immunology and Microbiology","cited_by":103,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"Canadian Institutes of Health Research","keywords":"Maraviroc; CCR5 receptor antagonist; Cancer research; Immune system; Chemokine; Primary tumor; Metastasis; Chemokine receptor CCR5; Immunology; Medicine; Biology; Chemokine receptor; Cancer; Internal medicine","score_opus":0.008929636011554665,"score_gpt":0.21276753879163793,"score_spread":0.20383790278008326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2403976714","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98778355,0.009483342,0.000022732032,0.0015544291,0.00026450198,0.0004126279,0.00006670532,0.000058313224,0.00035379716],"genre_scores_gemma":[0.9968883,0.0014650926,0.00009145363,0.0003991643,0.000020826952,0.000085136286,0.00008466619,0.000028964145,0.0009364262],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99684215,0.0012033224,0.00075271324,0.0005151797,0.0000699977,0.0006166113],"domain_scores_gemma":[0.9974767,0.0015197753,0.00037487957,0.0004950315,0.000108704655,0.000024906696],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006191334,0.00036739744,0.0007056046,0.00037684359,0.00016017653,0.000012595359,0.0005673453,0.0003488145,0.00038238853],"category_scores_gemma":[0.0003021405,0.00022281612,0.00012061659,0.00031150927,0.0016807135,0.00019342905,0.0001687983,0.00038405994,0.00031449276],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042321612,0.00045177518,0.0031903475,0.000029456773,0.00023847747,0.000027598202,0.0013720264,8.683221e-7,0.9881176,0.0012979582,0.0013560526,0.003494668],"study_design_scores_gemma":[0.005043143,0.0010458259,0.02117225,0.00013390422,0.00017252534,0.0005322675,0.0027732009,0.000006682021,0.95048296,0.0012258667,0.016976813,0.0004345828],"about_ca_topic_score_codex":0.00080760894,"about_ca_topic_score_gemma":0.00011344886,"teacher_disagreement_score":0.037634615,"about_ca_system_score_codex":0.00006305307,"about_ca_system_score_gemma":0.00016775163,"threshold_uncertainty_score":0.9086178},"labels":[],"label_agreement":null},{"id":"W2415943726","doi":"10.1080/2162402x.2015.1062210","title":"Ovarian cancer chemokines may not be a significant barrier during whole tumor antigen dendritic-cell vaccine and adoptive T-cell immunotherapy","year":2015,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"McMaster University; National Cancer Institute; Ovarian Cancer Research Fund","keywords":"Homing (biology); Immunotherapy; Dendritic cell; Medicine; T cell; Immunology; Cancer immunotherapy; Chemokine receptor; Adoptive cell transfer; Antigen; Ovarian cancer; Chimeric antigen receptor; Chemokine; Cancer research; Cancer; Biology; Immune system; Internal medicine","score_opus":0.01680430745610839,"score_gpt":0.25149677571340245,"score_spread":0.23469246825729406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2415943726","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9350851,0.058622666,0.0000464483,0.0023640876,0.0016377703,0.0006229937,0.00016565862,0.00019924167,0.0012560283],"genre_scores_gemma":[0.9708736,0.003750619,0.00026474718,0.0011533204,0.00009319252,0.00018954754,0.000114094015,0.00012707929,0.023433784],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99633855,0.0007147944,0.0008062897,0.0008530178,0.000112762355,0.001174572],"domain_scores_gemma":[0.99812776,0.00025441922,0.0003981384,0.0008750696,0.00026052044,0.00008407211],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005724939,0.00069895503,0.0010504881,0.00037755366,0.0005343921,0.000071295115,0.0006671466,0.00061000284,0.0013842742],"category_scores_gemma":[0.00009150124,0.0006434155,0.00020898499,0.00032753884,0.00060609746,0.0003157651,0.00028549632,0.0008656213,0.00036598754],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005996428,0.00043275458,0.0031374681,0.000036587557,0.00050247274,0.00007831072,0.002983093,0.0000069155158,0.982682,0.00011817656,0.001440106,0.0025856793],"study_design_scores_gemma":[0.011691902,0.00079800445,0.024441715,0.000053143238,0.000069645146,0.00036733336,0.0023565781,0.0000030634417,0.7291762,0.000028657218,0.23033822,0.0006754916],"about_ca_topic_score_codex":0.0012312043,"about_ca_topic_score_gemma":0.000040902876,"teacher_disagreement_score":0.25350577,"about_ca_system_score_codex":0.00021682422,"about_ca_system_score_gemma":0.00051343616,"threshold_uncertainty_score":0.9996017},"labels":[],"label_agreement":null},{"id":"W2416441449","doi":"10.1080/2162402x.2015.1127496","title":"CD73-adenosine reduces immune responses and survival in ovarian cancer patients","year":2016,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Immunosurveillance; Immune system; Adenosine; Ovarian cancer; Tumor microenvironment; Medicine; Cancer research; Immunity; CD8; Cancer; Mechanism (biology); Immunology; Biology; Internal medicine","score_opus":0.010326311061765877,"score_gpt":0.26100682693125865,"score_spread":0.25068051586949275,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2416441449","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98594767,0.012001495,0.000049773564,0.0011304524,0.00030826998,0.000090524365,0.000020430802,0.000008532227,0.00044288178],"genre_scores_gemma":[0.99529254,0.0022079293,0.00006269754,0.00008509618,0.00013646731,0.000027692984,0.000022510818,0.000018909708,0.0021461435],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99899364,0.0001379114,0.00023304185,0.00030787944,0.00006338997,0.00026416534],"domain_scores_gemma":[0.9995813,0.000048378894,0.00008060176,0.00020123798,0.000056979407,0.00003152183],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015160699,0.000141406,0.0001920634,0.00007605116,0.00005144662,0.000008426385,0.00014735077,0.00018260018,0.00008413413],"category_scores_gemma":[0.00014212809,0.000104679,0.000033308806,0.00007867112,0.0001473183,0.0000064213878,0.00015009793,0.00007354963,0.00000781602],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005704528,0.00008155626,0.076283224,0.000004042348,0.00004749284,0.000006690451,0.000063866864,9.810758e-7,0.91674495,0.00013787976,0.0006803355,0.005378502],"study_design_scores_gemma":[0.003776158,0.0006942803,0.60534364,0.00008465205,0.000018447274,0.000017503377,0.000092172224,9.3666205e-7,0.35589463,0.00015462203,0.03357221,0.00035076443],"about_ca_topic_score_codex":0.0002712769,"about_ca_topic_score_gemma":0.0000406417,"teacher_disagreement_score":0.5608503,"about_ca_system_score_codex":0.00002283879,"about_ca_system_score_gemma":0.00007482293,"threshold_uncertainty_score":0.4268686},"labels":[],"label_agreement":null},{"id":"W2419661260","doi":"10.1080/2162402x.2016.1175799","title":"Investigating potential exogenous tumor initiating and promoting factors for Cutaneous T-Cell Lymphomas (CTCL), a rare skin malignancy","year":2016,"lang":"en","type":"review","venue":"OncoImmunology","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University; Ottawa Hospital; University of Ottawa","funders":"Novo Nordisk Fonden","keywords":"Medicine; Malignancy; Immunology; Cancer; Cancer research; Internal medicine","score_opus":0.044574261023835444,"score_gpt":0.3364697416374679,"score_spread":0.29189548061363246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2419661260","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.020212725,0.972724,0.00008597874,0.00008463436,0.00030428485,0.004858794,0.0003149233,0.00019154036,0.0012230866],"genre_scores_gemma":[0.00685223,0.9880458,0.0014721443,0.00011810939,0.00040100433,0.0008414517,0.0005537014,0.0004057988,0.001309755],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9947272,0.00055497256,0.0014661675,0.0013470945,0.00044910904,0.0014554465],"domain_scores_gemma":[0.99606186,0.0014488708,0.0010469585,0.00073298346,0.0004034768,0.00030586435],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003979302,0.0010784403,0.0034344527,0.0006239664,0.00064456393,0.00010973676,0.0004553507,0.00084404345,0.00018281466],"category_scores_gemma":[0.0022677095,0.0008191623,0.00071361527,0.00039078985,0.0006315834,0.00010520951,0.00048573932,0.000733185,0.00006964697],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000090912705,0.00030911033,0.00042197408,0.040420618,0.0007694799,0.0017935475,0.0018101698,1.6175794e-7,0.0019343954,0.00007435633,0.00006783196,0.95230746],"study_design_scores_gemma":[0.011956083,0.008246338,0.00007002755,0.09669535,0.0043955925,0.19642298,0.0035944793,0.00024012708,0.0012443415,0.0010840981,0.67175204,0.0042985394],"about_ca_topic_score_codex":0.00009652585,"about_ca_topic_score_gemma":0.00001401149,"teacher_disagreement_score":0.9480089,"about_ca_system_score_codex":0.0008128379,"about_ca_system_score_gemma":0.002734186,"threshold_uncertainty_score":0.99942595},"labels":[],"label_agreement":null},{"id":"W2466658396","doi":"10.1080/2162402x.2016.1204507","title":"Intratumoral expression levels of <i>PD-L1</i>, <i>GZMA</i>, and <i>HLA-A</i> along with oligoclonal T cell expansion associate with response to nivolumab in metastatic melanoma","year":2016,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":130,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Regina","keywords":"Nivolumab; TIGIT; Perforin; Melanoma; Immune checkpoint; PD-L1; Granzyme; CD8; Immune system; Immunology; Cancer research; Tumor-infiltrating lymphocytes; Cytotoxic T cell; Medicine; Tumor microenvironment; Human leukocyte antigen; T cell; Immunotherapy; Antigen; Biology","score_opus":0.011640409059253743,"score_gpt":0.24676790515993152,"score_spread":0.2351274961006778,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2466658396","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99551356,0.0013137948,0.00022409759,0.0019394564,0.000091642585,0.00052006904,0.000052423944,0.000035181132,0.0003097779],"genre_scores_gemma":[0.99549496,0.00013765386,0.0027840643,0.0005361999,0.000019318915,0.00005632247,0.0000062563727,0.000043845972,0.0009214031],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979546,0.00034709825,0.00048727304,0.00045389443,0.00029842948,0.00045869141],"domain_scores_gemma":[0.99873114,0.00038262713,0.00025324812,0.00041502714,0.000115944735,0.00010199789],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006453673,0.00028537874,0.00070089503,0.00027650205,0.00006216446,0.000011234552,0.00014248653,0.00013898706,0.00009026757],"category_scores_gemma":[0.00006592445,0.00016780318,0.00005995991,0.00037463888,0.0003332513,0.00014704998,0.0000773426,0.00020674514,0.000008818629],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.074030094,0.00024924794,0.01709871,0.000048245747,0.00011653672,0.00023009378,0.0009289802,0.0000011116489,0.89736503,0.000007494348,0.00021966401,0.009704809],"study_design_scores_gemma":[0.01947753,0.008109247,0.42811024,0.0013702918,0.000099989185,0.00045315802,0.0006285831,0.0000019959134,0.53910637,0.00003300038,0.0022707821,0.00033880438],"about_ca_topic_score_codex":0.00033043747,"about_ca_topic_score_gemma":0.00034797334,"teacher_disagreement_score":0.41101155,"about_ca_system_score_codex":0.00021153444,"about_ca_system_score_gemma":0.00042832977,"threshold_uncertainty_score":0.6842815},"labels":[],"label_agreement":null},{"id":"W2509656165","doi":"10.1080/2162402x.2016.1224044","title":"Impaired functional responses in follicular lymphoma CD8<sup>+</sup>TIM-3<sup>+</sup>T lymphocytes following TCR engagement","year":2016,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Galectins and Cancer Biology","field":"Immunology and Microbiology","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Institute of Cancer Research; Institut National Du Cancer; Agence Nationale de la Recherche","keywords":"Cytotoxic T cell; Ex vivo; CD8; Immunology; Granzyme B; Biology; Immune system; Interleukin 21; Cancer research; In vivo; In vitro","score_opus":0.018991755649767426,"score_gpt":0.24509852728849207,"score_spread":0.22610677163872464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2509656165","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98172945,0.012421109,0.0002924384,0.001685608,0.0014757726,0.00057259516,0.00008255462,0.00030684803,0.0014336482],"genre_scores_gemma":[0.988344,0.0008089531,0.0001685732,0.0008214629,0.00015977513,0.00040060646,0.00017781218,0.0000852979,0.009033522],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9939107,0.0019563253,0.0010860345,0.0012774817,0.00013246242,0.0016370318],"domain_scores_gemma":[0.99719703,0.0012442352,0.00030453855,0.0010401487,0.00014097113,0.00007308873],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0013436507,0.0007245347,0.001145174,0.0006962347,0.0005722655,0.000032210057,0.00074470765,0.0011925144,0.0029825976],"category_scores_gemma":[0.0006450631,0.00056163355,0.00056718383,0.0005372184,0.00071242935,0.00025978356,0.0004881238,0.00046710248,0.0019155361],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008648211,0.0015193733,0.10232752,0.000050899565,0.003293979,0.0005508867,0.0031519262,0.00041999828,0.67711884,0.0035244124,0.012266787,0.18712716],"study_design_scores_gemma":[0.036711298,0.0032875952,0.18576424,0.00039877594,0.00035056935,0.0016405043,0.004185444,0.00010793961,0.054722857,0.0015236232,0.70918185,0.0021252837],"about_ca_topic_score_codex":0.0007947576,"about_ca_topic_score_gemma":0.00012984677,"teacher_disagreement_score":0.6969151,"about_ca_system_score_codex":0.0011700279,"about_ca_system_score_gemma":0.00088136183,"threshold_uncertainty_score":0.9996835},"labels":[],"label_agreement":null},{"id":"W2563769502","doi":"10.1080/2162402x.2016.1267094","title":"2B4-SAP signaling is required for the priming of naive CD8<sup>+</sup> T cells by antigen-expressing B cells and B lymphoma cells","year":2016,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"National Institute of Allergy and Infectious Diseases; Canadian Institutes of Health Research","keywords":"Cytotoxic T cell; CD8; Biology; T cell; B cell; Antigen-presenting cell; Interleukin 21; Priming (agriculture); CD40; Immunology; Antigen; Cancer research; Immune system; Cell biology; Antibody","score_opus":0.014742008964896802,"score_gpt":0.2354078282807221,"score_spread":0.2206658193158253,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2563769502","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96786255,0.015476635,0.009255894,0.00093647564,0.0042621624,0.00087436294,0.000119360426,0.0001210087,0.0010915413],"genre_scores_gemma":[0.97911274,0.00229909,0.00028852792,0.00051972346,0.00005561298,0.000054683816,0.00003769668,0.000055050226,0.017576862],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99779844,0.0002996023,0.00069799967,0.0005354952,0.00005570674,0.000612761],"domain_scores_gemma":[0.9973846,0.001351179,0.00051463104,0.0005337151,0.00019209828,0.000023787114],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004311227,0.00034466496,0.0005497687,0.0001578264,0.00052277144,0.000030838462,0.00037443254,0.00053626776,0.00082383247],"category_scores_gemma":[0.00007069636,0.00023172382,0.00021198732,0.00011609527,0.00070449227,0.00025638874,0.0001735278,0.00021218401,0.0002535999],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00067223504,0.00012806304,0.000043286644,0.000030810817,0.00037035273,0.0000010361871,0.0016495922,0.000010514489,0.9489802,0.00007889274,0.023147356,0.024887675],"study_design_scores_gemma":[0.0021568039,0.0003658223,0.000051556763,0.00012678101,0.000077819386,0.000026446802,0.0013386107,0.000046836034,0.732467,0.000033990837,0.26309484,0.00021348926],"about_ca_topic_score_codex":0.00019212461,"about_ca_topic_score_gemma":0.0000012655102,"teacher_disagreement_score":0.2399475,"about_ca_system_score_codex":0.000105345855,"about_ca_system_score_gemma":0.00010861212,"threshold_uncertainty_score":0.94494236},"labels":[],"label_agreement":null},{"id":"W2565577352","doi":"10.1080/2162402x.2016.1258506","title":"The influence of gut-decontamination prophylactic antibiotics on acute graft-versus-host disease and survival following allogeneic hematopoietic stem cell transplantation","year":2016,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Centre hospitalier universitaire de Québec; Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"McGill University","keywords":"Medicine; Hematopoietic stem cell transplantation; Hazard ratio; Gastroenterology; Internal medicine; Antibiotics; Gut flora; Graft-versus-host disease; Stem cell; Transplantation; Immunology; Haematopoiesis; Odds ratio; Confidence interval; Biology; Microbiology","score_opus":0.012330215459031504,"score_gpt":0.2618846061685484,"score_spread":0.2495543907095169,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2565577352","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968295,0.00034369717,0.00054458785,0.0008239081,0.00045817145,0.0005812918,0.000024299583,0.000044509838,0.00035003174],"genre_scores_gemma":[0.99774617,0.0017612875,0.00008732003,0.000038644415,0.000020110983,0.000009926036,0.00001730553,0.000029679351,0.0002895505],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9984552,0.000176086,0.00045259914,0.00032063882,0.00030170192,0.0002937472],"domain_scores_gemma":[0.99831295,0.0008992953,0.0002103604,0.00038007012,0.000103063874,0.000094282084],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003086166,0.00020939272,0.00034241105,0.0001119261,0.00014430872,0.000014833952,0.00013031167,0.00013883461,0.000007167906],"category_scores_gemma":[0.000041484676,0.00013128605,0.000101985665,0.00014724013,0.00022353555,0.00012668764,0.00001684186,0.00012695052,0.000029724253],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0050251344,0.00023947173,0.033693627,0.0008041409,0.00040649838,0.00029070786,0.0015572787,0.000011553622,0.9488788,0.0024030488,0.000003554484,0.0066861496],"study_design_scores_gemma":[0.009721153,0.0019356983,0.85114056,0.0007951305,0.0016438037,0.00010665852,0.0006088526,0.000018260585,0.13342129,0.00015257267,0.00011583104,0.00034020212],"about_ca_topic_score_codex":0.000012064769,"about_ca_topic_score_gemma":0.000016042994,"teacher_disagreement_score":0.81744695,"about_ca_system_score_codex":0.00008524539,"about_ca_system_score_gemma":0.00013798205,"threshold_uncertainty_score":0.535369},"labels":[],"label_agreement":null},{"id":"W2566747056","doi":"10.1080/2162402x.2016.1257452","title":"Tumor-infiltrating lymphocyte composition, organization and PD-1/ PD-L1 expression are linked in breast cancer","year":2016,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":236,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Tumor-infiltrating lymphocytes; CD8; Immunohistochemistry; PD-L1; CD19; Immune system; Breast cancer; Infiltration (HVAC); Pathology; Flow cytometry; Lymphocyte; Stroma; Biology; Cancer research; Medicine; Cancer; Immunotherapy; Immunology; Internal medicine","score_opus":0.008638446302255718,"score_gpt":0.25263621476796555,"score_spread":0.24399776846570984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2566747056","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916213,0.0026446169,0.000111841,0.0048809065,0.00024164651,0.00021067377,0.000026840136,0.00006852889,0.00019363425],"genre_scores_gemma":[0.99617445,0.0024229547,0.00014899144,0.0008567299,0.00011439504,0.000025630527,0.000021357757,0.000026337682,0.00020914973],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9990454,0.000075650285,0.00029528778,0.00026305253,0.000095911084,0.000224738],"domain_scores_gemma":[0.99940026,0.000069161215,0.00016671761,0.00020287791,0.000121769954,0.00003920309],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011034042,0.00014584107,0.00028243853,0.00012593987,0.000094043826,0.000012851935,0.00006924793,0.00013966662,0.0005316643],"category_scores_gemma":[0.000027448932,0.000102692655,0.00002897632,0.00026086686,0.000159947,0.00012257503,0.00004312279,0.00010012321,0.000014539084],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014362149,0.00006755299,0.14095943,0.00002903593,0.000038654915,0.000028073806,0.00025672914,5.5630727e-7,0.8308833,0.000020228545,0.00022203248,0.026058184],"study_design_scores_gemma":[0.0068667014,0.00011976278,0.928979,0.001071461,0.000024124609,0.0007184194,0.0002280499,0.0000126469995,0.060039986,0.000023533594,0.0017487025,0.00016762121],"about_ca_topic_score_codex":0.00027503783,"about_ca_topic_score_gemma":0.000045525234,"teacher_disagreement_score":0.78801954,"about_ca_system_score_codex":0.00038659427,"about_ca_system_score_gemma":0.0001732365,"threshold_uncertainty_score":0.58213514},"labels":[],"label_agreement":null},{"id":"W2576512904","doi":"10.1080/2162402x.2016.1271858","title":"Acquisition of tumor cell phenotypic diversity along the EMT spectrum under hypoxic pressure: Consequences on susceptibility to cell-mediated cytotoxicity","year":2017,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":80,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research; Institut Gustave-Roussy; Institut National Du Cancer; Ligue Contre le Cancer","keywords":"Biology; Cancer research; Immune system; Immunosurveillance; Epithelial–mesenchymal transition; Phenotype; SNAI1; Mesenchymal stem cell; Wnt signaling pathway; Immunology; Cancer; Signal transduction; Cell biology; Metastasis; Genetics; Gene","score_opus":0.013818321886010797,"score_gpt":0.24372681393102957,"score_spread":0.2299084920450188,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2576512904","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99348927,0.0017131461,0.00012341807,0.0008373681,0.0010865128,0.00041056098,0.00012044581,0.000016161392,0.002203116],"genre_scores_gemma":[0.9978856,0.00034712785,0.000057346322,0.0006088868,0.0003615359,0.00001726652,0.000040448107,0.000015059484,0.00066675525],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99852926,0.0002008548,0.00024982492,0.00048972794,0.00016596724,0.00036438485],"domain_scores_gemma":[0.998273,0.00005458272,0.00032117596,0.0011844134,0.00009518893,0.00007162326],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035091757,0.00021312117,0.00031339604,0.000045321718,0.00061918265,0.000029749712,0.0008060407,0.00020448423,0.00012157463],"category_scores_gemma":[0.00011962586,0.00017347137,0.00013680651,0.00005844484,0.00077075063,0.00001030103,0.00067197357,0.00019536554,0.000042998323],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005485298,0.00021943329,0.007056934,0.000026378722,0.00007240349,0.0000021621952,0.0001818439,0.00008351301,0.9903154,0.00015998642,0.0011109968,0.00022243914],"study_design_scores_gemma":[0.0009660662,0.0006045339,0.32755005,0.000010716733,0.000072150644,0.0000069613575,0.00020373243,0.0000048537017,0.66296166,0.0003645808,0.0070475144,0.00020718505],"about_ca_topic_score_codex":0.0015651879,"about_ca_topic_score_gemma":0.0013278647,"teacher_disagreement_score":0.32735372,"about_ca_system_score_codex":0.00003367556,"about_ca_system_score_gemma":0.00016857212,"threshold_uncertainty_score":0.70739573},"labels":[],"label_agreement":null},{"id":"W2585034864","doi":"10.1080/2162402x.2017.1285992","title":"Oncolytic measles virus encoding interleukin-12 mediates potent antitumor effects through T cell activation","year":2017,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Oncolytic virus; Measles virus; Immune system; Cancer research; CD8; T cell; Immunology; Immunotherapy; Tumor microenvironment; Virotherapy; Medicine; Biology; Measles; Vaccination","score_opus":0.023773286376553692,"score_gpt":0.31048334579199405,"score_spread":0.28671005941544037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2585034864","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98922795,0.0013184011,0.0003475187,0.00035262306,0.0005628387,0.00036655372,0.000008279231,0.000032438926,0.0077834073],"genre_scores_gemma":[0.9968694,0.0010054387,0.00029320756,0.00028448514,0.00032056475,0.00007588973,0.0000679276,0.000049109654,0.0010340085],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983027,0.00020226848,0.0002557334,0.0005155551,0.0002022336,0.00052151515],"domain_scores_gemma":[0.9983999,0.0000684185,0.00026462812,0.0011000488,0.00010335274,0.00006365599],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003092345,0.0002631173,0.00030585544,0.00007573626,0.00047565447,0.00009646206,0.00085127074,0.0002935929,0.00007143234],"category_scores_gemma":[0.00033986045,0.00024865603,0.0001325382,0.000042670625,0.00036159408,0.00002626418,0.00042322787,0.0002792921,0.00016814911],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011032377,0.00015984426,0.00076179,0.00003783384,0.00011348898,0.000022286049,0.00013527244,0.000012584304,0.9891651,0.00005151066,0.0005554777,0.007881558],"study_design_scores_gemma":[0.0015424018,0.0030086327,0.0044268956,0.00004528959,0.000020684425,0.000015879375,0.0000747854,0.000023975152,0.9808262,0.0002118259,0.00953913,0.00026429584],"about_ca_topic_score_codex":0.00024661535,"about_ca_topic_score_gemma":0.00040749027,"teacher_disagreement_score":0.008983653,"about_ca_system_score_codex":0.00010494525,"about_ca_system_score_gemma":0.0002016524,"threshold_uncertainty_score":0.99999654},"labels":[],"label_agreement":null},{"id":"W2587435215","doi":"10.1080/2162402x.2017.1287247","title":"The Interleukin (IL)-1R1 pathway is a critical negative regulator of PyMT-mediated mammary tumorigenesis and pulmonary metastasis","year":2017,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Canadian Institutes of Health Research","keywords":"Carcinogenesis; Cancer research; Metastasis; Cancer; Breast cancer; Medicine; Mammary tumor; Inflammation; Interleukin 6; Biology; Immunology; Oncology; Internal medicine","score_opus":0.01501972708692082,"score_gpt":0.2600620662682379,"score_spread":0.2450423391813171,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587435215","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92810816,0.024044499,0.00037868918,0.015920341,0.01217279,0.0007000332,0.00014176418,0.00019871704,0.018335024],"genre_scores_gemma":[0.98844886,0.0012757165,0.0000839735,0.0002641458,0.000030396817,0.00004847011,0.00003732053,0.000023570874,0.009787529],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981771,0.00041020216,0.00056396995,0.0003872815,0.000048721264,0.00041273137],"domain_scores_gemma":[0.99742126,0.000920278,0.00043086545,0.00097466377,0.00022789609,0.00002503807],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042338137,0.00024999125,0.00046320618,0.00012286229,0.0010514321,0.000065491506,0.000589893,0.00034176518,0.0005410941],"category_scores_gemma":[0.0012371453,0.00018572509,0.00015576446,0.000070176626,0.0017124596,0.00032980746,0.0004166465,0.00046924961,0.00028759733],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013558802,0.00025372635,0.0013265905,0.0000346921,0.0008262523,0.000030924377,0.0007491917,7.8020484e-8,0.9062036,0.010971196,0.006212105,0.07203571],"study_design_scores_gemma":[0.0017507048,0.0009967908,0.067375585,0.00009865706,0.00014765114,0.0008445508,0.0026675682,0.000037926657,0.5179065,0.0017392923,0.40599653,0.00043822036],"about_ca_topic_score_codex":0.00036327704,"about_ca_topic_score_gemma":0.00003077037,"teacher_disagreement_score":0.39978445,"about_ca_system_score_codex":0.000059763926,"about_ca_system_score_gemma":0.00010508009,"threshold_uncertainty_score":0.80868715},"labels":[],"label_agreement":null},{"id":"W2592318296","doi":"10.1080/2162402x.2017.1299303","title":"Immune biomarkers for prognosis and prediction of responses to immune checkpoint blockade in cutaneous melanoma","year":2017,"lang":"en","type":"review","venue":"OncoImmunology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research; Institut National Du Cancer","keywords":"Immune system; Medicine; Melanoma; Immune checkpoint; Adjuvant; Immunotherapy; Blockade; Immunology; Cancer research; Internal medicine; Receptor","score_opus":0.09316718438393705,"score_gpt":0.39413803994122476,"score_spread":0.3009708555572877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592318296","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009614294,0.9832396,0.000005682472,0.00042908324,0.0003508463,0.0053362357,0.00023112868,0.00004722079,0.0007458963],"genre_scores_gemma":[0.0012439577,0.9903524,0.00053572154,0.000006560516,0.000105037616,0.0013589773,0.00020187542,0.00011793433,0.0060775345],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99662507,0.00038085892,0.0014447642,0.00068426295,0.00024987085,0.00061515864],"domain_scores_gemma":[0.9970293,0.00080566976,0.0006531621,0.0012158585,0.00018769439,0.00010831847],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012083821,0.0004847424,0.0032618397,0.0012321714,0.00011023639,0.000026966762,0.00046943474,0.0008568232,0.00022057547],"category_scores_gemma":[0.0013061304,0.00041905456,0.00059876667,0.0003354124,0.00047263812,0.000044490913,0.00032724923,0.0006384695,0.000018777459],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003800987,0.0002562347,0.0001970956,0.008207562,0.0013167144,0.00013482316,0.00020956015,3.1901873e-8,0.03012276,0.00000774761,0.000029285824,0.9557172],"study_design_scores_gemma":[0.002313922,0.004167934,0.0022397672,0.012195738,0.00078249985,0.0024428244,0.00008482823,0.0000058778573,0.0017043476,0.000019558836,0.9737584,0.00028428854],"about_ca_topic_score_codex":0.00042964437,"about_ca_topic_score_gemma":0.00003551473,"teacher_disagreement_score":0.97372913,"about_ca_system_score_codex":0.00046149534,"about_ca_system_score_gemma":0.00083014445,"threshold_uncertainty_score":0.99982613},"labels":[],"label_agreement":null},{"id":"W2595319204","doi":"10.1080/2162402x.2017.1306618","title":"Gene expression analysis in Cutaneous T-Cell Lymphomas (CTCL) highlights disease heterogeneity and potential diagnostic and prognostic indicators","year":2017,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":98,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Université de Montréal; McGill University Health Centre; Université de Sherbrooke; Ottawa Hospital; University of Ottawa","funders":"Ottawa Hospital Research Institute","keywords":"Mycosis fungoides; Medicine; Cutaneous T-cell lymphoma; Lymphoma; Malignancy; Disease; Dermatology; Psoriasis; Gene expression profiling; Cutaneous lymphoma; Oncology; Pathology; Immunology; Gene expression; Gene; Biology","score_opus":0.010660680636948158,"score_gpt":0.28323493707237335,"score_spread":0.2725742564354252,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2595319204","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929564,0.005041374,0.00005422985,0.0007634537,0.000081733684,0.00071790646,0.00003081293,0.00003900949,0.00031506],"genre_scores_gemma":[0.99605,0.00316036,0.00022026824,0.00007090977,0.00004825987,0.00009139155,0.00007423345,0.000032364085,0.00025219226],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979059,0.00020009853,0.00034741047,0.00071936316,0.000302992,0.0005242331],"domain_scores_gemma":[0.99825215,0.000315202,0.00019258665,0.0008373561,0.00007693768,0.00032576706],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00014408254,0.0002870354,0.0006445517,0.0007131208,0.00048693552,0.000104506194,0.00024976846,0.0002207168,0.000068249894],"category_scores_gemma":[0.0010959557,0.00024971814,0.000111943395,0.0002422683,0.0007988033,0.00010584451,0.0003468961,0.00022875349,0.000017764085],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008842723,0.0005523485,0.93877095,0.00009343747,0.00028398866,0.005010731,0.0001798657,0.000012824103,0.05104743,0.000026132906,0.0000130042035,0.0031250075],"study_design_scores_gemma":[0.003180168,0.00045540303,0.9770855,0.000066071385,0.0006939491,0.0010221348,0.000059282895,0.0005185498,0.016367903,0.00014291106,0.0001370856,0.00027107605],"about_ca_topic_score_codex":0.00027156842,"about_ca_topic_score_gemma":0.0002500768,"teacher_disagreement_score":0.038314506,"about_ca_system_score_codex":0.00011882809,"about_ca_system_score_gemma":0.00022947113,"threshold_uncertainty_score":0.9999955},"labels":[],"label_agreement":null},{"id":"W2609176929","doi":"10.1080/2162402x.2017.1321185","title":"Downregulation of PTP1B and TC-PTP phosphatases potentiate dendritic cell-based immunotherapy through IL-12/IFNγ signaling","year":2017,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Protein Tyrosine Phosphatases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"Canadian Institutes of Health Research","keywords":"Downregulation and upregulation; Cancer research; Cancer immunotherapy; Dendritic cell; Immunotherapy; Cell biology; Protein tyrosine phosphatase; Biology; Signal transduction; Chemistry; Immune system; Immunology","score_opus":0.012057866923661701,"score_gpt":0.25807761070688806,"score_spread":0.24601974378322636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2609176929","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9346888,0.056832813,0.0068734754,0.00030170596,0.00030122034,0.0004038558,0.00027156636,0.000028838094,0.00029770436],"genre_scores_gemma":[0.9942956,0.0012308676,0.0036498266,0.00016174382,0.00007163422,0.000039532482,0.00040126772,0.000039078615,0.00011042224],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99864256,0.00009433296,0.0003576586,0.00044191402,0.00012250172,0.00034102346],"domain_scores_gemma":[0.9983538,0.000035340032,0.00044210925,0.0010257646,0.00010668938,0.000036343947],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00018222858,0.00025046966,0.00032783093,0.000045177425,0.00035215728,0.000059920054,0.0004658871,0.00025159476,0.00006525302],"category_scores_gemma":[0.00012664316,0.0002532181,0.000109228844,0.000033569682,0.0005668268,0.00002667546,0.00020434106,0.000115585884,0.0000093590825],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004182294,0.00010872184,0.0017972634,0.00005031039,0.00009589999,0.000009568625,0.000040333296,0.00010377555,0.99139464,0.00072123937,0.00016541616,0.0050946013],"study_design_scores_gemma":[0.0022025525,0.00048077834,0.018369721,0.00005490031,0.000043947028,0.000019136518,0.000039200524,0.00004254314,0.9723321,0.0006677271,0.0054814704,0.00026592475],"about_ca_topic_score_codex":0.00038642826,"about_ca_topic_score_gemma":0.000026076232,"teacher_disagreement_score":0.059606805,"about_ca_system_score_codex":0.000017935692,"about_ca_system_score_gemma":0.000108579334,"threshold_uncertainty_score":0.999992},"labels":[],"label_agreement":null},{"id":"W2609196580","doi":"10.1080/2162402x.2017.1321184","title":"Mapping the human T cell repertoire to recurrent driver mutations in MYD88 and EZH2 in lymphoma","year":2017,"lang":"en","type":"article","venue":"OncoImmunology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Canada's Michael Smith Genome Sciences Centre; University of Victoria; Simon Fraser University; BC Cancer Agency","funders":"Canadian Institutes of Health Research","keywords":"Lymphoma; CD8; Human leukocyte antigen; Immunology; Cytotoxic T cell; Antigen; Immune system; T cell; Biology; Cancer research; Medicine; Genetics","score_opus":0.0506683785153188,"score_gpt":0.34524345492769154,"score_spread":0.29457507641237274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2609196580","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97652775,0.000895318,0.000004414858,0.0058746105,0.00013229635,0.00047129186,0.000001732897,0.000013636964,0.016078927],"genre_scores_gemma":[0.99224347,0.0002501878,0.00009411201,0.00022138198,0.000046832847,0.00007526976,0.0000072522457,0.00001608964,0.00704541],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9989834,0.000110106426,0.00022179532,0.00026439325,0.000118202486,0.00030212558],"domain_scores_gemma":[0.9990473,0.00010064428,0.00006393395,0.0006986794,0.00004359605,0.000045854325],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035692248,0.00010375964,0.00024108881,0.00025187794,0.00026405475,0.000035664547,0.0002526854,0.00010651195,0.00030913315],"category_scores_gemma":[0.00015910588,0.000081394464,0.000035280445,0.00013230888,0.00028609575,0.000052822088,0.00021799914,0.0002645814,0.00004990251],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024609838,0.00034805946,0.11804991,0.0000403393,0.00004027676,0.00028716197,0.0129029555,0.0000027948024,0.42384395,0.00031868523,0.0003891409,0.44353062],"study_design_scores_gemma":[0.0028854134,0.00030693383,0.9454557,0.00011886779,0.0000058081,0.00006181629,0.0014755246,0.000052389896,0.0021128478,0.00028157528,0.047144078,0.00009909545],"about_ca_topic_score_codex":0.0011673213,"about_ca_topic_score_gemma":0.001606629,"teacher_disagreement_score":0.82740575,"about_ca_system_score_codex":0.00023647888,"about_ca_system_score_gemma":0.000097011165,"threshold_uncertainty_score":0.3384791},"labels":[],"label_agreement":null},{"id":"W2614729080","doi":"10.1080/2162402x.2017.1331195","title":"Targeting IL-5Rα with antibody-conjugates reveals a strategy for imaging and therapy for invasive bladder cancer","year":2017,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cégep de Sherbrooke; Fédération des Maisons D'Hébergement pour Femmes; Centre Hospitalier Universitaire de Sherbrooke; Université de Sherbrooke","funders":"Cancer Research Society","keywords":"Immunoconjugate; Medicine; Bladder cancer; Vinblastine; Internalization; Cancer research; In vivo; Cancer; Antibody; Monoclonal antibody; Internal medicine; Immunology; Chemotherapy; Biology; Receptor","score_opus":0.0328047252033114,"score_gpt":0.3537519918207152,"score_spread":0.3209472666174038,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2614729080","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9638627,0.026349597,0.00052845065,0.004742292,0.00030461993,0.0024904623,0.00022566569,0.00006306567,0.0014331245],"genre_scores_gemma":[0.99114484,0.0047552045,0.0013747776,0.00076875807,0.0002570706,0.00067256106,0.000068204565,0.00005238388,0.0009061948],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.999,0.000019897881,0.00018618345,0.00036117778,0.000056996258,0.0003757204],"domain_scores_gemma":[0.9990865,0.00014040875,0.00020050978,0.0003244317,0.0001932422,0.00005493751],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011308031,0.00020891074,0.00042592158,0.000048953945,0.00044301647,0.000065453874,0.00012287522,0.00008657531,0.000056519053],"category_scores_gemma":[0.000083017956,0.00014988829,0.00007628423,0.000022658533,0.0002636702,0.0001523471,0.000031380558,0.00010256495,0.0000022796935],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009208732,0.00040293185,0.35443953,0.00038483654,0.0034154113,0.00008276086,0.0018305714,0.0000084275625,0.4458227,0.00084143516,0.004062695,0.17949998],"study_design_scores_gemma":[0.0978969,0.01752468,0.7061604,0.0015316873,0.0021089115,0.0007966196,0.0043101734,0.0004112134,0.091891676,0.009995747,0.06552258,0.0018493714],"about_ca_topic_score_codex":0.00073617726,"about_ca_topic_score_gemma":0.00009215355,"teacher_disagreement_score":0.353931,"about_ca_system_score_codex":0.000048779104,"about_ca_system_score_gemma":0.00032570626,"threshold_uncertainty_score":0.6112267},"labels":[],"label_agreement":null},{"id":"W2615614831","doi":"10.1080/2162402x.2017.1328336","title":"CEACAM1 as a Multi-Purpose Target for Cancer Immunotherapy","year":2017,"lang":"en","type":"review","venue":"OncoImmunology","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":118,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McGill University Health Centre","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; Canadian Institutes of Health Research; National Institutes of Health","keywords":"Immunotherapy; Cancer immunotherapy; Context (archaeology); Cancer; Immune system; Immune checkpoint; Medicine; Disease; Cancer research; Immunology; Biology; Pathology; Internal medicine","score_opus":0.27580715846247555,"score_gpt":0.5474359294592606,"score_spread":0.271628770996785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2615614831","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000007661053,0.994228,0.00021741643,0.0005939183,0.0003580295,0.002161084,0.00018992805,0.00015421644,0.002089716],"genre_scores_gemma":[0.000008382187,0.97402006,0.0020825544,0.0002339928,0.00048859994,0.004224697,0.00038006293,0.00014560064,0.018416058],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982908,0.00004944666,0.00056039623,0.00054788403,0.00009251271,0.0004589729],"domain_scores_gemma":[0.99801034,0.00018843032,0.0004506978,0.0011270508,0.00010486159,0.00011861921],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00015802826,0.0004496841,0.0021224762,0.00007857519,0.00021338805,0.000026456913,0.0005356772,0.00081260974,0.00047913523],"category_scores_gemma":[0.00014841021,0.00036234842,0.00076258567,0.00009001322,0.00032394557,0.00003640047,0.000063737934,0.0007722052,0.00019225638],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000090172376,0.00024655063,0.0000017999241,0.005295364,0.0007625153,0.000018807605,0.000022416476,5.5909126e-8,0.00044385024,0.00025483206,0.0009447123,0.9919189],"study_design_scores_gemma":[0.0017387365,0.00016021714,0.0000044465187,0.0027402204,0.0009719834,0.0003304593,0.0000057554957,0.000006512423,0.00020269168,0.00008275629,0.99343264,0.0003235973],"about_ca_topic_score_codex":0.000040353505,"about_ca_topic_score_gemma":0.0000013990782,"teacher_disagreement_score":0.9924879,"about_ca_system_score_codex":0.00024952332,"about_ca_system_score_gemma":0.0009489572,"threshold_uncertainty_score":0.9998829},"labels":[],"label_agreement":null},{"id":"W2751411673","doi":"10.1080/2162402x.2017.1371895","title":"A library-based screening method identifies neoantigen-reactive T cells in peripheral blood prior to relapse of ovarian cancer","year":2017,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; University of Victoria; Canada's Michael Smith Genome Sciences Centre; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Ovarian cancer; Peripheral blood; Cancer; Oncology; Peripheral; Immunology; Cancer research; Internal medicine","score_opus":0.023411737154730772,"score_gpt":0.329068476526905,"score_spread":0.30565673937217425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2751411673","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9891647,0.0017424444,0.0010371772,0.0048156567,0.00058528734,0.0005890357,0.000042243697,0.000047437883,0.0019760071],"genre_scores_gemma":[0.96984637,0.0002835192,0.025174567,0.0009941321,0.0000979567,0.00010437673,0.000014048824,0.000051284343,0.003433736],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985411,0.00013832144,0.00043172148,0.00037978997,0.00015239436,0.0003566646],"domain_scores_gemma":[0.9986433,0.000101468315,0.00033445487,0.0007945358,0.00006297041,0.00006327947],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003154741,0.0002057081,0.0005891454,0.00026096046,0.00016621828,0.000049809478,0.00037245374,0.00021803477,0.0008178461],"category_scores_gemma":[0.00007996319,0.00018965949,0.0001715162,0.00019001686,0.00022975438,0.00024087851,0.00012415466,0.00030097459,0.000009008747],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008754109,0.0002923211,0.025177853,0.00006816427,0.0005177744,0.00012905509,0.002226805,0.000025849433,0.8941481,0.000059566424,0.00027307626,0.06832729],"study_design_scores_gemma":[0.009037187,0.00077783497,0.441755,0.00058102806,0.0001506214,0.000031500018,0.0004704024,0.00010210779,0.53019434,0.000039485734,0.016610047,0.00025047784],"about_ca_topic_score_codex":0.006379052,"about_ca_topic_score_gemma":0.00057414157,"teacher_disagreement_score":0.41657713,"about_ca_system_score_codex":0.000073114745,"about_ca_system_score_gemma":0.0003859103,"threshold_uncertainty_score":0.96432614},"labels":[],"label_agreement":null},{"id":"W2754718069","doi":"10.1080/2162402x.2017.1377873","title":"Interleukin-21 combined with PD-1 or CTLA-4 blockade enhances antitumor immunity in mouse tumor models","year":2017,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Saskatchewan","keywords":"Blockade; CD8; Monoclonal antibody; Cytotoxic T cell; CTLA-4; Cancer research; Immunotherapy; Medicine; T cell; Immune system; Blocking antibody; Cancer immunotherapy; Immunology; Immune checkpoint; Antibody; Receptor; Biology; In vitro; Internal medicine","score_opus":0.02885851850022436,"score_gpt":0.29853256680669993,"score_spread":0.26967404830647557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2754718069","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907496,0.0007800721,0.000058126334,0.0016085841,0.0003432528,0.0005438864,0.000015433217,0.000090819325,0.0058102547],"genre_scores_gemma":[0.9922273,0.00083288545,0.0005221224,0.00047425128,0.000059905295,0.00008871737,0.000022443255,0.00004540188,0.005726959],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983005,0.00010576031,0.0004700201,0.00040826018,0.00018921256,0.00052623876],"domain_scores_gemma":[0.99805313,0.000084501466,0.0003575305,0.0013330225,0.00010466866,0.00006714239],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002892553,0.00031667322,0.0007561368,0.00022058416,0.0003250307,0.000073940275,0.00062984455,0.00016417952,0.00036533576],"category_scores_gemma":[0.00009467642,0.00022199412,0.00011071148,0.00014899141,0.0008418179,0.00031917766,0.00017318112,0.00055276917,0.00004014475],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10093893,0.0016327737,0.018484993,0.00018718351,0.00087045215,0.0013573564,0.0020954115,0.0000118044745,0.8599143,0.0003609409,0.00036694767,0.013778894],"study_design_scores_gemma":[0.050155856,0.014607248,0.26245037,0.001658481,0.00023122049,0.0020141648,0.0024427383,0.00085309835,0.6527712,0.000602947,0.010832267,0.0013804443],"about_ca_topic_score_codex":0.0047103907,"about_ca_topic_score_gemma":0.0037729107,"teacher_disagreement_score":0.24396536,"about_ca_system_score_codex":0.00023642498,"about_ca_system_score_gemma":0.00044274208,"threshold_uncertainty_score":0.90526575},"labels":[],"label_agreement":null},{"id":"W2767656371","doi":"10.1080/2162402x.2017.1398875","title":"Harnessing innate lung anti-cancer effector functions with a novel bacterial-derived immunotherapy","year":2017,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Immune responses and vaccinations","field":"Immunology and Microbiology","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute; National Institute of General Medical Sciences; U.S. Public Health Service","keywords":"Immunotherapy; Innate immune system; Macrophage polarization; Immune system; Medicine; Immunology; Cancer immunotherapy; Lung cancer; Acquired immune system; Cytotoxic T cell; Cancer research; NKG2D; Immunity; Cancer; Effector; Macrophage; Biology; Oncology; Internal medicine; In vitro","score_opus":0.01574413630226103,"score_gpt":0.2816278328218257,"score_spread":0.26588369651956467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767656371","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9863768,0.005055114,0.0021086053,0.0016205726,0.0028929058,0.00045300525,0.00022026726,0.00017715157,0.0010955739],"genre_scores_gemma":[0.98462397,0.00062908145,0.00017931992,0.00011746651,0.00008125913,0.00022632992,0.00024423498,0.000066666675,0.0138316825],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99823546,0.0002257081,0.00036752448,0.00047968078,0.0000419875,0.0006496244],"domain_scores_gemma":[0.99795884,0.00017715052,0.0005060246,0.0011382245,0.00019912775,0.000020614358],"candidate_categories":["metaepi_narrow","sts","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00024667033,0.00036353606,0.00059925887,0.0002075426,0.0022357947,0.00017256875,0.00067825057,0.00043193903,0.0023821408],"category_scores_gemma":[0.000117577045,0.00029447107,0.00015008457,0.0001123512,0.00057970383,0.0004078822,0.00020416286,0.0005302625,0.00048535454],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012801763,0.00025292396,0.004541499,0.00001535504,0.0009034764,0.0000054212283,0.00029251233,0.0000055959163,0.97290283,0.00025167473,0.00068666873,0.01886189],"study_design_scores_gemma":[0.012357192,0.0005548494,0.5787899,0.00017576561,0.00017242349,0.00026781956,0.00024966671,0.000023808756,0.18323666,0.000009530041,0.22346321,0.0006991573],"about_ca_topic_score_codex":0.00078010623,"about_ca_topic_score_gemma":0.00010795617,"teacher_disagreement_score":0.7896662,"about_ca_system_score_codex":0.00012839341,"about_ca_system_score_gemma":0.00026043283,"threshold_uncertainty_score":0.99995077},"labels":[],"label_agreement":null},{"id":"W2773596288","doi":"10.1080/2162402x.2017.1407897","title":"Oncolytic viruses sensitize human tumor cells for NY-ESO-1 tumor antigen recognition by CD4+ effector T cells.","year":2017,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"Medical Research Council; Agence Nationale de la Recherche; Pancreatic Cancer UK","keywords":"Oncolytic virus; Cytotoxic T cell; Antigen; Cancer research; clone (Java method); Immune system; Immunotherapy; Biology; Virology; Melanoma; Vesicular stomatitis virus; Cancer immunotherapy; Immunology; Virus","score_opus":0.029007622710388085,"score_gpt":0.32380924515295617,"score_spread":0.2948016224425681,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2773596288","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99561113,0.0010862538,0.00009285367,0.00015588429,0.00061890273,0.0009982771,0.00058309146,0.000048835365,0.00080475304],"genre_scores_gemma":[0.9949577,0.00027880052,0.00048770668,0.0009415194,0.00050814205,0.00024601587,0.00061137334,0.00012427954,0.0018444555],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976038,0.00028057108,0.00038140817,0.00077037106,0.00018113709,0.00078274985],"domain_scores_gemma":[0.9979086,0.000095278665,0.0003526256,0.0012932847,0.00022440188,0.00012581023],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005604282,0.0003734669,0.00047003743,0.000097264274,0.00082255213,0.00012711433,0.00076958246,0.00029168447,0.00014577924],"category_scores_gemma":[0.00017542695,0.00038557497,0.00023837158,0.00005166559,0.0005082058,0.000015036411,0.00027009984,0.00027288764,0.00035911848],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019993149,0.00020621998,0.00018057498,0.000045049084,0.00018593654,0.000030682724,0.000027913744,0.0000022310205,0.97851753,0.000003047195,0.013562107,0.0052394173],"study_design_scores_gemma":[0.0025601087,0.005929668,0.0005317515,0.000030737203,0.000037445538,0.000028280487,0.000037266807,0.000019278626,0.9264057,0.00009065387,0.063899346,0.00042974096],"about_ca_topic_score_codex":0.00018778765,"about_ca_topic_score_gemma":0.00031376028,"teacher_disagreement_score":0.052111782,"about_ca_system_score_codex":0.00008697197,"about_ca_system_score_gemma":0.00021176628,"threshold_uncertainty_score":0.99985963},"labels":[],"label_agreement":null},{"id":"W2774491730","doi":"10.1080/2162402x.2017.1412909","title":"Glioblastoma stem cell-derived exosomes induce M2 macrophages and PD-L1 expression on human monocytes","year":2017,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":365,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital","funders":"National Center for Research Resources; National Institute of Neurological Disorders and Stroke; National Cancer Institute; National Institutes of Health; Cancer Prevention and Research Institute of Texas","keywords":"Microvesicles; Biology; Immune system; STAT protein; Cancer research; STAT3; Cell biology; CD14; Exosome; Tumor microenvironment; Phosphorylation; Immunology; microRNA","score_opus":0.01947856742363775,"score_gpt":0.2902528038109905,"score_spread":0.27077423638735276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2774491730","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99206436,0.005067888,0.000029761703,0.00012646236,0.00021259322,0.0001845271,0.000016806029,0.000032206783,0.0022653816],"genre_scores_gemma":[0.99637085,0.00045223229,0.00019017915,0.000101647376,0.00014513839,0.000036350295,0.000021293317,0.000044860353,0.0026374734],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986486,0.0001242007,0.00021936702,0.0005644556,0.000101768615,0.00034161768],"domain_scores_gemma":[0.9983757,0.000022937586,0.0002501272,0.0012088984,0.000047840796,0.00009448467],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00010435845,0.00026094288,0.00023800161,0.000057666206,0.00058728067,0.000089915324,0.00059066067,0.0003409815,0.000033469983],"category_scores_gemma":[0.0000467235,0.00024923275,0.00008097393,0.000020055131,0.00045111318,0.000012908471,0.000595484,0.00019846884,0.00004369433],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000313647,0.00014032854,0.0016065422,0.0000230363,0.000037113223,0.00005224877,0.00008923278,0.000002705364,0.9906177,0.00008674724,0.0003750732,0.006655611],"study_design_scores_gemma":[0.0011798795,0.00083231047,0.026962832,0.000037965452,0.000019104158,0.000021339747,0.00019541068,0.000003842973,0.9663333,0.00012696758,0.004020035,0.0002669755],"about_ca_topic_score_codex":0.000015782085,"about_ca_topic_score_gemma":0.000010164626,"teacher_disagreement_score":0.025356289,"about_ca_system_score_codex":0.000021196553,"about_ca_system_score_gemma":0.000040076422,"threshold_uncertainty_score":0.999996},"labels":[],"label_agreement":null},{"id":"W2788829911","doi":"10.1080/2162402x.2017.1423171","title":"Oncolytic influenza virus infection restores immunocompetence of lung tumor-associated alveolar macrophages","year":2018,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre","funders":"Deutsche Krebshilfe; Deutsche Forschungsgemeinschaft","keywords":"Oncolytic virus; Tumor microenvironment; Immunocompetence; Immune system; Cancer research; Lung cancer; Influenza A virus; Biology; Immunology; Virus; Medicine; Pathology","score_opus":0.01505696059833981,"score_gpt":0.3186987107642977,"score_spread":0.30364175016595785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2788829911","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942852,0.003916232,0.000058325368,0.000039778162,0.00031680317,0.0002757782,0.000023530161,0.000040169874,0.0010441556],"genre_scores_gemma":[0.9981848,0.0007107637,0.000100989266,0.0003070115,0.00017360921,0.00004618913,0.00004599958,0.000045138124,0.00038552636],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980737,0.00038485808,0.00041643967,0.00042671635,0.0002054785,0.00049280364],"domain_scores_gemma":[0.99852234,0.000046740883,0.0002646459,0.00071834144,0.00039222252,0.000055730692],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005183823,0.00022987138,0.00032511496,0.00016370697,0.00018646772,0.00001830555,0.00044006735,0.0002844335,0.00019047094],"category_scores_gemma":[0.0003415859,0.00023508875,0.00013893271,0.0003133095,0.0007743854,0.00001060461,0.00027244628,0.00025866908,0.00009052752],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001939763,0.00018607605,0.016202444,0.00001518787,0.00027642358,0.0000075946273,0.00010687208,0.000017659137,0.97857976,0.000030511466,0.0004813488,0.002156334],"study_design_scores_gemma":[0.001415895,0.0080741,0.06523019,0.000038690836,0.000030423405,0.000028766737,0.00002847788,0.000056773028,0.9144056,0.00009450601,0.010338842,0.00025773328],"about_ca_topic_score_codex":0.00083723885,"about_ca_topic_score_gemma":0.0014263572,"teacher_disagreement_score":0.06417418,"about_ca_system_score_codex":0.00012265665,"about_ca_system_score_gemma":0.00032861065,"threshold_uncertainty_score":0.9586641},"labels":[],"label_agreement":null},{"id":"W2791879337","doi":"10.1080/2162402x.2017.1423173","title":"Increased immune infiltration and chemokine receptor expression in head and neck epithelial tumors after neoadjuvant immunotherapy with the IRX-2 regimen","year":2018,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Chemokine; Immune system; CD8; Cancer research; Immunotherapy; Tumor microenvironment; Medicine; Dendritic cell; CD68; Immunohistochemistry; Immunology; Biology","score_opus":0.007076286795418588,"score_gpt":0.24744590405908215,"score_spread":0.24036961726366357,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2791879337","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98678565,0.0072407536,0.000027666496,0.00461684,0.00011967109,0.00058110553,0.000008339331,0.00004083024,0.0005791346],"genre_scores_gemma":[0.99580723,0.0015166765,0.00067913265,0.0013174618,0.0001433338,0.000119060285,0.000026659744,0.000036174166,0.00035425994],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9987018,0.000138843,0.0003453551,0.00034751112,0.00014731709,0.00031917664],"domain_scores_gemma":[0.99920523,0.00007938049,0.0001578663,0.00044050987,0.0000737875,0.00004322839],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036061936,0.00024476968,0.000405502,0.0001343618,0.00014017476,0.000030306057,0.000106448075,0.00017900244,0.00024197546],"category_scores_gemma":[0.000023387665,0.00014995308,0.000043933404,0.00022655503,0.000839247,0.00013426249,0.000054940043,0.0002899283,0.000009999365],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029682014,0.00013084765,0.018396912,0.000019885721,0.00010689726,0.00002090629,0.0024531349,6.402046e-8,0.90818954,0.000015778844,0.00018723929,0.04079676],"study_design_scores_gemma":[0.0131746465,0.003535989,0.8312244,0.0005344704,0.000028049311,0.0003502632,0.0006635449,0.0000209913,0.10858584,0.000033461172,0.041590855,0.00025753022],"about_ca_topic_score_codex":0.0009937601,"about_ca_topic_score_gemma":0.0002383879,"teacher_disagreement_score":0.81282747,"about_ca_system_score_codex":0.00009605489,"about_ca_system_score_gemma":0.000121303136,"threshold_uncertainty_score":0.6114909},"labels":[],"label_agreement":null},{"id":"W2792540082","doi":"10.1080/2162402x.2018.1442169","title":"Heating it up: Oncolytic viruses make tumors ‘hot’ and suitable for checkpoint blockade immunotherapies","year":2018,"lang":"en","type":"editorial","venue":"OncoImmunology","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":124,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Izaak Walton Killam Health Centre; Dalhousie University","funders":"Labex Immuno-Oncology; European Research Area Network on Cardiovascular Diseases; Ligue Contre le Cancer; Fondation pour la Recherche Médicale; Institut National Du Cancer; Institut National de la Santé et de la Recherche Médicale; Agence Nationale de la Recherche; Government of Canada; Canadian Institutes of Health Research; Association pour la Recherche sur le Cancer; Seerave Foundation; Institut Universitaire de France; Beatrice Hunter Cancer Research Institute; Fondation Leducq; European Commission","keywords":"Oncolytic virus; Blockade; Immune checkpoint; Tumor microenvironment; Medicine; Immunotherapy; Adjuvant; Cancer research; Immune system; Immunology; Receptor; Internal medicine","score_opus":0.02087913009251936,"score_gpt":0.32904397637263394,"score_spread":0.3081648462801146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2792540082","genre_codex":"empirical","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.47524926,0.046702996,0.00018110921,0.0006863302,0.47227556,0.0026341088,0.00092778105,0.00014847926,0.0011943729],"genre_scores_gemma":[0.024637265,0.013952327,0.0019042152,0.0012843632,0.9023239,0.0019852165,0.0033720736,0.00096555165,0.049575083],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962379,0.00030691907,0.000750004,0.0011817663,0.00040027837,0.001123145],"domain_scores_gemma":[0.9973124,0.00046426835,0.00041041334,0.0011611318,0.0005412227,0.00011055011],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0012020799,0.00069434923,0.00092994876,0.00022295398,0.0004249888,0.00012761558,0.00086600636,0.00196605,0.00016898758],"category_scores_gemma":[0.0012089395,0.0006995314,0.00028859996,0.0001483927,0.00080334005,0.000008029928,0.0005163551,0.00084107986,0.00005716237],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0065458333,0.00010309776,0.000014096105,0.00015781219,0.00077208015,0.000006031441,0.0002852001,0.0000036054846,0.62945807,0.0000051034613,0.35839093,0.004258175],"study_design_scores_gemma":[0.00241884,0.008359647,0.000010199291,0.00012303363,0.000059724003,0.000017661254,0.00023471727,0.000013187302,0.2361815,0.00010857933,0.7519073,0.0005656429],"about_ca_topic_score_codex":0.00038109525,"about_ca_topic_score_gemma":0.0012754453,"teacher_disagreement_score":0.45061198,"about_ca_system_score_codex":0.00017863094,"about_ca_system_score_gemma":0.0013260735,"threshold_uncertainty_score":0.9995456},"labels":[],"label_agreement":null},{"id":"W2793301215","doi":"10.1080/2162402x.2018.1445459","title":"Transforming the prostatic tumor microenvironment with oncolytic virotherapy","year":2018,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; McMaster University; Centre Hospitalier de l’Université de Montréal; Children's Hospital of Eastern Ontario; Ottawa Hospital; McMaster University Medical Centre","funders":"Canadian Institutes of Health Research; Terry Fox Foundation; Prostate Cancer Canada","keywords":"Oncolytic virus; Virotherapy; Tumor microenvironment; Cancer research; Medicine; Tumor cells","score_opus":0.009857343026171481,"score_gpt":0.2680147467404387,"score_spread":0.2581574037142672,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2793301215","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950265,0.0013179367,0.0007207446,0.0011073607,0.00006399888,0.00065588794,0.0000066835005,0.000015373062,0.0010854683],"genre_scores_gemma":[0.9960043,0.0003305645,0.00032059313,0.0014922068,0.00019612933,0.00017813724,0.00001848878,0.00005038786,0.0014092238],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987432,0.00014985025,0.00017634997,0.0003419113,0.00014929503,0.00043941595],"domain_scores_gemma":[0.99923885,0.000021286894,0.000062497544,0.00059277035,0.00004190507,0.000042717566],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002608341,0.00018470152,0.00015692196,0.000039937608,0.00023578452,0.000020918213,0.00038575503,0.000082531275,0.00019304726],"category_scores_gemma":[0.000010561382,0.00011860915,0.000056344114,0.000104774954,0.0008563246,0.0000038151034,0.00005234229,0.00016480152,0.00013156845],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032677124,0.00009297493,0.00030151132,0.000005348018,0.00013654717,0.000007690516,0.00031246146,0.0000068934646,0.9799577,0.000026975415,0.0002177267,0.015666444],"study_design_scores_gemma":[0.0015693455,0.015709642,0.00094616774,0.000014245821,0.000016423963,0.00012882554,0.00025086082,0.000016794524,0.86660665,0.00005455213,0.1144894,0.00019707489],"about_ca_topic_score_codex":0.000024046778,"about_ca_topic_score_gemma":0.00040699047,"teacher_disagreement_score":0.11427167,"about_ca_system_score_codex":0.0000529735,"about_ca_system_score_gemma":0.00017219105,"threshold_uncertainty_score":0.48367405},"labels":[],"label_agreement":null},{"id":"W2795354240","doi":"10.1080/2162402x.2018.1434468","title":"The intestinal microbiota determines the clinical efficacy of immune checkpoint blockers targeting PD-1/PD-L1","year":2018,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Blockade; PD-L1; Immunotherapy; Immune checkpoint; Immune system; Medicine; Cancer immunotherapy; Gut flora; Clinical efficacy; Immunology; Cancer research; Internal medicine; Receptor","score_opus":0.027641767298129286,"score_gpt":0.34032556835621924,"score_spread":0.31268380105808996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2795354240","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98014855,0.007857367,0.000028866922,0.008654957,0.0016210154,0.0004527653,0.000003852254,0.000055416327,0.0011771967],"genre_scores_gemma":[0.99534947,0.0011640046,0.0009581259,0.00057997106,0.00059775263,0.000015943577,0.00001209487,0.000034785182,0.0012878847],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9975613,0.00028709057,0.00121298,0.00032505434,0.00014824895,0.00046535925],"domain_scores_gemma":[0.9971491,0.001160985,0.00053799484,0.00084384816,0.00026557795,0.000042467054],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.001756279,0.00023332381,0.0005111728,0.0000622436,0.0003994613,0.000022803393,0.00055317435,0.00021183283,0.00020728503],"category_scores_gemma":[0.0010720071,0.00012565246,0.00044662692,0.00029419156,0.003265919,0.00003263296,0.00021596243,0.00052453566,0.00007425406],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01014925,0.00032525178,0.008612275,0.000028192506,0.0007387766,0.00001748042,0.000754596,1.17755015e-7,0.8585491,0.00005988955,0.0045117578,0.116253294],"study_design_scores_gemma":[0.008114551,0.00427436,0.4641101,0.00038050528,0.00029924224,0.00085482013,0.0015306146,0.00007229559,0.1478135,0.00007389468,0.37214005,0.00033607378],"about_ca_topic_score_codex":0.00033175474,"about_ca_topic_score_gemma":0.00006326971,"teacher_disagreement_score":0.7107356,"about_ca_system_score_codex":0.000079908285,"about_ca_system_score_gemma":0.0002881588,"threshold_uncertainty_score":0.99944663},"labels":[],"label_agreement":null},{"id":"W2799338998","doi":"10.1080/2162402x.2018.1467856","title":"Gene expression profiling and immune cell-type deconvolution highlight robust disease progression and survival markers in multiple cohorts of CTCL patients","year":2018,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa; Université Laval; Université de Montréal; McGill University Health Centre","funders":"Fonds de Recherche du Québec - Santé; Canadian Dermatology Foundation","keywords":"Mycosis fungoides; CD52; Disease; Immune system; Oncology; Medicine; Biology; T cell; Immunology; Internal medicine; Alemtuzumab; Lymphoma; Antibody","score_opus":0.017731974657137706,"score_gpt":0.2857776371904261,"score_spread":0.2680456625332884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2799338998","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945047,0.0038026005,0.000034196055,0.00010378901,0.00019277027,0.00093925133,0.00001015978,0.000023216791,0.00038933678],"genre_scores_gemma":[0.99751717,0.00070846453,0.0014096637,0.000012940997,0.000028178232,0.00003655557,0.00012590628,0.000026324438,0.00013478675],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984592,0.0002110269,0.00036723207,0.00039767002,0.00023330528,0.0003315582],"domain_scores_gemma":[0.99903744,0.00011682296,0.00013680193,0.00027869642,0.00031993148,0.000110304456],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025577546,0.00017372039,0.00039897786,0.00022152577,0.00012656224,0.000009355176,0.000073279836,0.00015807731,0.00006169053],"category_scores_gemma":[0.00041373682,0.00014783477,0.00003065655,0.00019817516,0.0005707501,0.00008403607,0.0002043067,0.0001692654,0.000006090048],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0050665955,0.000439246,0.7493798,0.00014372989,0.000022058477,0.000028510187,0.00019507819,0.0000018505403,0.2405013,0.000007640232,0.000021765129,0.004192384],"study_design_scores_gemma":[0.0050672623,0.0014166215,0.8762947,0.000251345,0.000030414543,0.000028160026,0.00018826591,0.0013105074,0.11515608,0.000030512809,0.000075862205,0.00015028802],"about_ca_topic_score_codex":0.00009094562,"about_ca_topic_score_gemma":0.000033550088,"teacher_disagreement_score":0.12691484,"about_ca_system_score_codex":0.00010909374,"about_ca_system_score_gemma":0.000184415,"threshold_uncertainty_score":0.6028527},"labels":[],"label_agreement":null},{"id":"W2886222140","doi":"10.1080/2162402x.2018.1486950","title":"EBV infection determines the immune hallmarks of plasmablastic lymphoma","year":2018,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research; Institut National Du Cancer; Institut Universitaire de France; Ligue Contre le Cancer; Agence Nationale de la Recherche","keywords":"Plasmablastic lymphoma; Immune checkpoint; Immune system; Lymphoma; Immunology; Medicine; Tumor microenvironment; Epstein–Barr virus; Cytotoxic T cell; Immunotherapy; Cancer research; Virus; Biology","score_opus":0.00991615788039044,"score_gpt":0.2606953859145428,"score_spread":0.2507792280341523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886222140","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97920066,0.0013605882,0.00007966266,0.0007708561,0.0007295687,0.00016054879,0.000002494611,0.000046164638,0.017649425],"genre_scores_gemma":[0.99813443,0.00037185944,0.00003650421,0.0002447693,0.0001161443,0.00001917702,0.000008252694,0.000016143946,0.0010527415],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9992012,0.00005733564,0.00026866808,0.00014589124,0.000098965495,0.00022796183],"domain_scores_gemma":[0.9992852,0.00008438738,0.00017386985,0.00029691219,0.00013807962,0.000021523556],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013609011,0.000114475035,0.00029485737,0.00008441788,0.00011559127,0.000005715656,0.00009419801,0.000163411,0.00023394577],"category_scores_gemma":[0.00019386338,0.000078868754,0.000105549414,0.00020189535,0.00046254016,0.000042630265,0.000050914612,0.000097696386,0.00008506389],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0056700716,0.0013242638,0.13601899,0.00022121497,0.0018429852,0.000053367112,0.003980259,0.00002183395,0.2714803,0.003357581,0.0067908755,0.56923825],"study_design_scores_gemma":[0.008234065,0.0041917153,0.9074792,0.00016142064,0.00033270443,0.00023057325,0.00050430535,0.00047258576,0.028274203,0.00078128313,0.049103413,0.00023448121],"about_ca_topic_score_codex":0.0011696061,"about_ca_topic_score_gemma":0.0003942512,"teacher_disagreement_score":0.77146024,"about_ca_system_score_codex":0.00010090745,"about_ca_system_score_gemma":0.00014969424,"threshold_uncertainty_score":0.32161742},"labels":[],"label_agreement":null},{"id":"W2886229095","doi":"10.1080/2162402x.2018.1498439","title":"Treatment-naïve HPV+ head and neck cancers display a T-cell-inflamed phenotype distinct from their HPV- counterparts that has implications for immunotherapy","year":2018,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":140,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lawson Health Research Institute; Western University","funders":"Canadian Institutes of Health Research","keywords":"TIGIT; Immune system; Immunotherapy; Immune checkpoint; Medicine; Head and neck squamous-cell carcinoma; Cancer research; Antigen; Immunology; HPV infection; T cell; Head and neck cancer; Cancer; Oncology; Internal medicine; Cervical cancer","score_opus":0.03692625881733523,"score_gpt":0.3077519065233821,"score_spread":0.27082564770604683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886229095","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97625226,0.012512304,0.00053824286,0.005174097,0.0007493954,0.0013399553,0.0005899916,0.00012916025,0.0027145764],"genre_scores_gemma":[0.993052,0.002720709,0.00059301005,0.001013681,0.00037818283,0.00054265984,0.00041473858,0.00007507804,0.0012099192],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9983234,0.00006170796,0.00039412468,0.00059252314,0.00009163714,0.0005366284],"domain_scores_gemma":[0.99844253,0.0002967456,0.00024083983,0.0007944686,0.00013284899,0.00009256875],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000097800425,0.00040536,0.0006490788,0.00010387996,0.00046765638,0.000067764726,0.00020314331,0.00025429082,0.00052752736],"category_scores_gemma":[0.000019421785,0.00030645166,0.00021491681,0.00016058136,0.00097460387,0.000110092624,0.000040668354,0.00013944083,0.000028523958],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028189855,0.0007728597,0.06969957,0.000051748724,0.0028036055,0.000010703432,0.0075020436,4.2093475e-7,0.37443337,0.00026418464,0.0038034031,0.5124682],"study_design_scores_gemma":[0.016330656,0.0048133633,0.56570154,0.00007287676,0.00021670277,0.00007061891,0.00047163147,0.000082905935,0.013156124,0.00046378156,0.39821434,0.00040541895],"about_ca_topic_score_codex":0.005201817,"about_ca_topic_score_gemma":0.0031179206,"teacher_disagreement_score":0.5120628,"about_ca_system_score_codex":0.0006980109,"about_ca_system_score_gemma":0.00051184034,"threshold_uncertainty_score":0.9999388},"labels":[],"label_agreement":null},{"id":"W2886634548","doi":"10.1080/2162402x.2018.1475875","title":"A point mutation in the <i>Ncr1</i> signal peptide impairs the development of innate lymphoid cell subsets","year":2018,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Medical Research Council; Centre National de la Recherche Scientifique; Institut National de la Santé et de la Recherche Médicale; Agence Nationale de la Recherche; Australian Government; National Health and Medical Research Council; CSL Limited; European Commission; Aix-Marseille Université","keywords":"Biology; Innate lymphoid cell; Mutant; Cell biology; Congenic; Immune system; Mutation; Point mutation; Innate immune system; Molecular biology; Immunology; Gene; Genetics","score_opus":0.010883113491059698,"score_gpt":0.23343832670887685,"score_spread":0.22255521321781715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886634548","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.979735,0.0010706591,0.00041136073,0.00061699504,0.0018908296,0.00032096048,0.0000019393606,0.00003489362,0.01591736],"genre_scores_gemma":[0.9964,0.00003334075,0.000091807946,0.00063333195,0.00003019046,0.000057933463,0.0000778328,0.00001319694,0.002662378],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998219,0.0005864019,0.00058245234,0.0002228111,0.000050938146,0.00033837667],"domain_scores_gemma":[0.9989548,0.00027159994,0.00028505104,0.00034469808,0.00013780649,0.0000060816596],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0008412817,0.00017589609,0.00022823109,0.00015564666,0.00030273173,0.000012582673,0.00040691855,0.0002157197,0.0011994718],"category_scores_gemma":[0.00005054085,0.00010818672,0.00008342164,0.00026557202,0.00047095158,0.00011130715,0.00008637487,0.0003753914,0.0013836009],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00077558024,0.0003750699,0.001139137,0.000013332452,0.00012363233,0.00000448836,0.025235897,0.0000055647456,0.95020664,0.0004556169,0.008594953,0.013070105],"study_design_scores_gemma":[0.00274048,0.00089730456,0.035119455,0.00004211842,0.000037897356,0.00049437594,0.015317883,0.000022436521,0.7260461,0.00018025945,0.2188492,0.00025253228],"about_ca_topic_score_codex":0.00023349667,"about_ca_topic_score_gemma":0.0002796655,"teacher_disagreement_score":0.22416055,"about_ca_system_score_codex":0.00011448201,"about_ca_system_score_gemma":0.00018729296,"threshold_uncertainty_score":0.99971354},"labels":[],"label_agreement":null},{"id":"W2887082004","doi":"10.1080/2162402x.2018.1478647","title":"Brain tumor-initiating cells export tenascin-C associated with exosomes to suppress T cell activity","year":2018,"lang":"en","type":"editorial","venue":"OncoImmunology","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":129,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Canada Research Chairs; Deutsche Forschungsgemeinschaft; Alberta Innovates - Health Solutions; Government of Canada; Alberta Cancer Foundation; University of Calgary","keywords":"Microvesicles; Tenascin C; Exosome; Immune system; Biology; Cancer research; T cell; Cell biology; Stem cell; Immunology; Extracellular matrix; microRNA; Gene","score_opus":0.006009878546964434,"score_gpt":0.2450397641880581,"score_spread":0.23902988564109365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887082004","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.61076266,0.0012238101,0.0002402589,0.00018103141,0.37857583,0.0010422223,0.0014669269,0.00015608672,0.006351208],"genre_scores_gemma":[0.5133132,0.0001494761,0.001189518,0.00081598613,0.45846733,0.0003786376,0.0057396106,0.00059653656,0.019349746],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9959859,0.00051544287,0.00050655,0.0014297004,0.0005622956,0.0010000675],"domain_scores_gemma":[0.99653685,0.0004389792,0.0006904653,0.0015053222,0.0005346369,0.00029371845],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0006099995,0.0007587581,0.0008177727,0.00016739596,0.00022779166,0.000082429964,0.001126132,0.0016453753,0.00015040714],"category_scores_gemma":[0.0024216755,0.00073754473,0.00023928926,0.0002189155,0.00043783477,0.000012232337,0.0007924737,0.0009197418,0.0001464161],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035620917,0.0002494443,0.000042073287,0.00004211199,0.00020060425,0.00011179092,0.00005738757,0.000004017071,0.46788836,5.10136e-7,0.5308216,0.00022585964],"study_design_scores_gemma":[0.001405864,0.001836594,0.00029955013,0.00012930852,0.00012993577,0.000008594555,0.00007940221,0.0000038289254,0.38351,0.000009929563,0.6117191,0.0008678963],"about_ca_topic_score_codex":0.00005488892,"about_ca_topic_score_gemma":0.00011416178,"teacher_disagreement_score":0.097449474,"about_ca_system_score_codex":0.00018562344,"about_ca_system_score_gemma":0.001336447,"threshold_uncertainty_score":0.9996507},"labels":[],"label_agreement":null},{"id":"W2888080031","doi":"10.1080/2162402x.2018.1502128","title":"TIM-3 expression in breast cancer","year":2018,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Galectins and Cancer Biology","field":"Immunology and Microbiology","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Centre for Advancing Health Outcomes; University of British Columbia","funders":"Fonds de Recherche du Québec - Santé; Canadian Cancer Society","keywords":"Breast cancer; Immune checkpoint; Medicine; Cancer; Tissue microarray; Estrogen receptor; Tumor-infiltrating lymphocytes; Oncology; Internal medicine; Triple-negative breast cancer; Cancer research; Immunotherapy; Pathology","score_opus":0.009024998491655035,"score_gpt":0.26445706968536276,"score_spread":0.2554320711937077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2888080031","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98009026,0.0054055178,0.0000333057,0.001616472,0.0027224198,0.00014154534,0.00003877915,0.000091761984,0.009859924],"genre_scores_gemma":[0.99571997,0.0004707637,0.000046926878,0.0005609003,0.00013513086,0.00007553309,0.000026960237,0.000017492248,0.0029463153],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99860847,0.00020117943,0.00026489922,0.00037919063,0.000017321114,0.00052893267],"domain_scores_gemma":[0.9994476,0.000048483336,0.000094095936,0.00031886072,0.00007780791,0.000013186568],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00014254462,0.00017260494,0.0003094482,0.00016140187,0.00013450092,0.000005308322,0.00028944973,0.00045798082,0.008051304],"category_scores_gemma":[0.000015097726,0.00014574817,0.000052633106,0.00021405074,0.0005968414,0.0000603336,0.00014047344,0.000356278,0.0015991388],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004000832,0.00011557571,0.040951565,0.0000038286926,0.00004646204,0.000005653712,0.0003660896,5.080628e-7,0.9194318,0.00034635537,0.007611402,0.03072069],"study_design_scores_gemma":[0.0026279173,0.00043446806,0.6079838,0.000068785215,0.000014995834,0.00043736683,0.00028550098,0.0000019139306,0.12634344,0.00038051637,0.26109618,0.0003250735],"about_ca_topic_score_codex":0.00078263594,"about_ca_topic_score_gemma":0.0005331024,"teacher_disagreement_score":0.7930883,"about_ca_system_score_codex":0.00010486917,"about_ca_system_score_gemma":0.000108808155,"threshold_uncertainty_score":0.99917823},"labels":[],"label_agreement":null},{"id":"W2888879984","doi":"10.1080/2162402x.2018.1503032","title":"Trial Watch: Oncolytic viro-immunotherapy of hematologic and solid tumors","year":2018,"lang":"en","type":"review","venue":"OncoImmunology","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":78,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa; Izaak Walton Killam Health Centre; Dalhousie University; McMaster University","funders":"Labex Immuno-Oncology; Weill Cornell Medical College; Institut National Du Cancer; Institut Universitaire de France; Ligue Contre le Cancer; Fondation pour la Recherche Médicale; Agence Nationale de la Recherche; E-Rare; Association pour la Recherche sur le Cancer; Seerave Foundation; Fondation Leducq; European Commission","keywords":"Oncolytic virus; Virotherapy; Medicine; Immunotherapy; Clinical trial; Herpes simplex virus; Food and drug administration; Melanoma; Cancer; Cancer immunotherapy; Cancer research; Immune system; Virus; Immunology; Virology; Internal medicine; Pharmacology","score_opus":0.05353625150915936,"score_gpt":0.3856434468778843,"score_spread":0.33210719536872496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2888879984","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.021684708,0.9758289,0.00001376232,0.000048891638,0.00039316618,0.0013938601,0.000048693775,0.000023439481,0.00056457956],"genre_scores_gemma":[0.00072429224,0.9967693,0.000113592454,0.000091793394,0.00037718812,0.00027541828,0.00022474787,0.0001232827,0.001300374],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99643093,0.0007954859,0.0010751322,0.0008485097,0.00021314234,0.00063681905],"domain_scores_gemma":[0.997607,0.00012817585,0.00070379465,0.0013017196,0.00017809107,0.00008124263],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007440581,0.0006167149,0.0024276406,0.00019497513,0.000111668414,0.000023189534,0.00090037106,0.0011934863,0.00016040678],"category_scores_gemma":[0.00020177376,0.0005051945,0.00056772603,0.00023951835,0.0010576508,0.0000039661204,0.00042185737,0.0004850479,0.00009483512],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.037741553,0.0006158697,0.0000040821824,0.0036495936,0.0023119682,0.000042570085,0.000101954975,3.54412e-7,0.02378782,0.00007921069,0.0024103129,0.9292547],"study_design_scores_gemma":[0.00971932,0.019456256,0.0000013324553,0.0010159258,0.00016936108,0.00028200823,0.000026746982,8.022937e-7,0.006191658,0.0000944944,0.9624963,0.0005457856],"about_ca_topic_score_codex":0.000021364556,"about_ca_topic_score_gemma":0.000037153684,"teacher_disagreement_score":0.960086,"about_ca_system_score_codex":0.00007536625,"about_ca_system_score_gemma":0.0008841766,"threshold_uncertainty_score":0.99973994},"labels":[],"label_agreement":null},{"id":"W2889975327","doi":"10.1080/2162402x.2018.1504728","title":"Somatic mutation-associated T follicular helper cell elevation in lung adenocarcinoma","year":2018,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Occupational Cancer Research Centre","funders":"Canadian Institutes of Health Research; Government of Canada","keywords":"Germinal center; Biology; Immune system; B cell; Lung cancer; Adenocarcinoma; Immunology; Immunohistochemistry; Cancer research; Follicular phase; Affinity maturation; Antigen; Follicular dendritic cells; Cancer; T cell; Pathology; Antibody; Medicine; Antigen-presenting cell","score_opus":0.010534164007506785,"score_gpt":0.26721513923945933,"score_spread":0.25668097523195255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2889975327","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99252343,0.0027245693,0.00010810112,0.00095252757,0.0003293908,0.00036212866,0.0000025439856,0.00006235599,0.0029349383],"genre_scores_gemma":[0.99745744,0.00009521598,0.00020804818,0.00066594343,0.00006485444,0.00004249931,0.00006713115,0.000022609029,0.0013762786],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.998909,0.000096296644,0.0003482156,0.00022414552,0.00013478822,0.0002875811],"domain_scores_gemma":[0.9994114,0.000060445615,0.00013457928,0.00025728357,0.000109549685,0.000026746846],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024142266,0.00013414619,0.00027521234,0.00020796015,0.00007374479,0.00001088758,0.00008829883,0.00020852924,0.0005717298],"category_scores_gemma":[0.00007636259,0.00012541011,0.000082204155,0.00041482953,0.00014499703,0.00007759204,0.000021480333,0.00015855972,0.00013755026],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022172807,0.0009158025,0.34803882,0.0001455081,0.0005180817,0.00020638095,0.0058624377,0.000002652851,0.6281429,0.00016472675,0.0018648056,0.011920594],"study_design_scores_gemma":[0.0070034117,0.0009956696,0.96339506,0.00013538351,0.00008077468,0.00008161428,0.00060983025,0.00079312775,0.024617327,0.00018860052,0.0019092591,0.00018992188],"about_ca_topic_score_codex":0.00051225664,"about_ca_topic_score_gemma":0.00024134787,"teacher_disagreement_score":0.61535627,"about_ca_system_score_codex":0.00038635932,"about_ca_system_score_gemma":0.00016034782,"threshold_uncertainty_score":0.62600404},"labels":[],"label_agreement":null},{"id":"W2892170876","doi":"10.1080/2162402x.2018.1509820","title":"Assessment of PD-L1 expression across breast cancer molecular subtypes, in relation to mutation rate, <i>BRCA1</i>-like status, tumor-infiltrating immune cells and survival","year":2018,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":120,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System; Lunenfeld-Tanenbaum Research Institute; University of Toronto; University Health Network","funders":"National Cancer Institute; National Institutes of Health; European Commission","keywords":"Tumor-infiltrating lymphocytes; Tissue microarray; Breast cancer; PD-L1; FOXP3; Cancer research; Immune system; Medicine; CD8; Estrogen receptor; Multiplex; Cancer; Immunohistochemistry; Oncology; Pathology; Biology; Internal medicine; Immunology; Immunotherapy; Bioinformatics","score_opus":0.0096826423141296,"score_gpt":0.31319507012572595,"score_spread":0.3035124278115964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2892170876","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99617076,0.0012753688,0.00035894272,0.00040186348,0.0007058296,0.00044357043,0.000048443162,0.000027864775,0.0005673483],"genre_scores_gemma":[0.9979665,0.0003168287,0.0011299207,0.0002790821,0.000051164934,0.000046015466,0.000049553724,0.000026895603,0.0001339881],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9984064,0.00019547963,0.00052170735,0.00033491847,0.00017284698,0.0003686196],"domain_scores_gemma":[0.99913996,0.00008244326,0.00024926045,0.00029487524,0.00017866865,0.0000547729],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005445605,0.00017891999,0.0004023002,0.0001337323,0.00008936863,0.00001799164,0.000080361635,0.0001423618,0.00014468306],"category_scores_gemma":[0.000025809291,0.00016587462,0.00005335551,0.0003662514,0.00021837855,0.00013104978,0.00006940827,0.00021142594,0.000004175605],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020843614,0.000105120125,0.040926334,0.000051453837,0.00007093497,0.00002265469,0.0014105254,0.000030870255,0.946758,0.000035349247,0.000038673013,0.008465765],"study_design_scores_gemma":[0.0031612234,0.00065770873,0.8428071,0.0003172468,0.00002362954,0.000048664817,0.0011998047,0.00012976068,0.15049565,0.000017316182,0.0009905524,0.00015134392],"about_ca_topic_score_codex":0.0028370572,"about_ca_topic_score_gemma":0.0005246774,"teacher_disagreement_score":0.8018808,"about_ca_system_score_codex":0.00027370936,"about_ca_system_score_gemma":0.0002675815,"threshold_uncertainty_score":0.67641705},"labels":[],"label_agreement":null},{"id":"W2892263168","doi":"10.1080/2162402x.2018.1512943","title":"Identification of PD-L2, B7-H3 and CTLA-4 immune checkpoint proteins in genetic subtypes of meningioma","year":2018,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotchkiss Brain Institute; Institute of Cancer Research; University of Calgary","funders":"Government of Canada; Health Research Board","keywords":"Immunotherapy; Immune checkpoint; Cancer research; Meningioma; Medicine; Immune system; CTLA-4; Mutation; PD-L1; Gene; Immunology; Biology; T cell; Pathology; Genetics","score_opus":0.012780361939719164,"score_gpt":0.26367748173064137,"score_spread":0.2508971197909222,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2892263168","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99460274,0.0019019861,0.00022068167,0.00032469266,0.00012459961,0.00051090226,0.0000019570282,0.00001763413,0.0022948042],"genre_scores_gemma":[0.9975552,0.000042043474,0.0015834098,0.000007080488,0.00003168501,0.00003879719,0.0000077811865,0.000012564021,0.00072142686],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9986561,0.00007338121,0.0007038817,0.00023691528,0.00013446002,0.00019529257],"domain_scores_gemma":[0.99907494,0.000027780217,0.00031600049,0.00042216005,0.00013268838,0.000026412752],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039903083,0.00011639005,0.00040096525,0.00031030446,0.000031205236,0.0000049361774,0.00011677643,0.00010889972,0.000099960365],"category_scores_gemma":[0.00011307715,0.000108050925,0.000052507075,0.00027019202,0.00035779495,0.000044332766,0.00010530722,0.00008400669,0.000017334823],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003528462,0.00017697296,0.016609315,0.00015609982,0.00010435657,0.000050543218,0.0011602383,6.917531e-7,0.9736652,0.0007737618,0.000018539306,0.0069314563],"study_design_scores_gemma":[0.0013214659,0.0010562093,0.58950925,0.00011195267,0.000061100516,0.00013039,0.0002878239,0.00014131764,0.40658912,0.00040336687,0.0003041956,0.00008381456],"about_ca_topic_score_codex":0.0002799441,"about_ca_topic_score_gemma":0.000020534995,"teacher_disagreement_score":0.57289994,"about_ca_system_score_codex":0.00004046848,"about_ca_system_score_gemma":0.000047146146,"threshold_uncertainty_score":0.44061887},"labels":[],"label_agreement":null},{"id":"W2892370845","doi":"10.1080/2162402x.2018.1512329","title":"Preclinical evaluation of a MAGE-A3 vaccination utilizing the oncolytic Maraba virus currently in first-in-human trials","year":2018,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":87,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; University of Guelph; University of Toronto; University Health Network; Toronto General Hospital; Children's Hospital of Eastern Ontario; McMaster University","funders":"Ontario Institute for Cancer Research; Terry Fox Foundation","keywords":"Oncolytic virus; Immunogenicity; Immunotherapy; Vaccination; Immunology; Immune system; Virology; CD8; Medicine; Antibody; Biology","score_opus":0.1424572244090407,"score_gpt":0.4622458880018727,"score_spread":0.319788663592832,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2892370845","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99276924,0.0036520923,0.000021277623,0.000436713,0.00024205704,0.0008480796,0.000008260502,0.0000061016353,0.0020161946],"genre_scores_gemma":[0.99894685,0.00046293208,0.000027618435,0.000061695304,0.00018645266,0.00015488119,0.000050961746,0.000018750454,0.00008984203],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9961345,0.0020968907,0.00078662514,0.00037264495,0.00029635764,0.0003129608],"domain_scores_gemma":[0.99861395,0.00024094114,0.0002766473,0.00056884554,0.00027582404,0.000023787688],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008587642,0.00014487086,0.0003698001,0.00017542283,0.00008391975,0.000012981679,0.00041188303,0.00026724965,0.00038514132],"category_scores_gemma":[0.0018095319,0.000118140895,0.00011255363,0.00025458637,0.00020505789,0.000007436687,0.00015375517,0.00024678395,0.000022248361],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037090492,0.0005003937,0.0066531044,0.000021327707,0.0001027911,0.000001835463,0.0003612607,0.00010777947,0.83373374,0.000089482346,0.00031506512,0.15440416],"study_design_scores_gemma":[0.014641462,0.01303433,0.22056988,0.00012823015,0.00012749012,0.000014742359,0.0004886183,0.005046059,0.7361313,0.002789722,0.0065831044,0.00044502498],"about_ca_topic_score_codex":0.00014207845,"about_ca_topic_score_gemma":0.009208205,"teacher_disagreement_score":0.21391678,"about_ca_system_score_codex":0.00013340545,"about_ca_system_score_gemma":0.00032991963,"threshold_uncertainty_score":0.5138395},"labels":[],"label_agreement":null},{"id":"W2894424410","doi":"10.1080/2162402x.2018.1502905","title":"Adoptive cell therapy with tumor-infiltrating lymphocytes in patients with metastatic ovarian cancer: a pilot study","year":2018,"lang":"en","type":"article","venue":"OncoImmunology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":124,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Anticancer Fund; Kræftens Bekæmpelse","keywords":"Medicine; Tumor-infiltrating lymphocytes; Tolerability; Ovarian cancer; Melanoma; Oncology; Immunotherapy; Internal medicine; Cancer; Immune system; Aldesleukin; Progressive disease; T cell; Chemotherapy; Immunology; Cancer research; Adverse effect","score_opus":0.03149604510729136,"score_gpt":0.3048349407159007,"score_spread":0.27333889560860936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2894424410","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99321073,0.000385306,0.000019572231,0.0001131247,0.00007949088,0.0019989985,0.000008233061,0.00005639232,0.0041281683],"genre_scores_gemma":[0.99743074,0.0000531562,0.0009436783,0.0002910082,0.00007228512,0.00028301132,0.000017235347,0.000070071364,0.00083883625],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997876,0.000297829,0.00032524753,0.00049320725,0.00041874114,0.0005889721],"domain_scores_gemma":[0.9987028,0.00013927754,0.00016408577,0.00054432894,0.00036805982,0.00008141391],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003150902,0.00029210717,0.0006146109,0.00028717224,0.000120048346,0.000026296138,0.00021023527,0.00003674148,0.0018254424],"category_scores_gemma":[0.000023675482,0.00019757287,0.000027660284,0.00067063776,0.00042660194,0.00010362197,0.000056239758,0.00037496965,0.000041456504],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03694336,0.00616166,0.9097241,0.000024812705,0.00070418726,0.00021110791,0.0055641215,0.000008229799,0.020777963,0.000017798204,0.000032700438,0.019829951],"study_design_scores_gemma":[0.04453985,0.116145015,0.82796574,0.000116827665,0.00008196664,0.000038539667,0.0032503873,0.000038122,0.006723002,0.000011724343,0.0007883446,0.00030049053],"about_ca_topic_score_codex":0.0045200307,"about_ca_topic_score_gemma":0.0021313347,"teacher_disagreement_score":0.109983355,"about_ca_system_score_codex":0.0004922738,"about_ca_system_score_gemma":0.0007664163,"threshold_uncertainty_score":0.99908704},"labels":[],"label_agreement":null},{"id":"W2897635618","doi":"10.1080/2162402x.2018.1527497","title":"IL-33 increases ST2<sup>+</sup>Tregs and promotes metastatic tumour growth in the lungs in an amphiregulin-dependent manner","year":2018,"lang":"en","type":"article","venue":"OncoImmunology","topic":"IL-33, ST2, and ILC Pathways","field":"Immunology and Microbiology","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Terry Fox Research Institute; University of British Columbia","funders":"BC Cancer Agency; Canadian Institutes of Health Research; Cancer Research Society","keywords":"Amphiregulin; Cancer research; Epidermal growth factor receptor; Medicine; Epidermal growth factor; Immunology; Immunotherapy; In vivo; Receptor; Biology; Internal medicine; Immune system","score_opus":0.01616851224553476,"score_gpt":0.24731054568069682,"score_spread":0.23114203343516207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2897635618","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943147,0.0019589947,0.000018639717,0.0005308703,0.0002628331,0.0006093252,0.00062748324,0.00008544328,0.0015917307],"genre_scores_gemma":[0.99782753,0.0003841367,0.00014769535,0.00054129213,0.00008728807,0.00012738195,0.00022939582,0.000042101234,0.0006131841],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99613404,0.0015084461,0.0006367998,0.0007222756,0.0000840718,0.000914379],"domain_scores_gemma":[0.9986578,0.0004154253,0.00019596174,0.00054901215,0.0001437523,0.000038046936],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010083861,0.00044627656,0.00070948363,0.00043075206,0.00030971383,0.00004792818,0.0007172166,0.00040308313,0.00017875459],"category_scores_gemma":[0.00034894104,0.0003307223,0.00007854122,0.00040904703,0.0011010309,0.00033790653,0.00026115074,0.0007385246,0.0003969006],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044682263,0.0071970946,0.094120935,0.0003547514,0.0014357271,0.0011852556,0.091715805,0.00001551368,0.7300619,0.04074249,0.004981798,0.023720486],"study_design_scores_gemma":[0.032459274,0.017487701,0.61253345,0.0007387511,0.0009306804,0.0076203817,0.06611717,0.00034645057,0.14379844,0.028390164,0.08549629,0.004081238],"about_ca_topic_score_codex":0.0032390791,"about_ca_topic_score_gemma":0.0031586376,"teacher_disagreement_score":0.5862635,"about_ca_system_score_codex":0.00009211176,"about_ca_system_score_gemma":0.00019751876,"threshold_uncertainty_score":0.99991447},"labels":[],"label_agreement":null},{"id":"W2901910720","doi":"10.1080/2162402x.2018.1539613","title":"Blockade of TGF-β signaling with novel synthetic antibodies limits immune exclusion and improves chemotherapy response in metastatic ovarian cancer models","year":2018,"lang":"en","type":"article","venue":"OncoImmunology","topic":"TGF-β signaling in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Queen's University","funders":"Canadian Cancer Society","keywords":"Cancer research; Ovarian cancer; Antibody; Medicine; Immune system; Immune checkpoint; Tumor microenvironment; Metastasis; Cancer; Chemotherapy; Immunotherapy; Transforming growth factor; Blockade; Immunology; Receptor; Internal medicine","score_opus":0.015940038833988014,"score_gpt":0.2739481539280792,"score_spread":0.25800811509409116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2901910720","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99087733,0.0068110256,0.0017102305,0.00020676292,0.000068645306,0.00022435069,0.000027543978,0.000015107718,0.000059020527],"genre_scores_gemma":[0.9964465,0.00036979522,0.002843157,0.000088257395,0.000047370784,0.00003726296,0.000013852167,0.00004068495,0.0001131224],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986846,0.00014305471,0.0003478452,0.000412716,0.00010591779,0.00030585317],"domain_scores_gemma":[0.9991493,0.00008590654,0.00020084699,0.0003932358,0.00013164585,0.000039056864],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002915526,0.0002243677,0.00035661462,0.00013757874,0.00008939897,0.000012867541,0.00021729173,0.00014458108,0.000019402101],"category_scores_gemma":[0.000098196804,0.00019303162,0.000048311656,0.00012997983,0.00057936285,0.000010434367,0.000098955905,0.00010457526,8.953028e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0058711455,0.00020104015,0.0005321779,0.000040147672,0.00018229094,0.0000042436263,0.0006822062,0.0003685763,0.98994595,0.000033748576,0.0000034382442,0.002135066],"study_design_scores_gemma":[0.0023427536,0.0014025776,0.012320149,0.00019889534,0.000056114714,0.000034974528,0.0002864538,0.0006155627,0.98203486,0.00011447048,0.00033577424,0.00025742842],"about_ca_topic_score_codex":0.00022515138,"about_ca_topic_score_gemma":0.00008486233,"teacher_disagreement_score":0.0117879715,"about_ca_system_score_codex":0.000024560368,"about_ca_system_score_gemma":0.00023696042,"threshold_uncertainty_score":0.7871601},"labels":[],"label_agreement":null},{"id":"W2905858794","doi":"10.1080/2162402x.2018.1556080","title":"Neoantigen characteristics in the context of the complete predicted MHC class I self-immunopeptidome","year":2018,"lang":"en","type":"article","venue":"OncoImmunology","topic":"vaccines and immunoinformatics approaches","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; Canada's Michael Smith Genome Sciences Centre; Genome British Columbia; University of British Columbia","funders":"National Cancer Institute; Canadian Institutes of Health Research; National Institutes of Health","keywords":"Major histocompatibility complex; Human leukocyte antigen; MHC class I; Biology; Context (archaeology); Population; Immunogenicity; Immune system; Computational biology; Immunology; Genetics; Molecular biology; Medicine; Antigen","score_opus":0.012336727366703533,"score_gpt":0.2237010912901301,"score_spread":0.21136436392342658,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905858794","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946594,0.00046673795,0.000040273197,0.00056444545,0.0003705063,0.0003492774,0.000055212924,0.000010673654,0.0034834256],"genre_scores_gemma":[0.9984044,0.00025578504,0.000114192764,0.000764346,0.00013060757,0.000026088208,0.0001077585,0.000016391674,0.00018042764],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99874234,0.00018190312,0.00049747486,0.00017282391,0.000113661736,0.00029178272],"domain_scores_gemma":[0.9986781,0.00003382216,0.00028010062,0.00086021906,0.00013406468,0.0000137246],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003432625,0.00017119302,0.00026275768,0.000041805008,0.00013879045,0.000020936777,0.0009036063,0.00019745843,0.00002854906],"category_scores_gemma":[0.00009589855,0.000103452745,0.00010587692,0.00019032291,0.00034130563,0.000006536806,0.00031503863,0.00021027177,0.000025814488],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005663513,0.0005736173,0.035703517,0.000085509666,0.0005625824,0.0000027445208,0.008805116,0.0000020759699,0.9337549,0.0034754667,0.0050489227,0.011419168],"study_design_scores_gemma":[0.0023768144,0.0015716341,0.5322629,0.000058325313,0.000066318935,0.00014867619,0.004049224,0.0005563531,0.03097998,0.00009536706,0.42747745,0.00035692216],"about_ca_topic_score_codex":0.000056759687,"about_ca_topic_score_gemma":0.000050864084,"teacher_disagreement_score":0.90277493,"about_ca_system_score_codex":0.000017909704,"about_ca_system_score_gemma":0.00010520693,"threshold_uncertainty_score":0.42186803},"labels":[],"label_agreement":null},{"id":"W2918152867","doi":"10.1080/2162402x.2019.1568812","title":"Antibiotics are associated with decreased progression-free survival of advanced melanoma patients treated with immune checkpoint inhibitors","year":2019,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":207,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Centre Hospitalier de l’Université de Montréal; Jewish General Hospital","funders":"","keywords":"Medicine; Melanoma; Immune checkpoint; Antibiotics; Immune system; Oncology; Immunotherapy; Cancer research; Immunology; Internal medicine; Biology; Microbiology","score_opus":0.007036063694775429,"score_gpt":0.23986660714244068,"score_spread":0.23283054344766524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2918152867","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960928,0.0008299229,0.0000030241736,0.00020937521,0.00022139295,0.0009961801,0.00004623512,0.0000956501,0.0015054333],"genre_scores_gemma":[0.99868983,0.000083936844,0.00028611982,0.00005032435,0.000016524233,0.000007763196,0.00027851338,0.000060295988,0.00052670593],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981319,0.000121850164,0.000551424,0.00037744927,0.00040793614,0.0004094936],"domain_scores_gemma":[0.99789315,0.00011719732,0.00074215326,0.00076442974,0.00041451462,0.00006854683],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021757589,0.00031517155,0.0008608983,0.00016805054,0.00006163126,0.000008679244,0.00021421783,0.00026393254,0.00012990006],"category_scores_gemma":[0.00014682292,0.00020793316,0.00013553427,0.0005269086,0.00034828833,0.000087203254,0.00006972906,0.0002641192,0.0000111629415],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020842269,0.001279904,0.8853437,0.00007700783,0.0010482485,0.000038775153,0.00015436906,0.0000023449713,0.08442916,0.000008349215,0.000030023006,0.006745853],"study_design_scores_gemma":[0.025549179,0.0082961945,0.8725558,0.0014483035,0.00015962913,0.000020642425,0.00042349737,0.000008194623,0.09092364,0.0000036612387,0.00035200335,0.00025927462],"about_ca_topic_score_codex":0.00018736295,"about_ca_topic_score_gemma":0.00012915808,"teacher_disagreement_score":0.012787914,"about_ca_system_score_codex":0.00023578311,"about_ca_system_score_gemma":0.0002448735,"threshold_uncertainty_score":0.84792686},"labels":[],"label_agreement":null},{"id":"W2923466071","doi":"10.1080/2162402x.2019.1581545","title":"WISP1 is associated to advanced disease, EMT and an inflamed tumor microenvironment in multiple solid tumors","year":2019,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Connective Tissue Growth Factor Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"National Cancer Institute; Fonds de Recherche du Québec - Santé; National Institute of Dental and Craniofacial Research; Canadian Institutes of Health Research; National Institutes of Health","keywords":"Cancer research; Tumor microenvironment; Prostate cancer; Immunotherapy; Medicine; Immune checkpoint; Immune system; Cancer; Oncology; Internal medicine; Immunology","score_opus":0.009426189915984528,"score_gpt":0.2801354855204264,"score_spread":0.27070929560444185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2923466071","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99790245,0.00080032554,0.000011429108,0.00041900316,0.00007657686,0.00060641265,0.000052354066,0.000013108682,0.0001183559],"genre_scores_gemma":[0.99843144,0.000089843255,0.00008567708,0.0005137223,0.000023995059,0.00008452452,0.00010898241,0.000032980486,0.00062883465],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99846506,0.00015646871,0.00021861492,0.0005811284,0.000113501424,0.0004651992],"domain_scores_gemma":[0.99923223,0.000035716854,0.000067242574,0.0004736603,0.000039105827,0.00015205615],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015564129,0.00018743308,0.00027067246,0.000109981964,0.00004641197,0.000015274294,0.00023969122,0.00010462027,0.00013742945],"category_scores_gemma":[0.00028242872,0.00020179972,0.000039879644,0.00011025527,0.00010851331,0.000009505645,0.00035228874,0.00017108276,0.000104157596],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004411965,0.0001254785,0.18836941,0.000008879968,0.000032687363,0.000022613165,0.00017325697,0.00002999046,0.80711,0.0000054561556,0.00006204442,0.0036190015],"study_design_scores_gemma":[0.0020882399,0.0010665688,0.8593276,0.000030489304,0.0000059754884,0.000007285182,0.00024039774,0.00007886278,0.12360563,0.000036110196,0.013221292,0.00029155266],"about_ca_topic_score_codex":0.00011250007,"about_ca_topic_score_gemma":0.00028758284,"teacher_disagreement_score":0.68350434,"about_ca_system_score_codex":0.00010744163,"about_ca_system_score_gemma":0.00007972273,"threshold_uncertainty_score":0.8229154},"labels":[],"label_agreement":null},{"id":"W2927753063","doi":"10.1080/2162402x.2019.1596006","title":"Oncolytic viruses: how “lytic” must they be for therapeutic efficacy?","year":2019,"lang":"en","type":"review","venue":"OncoImmunology","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":144,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Oncolytic virus; Lytic cycle; Virotherapy; Immune system; Virus; Mode of action; Viral replication; Virology; Biology; Cancer research; Immunology","score_opus":0.13032094193272278,"score_gpt":0.4091072281490994,"score_spread":0.2787862862163766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2927753063","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00025419594,0.99401635,0.0002122491,0.00029616937,0.0007777754,0.0033494923,0.0002597758,0.000053010488,0.00078098546],"genre_scores_gemma":[0.00026662278,0.9882027,0.00012451966,0.00069782423,0.0006367826,0.0008713549,0.0009518471,0.00031782355,0.007930515],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.996085,0.00066638016,0.0006242216,0.0012602805,0.00026816246,0.0010959953],"domain_scores_gemma":[0.99663967,0.00042034546,0.00048257812,0.002143649,0.00019622331,0.00011755496],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00069193216,0.0008838228,0.0021092964,0.00028217613,0.00017777749,0.00009571669,0.0016165992,0.0016208751,0.00010393105],"category_scores_gemma":[0.00020677295,0.00074015843,0.0012306812,0.00021636912,0.0003118567,0.000006284452,0.00041379925,0.00071808684,0.0003167308],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001226873,0.00030828433,0.0000012593763,0.0032305655,0.0022727074,0.000008497977,0.000052733692,0.000004080502,0.009101372,0.00017082723,0.0030291865,0.9805936],"study_design_scores_gemma":[0.0016412012,0.006838149,0.0000013113158,0.0006597769,0.00070506183,0.000073056275,0.000040967327,0.000006063331,0.0009888698,0.0000329722,0.9882489,0.00076366396],"about_ca_topic_score_codex":0.000014988939,"about_ca_topic_score_gemma":0.00009998119,"teacher_disagreement_score":0.9852197,"about_ca_system_score_codex":0.0002376914,"about_ca_system_score_gemma":0.0017518245,"threshold_uncertainty_score":0.9996752},"labels":[],"label_agreement":null},{"id":"W2939235761","doi":"10.1080/2162402x.2019.1599636","title":"Daratumumab in combination with urelumab to potentiate anti-myeloma activity in lymphocyte-deficient mice reconstituted with human NK cells","year":2019,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"H2020 European Institute of Innovation and Technology; Instituto de Salud Carlos III; Worldwide Cancer Research","keywords":"Daratumumab; Antibody-dependent cell-mediated cytotoxicity; CD137; Cancer research; CD38; Medicine; Monoclonal antibody; Immunology; CD8; Multiple myeloma; Immunotherapy; Antibody; Immune system; Biology; Cell biology; CD34","score_opus":0.013188750396068554,"score_gpt":0.27480009527139615,"score_spread":0.2616113448753276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2939235761","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933282,0.00014332285,0.000051931853,0.00033188812,0.00014518217,0.0014532632,0.000015456479,0.000047923946,0.004482829],"genre_scores_gemma":[0.99849594,0.000041059287,0.00038394818,0.00007551644,0.000009802859,0.00008571269,0.000083648265,0.000030148512,0.0007942357],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9981652,0.0001562036,0.00025825202,0.000539897,0.00028929178,0.000591154],"domain_scores_gemma":[0.9991332,0.000060169354,0.00010663106,0.00048020313,0.0001132494,0.00010652483],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020399476,0.00024662647,0.0005625906,0.0006193258,0.00008043395,0.000023394387,0.00015265623,0.00016129161,0.00010442862],"category_scores_gemma":[0.000022676668,0.00019227159,0.000038163984,0.00066364714,0.00014009164,0.00014644106,0.0000804584,0.0003561121,0.00031210174],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009195141,0.0037100012,0.33240804,0.00015452718,0.00029164477,0.0017320688,0.00065053324,0.0003094301,0.6315078,0.00039727698,0.0000363411,0.0196072],"study_design_scores_gemma":[0.028241932,0.004205762,0.92063785,0.000430061,0.00003234902,0.00021925372,0.0002214455,0.00027847363,0.044861637,0.000011365622,0.00060180586,0.00025808814],"about_ca_topic_score_codex":0.0022076322,"about_ca_topic_score_gemma":0.0022832707,"teacher_disagreement_score":0.5882298,"about_ca_system_score_codex":0.000884332,"about_ca_system_score_gemma":0.00038163856,"threshold_uncertainty_score":0.7840608},"labels":[],"label_agreement":null},{"id":"W2941829696","doi":"10.1080/2162402x.2019.1601481","title":"Adenosine A2a receptor promotes lymphangiogenesis and lymph node metastasis","year":2019,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"Institute of Cancer Research; Canadian Institutes of Health Research","keywords":"Lymphangiogenesis; Medicine; Cancer research; Adenosine; Adenosine receptor; Receptor; Lymph node metastasis; Metastasis; Lymph node; Internal medicine; Oncology; Cancer; Agonist","score_opus":0.007330780881216674,"score_gpt":0.225946369172674,"score_spread":0.21861558829145733,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2941829696","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9689852,0.028639443,0.00021915435,0.0004728136,0.00025161356,0.00015750843,0.000019922725,0.000027178447,0.00122714],"genre_scores_gemma":[0.9929989,0.0010734062,0.0016261803,0.00040541386,0.00019584573,0.00002662299,0.00015722145,0.000039491297,0.003476923],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99887294,0.000083140556,0.00020942104,0.00043485026,0.00008195423,0.0003177045],"domain_scores_gemma":[0.9993746,0.000026007465,0.00009120637,0.0003897276,0.00006533075,0.000053109],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013704802,0.00020451072,0.00025990195,0.00007344665,0.00007059327,0.000018958735,0.00019307752,0.00022898463,0.00035252966],"category_scores_gemma":[0.000046655525,0.00018932062,0.000090183894,0.00011117522,0.000095991585,0.000006169694,0.00020182255,0.000036879337,0.00016737456],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014780341,0.00007484102,0.021304222,0.000030361061,0.00027330001,0.0000047306303,0.00006427084,0.000016319076,0.9700878,0.0001834817,0.003268915,0.0045439317],"study_design_scores_gemma":[0.0032691925,0.0008716637,0.021939998,0.000058758273,0.00016299078,0.0003417688,0.00037681358,0.00005279449,0.73073316,0.00011452946,0.24122164,0.0008567062],"about_ca_topic_score_codex":0.00006490679,"about_ca_topic_score_gemma":0.0000013105979,"teacher_disagreement_score":0.23935467,"about_ca_system_score_codex":0.000017940096,"about_ca_system_score_gemma":0.000069746275,"threshold_uncertainty_score":0.7720271},"labels":[],"label_agreement":null},{"id":"W2942706196","doi":"10.1080/2162402x.2019.1608106","title":"Exposure to the antimicrobial peptide LL-37 produces dendritic cells optimized for immunotherapy","year":2019,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"McMaster University; University of Edinburgh; Manchester Collaborative Centre for Inflammation Research; University of Glasgow; Medical Research Council; Royal Society","keywords":"Immunotherapy; Dendritic cell; Ex vivo; CD8; Cancer research; T cell; Immunology; Antigen presentation; Immune system; Cross-presentation; Cytotoxic T cell; Antigen-presenting cell; Medicine; Biology; In vivo; In vitro","score_opus":0.00952301899529523,"score_gpt":0.24144026733552867,"score_spread":0.23191724834023345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2942706196","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9615179,0.019893564,0.0007927711,0.0052254866,0.007824335,0.0034343682,0.00011575689,0.00024237382,0.0009534446],"genre_scores_gemma":[0.9308008,0.0014369907,0.0016998822,0.0036800508,0.00016273354,0.00060092064,0.00017362282,0.000150002,0.06129502],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9964191,0.00074901164,0.00077906594,0.0008051799,0.00007097313,0.00117667],"domain_scores_gemma":[0.9970803,0.0008946265,0.00027960038,0.0014894154,0.00023119453,0.000024826035],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00089996844,0.0005500068,0.0009080011,0.00022604309,0.0006338514,0.00008171962,0.0013652848,0.0005728585,0.0016557707],"category_scores_gemma":[0.0001451586,0.0004091153,0.00044489812,0.00034306163,0.00040191598,0.00019067682,0.00020221528,0.0006318075,0.0050114226],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006392207,0.00027176013,0.00009548192,0.000028874898,0.00077610597,0.0000025994193,0.001705757,0.0001298039,0.96335685,0.00044432387,0.015684681,0.011111551],"study_design_scores_gemma":[0.005462317,0.0017041519,0.001101699,0.000060012433,0.00004820734,0.00015454736,0.00052263425,0.0000025350644,0.50527763,0.000033429555,0.48518845,0.00044435277],"about_ca_topic_score_codex":0.000118968914,"about_ca_topic_score_gemma":0.000017206086,"teacher_disagreement_score":0.4695038,"about_ca_system_score_codex":0.000112511894,"about_ca_system_score_gemma":0.00026403283,"threshold_uncertainty_score":0.9998361},"labels":[],"label_agreement":null},{"id":"W2943603503","doi":"10.1080/2162402x.2019.1607673","title":"Daratumumab- <sup>225</sup> Actinium conjugate demonstrates greatly enhanced antitumor activity against experimental multiple myeloma tumors","year":2019,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"Actinium Pharmaceuticals","keywords":"Daratumumab; Antibody-dependent cell-mediated cytotoxicity; Medicine; Monoclonal antibody; Cancer research; Antibody; Multiple myeloma; Cytotoxicity; Radioimmunotherapy; CD38; Bortezomib; Immunology; Pharmacology; In vitro; Chemistry; Biology; Biochemistry","score_opus":0.0184873553415234,"score_gpt":0.3007236379285656,"score_spread":0.2822362825870422,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2943603503","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96547544,0.00044010964,0.000049728933,0.00060027186,0.00014066743,0.0006741407,0.000029250548,0.00020607963,0.03238433],"genre_scores_gemma":[0.99700063,0.00007248269,0.0003342724,0.00034197624,0.00014442857,0.00013884075,0.00010118827,0.000043256434,0.0018229284],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981849,0.00007280246,0.00036362745,0.0006200915,0.00018152085,0.00057703664],"domain_scores_gemma":[0.9987314,0.00020045435,0.00015944467,0.0006401478,0.000076990545,0.00019160793],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00011101513,0.00034357535,0.0006247582,0.00006795535,0.0002034998,0.00002905215,0.00024418702,0.00025638318,0.00061371754],"category_scores_gemma":[0.00007345459,0.00032651133,0.0001665884,0.0002340517,0.0004364396,0.00017865865,0.00010285697,0.00054118916,0.00080624264],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008158522,0.00056864927,0.0036059122,0.00005677265,0.00013231477,0.0000582019,0.00020864402,0.000032201468,0.9915362,0.00014985159,0.0001325853,0.002702821],"study_design_scores_gemma":[0.0035749755,0.0003679687,0.011543096,0.00007579377,0.000049301296,0.00029680264,0.00076475955,0.0016940505,0.9768488,0.000011108209,0.0044617644,0.00031159367],"about_ca_topic_score_codex":0.00002259638,"about_ca_topic_score_gemma":0.0000012229574,"teacher_disagreement_score":0.031525202,"about_ca_system_score_codex":0.0001686303,"about_ca_system_score_gemma":0.00018020709,"threshold_uncertainty_score":0.99997175},"labels":[],"label_agreement":null},{"id":"W2948320538","doi":"10.1080/2162402x.2019.1615817","title":"Vaccinia-based oncolytic immunotherapy Pexastimogene Devacirepvec in patients with advanced hepatocellular carcinoma after sorafenib failure: a randomized multicenter Phase IIb trial (TRAVERSE)","year":2019,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":130,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Hospital; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Sorafenib; Medicine; Oncolytic virus; Clinical endpoint; Hepatocellular carcinoma; Immunotherapy; Internal medicine; Randomized controlled trial; Oncology; Clinical trial; Gastroenterology; Surgery; Cancer","score_opus":0.005686685340311424,"score_gpt":0.2535832565696906,"score_spread":0.2478965712293792,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2948320538","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99336153,0.001186035,0.00022341867,0.00014074215,0.0002902785,0.0046585253,0.00004198945,0.00002986281,0.00006762805],"genre_scores_gemma":[0.99724257,0.00007329039,0.0005934536,0.00041530345,0.000075314114,0.00083589193,0.0003970665,0.00012045854,0.0002466749],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9962175,0.00086999626,0.0007398456,0.00094475725,0.00037215123,0.00085575687],"domain_scores_gemma":[0.9980334,0.00011967029,0.00029258511,0.0011997988,0.0002437547,0.00011079054],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00066487433,0.0005368624,0.0010240355,0.00029232056,0.000072502524,0.000036827874,0.0005242888,0.00042925114,0.00067916344],"category_scores_gemma":[0.00009027279,0.00046047382,0.00032935845,0.00028222645,0.00025012984,0.000019716877,0.000115069204,0.0004061488,0.00014433959],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7688606,0.001355849,0.017070709,0.000019217967,0.00026657103,0.0000275893,0.00009258581,0.000066386325,0.20915805,0.000002115022,0.000012563194,0.0030677812],"study_design_scores_gemma":[0.8600651,0.027569935,0.003860982,0.000037800655,0.000048337617,0.0000025198706,0.000043312077,0.00059643446,0.1052621,0.0000059546824,0.0019429818,0.00056451716],"about_ca_topic_score_codex":0.000054459168,"about_ca_topic_score_gemma":0.00014908038,"teacher_disagreement_score":0.10389594,"about_ca_system_score_codex":0.00019047399,"about_ca_system_score_gemma":0.00053477177,"threshold_uncertainty_score":0.9997847},"labels":[],"label_agreement":null},{"id":"W2954718550","doi":"10.1080/2162402x.2019.1629780","title":"Expression of MHC class I, HLA-A and HLA-B identifies immune-activated breast tumors with favorable outcome","year":2019,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Instituto de Salud Carlos III; Universidad de Castilla-La Mancha; Secretaría de Estado de Investigación, Desarrollo e Innovación; CRIS Cancer Foundation; Fundación Científica Asociación Española Contra el Cáncer","keywords":"Immune system; Major histocompatibility complex; Human leukocyte antigen; Breast cancer; MHC class I; Immunology; Medicine; CD8; Antigen; Proportional hazards model; Oncology; Biology; Cancer; Cancer research; Internal medicine","score_opus":0.008402083847731799,"score_gpt":0.23174046359173806,"score_spread":0.22333837974400625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954718550","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9842104,0.012172582,0.000043928063,0.00019855578,0.0007300537,0.0004831912,0.000043152002,0.00012712103,0.0019910159],"genre_scores_gemma":[0.98379534,0.00038588655,0.00009853955,0.00008150608,0.0000093566605,0.00003622591,0.00009146024,0.000060485185,0.015441187],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99731225,0.0005549397,0.00082819886,0.000548823,0.00008057464,0.0006752023],"domain_scores_gemma":[0.99797267,0.00037452672,0.0005595282,0.00090549677,0.00016620723,0.000021552885],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004193269,0.00044595907,0.0010801894,0.00034387395,0.00025269698,0.00002999517,0.0004960857,0.0005365851,0.001575521],"category_scores_gemma":[0.000055920966,0.00034589547,0.00015246501,0.00029997548,0.000923986,0.00037370814,0.00026104064,0.0006629815,0.00046454882],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004698233,0.00018977755,0.017152945,0.000070217735,0.00039180557,0.00000892622,0.0007243493,0.000007528837,0.97257817,0.0003959962,0.00010538953,0.0036766808],"study_design_scores_gemma":[0.0044632484,0.0011225193,0.14267623,0.00028061811,0.000053759402,0.001000799,0.001957979,0.000001573537,0.8335557,0.00006651714,0.014382632,0.00043839548],"about_ca_topic_score_codex":0.0005624736,"about_ca_topic_score_gemma":0.0000114878085,"teacher_disagreement_score":0.13902244,"about_ca_system_score_codex":0.00008468574,"about_ca_system_score_gemma":0.00018176598,"threshold_uncertainty_score":0.9998993},"labels":[],"label_agreement":null},{"id":"W2958209428","doi":"10.1080/2162402x.2019.1641387","title":"Staphylococcal alpha-toxin tilts the balance between malignant and non-malignant CD4 <sup>+</sup> T cells in cutaneous T-cell lymphoma","year":2019,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Bispebjerg Hospital; LEO Fondet; H. Lundbeck A/S; Lundbeckfonden; Kom op tegen Kanker; Novo Nordisk UK Research Foundation; Novo Nordisk; Gentofte Hospital; Novo Nordisk Fonden; Kræftens Bekæmpelse","keywords":"Medicine; Cutaneous T-cell lymphoma; Cancer research; Lymphoma; Staphylococcus aureus; Immunology; T cell; Mycosis fungoides; Biology; Immune system; Bacteria","score_opus":0.009747334211357015,"score_gpt":0.25661911363197265,"score_spread":0.24687177942061564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2958209428","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98828226,0.0020838517,0.000028015334,0.0013946593,0.00013110576,0.001827996,0.00006658818,0.000055924666,0.006129599],"genre_scores_gemma":[0.9928027,0.000991367,0.0001642505,0.00053184206,0.00009709186,0.000093033916,0.00005211355,0.00008406986,0.0051835324],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99645907,0.0003578057,0.000659795,0.0008831713,0.00048669064,0.0011534694],"domain_scores_gemma":[0.99776334,0.00071960763,0.00015688459,0.0010255699,0.00016158655,0.0001730405],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00048210792,0.00046873023,0.0010040136,0.00032528487,0.00015902413,0.000054116896,0.0005071431,0.0004189869,0.00025345033],"category_scores_gemma":[0.000102147744,0.000342405,0.00014646233,0.00048458096,0.0006112819,0.00008151636,0.00038372114,0.00054153946,0.00072360714],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020537204,0.0011716408,0.5561,0.0003905305,0.0003181045,0.0026747044,0.004507445,0.00012513234,0.40669137,0.00010435015,0.0011472271,0.024715792],"study_design_scores_gemma":[0.06765101,0.018409844,0.42591298,0.001863683,0.00058569334,0.018911878,0.018732518,0.026949123,0.3289494,0.0016085367,0.086316146,0.0041091857],"about_ca_topic_score_codex":0.00078429957,"about_ca_topic_score_gemma":0.00009958846,"teacher_disagreement_score":0.130187,"about_ca_system_score_codex":0.00039167638,"about_ca_system_score_gemma":0.0005719315,"threshold_uncertainty_score":0.9999028},"labels":[],"label_agreement":null},{"id":"W2969967850","doi":"10.1080/2162402x.2019.1655363","title":"Pre-surgical oncolytic virotherapy improves breast cancer outcomes","year":2019,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Oncolytic virus; Medicine; Breast cancer; Virotherapy; Cancer; Immunotherapy; Oncology; Cancer research; Immune system; Internal medicine; Immunology","score_opus":0.008930607414630457,"score_gpt":0.3139806672860841,"score_spread":0.3050500598714536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2969967850","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931274,0.0028387834,0.000010298884,0.001358874,0.00039852053,0.00046160357,0.00004263779,0.000034194552,0.0017276587],"genre_scores_gemma":[0.983623,0.0015360838,0.000047273097,0.0006824412,0.0002149091,0.0001436893,0.000040355048,0.000060409653,0.013651818],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99836534,0.000160366,0.00024773378,0.0005183268,0.00017872556,0.0005294923],"domain_scores_gemma":[0.9989749,0.000034333774,0.00008598101,0.00074662635,0.00008272555,0.000075414006],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00020656099,0.00024532827,0.00033936527,0.000073993026,0.000069718655,0.000023425098,0.00047458275,0.00032181642,0.0012079477],"category_scores_gemma":[0.000010624483,0.00020662225,0.00016801065,0.00011298275,0.0001864444,0.000006169699,0.00016043297,0.00024481877,0.00029792395],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040775137,0.00016465381,0.025889643,0.000011045741,0.0003067836,0.000008225481,0.00004725205,0.000029520834,0.92608595,0.000054694465,0.0003013178,0.04302343],"study_design_scores_gemma":[0.012480187,0.013608424,0.309302,0.000043714896,0.00004861674,0.00036560145,0.00015719149,0.00015105402,0.40006784,0.00020462136,0.2622835,0.0012872416],"about_ca_topic_score_codex":0.00015207015,"about_ca_topic_score_gemma":0.00018652085,"teacher_disagreement_score":0.5260181,"about_ca_system_score_codex":0.00007406277,"about_ca_system_score_gemma":0.0002800125,"threshold_uncertainty_score":0.9997051},"labels":[],"label_agreement":null},{"id":"W2971391427","doi":"10.1080/2162402x.2019.1659092","title":"Aberrant upregulation of PDK1 in ovarian cancer cells impairs CD8<sup>+</sup> T cell function and survival through elevation of PD-L1","year":2019,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Hong Kong; University of Ottawa","keywords":"Ovarian cancer; Cancer research; Downregulation and upregulation; CD8; Cancer cell; Gene knockdown; Cell growth; T cell; Cytotoxic T cell; Chemistry; Biology; Cancer; Apoptosis; Medicine; Internal medicine; Immune system; Immunology; In vitro; Biochemistry","score_opus":0.012666189428212179,"score_gpt":0.2560772161786536,"score_spread":0.2434110267504414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2971391427","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945332,0.0020769963,0.00019878734,0.0003341503,0.0004553072,0.00046919886,0.000013776823,0.000014639699,0.0019039914],"genre_scores_gemma":[0.9980675,0.0009236647,0.00018227345,0.000085235835,0.000039761908,0.000016933192,0.000039776747,0.000018509789,0.00062634307],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9988292,0.000099928046,0.0004774218,0.00024206446,0.000154143,0.00019724878],"domain_scores_gemma":[0.9992599,0.000080727295,0.00026430545,0.00028083508,0.00009755221,0.000016689353],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029299635,0.00014310086,0.0004388015,0.00014725211,0.000021606049,0.0000034609743,0.000060926683,0.00022427441,0.0006232059],"category_scores_gemma":[0.00000908392,0.00013090124,0.000077307595,0.0002874813,0.00013620684,0.00012659357,0.000025604228,0.0001527505,0.000007898076],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0057210564,0.00019694137,0.07449158,0.00021654353,0.00013772375,9.764178e-7,0.0016045223,0.0002655536,0.91096646,0.0002247342,0.00007797133,0.0060959654],"study_design_scores_gemma":[0.009515551,0.0014341173,0.8616793,0.00022711424,0.00010336532,0.000007991947,0.0013247804,0.0008610514,0.1223162,0.0002835479,0.002074855,0.00017209718],"about_ca_topic_score_codex":0.0039128894,"about_ca_topic_score_gemma":0.0001617137,"teacher_disagreement_score":0.7886502,"about_ca_system_score_codex":0.00013955544,"about_ca_system_score_gemma":0.00015533094,"threshold_uncertainty_score":0.6823667},"labels":[],"label_agreement":null},{"id":"W2988646927","doi":"10.1080/2162402x.2019.1684713","title":"Identification of a CD8+ T-cell response to a predicted neoantigen in malignant mesothelioma","year":2019,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Occupational and environmental lung diseases","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre","funders":"National Health and Medical Research Council","keywords":"Medicine; ELISPOT; Immunotherapy; CD8; Immune system; T cell; Immunology; Cancer research; Cancer; Cytotoxic T cell; Cancer immunotherapy; Biology; Internal medicine; Genetics","score_opus":0.00596238603849095,"score_gpt":0.24776008396352986,"score_spread":0.2417976979250389,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2988646927","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99785936,0.00027556912,0.000015257538,0.000613575,0.00008909504,0.0004246161,0.00003277278,0.000017395076,0.000672353],"genre_scores_gemma":[0.9960874,0.000027957509,0.00009653777,0.00016875601,0.00000926826,0.000028291452,0.00003859354,0.000010974793,0.0035322476],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9991895,0.000078308934,0.0002884869,0.00018143057,0.00012909141,0.00013317894],"domain_scores_gemma":[0.99953175,0.000061710336,0.000075972515,0.00026915938,0.000021605993,0.00003980944],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017090814,0.00007491513,0.00019193284,0.00021322216,0.000010649744,0.000002220694,0.00007831551,0.000067248635,0.00041701715],"category_scores_gemma":[0.000059327995,0.00006709505,0.000044446355,0.00020287254,0.000045177283,0.000034138815,0.000045063873,0.00005537828,0.0006466289],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004392761,0.00030989083,0.23560692,0.000026224667,0.000015968526,0.00001185907,0.00020562233,0.000018750226,0.7587949,0.000036481964,0.000063779415,0.0005168467],"study_design_scores_gemma":[0.001376499,0.00066976296,0.93624306,0.000059526243,0.000020473488,0.000014599228,0.000162869,0.00006144211,0.059829086,0.000041652944,0.0014619892,0.00005902117],"about_ca_topic_score_codex":0.000047789785,"about_ca_topic_score_gemma":0.0000038085552,"teacher_disagreement_score":0.70063615,"about_ca_system_score_codex":0.00008164853,"about_ca_system_score_gemma":0.00006964545,"threshold_uncertainty_score":0.83113223},"labels":[],"label_agreement":null},{"id":"W3010808413","doi":"10.1080/2162402x.2020.1736792","title":"LAG-3 and PD-1+LAG-3 inhibition promote anti-tumor immune responses in human autologous melanoma/T cell co-cultures","year":2020,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Université de Lausanne; Krebsliga Schweiz; Ludwig Institute for Cancer Research; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; Cancer Research Institute","keywords":"Tumor microenvironment; Blockade; Melanoma; Cancer research; Cytotoxic T cell; Immunotherapy; Cancer immunotherapy; CD8; Immune checkpoint; T cell; Cytokine; Immunology; Antibody; Blocking antibody; Medicine; Immune system; Receptor; Biology; Internal medicine; In vitro","score_opus":0.016431249213954606,"score_gpt":0.293452555546814,"score_spread":0.2770213063328594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3010808413","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98280615,0.0084370095,0.000007911865,0.005512256,0.000117032905,0.00056470797,0.00002440307,0.00013680487,0.0023937027],"genre_scores_gemma":[0.9967556,0.00060598174,0.00016679714,0.0016560949,0.00008016395,0.000040182156,0.00009296897,0.00003415314,0.0005680816],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982839,0.00021726511,0.00051706604,0.00045079528,0.00014077364,0.00039018894],"domain_scores_gemma":[0.9993387,0.000066855486,0.00018688284,0.00028265477,0.000050179733,0.00007476896],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027466682,0.0002617342,0.00061988115,0.00017957194,0.00015359763,0.000027127357,0.000115826995,0.00025670658,0.00024941168],"category_scores_gemma":[0.00007871555,0.00022844858,0.00010665575,0.00028343158,0.00041681,0.00009807944,0.00007564952,0.00045273852,0.00003920894],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040715057,0.00021519803,0.0062037935,0.000120431236,0.00008843453,0.000557084,0.0021292958,4.4959384e-7,0.98248374,0.00009009677,0.0006681571,0.003371808],"study_design_scores_gemma":[0.012220708,0.0044736844,0.4573191,0.00024031491,0.000094723386,0.0009027499,0.0012332029,0.000028552868,0.4664209,0.00010638481,0.056475684,0.00048401693],"about_ca_topic_score_codex":0.00037214014,"about_ca_topic_score_gemma":0.000051576848,"teacher_disagreement_score":0.51606286,"about_ca_system_score_codex":0.00012120209,"about_ca_system_score_gemma":0.00013849868,"threshold_uncertainty_score":0.93158627},"labels":[],"label_agreement":null},{"id":"W3010990547","doi":"10.1080/2162402x.2020.1737385","title":"Osteosarcoma and soft-tissue sarcomas with an immune infiltrate express PD-L1: relation to clinical outcome and Th1 pathway activation","year":2020,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System; Lunenfeld-Tanenbaum Research Institute; Public Health Ontario; University of Toronto","funders":"Memorial Sloan-Kettering Cancer Center","keywords":"Immunohistochemistry; Osteosarcoma; Sarcoma; Undifferentiated Pleomorphic Sarcoma; PD-L1; Medicine; Immune system; Soft tissue sarcoma; Leiomyosarcoma; Cancer research; Liposarcoma; Immune checkpoint; Pathology; Internal medicine; Oncology; Immunotherapy; Immunology","score_opus":0.050693231766555026,"score_gpt":0.33524057624296144,"score_spread":0.2845473444764064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3010990547","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98914784,0.0012320324,0.00092871167,0.007501163,0.00013457339,0.0005910333,0.000008214192,0.00010182647,0.0003545782],"genre_scores_gemma":[0.99469817,0.00017692184,0.002145792,0.0025202406,0.00013797398,0.000031261774,0.000057088197,0.000034920566,0.00019765644],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.998412,0.00018687961,0.00055860344,0.00044832192,0.00014148906,0.0002526769],"domain_scores_gemma":[0.99909836,0.00015900725,0.0001809653,0.0003315776,0.00007245624,0.00015760411],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032193598,0.000214014,0.00051356026,0.00008705291,0.000116569325,0.000034185618,0.00009918449,0.00024654047,0.00009448384],"category_scores_gemma":[0.00012260271,0.00017224139,0.000044653676,0.00020926802,0.0002782293,0.0002411326,0.000076478886,0.00037009802,0.00001710153],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019490732,0.00018921356,0.18320605,0.00007458447,0.0002552488,0.00004811791,0.0025264767,0.0000020712498,0.538442,0.00020608625,0.00007842631,0.25548095],"study_design_scores_gemma":[0.0066396673,0.009026033,0.92836356,0.00010263071,0.00006758377,0.00018117842,0.0009499338,0.00007294553,0.011577232,0.000042486034,0.04268918,0.00028758563],"about_ca_topic_score_codex":0.0001449792,"about_ca_topic_score_gemma":0.000024741641,"teacher_disagreement_score":0.7451575,"about_ca_system_score_codex":0.00004627381,"about_ca_system_score_gemma":0.000091043934,"threshold_uncertainty_score":0.70238},"labels":[],"label_agreement":null},{"id":"W3015467025","doi":"10.1080/2162402x.2020.1747340","title":"Tumor-associated macrophages and macrophage-related immune checkpoint expression in sarcomas","year":2020,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Phagocytosis and Immune Regulation","field":"Immunology and Microbiology","cited_by":178,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital; Vancouver Coastal Health Research Institute; University of British Columbia; Vancouver Coastal Health","funders":"Canadian Cancer Society Research Institute; Terry Fox Research Institute; Icahn School of Medicine at Mount Sinai","keywords":"CD163; CD68; Sarcoma; Cancer research; Macrophage; Immune system; Immune checkpoint; Undifferentiated Pleomorphic Sarcoma; Biology; Immunotherapy; Macrophage polarization; Medicine; Immunology; Soft tissue sarcoma; Pathology; Immunohistochemistry","score_opus":0.011362589904106692,"score_gpt":0.2255924015768833,"score_spread":0.2142298116727766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3015467025","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9502901,0.046240732,0.000023699782,0.0015168006,0.0004248333,0.00032491214,0.00001710605,0.0001654678,0.0009963894],"genre_scores_gemma":[0.9981332,0.00061813375,0.000067249326,0.0002636122,0.000013907205,0.00003254894,0.00016181028,0.000041004023,0.000668571],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974136,0.00056229346,0.0008276975,0.0005497287,0.00004933096,0.0005973762],"domain_scores_gemma":[0.9991229,0.00013638021,0.00033630952,0.00031044727,0.000054610104,0.00003936044],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00033460814,0.00033270466,0.00071438914,0.00016934893,0.0001986319,0.00002289347,0.00031052064,0.00050748227,0.00082351884],"category_scores_gemma":[0.00028631667,0.00031289246,0.0001274067,0.00038842106,0.00040787566,0.00019085065,0.0003492405,0.00076782174,0.00044117367],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028115205,0.00018495796,0.0038376008,0.000017628869,0.00012017085,0.000048484093,0.0012733238,0.000009630418,0.984666,0.00020789632,0.0001487183,0.009204461],"study_design_scores_gemma":[0.006168249,0.00057611783,0.3839203,0.00011058624,0.000036802787,0.00014626356,0.00050175126,0.000081260805,0.60152006,0.00032942856,0.006199701,0.00040948918],"about_ca_topic_score_codex":0.00015876215,"about_ca_topic_score_gemma":0.000012089703,"teacher_disagreement_score":0.38314596,"about_ca_system_score_codex":0.000111698595,"about_ca_system_score_gemma":0.00006166378,"threshold_uncertainty_score":0.9999323},"labels":[],"label_agreement":null},{"id":"W3015474692","doi":"10.1080/2162402x.2020.1738812","title":"An innovative plasmacytoid dendritic cell line-based cancer vaccine primes and expands antitumor T-cells in melanoma patients in a first-in-human trial","year":2020,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Purdue Pharma (Canada)","funders":"Ligue Contre le Cancer; Etablissement Français du Sang; Agence Nationale de la Recherche","keywords":"Medicine; Cancer vaccine; Melanoma; Antigen; Priming (agriculture); Tolerability; Clinical trial; Immune system; Immunology; Cancer; CD8; Cytotoxic T cell; Cancer research; Immunotherapy; Oncology; Internal medicine; In vitro; Adverse effect; Biology","score_opus":0.013018813956085427,"score_gpt":0.2663258182441964,"score_spread":0.2533070042881109,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3015474692","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913318,0.0065760487,0.0000075555704,0.00047215555,0.00054757827,0.0008816566,0.00004631703,0.000046456782,0.000090422676],"genre_scores_gemma":[0.99805033,0.00084272557,0.000040040155,0.0005315386,0.000027801838,0.00019087756,0.00015711943,0.000041575895,0.000117995995],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99710053,0.00071729586,0.0008811454,0.0006028854,0.000046922312,0.00065120787],"domain_scores_gemma":[0.9990076,0.00032312245,0.00024303545,0.0003161046,0.00008533078,0.000024852232],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00028366296,0.00037891258,0.0008562181,0.00058161735,0.00012938873,0.000021901207,0.0003947523,0.00046559595,0.00032870856],"category_scores_gemma":[0.00010200812,0.00037283904,0.000057719786,0.00074127555,0.00022720886,0.00020795577,0.00010052371,0.00079165347,0.000038879247],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.060665816,0.0019750665,0.11161586,0.000063447005,0.00007702372,0.0000702574,0.004275338,0.0000652082,0.81811595,0.00004961109,0.00007670569,0.0029496925],"study_design_scores_gemma":[0.188657,0.008779621,0.21884055,0.0001928334,0.000021314296,0.000008356015,0.0006628022,0.000061642815,0.5761346,0.000022757968,0.0059612277,0.00065726193],"about_ca_topic_score_codex":0.0018706899,"about_ca_topic_score_gemma":0.0015225139,"teacher_disagreement_score":0.24198134,"about_ca_system_score_codex":0.00015841542,"about_ca_system_score_gemma":0.00028242453,"threshold_uncertainty_score":0.9998723},"labels":[],"label_agreement":null},{"id":"W3015879164","doi":"10.1080/2162402x.2020.1737368","title":"Overproduction of IL-2 by Cbl-b deficient CD4 <sup>+</sup> T cells provides resistance against regulatory T cells","year":2020,"lang":"en","type":"article","venue":"OncoImmunology","topic":"T-cell and B-cell Immunology","field":"Immunology and Microbiology","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"Canadian Institutes of Health Research","keywords":"Overproduction; Cancer research; Chemistry; Medicine; Biology; Immunology; Cell biology; Genetics; Gene","score_opus":0.008863508587524912,"score_gpt":0.19716984411687924,"score_spread":0.18830633552935433,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3015879164","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9647215,0.024141222,0.00016965014,0.0024657408,0.0017393292,0.00072383054,0.0002733286,0.00031708396,0.005448322],"genre_scores_gemma":[0.9860051,0.001277845,0.00027706273,0.0009745417,0.00009112936,0.000054753218,0.00030276604,0.000077850615,0.010938921],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99596465,0.0006701638,0.001095371,0.0011580294,0.0001174506,0.0009943596],"domain_scores_gemma":[0.9977721,0.00023063291,0.0006563902,0.0010522541,0.00022710765,0.00006149207],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00037049557,0.0005743576,0.0010626594,0.00020136395,0.00033544676,0.000018726556,0.00086242746,0.00096075225,0.0007208507],"category_scores_gemma":[0.00012746984,0.0005618156,0.00029548895,0.00048167096,0.0014732333,0.00018776896,0.00036389686,0.0009591482,0.0012740019],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00092761376,0.00047356126,0.00009765616,0.000119746794,0.0003505985,0.000012881049,0.001500128,0.00018588343,0.9325681,0.00074206816,0.0587521,0.0042697163],"study_design_scores_gemma":[0.0014491426,0.0005205422,0.00006137592,0.000037609396,0.000065692584,0.0000144473415,0.00076602615,0.00001411039,0.62129813,0.00005740023,0.3753649,0.00035062825],"about_ca_topic_score_codex":0.0000994189,"about_ca_topic_score_gemma":0.000012616889,"teacher_disagreement_score":0.3166128,"about_ca_system_score_codex":0.00016356127,"about_ca_system_score_gemma":0.0002568539,"threshold_uncertainty_score":0.9996833},"labels":[],"label_agreement":null},{"id":"W3016599419","doi":"10.1080/2162402x.2020.1751561","title":"<i>Staphylococcus aureus</i> alpha-toxin inhibits CD8 <sup>+</sup> T cell-mediated killing of cancer cells in cutaneous T-cell lymphoma","year":2020,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; LEO Fondet; Lundbeckfonden; Kræftens Bekæmpelse; Novo Nordisk Fonden; Novo Nordisk UK Research Foundation","keywords":"Cytotoxic T cell; CD8; Staphylococcus aureus; Cutaneous T-cell lymphoma; Immunology; Cancer research; T cell; Medicine; Cancer; Lymphoma; Immune system; Biology; Mycosis fungoides; In vitro; Internal medicine","score_opus":0.015721376673968824,"score_gpt":0.27203376169969995,"score_spread":0.2563123850257311,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3016599419","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98057556,0.010081297,0.000041938423,0.0023295295,0.00013178721,0.0011868062,0.00015438978,0.00012253568,0.00537615],"genre_scores_gemma":[0.9922892,0.0039345566,0.0002596367,0.002112559,0.00013134087,0.00011814361,0.00011484457,0.00012415854,0.0009155664],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9961073,0.00030544432,0.0010110303,0.0008846865,0.00060403696,0.0010875034],"domain_scores_gemma":[0.9979598,0.00047025198,0.00029415768,0.00059005193,0.00037366635,0.0003120592],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00020008812,0.0005187405,0.0012475568,0.00044625244,0.000102061356,0.00002108484,0.00048100954,0.00054178067,0.00080175797],"category_scores_gemma":[0.0002500141,0.0005149168,0.00023673537,0.001215866,0.00050250365,0.00008249096,0.00028602144,0.0006681234,0.00034892326],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021692265,0.0013475334,0.01920599,0.00054251263,0.00015258731,0.0016015255,0.00501543,0.0014876607,0.96146685,0.000010350227,0.001872728,0.0051276204],"study_design_scores_gemma":[0.014487417,0.0024790305,0.00044957938,0.0002451011,0.00012979594,0.00025516824,0.0033729647,0.014759337,0.9446693,0.000035885925,0.01841197,0.00070441706],"about_ca_topic_score_codex":0.0015291984,"about_ca_topic_score_gemma":0.0001971325,"teacher_disagreement_score":0.01875641,"about_ca_system_score_codex":0.0005283748,"about_ca_system_score_gemma":0.0013102576,"threshold_uncertainty_score":0.9997302},"labels":[],"label_agreement":null},{"id":"W3018073147","doi":"10.1080/2162402x.2020.1746138","title":"Prognostic value of CD73 expression in resected colorectal cancer liver metastasis","year":2020,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Colorectal cancer; Metastasis; Pathological; Internal medicine; Tissue microarray; Immune system; Cancer; Chemotherapy; Oncology; Blockade; Gastroenterology; Pathology; Immunology; Receptor","score_opus":0.017236692149681442,"score_gpt":0.264417599551246,"score_spread":0.24718090740156456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3018073147","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9845181,0.014437227,0.00023971623,0.0002620737,0.00006882796,0.00014541876,0.000016496671,0.000009857744,0.00030227908],"genre_scores_gemma":[0.99839085,0.0006548582,0.00054482266,0.00015872633,0.000098063785,0.00003903322,0.0000512957,0.000015328234,0.000047041936],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99913496,0.00013260958,0.00021806672,0.000254366,0.000071043025,0.00018898667],"domain_scores_gemma":[0.9996624,0.000031684296,0.0000934322,0.00011908552,0.000058194124,0.000035202716],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006934266,0.00011172623,0.0002058277,0.00004151947,0.000023750667,0.000003264513,0.00017347735,0.00016114574,0.00012228888],"category_scores_gemma":[0.00018291507,0.000102470636,0.00005567729,0.00016484284,0.00008133607,0.0000032605008,0.00014934267,0.00012633642,0.0000057330226],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039387212,0.0000595453,0.012507259,0.000024822733,0.00005487663,0.000018761848,0.0002490404,0.00026499407,0.983808,0.000041034647,0.0016544615,0.0009233631],"study_design_scores_gemma":[0.000852882,0.0007038025,0.026574044,0.0000397608,0.00002822964,0.000010780245,0.00013412334,0.0002126243,0.96479553,0.000015762695,0.006485823,0.00014660884],"about_ca_topic_score_codex":0.00018213078,"about_ca_topic_score_gemma":0.00002206634,"teacher_disagreement_score":0.01901241,"about_ca_system_score_codex":0.0000112166335,"about_ca_system_score_gemma":0.00010011476,"threshold_uncertainty_score":0.41786313},"labels":[],"label_agreement":null},{"id":"W3033817849","doi":"10.1080/2162402x.2020.1774298","title":"Trial watch : the gut microbiota as a tool to boost the clinical efficacy of anticancer immunotherapy","year":2020,"lang":"en","type":"review","venue":"OncoImmunology","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Labex Immuno-Oncology; High-end Foreign Experts Recruitment Plan of China; European Research Area Network on Cardiovascular Diseases; Institut Universitaire de France; Centre National de la Recherche Scientifique; Ligue Contre le Cancer; Fondation pour la Recherche Médicale; Institut National Du Cancer; Institut National de la Santé et de la Recherche Médicale; Agence Nationale de la Recherche; E-Rare; Cancer Research UK; Association pour la Recherche sur le Cancer; Seerave Foundation; Institut Gustave-Roussy; Fondation Leducq; European Commission","keywords":"Gut flora; Clinical trial; Medicine; Immunotherapy; Cancer; Immune checkpoint; Cancer immunotherapy; Immune system; Microbiome; Blockade; Immunology; Bioinformatics; Internal medicine; Biology; Receptor","score_opus":0.05187093223350447,"score_gpt":0.419610271864628,"score_spread":0.36773933963112354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3033817849","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005735144,0.98549706,0.000017233622,0.0037801361,0.0015392035,0.002951421,0.000106136424,0.000014950441,0.0003587241],"genre_scores_gemma":[0.00033282564,0.9942935,0.00011852173,0.0024254166,0.001049232,0.00011696626,0.00018250849,0.000085666514,0.0013953664],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99607766,0.0010428341,0.0014612917,0.0007608612,0.00012186708,0.0005354658],"domain_scores_gemma":[0.9971738,0.0003545412,0.0006796708,0.0016213584,0.00010470566,0.00006595445],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00091888744,0.0005084954,0.0018720352,0.0000413513,0.00019010299,0.000033726614,0.0016311787,0.0009529857,0.00013473272],"category_scores_gemma":[0.0004019846,0.00027930812,0.0011280733,0.0002928427,0.00055939367,0.0000018636362,0.00057906896,0.00090882083,0.00033331048],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005800384,0.0002816403,0.0000031255338,0.00044852417,0.0012038662,0.0000065034537,0.00014640678,1.4153176e-7,0.02456904,0.00019661344,0.019519469,0.9478243],"study_design_scores_gemma":[0.006113082,0.0021358358,0.000111206544,0.000447761,0.00029960388,0.00009680164,0.000023126368,4.7053287e-8,0.00010913268,0.000006693197,0.99034214,0.00031455993],"about_ca_topic_score_codex":0.00010316026,"about_ca_topic_score_gemma":0.000028130427,"teacher_disagreement_score":0.9708227,"about_ca_system_score_codex":0.00005551936,"about_ca_system_score_gemma":0.0018358321,"threshold_uncertainty_score":0.9999659},"labels":[],"label_agreement":null},{"id":"W3036744650","doi":"10.1080/2162402x.2020.1779991","title":"Tumor-derived exosomes: the next generation of promising cell-free vaccines in cancer immunotherapy","year":2020,"lang":"en","type":"review","venue":"OncoImmunology","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":145,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital","funders":"","keywords":"Immune system; Microvesicles; Tumor microenvironment; Immunogenicity; Immunotherapy; Cancer immunotherapy; Cancer research; Antigen; Cancer; Cancer vaccine; Medicine; Vaccination; Immunology; Biology; microRNA","score_opus":0.0745422422957121,"score_gpt":0.32984493531963005,"score_spread":0.25530269302391795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3036744650","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013730002,0.9847033,0.000047725087,0.00013190074,0.0003600916,0.0008512932,0.000044678156,0.000019700383,0.0001112968],"genre_scores_gemma":[0.002538141,0.995861,0.00026953733,0.00013081897,0.00039797366,0.00032336428,0.00021655585,0.0001279216,0.00013468842],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977508,0.0004899537,0.00077138416,0.00055906124,0.000116672825,0.00031211384],"domain_scores_gemma":[0.9980485,0.000048389815,0.0006287947,0.0011670096,0.00007112512,0.00003620217],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001969105,0.00042473702,0.0010343973,0.000092769515,0.000056445704,0.000027035505,0.0011050112,0.00040739108,0.00004563204],"category_scores_gemma":[0.00012889257,0.00032057328,0.00037278072,0.00024632204,0.00016311824,0.0000067249694,0.00036360856,0.00037801775,0.000008159939],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000686713,0.00014368075,0.00001800543,0.001655761,0.00026290643,0.000025369804,0.00011532716,0.00000829839,0.49830294,0.000023859617,0.0006118568,0.49876332],"study_design_scores_gemma":[0.00093556324,0.0002264763,0.000032426593,0.0008627454,0.00019803602,0.000039027047,0.00006934219,0.00001560467,0.023329737,0.000035117086,0.9738584,0.00039750425],"about_ca_topic_score_codex":0.00007721398,"about_ca_topic_score_gemma":0.00007035362,"teacher_disagreement_score":0.9732466,"about_ca_system_score_codex":0.00008455518,"about_ca_system_score_gemma":0.00075008144,"threshold_uncertainty_score":0.99992466},"labels":[],"label_agreement":null},{"id":"W3037613484","doi":"10.1080/2162402x.2020.1782574","title":"Generation of highly activated, antigen-specific tumor-infiltrating CD8 <sup>+</sup> T cells induced by a novel T cell-targeted immunotherapy","year":2020,"lang":"en","type":"article","venue":"OncoImmunology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"National Cancer Institute","keywords":"Cytotoxic T cell; CD8; Cancer research; Immunotherapy; Tumor antigen; Antigen; T cell; Immunology; Medicine; Population; Biology; Immune system; In vitro","score_opus":0.05836458485133783,"score_gpt":0.29136447492183964,"score_spread":0.23299989007050181,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3037613484","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912618,0.0027786666,0.0007387931,0.001663307,0.00018624312,0.00091531145,0.000053241285,0.000155204,0.0022474383],"genre_scores_gemma":[0.99403614,0.0016470354,0.001876692,0.0010151855,0.00036529187,0.00004997703,0.00024400999,0.00012770205,0.0006379872],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9970226,0.00024506025,0.00084276544,0.00069003296,0.0005100406,0.00068947225],"domain_scores_gemma":[0.9982762,0.00018137072,0.000356345,0.00070990645,0.00030689721,0.00016928623],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00033674994,0.00040978286,0.00089628424,0.00024035982,0.00015920293,0.00004011747,0.00039680974,0.000374741,0.0029355683],"category_scores_gemma":[0.000062565065,0.00040286832,0.00022722613,0.0008066245,0.00022336308,0.00016062465,0.000098548844,0.0009561835,0.00012704785],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013790452,0.00050131825,0.00022059919,0.000041000578,0.00027225926,0.00002704376,0.0024304152,0.00008254423,0.98370785,0.00006208291,0.0024775527,0.00879828],"study_design_scores_gemma":[0.0054312153,0.0019162432,0.00046809818,0.00003387643,0.000015530326,0.000033032557,0.00070262444,0.0015748912,0.92919576,0.000003720903,0.060322404,0.00030259666],"about_ca_topic_score_codex":0.00027812851,"about_ca_topic_score_gemma":0.0000023102964,"teacher_disagreement_score":0.05784485,"about_ca_system_score_codex":0.00021489098,"about_ca_system_score_gemma":0.00037185292,"threshold_uncertainty_score":0.99984235},"labels":[],"label_agreement":null},{"id":"W3041665519","doi":"10.1080/2162402x.2020.1792058","title":"Complete and long-lasting clinical responses in immune checkpoint inhibitor-resistant, metastasized melanoma treated with adoptive T cell transfer combined with DC vaccination","year":2020,"lang":"en","type":"article","venue":"OncoImmunology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"Cancerföreningen i Stockholm; Medicinska Forskningsrådet; Knut och Alice Wallenbergs Stiftelse; Kommunfullmäktige, Stockholms Stad; Stiftelsen för Strategisk Forskning","keywords":"Medicine; Immunotherapy; Melanoma; Cohort; T cell; Internal medicine; Adoptive cell transfer; Vaccination; Oncology; Immune system; Immunology; Surgery; Cancer research","score_opus":0.052239993790942296,"score_gpt":0.31734485816633023,"score_spread":0.26510486437538794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3041665519","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937027,0.00096406596,0.00025889964,0.0025294782,0.00002916677,0.0011703054,0.000027673379,0.000093205395,0.0012245049],"genre_scores_gemma":[0.99790287,0.0002284349,0.00073960086,0.00017309077,0.000047849546,0.00005955302,0.000113326096,0.0000673132,0.00066795596],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99699455,0.00084217516,0.00076878496,0.0006152143,0.0003039819,0.00047531305],"domain_scores_gemma":[0.99838674,0.0007512922,0.00013129615,0.00033813278,0.00023071181,0.00016182811],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00074059534,0.000328136,0.0011004544,0.00024991613,0.00009333746,0.00002914857,0.00014414378,0.00021524099,0.0006150406],"category_scores_gemma":[0.00017857205,0.00024382639,0.00010263699,0.0006492826,0.00034148357,0.000102268576,0.000071136325,0.00087206345,0.000016853714],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.20226029,0.00064422586,0.068723515,0.00013657029,0.00053639413,0.0010344158,0.0013132006,0.000005374183,0.71896756,0.000045465407,0.000011446037,0.0063215755],"study_design_scores_gemma":[0.05886685,0.035887696,0.81057626,0.00024409944,0.00032254256,0.00023024071,0.0013462713,0.00042216043,0.090174295,0.000008657842,0.0014770805,0.00044386912],"about_ca_topic_score_codex":0.00019054278,"about_ca_topic_score_gemma":0.00028892123,"teacher_disagreement_score":0.7418527,"about_ca_system_score_codex":0.00015187835,"about_ca_system_score_gemma":0.0002836685,"threshold_uncertainty_score":0.9942952},"labels":[],"label_agreement":null},{"id":"W3043742068","doi":"10.1080/2162402x.2020.1794423","title":"Elucidating the gut microbiota composition and the bioactivity of immunostimulatory commensals for the optimization of immune checkpoint inhibitors","year":2020,"lang":"en","type":"review","venue":"OncoImmunology","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Agence Nationale de la Recherche","keywords":"Immune system; Commensalism; Gut flora; Immune checkpoint; Immunology; Blockade; Biology; Immunotherapy; Medicine; Bacteria; Receptor","score_opus":0.020402985294190934,"score_gpt":0.302963220960496,"score_spread":0.28256023566630506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3043742068","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00048798847,0.99369997,0.0024410125,0.0010438926,0.0002788061,0.001838978,0.00017067541,0.0000062657227,0.00003240177],"genre_scores_gemma":[0.015898364,0.9827667,0.00047507533,0.00011912123,0.00011116974,0.000091509595,0.00047744546,0.000041650612,0.000018990831],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99784726,0.00060486,0.00096178683,0.00030554028,0.00005865322,0.00022192857],"domain_scores_gemma":[0.9972214,0.00063701073,0.0013364285,0.0006550554,0.00013325457,0.000016814334],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009419578,0.00030072304,0.001092553,0.000043357777,0.00029517352,0.000016923164,0.00048314588,0.00040460614,0.000005635681],"category_scores_gemma":[0.00015977553,0.00015551169,0.00049421197,0.00014052994,0.0009920802,0.0000038503745,0.00039777986,0.00035821917,0.0000010042946],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00074297766,0.00018547827,0.0000046064106,0.005974086,0.0021169216,5.361163e-7,0.00059612084,0.00021799338,0.73760164,0.0007424114,0.0005078631,0.25130937],"study_design_scores_gemma":[0.0035257898,0.0007682885,0.00013978954,0.002579196,0.0019366967,0.00017604204,0.0004288741,0.00031016805,0.021434287,0.000028922199,0.9681516,0.0005202939],"about_ca_topic_score_codex":0.00013420197,"about_ca_topic_score_gemma":0.0000063133093,"teacher_disagreement_score":0.9676438,"about_ca_system_score_codex":0.00003482516,"about_ca_system_score_gemma":0.00025737213,"threshold_uncertainty_score":0.6341583},"labels":[],"label_agreement":null},{"id":"W3081716951","doi":"10.1080/2162402x.2020.1792038","title":"An integrated classifier improves prognostic accuracy in non-metastatic gastric cancer","year":2020,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Gastric Cancer Management and Outcomes","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"MD Precision (Canada)","funders":"","keywords":"Medicine; Cancer; Classifier (UML); Oncology; Internal medicine; Artificial intelligence; Computer science","score_opus":0.030801698025727874,"score_gpt":0.3188286277955083,"score_spread":0.28802692976978045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3081716951","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9872554,0.0008604258,0.00085858424,0.008641292,0.0003339083,0.0008509204,0.0000089834075,0.00011810432,0.0010723664],"genre_scores_gemma":[0.99494046,0.00033173224,0.0011860781,0.002713735,0.00010882831,0.00015227718,0.000061352555,0.000029149198,0.0004764118],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99866205,0.000065149834,0.00036094006,0.0003708099,0.00013534792,0.00040568522],"domain_scores_gemma":[0.9993264,0.00011211302,0.00012267593,0.0002576776,0.00006675677,0.00011439275],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000096339994,0.00020588258,0.0004806286,0.00022966802,0.00003373793,0.000024108258,0.00020089635,0.00007974594,0.00049555453],"category_scores_gemma":[0.0003276858,0.00016990677,0.000069302194,0.0008492007,0.000095256924,0.00016148518,0.000066934284,0.00041538104,0.00008659027],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011142486,0.000511741,0.46036664,0.00026882457,0.00034421028,0.00047994315,0.0016447309,0.000066498025,0.040414207,0.00012597768,0.0037200137,0.49094298],"study_design_scores_gemma":[0.004526497,0.0018578283,0.9701852,0.00009569945,0.00022606179,0.000028982548,0.0016898356,0.0036552267,0.00024247778,0.00003468464,0.01723598,0.00022150109],"about_ca_topic_score_codex":0.00066150713,"about_ca_topic_score_gemma":0.0001851911,"teacher_disagreement_score":0.5098186,"about_ca_system_score_codex":0.00016126638,"about_ca_system_score_gemma":0.00024755963,"threshold_uncertainty_score":0.6928597},"labels":[],"label_agreement":null},{"id":"W3096233695","doi":"10.1080/2162402x.2020.1836766","title":"Angiotensin-converting enzyme (ACE) inhibitor prescription affects non-small-cell lung cancer (NSCLC) patients response to PD-1/PD-L1 immune checkpoint blockers","year":2020,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; ACE inhibitor; Lung cancer; Internal medicine; PD-L1; Angiotensin-converting enzyme; Concomitant; Immune system; Captopril; Nivolumab; Cancer; Oncology; Pharmacology; Immunology; Immunotherapy","score_opus":0.011486278366947988,"score_gpt":0.25254715569708575,"score_spread":0.24106087733013776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096233695","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9725544,0.006647589,0.0001345141,0.016785378,0.0015890418,0.001762927,0.000028385064,0.00019455627,0.00030321834],"genre_scores_gemma":[0.9915464,0.00034408915,0.0007326191,0.0053613214,0.00038392414,0.00015320926,0.000057609144,0.00010813568,0.001312697],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9970463,0.0002921393,0.00075156504,0.00077825726,0.00032257813,0.00080919673],"domain_scores_gemma":[0.99839014,0.00013830324,0.00035595827,0.00059912656,0.00025315915,0.00026330038],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004956958,0.0004784009,0.0007936202,0.00025725376,0.00020069916,0.0000393545,0.00028867676,0.00041409684,0.00034385105],"category_scores_gemma":[0.0002741483,0.00045871251,0.00037629952,0.000642734,0.0001606039,0.00013145038,0.0002418489,0.00057097396,0.00012890981],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.043778382,0.00027282932,0.009080021,0.00016358773,0.00042236113,0.00006667104,0.0048916596,0.00001030904,0.924575,9.561152e-7,0.008668144,0.008070088],"study_design_scores_gemma":[0.016659362,0.0043286826,0.26018345,0.0008712339,0.00037145722,0.000034341712,0.00080659403,0.00068319053,0.6640659,0.0000013507675,0.051236838,0.0007576063],"about_ca_topic_score_codex":0.0008771125,"about_ca_topic_score_gemma":0.000044065244,"teacher_disagreement_score":0.2605091,"about_ca_system_score_codex":0.0007632317,"about_ca_system_score_gemma":0.0005156543,"threshold_uncertainty_score":0.99978644},"labels":[],"label_agreement":null},{"id":"W3107429554","doi":"10.1080/2162402x.2020.1846901","title":"Soluble forms of PD-L1 and PD-1 as prognostic and predictive markers of sunitinib efficacy in patients with metastatic clear cell renal cell carcinoma","year":2020,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"Canceropôle PACA","keywords":"Sunitinib; Renal cell carcinoma; Medicine; Bevacizumab; Internal medicine; Oncology; Immunotherapy; Cancer; Chemotherapy","score_opus":0.01270006059543189,"score_gpt":0.22113384894628305,"score_spread":0.20843378835085116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3107429554","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99510443,0.001115959,0.000008410911,0.00014135656,0.000021710199,0.0010982871,0.000026656202,0.000012253536,0.0024709287],"genre_scores_gemma":[0.9991217,0.00006021431,0.00053790834,0.000056984696,0.000006532611,0.000026229305,0.00008107149,0.00003099354,0.000078314784],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99863327,0.000113822556,0.00041653638,0.00033817778,0.00021230563,0.00028590907],"domain_scores_gemma":[0.9990465,0.00023320169,0.00025352187,0.00021667898,0.00012678221,0.00012328241],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001056453,0.00022019962,0.00064726966,0.00015017958,0.000028460632,0.0000046199493,0.00007821057,0.00008984792,0.00004487407],"category_scores_gemma":[0.00009018474,0.00016553895,0.00004877802,0.00021272598,0.0003553324,0.00007126317,0.000106808875,0.00023209186,0.000004877457],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.037752297,0.0021870504,0.9377126,0.0011483895,0.00036255582,0.0002162656,0.0042128274,0.000022581244,0.014388569,0.000042539963,0.000059636266,0.0018946757],"study_design_scores_gemma":[0.014348524,0.03270212,0.9302422,0.00011393877,0.00042551468,0.000021774322,0.0010043109,0.00009298813,0.020858308,0.000018267265,0.000043753582,0.0001283209],"about_ca_topic_score_codex":0.00015687462,"about_ca_topic_score_gemma":0.000009325259,"teacher_disagreement_score":0.03051507,"about_ca_system_score_codex":0.000059134538,"about_ca_system_score_gemma":0.00015728423,"threshold_uncertainty_score":0.67504823},"labels":[],"label_agreement":null},{"id":"W3110044506","doi":"10.1080/2162402x.2020.1851539","title":"Quantitative MRI cell tracking of immune cell recruitment to tumors and draining lymph nodes in response to anti-PD-1 and a DPX-based immunotherapy","year":2020,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Izaak Walton Killam Health Centre; Dalhousie University","funders":"National Cancer Institute; Nova Scotia Health Research Foundation","keywords":"Medicine; Immunotherapy; Immune system; Cytotoxic T cell; T cell; CTL*; Cancer research; Cancer immunotherapy; Immunology; CD8; Biology","score_opus":0.04033887026019693,"score_gpt":0.29533635892852506,"score_spread":0.2549974886683281,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3110044506","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96014374,0.03373323,0.00083324243,0.0035975538,0.00023667263,0.0011183324,0.000047384267,0.000076558754,0.00021327706],"genre_scores_gemma":[0.99454725,0.0008735153,0.00228762,0.0017088617,0.000008254512,0.0001556016,0.000023667935,0.000075727956,0.0003194842],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99566877,0.0016158439,0.0010902322,0.00076817255,0.00007907715,0.0007778764],"domain_scores_gemma":[0.99748147,0.00144984,0.00037254635,0.00051213655,0.00011897059,0.00006506236],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012527857,0.00051374943,0.0012061071,0.0006702532,0.00024033031,0.00003832509,0.0004754039,0.0003948557,0.0001660397],"category_scores_gemma":[0.00036606073,0.00051206665,0.00014724731,0.00067890936,0.00051756087,0.00015938457,0.00023010767,0.00048731102,0.000104305866],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.037331995,0.0003037738,0.002432439,0.00006768829,0.00013646396,0.000031655003,0.021471795,0.0001479097,0.9295643,0.00009670824,0.000029375253,0.0083858725],"study_design_scores_gemma":[0.010736594,0.006592361,0.1400398,0.000352267,0.00003647561,0.00005689896,0.008765564,0.000042993754,0.8198543,0.000029246934,0.012759718,0.0007337601],"about_ca_topic_score_codex":0.00038442118,"about_ca_topic_score_gemma":0.000008789191,"teacher_disagreement_score":0.13760735,"about_ca_system_score_codex":0.00011678121,"about_ca_system_score_gemma":0.00031013796,"threshold_uncertainty_score":0.9997331},"labels":[],"label_agreement":null},{"id":"W3110606521","doi":"10.1080/2162402x.2020.1851950","title":"Immune-focused multi-omics analysis of prostate cancer: leukocyte Ig-Like receptors are associated with disease progression","year":2020,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Ferroptosis and cancer prognosis","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Prostate Cancer Canada; University of Toronto; Université Laval; Centre hospitalier de l'Université Laval","funders":"National Cancer Institute","keywords":"Omics; Immunotherapy; Prostate cancer; Immune system; Cancer; breakpoint cluster region; Biology; Cancer immunotherapy; Disease; Computational biology; Bioinformatics; Immunology; Oncology; Gene; Medicine; Internal medicine; Genetics","score_opus":0.025554059833030923,"score_gpt":0.2902676242626001,"score_spread":0.26471356442956917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3110606521","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98629504,0.007957814,0.000036006644,0.0044556255,0.00020664408,0.00074729143,0.000106859625,0.00013965253,0.00005504462],"genre_scores_gemma":[0.99576956,0.002247112,0.00039766353,0.00059937785,0.00003167264,0.00025570986,0.00033736293,0.000053124488,0.00030841958],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981136,0.00014485957,0.00053168065,0.00050757447,0.00030182488,0.00040050884],"domain_scores_gemma":[0.99837995,0.000052378844,0.0006274507,0.00040111938,0.00032810893,0.00021101396],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013757576,0.0002815176,0.0010987249,0.00022396997,0.0000966916,0.000014178995,0.00019486273,0.00017737878,0.00023325262],"category_scores_gemma":[0.00016479098,0.00021419181,0.00029529186,0.0015549847,0.0002817341,0.000080468286,0.00009998519,0.0003413079,0.000007885727],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0056263898,0.00082003366,0.9462783,0.0001471977,0.006159618,0.000055506018,0.0016936401,0.0002845086,0.008444602,0.0000102170325,0.00040473862,0.030075297],"study_design_scores_gemma":[0.0070307064,0.0016703209,0.9637506,0.00060083607,0.0061375517,0.0000012615053,0.0007302693,0.0041737934,0.00899979,0.0000015055987,0.0065171495,0.00038620707],"about_ca_topic_score_codex":0.00024276291,"about_ca_topic_score_gemma":0.00014980002,"teacher_disagreement_score":0.02968909,"about_ca_system_score_codex":0.0002781208,"about_ca_system_score_gemma":0.00041514446,"threshold_uncertainty_score":0.87344885},"labels":[],"label_agreement":null},{"id":"W3113450031","doi":"10.1080/2162402x.2020.1863626","title":"Discovery of immunogenic cell death-inducing ruthenium-based photosensitizers for anticancer photodynamic therapy","year":2020,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Nanoplatforms for cancer theranostics","field":"Engineering","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Beatrice Hunter Cancer Research Institute; Dalhousie University","funders":"National Cancer Institute; National Institutes of Health","keywords":"Photodynamic therapy; Cytotoxicity; Melanoma; Ruthenium; Immunogenic cell death; Cancer research; Cytotoxic T cell; Programmed cell death; Immunotherapy; Photosensitizer; Medicine; Chemistry; Apoptosis; Immunology; Immune system; In vitro; Biochemistry; Photochemistry","score_opus":0.016390434016626983,"score_gpt":0.22393754889902015,"score_spread":0.20754711488239316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3113450031","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97997904,0.0027588161,0.015128209,0.00006941544,0.0006551417,0.000552901,0.00013136926,0.00021380579,0.0005113199],"genre_scores_gemma":[0.99724776,0.00065138104,0.001490388,0.00028715498,0.00006997049,0.000063998006,0.00004622965,0.000114062976,0.000029060146],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99874645,0.000019475217,0.00041267776,0.00026370568,0.000121890116,0.0004358013],"domain_scores_gemma":[0.9992236,0.00020095735,0.000111734014,0.00036412393,0.000058383845,0.000041222214],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000083817504,0.00028105776,0.0005034224,0.00009205476,0.000055846398,0.00002056133,0.00030437982,0.00019347452,0.00003510644],"category_scores_gemma":[0.00002191731,0.00027897008,0.00023635526,0.0002166683,0.00010086141,0.00014912566,0.000027214955,0.00022714662,0.000015657728],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004911031,0.000034082575,0.00007208911,0.000117544536,0.0001862871,0.0000042087872,0.00041997,0.002991074,0.9936877,0.00007647456,0.000037937716,0.0018815108],"study_design_scores_gemma":[0.0031312888,0.0004455242,0.00026846564,0.000034890603,0.000048555397,0.000003160933,0.0001349713,0.01666681,0.97769153,0.00012763195,0.0011386861,0.0003084894],"about_ca_topic_score_codex":0.00005532544,"about_ca_topic_score_gemma":0.0000067435485,"teacher_disagreement_score":0.017268734,"about_ca_system_score_codex":0.00016235995,"about_ca_system_score_gemma":0.00013808746,"threshold_uncertainty_score":0.99996626},"labels":[],"label_agreement":null},{"id":"W3130326316","doi":"10.1080/2162402x.2021.1885778","title":"Synergistic anti-tumor efficacy of oncolytic influenza viruses and B7-H3 immune- checkpoint inhibitors against IC-resistant lung cancers","year":2021,"lang":"en","type":"article","venue":"OncoImmunology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; McMaster University Medical Centre","funders":"Deutsche Krebshilfe","keywords":"Oncolytic virus; Cancer research; Tumor microenvironment; Immune system; Medicine; Cytotoxic T cell; Immunotherapy; Immune checkpoint; Lung cancer; Cancer; Immunology; Oncolytic adenovirus; Biology; Oncology; Internal medicine","score_opus":0.026666207144907386,"score_gpt":0.32993254255462107,"score_spread":0.3032663354097137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3130326316","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97577703,0.018232351,0.00001541881,0.00033525383,0.00043828355,0.00051718025,0.000022376655,0.00007333015,0.004588771],"genre_scores_gemma":[0.99632883,0.0014050244,0.00013170838,0.0005664407,0.0001500861,0.00004507751,0.000024557981,0.0000748479,0.0012734426],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972023,0.00023793071,0.0009323905,0.0005684832,0.0004117669,0.000647143],"domain_scores_gemma":[0.9977928,0.0005267597,0.00029680534,0.0008809932,0.00034033536,0.00016229638],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00045403774,0.00032709577,0.0010710605,0.00030632748,0.00013178185,0.000030514047,0.00021409964,0.00023087834,0.0009146469],"category_scores_gemma":[0.0010216157,0.0003108705,0.00024223218,0.0006257617,0.00080545055,0.000077859855,0.00030148754,0.0005846912,0.000025257681],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015076498,0.00030899094,0.0072762743,0.000319211,0.00056823913,0.00074806233,0.00057982735,0.00004115309,0.98029697,0.00015078139,0.00015519728,0.008047625],"study_design_scores_gemma":[0.011371651,0.0012498592,0.10847101,0.0011167958,0.00034707406,0.00025701604,0.0017882922,0.00021966577,0.8337392,0.000041043128,0.04086625,0.00053210964],"about_ca_topic_score_codex":0.0012926534,"about_ca_topic_score_gemma":0.00017696572,"teacher_disagreement_score":0.14655775,"about_ca_system_score_codex":0.00086582405,"about_ca_system_score_gemma":0.0015547447,"threshold_uncertainty_score":0.9999986},"labels":[],"label_agreement":null},{"id":"W3135795993","doi":"10.1080/2162402x.2021.1945202","title":"Distinct microbial communities colonize tonsillar squamous cell carcinoma","year":2021,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Oral Health Pathology and Treatment","field":"Dentistry","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; National Science Foundation","keywords":"Tonsil; Prevotella; Microbiome; Biology; Fusobacteria; Cancer; Pathology; Firmicutes; Streptococcus bovis; Medicine; Internal medicine; Bioinformatics; 16S ribosomal RNA; Genetics; Gene","score_opus":0.023789258400418227,"score_gpt":0.2845732960484921,"score_spread":0.26078403764807384,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3135795993","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97087246,0.00522329,0.000012441237,0.00047667735,0.0018680603,0.0001493316,0.00010839993,0.00010523854,0.021184076],"genre_scores_gemma":[0.9896141,0.00004005984,0.00039841543,0.00052292796,0.00008358393,0.000035889105,0.0002752356,0.000024374986,0.0090053575],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981741,0.00062003377,0.0003489527,0.00026335823,0.00008255199,0.0005110267],"domain_scores_gemma":[0.99861306,0.00036298265,0.00012572875,0.00070716074,0.00012969534,0.00006135147],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00013196407,0.00021968433,0.0004107994,0.000058464073,0.00046306913,0.000022631988,0.00023745724,0.00037577137,0.0015802167],"category_scores_gemma":[0.000041294716,0.00022486545,0.00011877885,0.00014255759,0.00033305728,0.00005139627,0.0002697186,0.00047414878,0.0019475069],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000812387,0.003177751,0.91740936,0.00036206376,0.00015123533,0.019148396,0.0056184074,0.000005281402,0.028572382,0.0077862404,0.011304476,0.0056520407],"study_design_scores_gemma":[0.004741985,0.0008850852,0.8887157,0.000017528944,0.00014605556,0.004792595,0.0023799308,0.000009575826,0.027388655,0.00055655895,0.06993176,0.00043456838],"about_ca_topic_score_codex":0.0009512982,"about_ca_topic_score_gemma":0.0037639563,"teacher_disagreement_score":0.058627285,"about_ca_system_score_codex":0.00017920286,"about_ca_system_score_gemma":0.00028973832,"threshold_uncertainty_score":0.9993325},"labels":[],"label_agreement":null},{"id":"W3135861526","doi":"10.1080/2162402x.2021.1893466","title":"Tumor-intrinsic determinants of immunogenic cell death modalities","year":2021,"lang":"en","type":"review","venue":"OncoImmunology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"Agence Nationale de la Recherche","keywords":"Immunosurveillance; Immunogenic cell death; Cytotoxic T cell; Immune system; Acquired immune system; Immunology; Antigen presentation; T cell; Antigen; Antigen-presenting cell; Inflammation; Major histocompatibility complex; Secretion; Biology; Immunotherapy; Cancer research; In vitro","score_opus":0.05194550613869627,"score_gpt":0.3467005463507449,"score_spread":0.2947550402120486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3135861526","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0041634007,0.9917048,0.000002076156,0.000010985544,0.00085059204,0.0006925032,0.00008285174,0.000052269366,0.0024404998],"genre_scores_gemma":[0.0004885589,0.99425757,0.0001980058,0.00008345622,0.0001231936,0.0001168168,0.00017257377,0.000105354724,0.00445449],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99697113,0.00031466837,0.0013946998,0.0005538043,0.00023211274,0.00053360575],"domain_scores_gemma":[0.9974864,0.00022907423,0.0008724714,0.001193669,0.00016006244,0.000058296428],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00029316207,0.000596716,0.004232357,0.0003727722,0.000071913804,0.00001415471,0.0004075278,0.0006104708,0.00063528697],"category_scores_gemma":[0.00005590125,0.0004914708,0.0015512514,0.00043659896,0.000329916,0.000046268848,0.00020828098,0.00062146207,0.00006809769],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024805136,0.00024596837,0.00008055869,0.013661165,0.00102212,0.0003781017,0.00009283833,1.3339862e-8,0.00018801137,0.00005708267,0.0001777516,0.98384833],"study_design_scores_gemma":[0.0015701411,0.00068130594,0.0002665788,0.015499735,0.0019059369,0.002527082,0.00013417014,3.850967e-7,0.0005404979,0.000012187458,0.97643876,0.00042323157],"about_ca_topic_score_codex":0.00050043286,"about_ca_topic_score_gemma":0.000020031208,"teacher_disagreement_score":0.9834251,"about_ca_system_score_codex":0.0004003396,"about_ca_system_score_gemma":0.0021473088,"threshold_uncertainty_score":0.9997537},"labels":[],"label_agreement":null},{"id":"W3157232913","doi":"10.1080/2162402x.2021.1918373","title":"A bacterium-derived, cancer-associated immunopeptidome","year":2021,"lang":"en","type":"letter","venue":"OncoImmunology","topic":"Bacteriophages and microbial interactions","field":"Environmental Science","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"","keywords":"Context (archaeology); Immune system; Biology; Cancer; Bacteria; Medicine; Immunology; Microbiology; Genetics","score_opus":0.014046707574041015,"score_gpt":0.2408466630210687,"score_spread":0.2267999554470277,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3157232913","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.26499435,0.0021525004,0.000015893802,0.6901022,0.008334331,0.00061133684,0.00061975775,0.00034060425,0.03282902],"genre_scores_gemma":[0.015592685,0.0028546043,0.00030525,0.8093309,0.001756107,0.00037309635,0.0031490452,0.00025940896,0.16637895],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99754107,0.00027331038,0.00046912668,0.0007420174,0.00017192715,0.00080257],"domain_scores_gemma":[0.99871397,0.00009501644,0.00039207193,0.00072152226,0.00003606603,0.00004135147],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity","insufficient_payload"],"category_scores_codex":[0.00008456641,0.0004771781,0.0006986915,0.00007495845,0.00023375891,0.00010557442,0.0006561781,0.0013680261,0.07215414],"category_scores_gemma":[0.00004471739,0.0004915947,0.00030954366,0.00028854367,0.00039353524,0.00020411742,0.0007443086,0.0025165984,0.0038108004],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000083942095,0.00005594508,0.00004428071,0.000008143229,0.00018018736,0.00031974338,0.00011486106,0.000001557305,0.44367942,4.6767815e-7,0.55290484,0.0026821592],"study_design_scores_gemma":[0.0003586282,0.00009038282,0.012780771,0.00010689346,0.000095343574,0.00015956468,0.00003401891,0.0000017033589,0.0025014747,0.000010775696,0.9833591,0.0005013531],"about_ca_topic_score_codex":0.007654062,"about_ca_topic_score_gemma":0.0011513745,"teacher_disagreement_score":0.44117793,"about_ca_system_score_codex":0.0011677635,"about_ca_system_score_gemma":0.000099051074,"threshold_uncertainty_score":0.9999284},"labels":[],"label_agreement":null},{"id":"W3160437920","doi":"10.1080/2162402x.2021.1924492","title":"The immune microenvironment and relation to outcome in patients with advanced breast cancer treated with docetaxel with or without gemcitabine","year":2021,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; Centre for Advancing Health Outcomes; University of British Columbia","funders":"Canadian Institutes of Health Research; Else og Mogens Wedell Wedellsborgs Fond; Købmand M. Kristjan Kjær og Hustru Margrethe Kjær, Født la Cour-Holmes Fond; Canadian Cancer Society","keywords":"Docetaxel; Medicine; Gemcitabine; Breast cancer; Oncology; Internal medicine; Clinical endpoint; Biomarker; FOXP3; Cancer; Immune system; Clinical trial; Immunology","score_opus":0.0067823068047744425,"score_gpt":0.24567822307952522,"score_spread":0.2388959162747508,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3160437920","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927231,0.0023114593,0.000023111783,0.0039869067,0.000044695964,0.0007330227,0.000020002202,0.000024240977,0.00013342676],"genre_scores_gemma":[0.995915,0.0007396817,0.00063159835,0.00035759233,0.000012064991,0.00014951693,0.000041083233,0.00003852797,0.0021149297],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987804,0.000060982864,0.0003015896,0.0003577388,0.00017724508,0.00032202445],"domain_scores_gemma":[0.99928075,0.00004556837,0.00013344486,0.0003971333,0.00009198312,0.00005113819],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000078621546,0.000228217,0.00042190615,0.00007308561,0.00012691742,0.00001913759,0.00007098726,0.00007898456,0.0000975568],"category_scores_gemma":[0.0000085359225,0.00011114199,0.00002370845,0.00036556207,0.00024304651,0.00008633676,0.00003952219,0.00020794144,0.0000041471],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05802868,0.00023342694,0.89994115,0.000019621433,0.00033030353,0.00004870804,0.00026608442,0.000016849142,0.008392968,0.0000070217106,0.0000062776644,0.032708917],"study_design_scores_gemma":[0.01850862,0.0026008405,0.973808,0.00025464036,0.00010495502,0.00026312494,0.000370575,0.0000062947965,0.0009195965,7.6517335e-7,0.0029774006,0.00018521222],"about_ca_topic_score_codex":0.00044658594,"about_ca_topic_score_gemma":0.0013686398,"teacher_disagreement_score":0.07386683,"about_ca_system_score_codex":0.00032245283,"about_ca_system_score_gemma":0.0001436243,"threshold_uncertainty_score":0.45322388},"labels":[],"label_agreement":null},{"id":"W3174761433","doi":"10.1080/2162402x.2021.1943168","title":"Type 2 innate lymphoid cells: a novel actor in anti-melanoma immunity","year":2021,"lang":"en","type":"review","venue":"OncoImmunology","topic":"IL-33, ST2, and ILC Pathways","field":"Immunology and Microbiology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"Cancer Council NSW; National Health and Medical Research Council; University of Queensland","keywords":"Innate lymphoid cell; Melanoma; Immunology; Innate immune system; Acquired immune system; Immunity; Immune system; Immunotherapy; Medicine; Eosinophil; Cancer research; Biology","score_opus":0.051531088889887465,"score_gpt":0.30342024517145333,"score_spread":0.2518891562815659,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3174761433","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0031850652,0.98246026,0.00000914982,0.000015913984,0.006741677,0.0006885512,0.0022669903,0.0001589898,0.0044733845],"genre_scores_gemma":[0.00095152,0.990107,0.00008503532,0.000109084256,0.00011371173,0.0001121846,0.00337971,0.00014967471,0.004992072],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99441594,0.0015081279,0.001533158,0.0011149067,0.00006966609,0.001358201],"domain_scores_gemma":[0.99665236,0.00064401975,0.0007936732,0.0016145462,0.00025185425,0.00004355526],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity","insufficient_payload"],"category_scores_codex":[0.0006240213,0.0010984817,0.0045020846,0.00078307686,0.00028428528,0.00004099516,0.0013979417,0.0033448753,0.0010374351],"category_scores_gemma":[0.00043247372,0.0010012961,0.000685581,0.0013481944,0.0006221252,0.00014075286,0.0008845362,0.0026093416,0.0044841953],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019473517,0.0026938398,0.00012042145,0.007048144,0.0038155788,0.0006017688,0.0015110691,0.0000010069479,0.06711871,0.0019393609,0.005061992,0.9098934],"study_design_scores_gemma":[0.0016955797,0.0003586979,0.00008585209,0.003773496,0.00040011783,0.0014799574,0.00018793941,1.6642984e-7,0.0009696147,0.000011896274,0.9901015,0.000935155],"about_ca_topic_score_codex":0.0007786984,"about_ca_topic_score_gemma":0.00017768076,"teacher_disagreement_score":0.98503953,"about_ca_system_score_codex":0.00056830386,"about_ca_system_score_gemma":0.0026926135,"threshold_uncertainty_score":0.9998757},"labels":[],"label_agreement":null},{"id":"W3186130481","doi":"10.1080/2162402x.2021.1952539","title":"Alternol triggers immunogenic cell death <i>via</i> reactive oxygen species generation","year":2021,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Immunogenic cell death; Calreticulin; Cancer research; Immune system; HMGB1; Cytokine; Prostate cancer; Immunology; Inflammation; T cell; Medicine; Cancer; Biology; Immunotherapy; Endoplasmic reticulum; Cell biology; Internal medicine","score_opus":0.030107106238168986,"score_gpt":0.26766494366361293,"score_spread":0.23755783742544395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3186130481","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9455748,0.02055221,0.0005641678,0.0020673366,0.0012242307,0.00035574497,0.00001957692,0.00011254203,0.029529346],"genre_scores_gemma":[0.9695583,0.004930233,0.0010736246,0.0018748763,0.0004386722,0.000053176114,0.0004048971,0.000050420862,0.021615798],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998422,0.00013947408,0.0004088596,0.0004397351,0.0001956329,0.00039428132],"domain_scores_gemma":[0.99891686,0.00006158912,0.00015902317,0.0006155482,0.00019112692,0.00005584159],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001750173,0.00023883668,0.00044948547,0.00011671673,0.00016481175,0.0000290519,0.00013503828,0.00024229898,0.0010809725],"category_scores_gemma":[0.00003257348,0.00022451076,0.00027833262,0.00029528042,0.00014289981,0.000108803564,0.0000660341,0.0003069529,0.00015879323],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011055438,0.0002663856,0.0006586384,0.000019434723,0.000434963,0.00017683365,0.00040045744,0.0000012668669,0.9754579,0.000091718066,0.0018479066,0.019538919],"study_design_scores_gemma":[0.0047569475,0.0006054537,0.023649935,0.000034989123,0.00017053843,0.00075079786,0.0004617692,0.000044375396,0.7621999,0.000057906534,0.2069939,0.00027352865],"about_ca_topic_score_codex":0.00018996182,"about_ca_topic_score_gemma":0.000045279106,"teacher_disagreement_score":0.21325807,"about_ca_system_score_codex":0.00041286892,"about_ca_system_score_gemma":0.00045797945,"threshold_uncertainty_score":0.99983215},"labels":[],"label_agreement":null},{"id":"W3189341011","doi":"10.1080/2162402x.2021.1956173","title":"Association of <i>PIK3CA</i> mutation and PTEN loss with expression of CD274 (PD-L1) in colorectal carcinoma","year":2021,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute; Uehara Memorial Foundation; Stand Up To Cancer; National Institutes of Health; American Association for Cancer Research; Yasuda Memorial Medical Foundation; George W. Stone Family Foundation; Mitsukoshi Health and Welfare Foundation; Japan Society for the Promotion of Science; Dana-Farber/Harvard Cancer Center; Gary Bennett Family Fund; Dana-Farber Cancer Institute","keywords":"PTEN; Microsatellite instability; Cancer research; Medicine; Colorectal cancer; Oncology; Cancer; Immune checkpoint; KRAS; Internal medicine; Odds ratio; Immunotherapy; Biology; PI3K/AKT/mTOR pathway; Genetics; Signal transduction; Allele","score_opus":0.00587155657809464,"score_gpt":0.23575548685067801,"score_spread":0.2298839302725834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3189341011","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961209,0.002108532,0.000016984946,0.0005963198,0.00007629487,0.00013648324,0.000008465294,0.000007662484,0.0009283095],"genre_scores_gemma":[0.99899817,0.0003061274,0.00027334693,0.000064581924,0.00001312856,0.000010912048,0.00003660611,0.000008717746,0.00028843744],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9992687,0.00008649799,0.0002565591,0.00014580936,0.00012150482,0.00012091472],"domain_scores_gemma":[0.9994231,0.00010265007,0.0002101464,0.00011174935,0.00013831486,0.00001403147],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016215997,0.00007642836,0.00029965225,0.0000830131,0.000016878395,0.000002419536,0.00003096703,0.00014306798,0.000060176466],"category_scores_gemma":[0.000059460162,0.00006458906,0.00003555163,0.00021399547,0.00010241312,0.000047979298,0.000023011571,0.00010799727,6.779529e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035681312,0.00013356072,0.30567232,0.00006328924,0.00007619315,0.000066050845,0.0009480896,0.000001237382,0.6846058,0.00001763594,0.000054912787,0.004792806],"study_design_scores_gemma":[0.004015433,0.0005761265,0.5951134,0.00012705555,0.000036048314,0.0001286125,0.0005392172,0.000011334356,0.39906725,0.000020497855,0.0003166983,0.00004835195],"about_ca_topic_score_codex":0.00029331146,"about_ca_topic_score_gemma":0.00026424616,"teacher_disagreement_score":0.28944105,"about_ca_system_score_codex":0.00012789831,"about_ca_system_score_gemma":0.00017251323,"threshold_uncertainty_score":0.26338655},"labels":[],"label_agreement":null},{"id":"W3191190767","doi":"10.1080/2162402x.2021.1959978","title":"Germinal center hypoxia in tumor-draining lymph nodes negatively regulates tumor-induced humoral immune responses in mouse models of breast cancer","year":2021,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Germinal center; Immune system; Tumor hypoxia; Lymph; Antibody; Cancer research; Hypoxia (environmental); Lymph node; Biology; Tumor progression; Immunology; Cancer; Medicine; Pathology; Chemistry; B cell; Internal medicine; Radiation therapy","score_opus":0.02564010086865083,"score_gpt":0.2682532652089415,"score_spread":0.24261316434029068,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3191190767","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99239784,0.0036734615,0.000012220324,0.00054108084,0.0016665657,0.0001687243,0.000049922663,0.000056623645,0.0014335366],"genre_scores_gemma":[0.99274164,0.00022980628,0.00006847522,0.00026312986,0.000023673078,0.000069667956,0.000108834334,0.000042476644,0.0064523127],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.996747,0.0009616897,0.0010123941,0.000552376,0.00006287579,0.00066367036],"domain_scores_gemma":[0.9985555,0.00027960935,0.00042654862,0.00046591397,0.00025316371,0.00001925327],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00038798887,0.00035179773,0.0008338338,0.0005703772,0.0001225358,0.000019067238,0.00029929663,0.00032318902,0.0014736338],"category_scores_gemma":[0.00015671675,0.00036247133,0.00017407852,0.0004677524,0.0003393016,0.00040205073,0.00022359531,0.00072636805,0.0000970524],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003225519,0.000558954,0.011013873,0.000028613147,0.00014934478,0.0001188818,0.0016781922,0.0001406647,0.9800193,0.00053183874,0.00007953277,0.0024553027],"study_design_scores_gemma":[0.005846785,0.00017230812,0.3437543,0.00036652636,0.000025265072,0.001653736,0.004558623,0.0001808432,0.64195347,0.00021489999,0.0008434693,0.00042975674],"about_ca_topic_score_codex":0.0028942225,"about_ca_topic_score_gemma":0.00029564643,"teacher_disagreement_score":0.3380658,"about_ca_system_score_codex":0.00037877043,"about_ca_system_score_gemma":0.000460234,"threshold_uncertainty_score":0.9998827},"labels":[],"label_agreement":null},{"id":"W3200729455","doi":"10.1080/2162402x.2021.1939518","title":"Phased differentiation of γδ T and T CD8 tumor-infiltrating lymphocytes revealed by single-cell transcriptomics of human cancers","year":2021,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Nautical Research Society","funders":"Centre National de la Recherche Scientifique; Institut National de la Santé et de la Recherche Médicale; Fondation ARC pour la Recherche sur le Cancer; Agence Nationale de la Recherche","keywords":"CD8; Cytotoxic T cell; Biology; Cancer research; T cell; Immune system; Transcriptome; Immunophenotyping; Immunology; Cancer immunotherapy; Tumor-infiltrating lymphocytes; Immunotherapy; Antigen; Gene expression; Gene; In vitro; Genetics","score_opus":0.012480476062551111,"score_gpt":0.22823484315430226,"score_spread":0.21575436709175114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3200729455","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98506576,0.009926235,0.00033325973,0.00006154176,0.0012705713,0.00011151064,0.000022547256,0.00003115108,0.0031774135],"genre_scores_gemma":[0.99578714,0.00029094433,0.0000514788,0.00008382136,0.000010093744,0.000009212835,0.00033577697,0.000017144504,0.0034143666],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99867916,0.00025360298,0.0005638093,0.00025358686,0.000030893403,0.00021893012],"domain_scores_gemma":[0.9990574,0.0001255694,0.0004135752,0.0002280139,0.00016459893,0.00001084927],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010580948,0.00016671658,0.0004454484,0.00010322909,0.00012308056,0.000007595895,0.00010040867,0.00021507962,0.0008311958],"category_scores_gemma":[0.000056457677,0.00017536446,0.00009914778,0.00012537235,0.00025517866,0.000101021236,0.000024553117,0.00021317022,0.000010232272],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022776691,0.0002728412,0.0016592542,0.00006609972,0.00015493885,0.000001075012,0.0005974921,0.0000018178351,0.9943682,0.00016641994,0.0009787242,0.0015053614],"study_design_scores_gemma":[0.003219881,0.0005807344,0.0016369598,0.00006304682,0.00007952808,0.00006153166,0.0012242843,0.000007572146,0.98601776,0.00002804716,0.006938509,0.00014214443],"about_ca_topic_score_codex":0.00041213012,"about_ca_topic_score_gemma":0.000047045098,"teacher_disagreement_score":0.010721392,"about_ca_system_score_codex":0.0001356613,"about_ca_system_score_gemma":0.00012304759,"threshold_uncertainty_score":0.9101011},"labels":[],"label_agreement":null},{"id":"W3204866712","doi":"10.1080/2162402x.2021.1943234","title":"The PKN1- TRAF1 signaling axis as a potential new target for chronic lymphocytic leukemia","year":2021,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; Ontario Institute for Cancer Research; York University; University of Toronto","funders":"Canadian Cancer Society Research Institute; Canadian Institutes of Health Research","keywords":"Venetoclax; Chronic lymphocytic leukemia; Medicine; Cancer research; Kinase; Leukemia; Lymphoma; Immunology; Biology; Cell biology","score_opus":0.01566190881699383,"score_gpt":0.30334040842277543,"score_spread":0.2876784996057816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3204866712","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8724442,0.09678451,0.008530829,0.0073950817,0.0027952981,0.0023523036,0.000029186835,0.0004357057,0.009232872],"genre_scores_gemma":[0.9394785,0.00192726,0.0030881073,0.00084101676,0.001645435,0.00021371133,0.0001687469,0.00012997289,0.052507225],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969858,0.00016942131,0.0005717204,0.00063352694,0.00045869336,0.0011808705],"domain_scores_gemma":[0.9974958,0.00079588994,0.00013666123,0.0010032286,0.0003316548,0.00023679364],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00050222356,0.000308233,0.00060399674,0.00010776371,0.0004745297,0.00008843645,0.0004436358,0.0003980883,0.0009713946],"category_scores_gemma":[0.0010259078,0.00024014624,0.0003850738,0.00040529037,0.00039862137,0.000086585685,0.00024436665,0.00047533086,0.0005440672],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0080851875,0.00023669889,0.0000325773,0.0008416955,0.0042256312,0.0054013715,0.002015422,0.0068358155,0.58250266,0.011997887,0.052677635,0.32514742],"study_design_scores_gemma":[0.07472878,0.0034165867,0.0001353148,0.00030424978,0.0005493129,0.011314991,0.0013080247,0.060465302,0.15899634,0.00668346,0.68142927,0.0006683587],"about_ca_topic_score_codex":0.0016206027,"about_ca_topic_score_gemma":0.00013912664,"teacher_disagreement_score":0.62875164,"about_ca_system_score_codex":0.082207,"about_ca_system_score_gemma":0.16403309,"threshold_uncertainty_score":0.9999418},"labels":[],"label_agreement":null},{"id":"W3205381631","doi":"10.1080/2162402x.2021.1984677","title":"Trial watch: intratumoral immunotherapy","year":2021,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Labex Immuno-Oncology; High-end Foreign Experts Recruitment Plan of China; Stand Up To Cancer; Weill Cornell Medical College; European Research Area Network on Cardiovascular Diseases; Institut Universitaire de France; Centre National de la Recherche Scientifique; Ligue Contre le Cancer; Fondation pour la Recherche Médicale; Institut National Du Cancer; Institut National de la Santé et de la Recherche Médicale; Association pour la Recherche sur le Cancer; Seerave Foundation; Institut Gustave-Roussy; Fondation Leducq; European Commission; Agence Nationale de la Recherche; E-Rare; Leukemia and Lymphoma Society","keywords":"Oncolytic virus; Immunotherapy; Immune system; Chemotherapy; Context (archaeology); Radiation therapy; T cell; Cancer immunotherapy; Myeloid","score_opus":0.022843804974087212,"score_gpt":0.3018789860251105,"score_spread":0.27903518105102326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3205381631","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9567018,0.010791923,0.00007980916,0.011069863,0.0022990755,0.00039773056,0.000006399263,0.00014736259,0.018506005],"genre_scores_gemma":[0.9681282,0.0034305193,0.0011744678,0.0050265086,0.00059800426,0.000082833605,0.00011616905,0.000057809546,0.02138551],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986664,0.00011381685,0.00037731434,0.000318574,0.00015815019,0.0003657109],"domain_scores_gemma":[0.99911183,0.000058616286,0.00008739859,0.00057030644,0.0001231785,0.000048644797],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00019010664,0.00018070507,0.00045346268,0.00005616305,0.00009068122,0.000025399315,0.000118505435,0.00021927891,0.0030252328],"category_scores_gemma":[0.00005135313,0.00015886199,0.00025558233,0.00031635497,0.00020561428,0.00006187192,0.00004176258,0.0003277101,0.00015387623],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.18156585,0.0008623378,0.0009019213,0.000024462985,0.00085712917,0.00064227544,0.0004982805,2.1649606e-7,0.6401304,0.0011418075,0.008585354,0.16478997],"study_design_scores_gemma":[0.15525779,0.0028121194,0.013333073,0.00006374115,0.00007417635,0.0015748554,0.00044860278,0.0000049573996,0.07005774,0.00040895352,0.755648,0.0003159835],"about_ca_topic_score_codex":0.000082870385,"about_ca_topic_score_gemma":0.000022887698,"teacher_disagreement_score":0.7470626,"about_ca_system_score_codex":0.00014857433,"about_ca_system_score_gemma":0.00053379947,"threshold_uncertainty_score":0.9978861},"labels":[],"label_agreement":null},{"id":"W3213274906","doi":"10.1080/2162402x.2021.1995168","title":"Manufacturing T cells in hollow fiber membrane bioreactors changes their programming and enhances their potency","year":2021,"lang":"en","type":"article","venue":"OncoImmunology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre; McMaster University; TRIUMF","funders":"Canada Research Chairs","keywords":"Cryopreservation; Bioreactor; Cell; Cell culture; Chemistry; Cell biology; Biotechnology; Biology; Biochemistry; Embryo","score_opus":0.02288096904731359,"score_gpt":0.2790658329351818,"score_spread":0.2561848638878682,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213274906","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9876094,0.005351103,0.0000026798245,0.0019399339,0.0002067954,0.00037710322,0.0000069005987,0.00006231884,0.0044437805],"genre_scores_gemma":[0.98167276,0.0052093207,0.0003960097,0.00016989422,0.00012336098,0.00006396086,0.00003440341,0.000044264067,0.012286],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99848795,0.00014674617,0.00022330895,0.00043985771,0.00014725952,0.0005548715],"domain_scores_gemma":[0.9991742,0.00021492032,0.00006355617,0.0004115459,0.000059125057,0.00007666531],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00027503388,0.00022850833,0.00049978175,0.00023000251,0.00006698946,0.000033308967,0.00012903355,0.00022671954,0.0020116512],"category_scores_gemma":[0.000034783166,0.00017528042,0.000078496334,0.00023730828,0.00022300938,0.0000638247,0.00015636018,0.00050543575,0.000035029123],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013676766,0.00010822797,0.00042662272,0.00006149519,0.000081188875,0.00017258573,0.0013003413,2.3601976e-7,0.63908535,0.0000045656325,0.000008903808,0.35861373],"study_design_scores_gemma":[0.0012702721,0.00031046447,0.008049879,0.00011651456,0.000014372341,0.00021035163,0.0019253546,0.0000053459075,0.8766673,0.000043357297,0.11123374,0.00015304591],"about_ca_topic_score_codex":0.0002616812,"about_ca_topic_score_gemma":0.00047718827,"teacher_disagreement_score":0.35846066,"about_ca_system_score_codex":0.00010047255,"about_ca_system_score_gemma":0.00012422164,"threshold_uncertainty_score":0.99890065},"labels":[],"label_agreement":null},{"id":"W3215925274","doi":"10.1080/2162402x.2021.2006893","title":"Keratinocyte differentiation antigen-specific T cells in immune checkpoint inhibitor-treated NSCLC patients are associated with improved survival","year":2021,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; Novartis Foundation; Sanofi; Bristol-Myers Squibb; Krebsliga Schweiz; National Science Foundation","keywords":"Epitope; Antigen; Immunology; Lung cancer; Human leukocyte antigen; Immune system; Immunotherapy; CD8; Medicine; Cancer research; Biology; Oncology","score_opus":0.012535353175104302,"score_gpt":0.22722299800351764,"score_spread":0.21468764482841335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215925274","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949627,0.0027015656,0.000029586909,0.00031356845,0.0007448353,0.00048184633,0.000038214064,0.00008723274,0.0006404789],"genre_scores_gemma":[0.9965918,0.0015273492,0.0000739645,0.00010830746,0.000057278397,0.000039397313,0.0008350564,0.00005013379,0.00071672624],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9978902,0.00025869478,0.0006555825,0.000492476,0.00023579015,0.0004672994],"domain_scores_gemma":[0.9986572,0.00008086455,0.00038208233,0.0004637819,0.000365372,0.000050681832],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002009439,0.00030809586,0.00069999776,0.00017555145,0.00010746757,0.00003849984,0.00010505384,0.0003259795,0.00030771503],"category_scores_gemma":[0.00006287902,0.00026331007,0.00015591408,0.000629975,0.0001438853,0.00009753745,0.00006529256,0.00041442108,0.000022778073],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033289487,0.0011777035,0.20077723,0.00001740792,0.00043749512,0.00010240154,0.0003089443,0.0000010010142,0.7870754,0.0000062354047,0.000057722194,0.0067095174],"study_design_scores_gemma":[0.011604503,0.000577477,0.7373059,0.00030604456,0.000027106757,0.000009050521,0.00028778866,0.0000315498,0.24857308,0.000003855999,0.0010521912,0.00022149539],"about_ca_topic_score_codex":0.00027759344,"about_ca_topic_score_gemma":0.00072195125,"teacher_disagreement_score":0.5385023,"about_ca_system_score_codex":0.0005635962,"about_ca_system_score_gemma":0.00019097485,"threshold_uncertainty_score":0.99998194},"labels":[],"label_agreement":null},{"id":"W3217061495","doi":"10.1080/2162402x.2021.2005859","title":"Radiochemotherapy-induced elevations of plasma HMGB1 levels predict therapeutic responses in cancer patients","year":2021,"lang":"en","type":"editorial","venue":"OncoImmunology","topic":"Advanced Glycation End Products research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Labex Immuno-Oncology; European Research Area Network on Cardiovascular Diseases; Horizon 2020 Framework Programme; Chancellerie des Universités de Paris; Centre de Compétences Nanosciences Ile-de-France; Canadian Rheumatology Association; Institut Universitaire de France; Labex; Ligue Contre le Cancer; Division of Arctic Sciences; Fondation pour la Recherche Médicale; Institut National Du Cancer; Institut National de la Santé et de la Recherche Médicale; Agence Nationale de la Recherche; Association pour la Recherche sur le Cancer; Seerave Foundation; Institut national de la recherche scientifique; Institut Gustave-Roussy; Fondation Leducq","keywords":"Medicine; HMGB1; Breast cancer; Context (archaeology); Internal medicine; Oncology; Head and neck cancer; Chemoradiotherapy; Cancer; Squamous cell cancer; Colorectal cancer; Inflammation; Cancer research; Biology","score_opus":0.02726564328689017,"score_gpt":0.34997913794197294,"score_spread":0.32271349465508276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3217061495","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6648219,0.012669621,0.00010780521,0.000468982,0.319183,0.0009778187,0.0012426323,0.000028175156,0.0005000806],"genre_scores_gemma":[0.6677807,0.022592995,0.00079292484,0.00019608384,0.28299403,0.00087309035,0.0078141475,0.0003562476,0.016599761],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974075,0.00048579756,0.0005628051,0.0007191148,0.0004055829,0.00041919353],"domain_scores_gemma":[0.99764156,0.00029685054,0.0003509685,0.0008226646,0.00084796,0.00003998066],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000310809,0.0003111006,0.0005120466,0.00025265248,0.000060589096,0.000012552585,0.00052826124,0.0011453187,0.00013812887],"category_scores_gemma":[0.0018901404,0.0003262955,0.00010827393,0.00035372208,0.00019285298,0.000007517271,0.00017746275,0.0006944907,0.0000055737914],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014880723,0.0006478387,0.001440644,0.00014280695,0.0005823,0.00000554171,0.00025529214,0.00007392456,0.82865447,0.000030084966,0.13841735,0.028261688],"study_design_scores_gemma":[0.0022279958,0.00081328454,0.0038988518,0.000098827295,0.000025269688,0.0000013989995,0.00004736569,0.0000058640703,0.22342992,0.000051741274,0.7690769,0.00032260318],"about_ca_topic_score_codex":0.00011988919,"about_ca_topic_score_gemma":0.00016410823,"teacher_disagreement_score":0.6306595,"about_ca_system_score_codex":0.00017295849,"about_ca_system_score_gemma":0.0020431944,"threshold_uncertainty_score":0.99991894},"labels":[],"label_agreement":null},{"id":"W4200464648","doi":"10.1080/2162402x.2021.2010905","title":"CCL5 production in lung cancer cells leads to an altered immune microenvironment and promotes tumor development","year":2021,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Terry Fox Research Institute; University of British Columbia","funders":"Canadian Institutes of Health Research; BC Cancer Foundation; Terry Fox Research Institute","keywords":"CCL5; Tumor microenvironment; Immune system; Cancer research; Chemokine; KRAS; Lung cancer; Immunotherapy; Cytokine; Immunology; Medicine; T cell; CD8; Cancer; Biology; IL-2 receptor; Oncology; Internal medicine","score_opus":0.012650492094816673,"score_gpt":0.27437048894631544,"score_spread":0.26171999685149877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200464648","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98288804,0.01257209,0.000010306321,0.0033812698,0.0005391362,0.0005176365,0.0000031412821,0.000025214109,0.00006319101],"genre_scores_gemma":[0.99343336,0.0013435575,0.0024052288,0.0007392223,0.00009515826,0.00018144805,0.00003286846,0.000027801829,0.0017413521],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99875224,0.00007581477,0.0003399173,0.0004344724,0.00009919636,0.0002983482],"domain_scores_gemma":[0.9995287,0.000010950036,0.0000684378,0.00030383313,0.000035180026,0.000052884774],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019031725,0.00016064355,0.00031480627,0.0001135512,0.00006730607,0.000013495381,0.00006481709,0.00007508688,0.00025733325],"category_scores_gemma":[0.000016214535,0.00015357624,0.0000315882,0.00018954152,0.00009023281,0.00006513034,0.00007338233,0.00016693091,0.000011200235],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008403811,0.0003182898,0.0132372,0.00008048647,0.0000956059,0.000051349114,0.001993691,0.0000040263103,0.93629706,0.0000016960727,0.00012927216,0.046950962],"study_design_scores_gemma":[0.0013528032,0.00023111777,0.32923368,0.00018091354,0.000022340522,0.00014132807,0.00028643207,0.000006212847,0.6568439,0.0000020264117,0.011562738,0.00013652313],"about_ca_topic_score_codex":0.00026521937,"about_ca_topic_score_gemma":0.0005370377,"teacher_disagreement_score":0.31599647,"about_ca_system_score_codex":0.0004577108,"about_ca_system_score_gemma":0.00028066523,"threshold_uncertainty_score":0.62626576},"labels":[],"label_agreement":null},{"id":"W4210679360","doi":"10.1080/2162402x.2022.2033433","title":"CD4+ T cells in classical Hodgkin lymphoma express exhaustion associated transcription factors TOX and TOX2","year":2022,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Spinal Cord Injury BC","funders":"Rijksuniversiteit Groningen; Canadian Cancer Society Research Institute; Universitair Medisch Centrum Groningen; Genome British Columbia; Genome Canada","keywords":"Immune system; Antigen; Biology; Population; T cell; Cancer research; Lymphoma; Immunology; Molecular biology; Medicine","score_opus":0.018380466357034587,"score_gpt":0.2532166011963488,"score_spread":0.23483613483931423,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210679360","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961179,0.0012635321,0.000033049117,0.00092945795,0.0006321106,0.00028973914,0.000031273776,0.00006204776,0.0006409117],"genre_scores_gemma":[0.9978612,0.00029602845,0.00003848155,0.0003295446,0.000026653865,0.0000668374,0.000105957326,0.000020477399,0.0012547923],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9987257,0.00022578449,0.00029386126,0.0002861308,0.00018337066,0.0002851318],"domain_scores_gemma":[0.9995919,0.00007444195,0.00009057839,0.00018448393,0.000021327012,0.000037293215],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027143545,0.00015150353,0.0003286174,0.00020005048,0.0001325529,0.000011604889,0.00008833505,0.00017420258,0.00056609],"category_scores_gemma":[0.00002313336,0.00014794631,0.00008676884,0.00027901976,0.0001337707,0.000068797905,0.000048501453,0.00026459649,0.0000032434166],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030024345,0.00064211665,0.013185497,0.000017263073,0.00011448899,0.000060451785,0.0022427777,0.000011909893,0.9498716,0.000048729875,0.00079784816,0.030004907],"study_design_scores_gemma":[0.013483419,0.0025276938,0.88260156,0.00006619689,0.00009492275,0.00012894592,0.0038680553,0.000491991,0.017223785,0.00008926915,0.0790703,0.00035387886],"about_ca_topic_score_codex":0.00054839934,"about_ca_topic_score_gemma":0.00009654555,"teacher_disagreement_score":0.93264776,"about_ca_system_score_codex":0.00064872025,"about_ca_system_score_gemma":0.000099815225,"threshold_uncertainty_score":0.6198289},"labels":[],"label_agreement":null},{"id":"W4211179856","doi":"10.4161/onci.22789","title":"Trial watch","year":2012,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":89,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research; Institut National Du Cancer","keywords":"Clinical trial; Medicine; Monoclonal antibody; Cancer; Basic research; Cancer research; Antibody; Immunology; Pathology; Internal medicine; Computer science","score_opus":0.05138908683919521,"score_gpt":0.37355995844054085,"score_spread":0.32217087160134567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4211179856","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.919228,0.0019837471,0.000010941823,0.0064861383,0.000698326,0.00022891742,0.000002329772,0.000041958498,0.071319595],"genre_scores_gemma":[0.95859075,0.0002537964,0.00038952235,0.00058904313,0.00092368625,0.00002645468,0.000023433391,0.00001209811,0.039191216],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99908996,0.00005340102,0.0001518468,0.000103799706,0.00015199784,0.0004489934],"domain_scores_gemma":[0.99954313,0.0000805789,0.000025032825,0.0001959389,0.00004019556,0.00011509914],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0002017035,0.00008579455,0.0002247425,0.000044351556,0.000060604696,0.000004009947,0.000077392106,0.00011262305,0.0018051012],"category_scores_gemma":[0.000072114504,0.00006192125,0.000090769754,0.00009398937,0.00012896319,0.00005280536,0.00007376006,0.00025785112,0.001769644],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2425742,0.0044569466,0.21780479,0.00017741042,0.001039019,0.00022762669,0.0022412017,2.4591574e-7,0.1325296,0.05204756,0.0914967,0.25540468],"study_design_scores_gemma":[0.019274106,0.0011383793,0.05729734,0.000010961546,0.000028190128,0.00031804634,0.000071081085,0.0000031216973,0.0034502824,0.00013512679,0.9181769,0.00009648267],"about_ca_topic_score_codex":0.00011109538,"about_ca_topic_score_gemma":0.0000022342426,"teacher_disagreement_score":0.8266802,"about_ca_system_score_codex":0.000038239912,"about_ca_system_score_gemma":0.00006119096,"threshold_uncertainty_score":0.99910736},"labels":[],"label_agreement":null},{"id":"W4220769687","doi":"10.1080/2162402x.2022.2057399","title":"Translocation of <i>Helicobacter hepaticus</i> synergizes with myeloid-derived suppressor cells and contributes to breast carcinogenesis","year":2022,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"National Institute of Environmental Health Sciences; National Cancer Institute; National Natural Science Foundation of China; National Institutes of Health; National Science Foundation","keywords":"Carcinogenesis; Adoptive cell transfer; Population; Haematopoiesis; Mesenteric lymph nodes; Suppressor; Mammary gland; Myeloid-derived Suppressor Cell","score_opus":0.005088628074043257,"score_gpt":0.19320254079558566,"score_spread":0.1881139127215424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220769687","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9851392,0.0115877,0.00024118392,0.0011122557,0.0008130753,0.00050224835,0.00035464778,0.00005638765,0.00019333743],"genre_scores_gemma":[0.99785894,0.00027839598,0.00014323473,0.00042258328,0.000010278941,0.00029047634,0.00012604451,0.000038558508,0.0008314882],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99820787,0.00043265647,0.0004281092,0.00042576273,0.000058104746,0.0004475031],"domain_scores_gemma":[0.99892163,0.00023975899,0.00019369888,0.00047775364,0.00014768534,0.000019475876],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021237819,0.00025269264,0.00058177306,0.0002127799,0.00029543287,0.000009310256,0.00036948026,0.0001754664,0.0007485202],"category_scores_gemma":[0.000015085466,0.00023151367,0.00006752387,0.00028472982,0.0005086263,0.000064908076,0.00024824493,0.0003177983,0.000043725697],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016032095,0.00016178629,0.003996965,0.000031710577,0.00039259144,0.000004781526,0.0012880815,0.000094352,0.9859165,0.00019883398,0.0007984929,0.0055127256],"study_design_scores_gemma":[0.0029311415,0.0007778438,0.029611148,0.000027074999,0.00013307828,0.0002610659,0.0011492367,0.0000018606949,0.9365182,0.000031674237,0.028288502,0.00026920042],"about_ca_topic_score_codex":0.0006970632,"about_ca_topic_score_gemma":0.00008460389,"teacher_disagreement_score":0.049398296,"about_ca_system_score_codex":0.0001212339,"about_ca_system_score_gemma":0.00014532228,"threshold_uncertainty_score":0.94408536},"labels":[],"label_agreement":null},{"id":"W4226175296","doi":"10.1080/2162402x.2022.2060907","title":"LILRB4 promotes tumor metastasis by regulating MDSCs and inhibiting miR-1 family miRNAs","year":2022,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Aging","funders":"Japan Society for the Promotion of Science; Japan Agency for Medical Research and Development","keywords":"microRNA; Metastasis; Cancer research; Medicine; Cancer; Biology; Internal medicine; Gene; Genetics","score_opus":0.012664241322099467,"score_gpt":0.23345899998469374,"score_spread":0.22079475866259426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4226175296","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92449325,0.06862479,0.00004613904,0.00067785615,0.0015190801,0.00041014125,0.00012724978,0.00020337861,0.0038981435],"genre_scores_gemma":[0.9908662,0.00017436878,0.0008183424,0.0009192782,0.00003226728,0.00026550537,0.00026174405,0.00007879124,0.0065835253],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99702674,0.0007978386,0.0006137628,0.00067109783,0.000083183506,0.000807352],"domain_scores_gemma":[0.9986435,0.00037977324,0.0003931379,0.00049261533,0.00006855934,0.00002240893],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00065174385,0.00035726992,0.0006105496,0.00019450666,0.001074646,0.000027899094,0.0004647739,0.0002023435,0.0013278446],"category_scores_gemma":[0.00016489567,0.0003815734,0.00011818279,0.0003115511,0.0006164433,0.00013158933,0.0010612464,0.0011128194,0.00014140649],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001638529,0.00013441202,0.0007270347,0.000025012367,0.0003035763,0.000016253729,0.0009221693,0.000005198302,0.9667874,0.00031544545,0.013273054,0.017326565],"study_design_scores_gemma":[0.0033150516,0.0009977531,0.002417465,0.000047353875,0.00014406422,0.0014889213,0.005893458,0.000010489945,0.38784897,0.0004293709,0.5966603,0.00074679777],"about_ca_topic_score_codex":0.00048747263,"about_ca_topic_score_gemma":0.000013911717,"teacher_disagreement_score":0.58338726,"about_ca_system_score_codex":0.0002217191,"about_ca_system_score_gemma":0.00013161614,"threshold_uncertainty_score":0.9998636},"labels":[],"label_agreement":null},{"id":"W4229368328","doi":"10.1080/2162402x.2022.2066050","title":"OX40 and 4-1BB delineate distinct immune profiles in sarcoma","year":2022,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Ottawa Mental Health Centre; Institute of Cancer Research","funders":"Cancer Research UK; National Institute for Health and Care Research; NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research; Rosetrees Trust; Royal Marsden NHS Foundation Trust","keywords":"Sarcoma; Immunotherapy; Medicine; Immune system; Radiation therapy; Cancer research; Immunology; Oncology; Biology; Internal medicine; Pathology","score_opus":0.010716853905956865,"score_gpt":0.2391249743004987,"score_spread":0.22840812039454184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4229368328","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91634846,0.07991472,0.000025592677,0.00092219317,0.0010064874,0.00038547165,0.00005173372,0.000112974434,0.0012323703],"genre_scores_gemma":[0.9907627,0.00080101885,0.00007135133,0.0002564587,0.000016013744,0.00028919743,0.00020844143,0.000044040637,0.007550787],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9968986,0.0012122937,0.00064928323,0.0004853931,0.000053075164,0.0007013729],"domain_scores_gemma":[0.99884844,0.00035965597,0.00019927428,0.0005401766,0.000038996815,0.000013464697],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007275837,0.00031554262,0.0005971564,0.00039708533,0.00066615426,0.00001828806,0.0005063689,0.00022608684,0.0028391832],"category_scores_gemma":[0.00012272011,0.0003121224,0.00011440848,0.00036388793,0.0005508904,0.00011500609,0.0006487461,0.0009940194,0.00020713675],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036909902,0.0005829857,0.016455764,0.000019235524,0.0002888852,0.00008623329,0.0015449374,0.000011292202,0.9041343,0.002224909,0.00061031745,0.070350155],"study_design_scores_gemma":[0.009535971,0.0022840325,0.35204047,0.00004568579,0.00005069019,0.0023936406,0.0035354812,0.000024132889,0.044319328,0.00062968006,0.5842573,0.00088357145],"about_ca_topic_score_codex":0.0006357275,"about_ca_topic_score_gemma":0.00004210408,"teacher_disagreement_score":0.85981494,"about_ca_system_score_codex":0.00015274402,"about_ca_system_score_gemma":0.00014352454,"threshold_uncertainty_score":0.99993306},"labels":[],"label_agreement":null},{"id":"W4283662383","doi":"10.1080/2162402x.2022.2093426","title":"Trogocytosis and fratricide killing impede MSLN-directed CAR T cell functionality","year":2022,"lang":"en","type":"article","venue":"OncoImmunology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"Cancerföreningen i Stockholm; Vetenskapsrådet; Karolinska Institutet; Cancerfonden","keywords":"Mesothelin; Chimeric antigen receptor; Cancer research; T cell; Antigen; CD28; Tumor microenvironment; Immunology; Medicine; Immune system; Tumor cells","score_opus":0.024159371536268178,"score_gpt":0.29159067560473584,"score_spread":0.26743130406846766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283662383","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9835264,0.005291494,0.000044701985,0.0013792033,0.00036282718,0.00034750093,0.000032280557,0.00017549573,0.008840086],"genre_scores_gemma":[0.98392487,0.00056681124,0.00033783386,0.000499346,0.00015121001,0.00012075654,0.000112785885,0.000039131777,0.014247274],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982974,0.00030309646,0.00026708868,0.00039149928,0.00033199042,0.00040890806],"domain_scores_gemma":[0.99911135,0.00022758656,0.00007722565,0.00039535516,0.000097348464,0.00009113398],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004599093,0.00015655844,0.00038374958,0.0002308195,0.0003473543,0.000013184694,0.00012927427,0.00011165216,0.011295948],"category_scores_gemma":[0.00006548988,0.00015729707,0.000110354405,0.00044206533,0.00015155383,0.000037442915,0.0002581554,0.00076775753,0.000035308258],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017077044,0.00030652597,0.032490388,0.000043128053,0.00024453728,0.00012298799,0.00061158784,0.000016211614,0.93811417,0.00011127969,0.001967638,0.024263853],"study_design_scores_gemma":[0.010477273,0.0043802327,0.12638816,0.000019056795,0.0003271834,0.0014708294,0.0040986496,0.0013027658,0.051905572,0.0005983719,0.7983909,0.0006409492],"about_ca_topic_score_codex":0.0007438453,"about_ca_topic_score_gemma":0.000018065122,"teacher_disagreement_score":0.8862086,"about_ca_system_score_codex":0.00040438605,"about_ca_system_score_gemma":0.00024542562,"threshold_uncertainty_score":0.9896079},"labels":[],"label_agreement":null},{"id":"W4284674170","doi":"10.1080/2162402x.2022.2096535","title":"<i>Helicobacter pylori</i> serology is associated with worse overall survival in patients with melanoma treated with immune checkpoint inhibitors","year":2022,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Jewish General Hospital; McGill University Health Centre; Centre Hospitalier de l’Université de Montréal","funders":"Institute of Cancer Research; Canadian Institutes of Health Research; Institut Du Cancer de Montréal; Fonds de Recherche du Québec - Santé; Fondation pour la Recherche Nuovo-Soldati","keywords":"Helicobacter pylori; Medicine; Serology; Melanoma; Pembrolizumab; Immune system; Nivolumab; Immunology; Immune checkpoint; Oncology; Cancer research; Immunotherapy; Internal medicine; Antibody","score_opus":0.008021120937645447,"score_gpt":0.21284744110005052,"score_spread":0.20482632016240507,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4284674170","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99578685,0.00037556278,0.0000022049185,0.0013751813,0.00023310148,0.00082248,0.000065920314,0.000108954126,0.0012297666],"genre_scores_gemma":[0.9964859,0.000038951915,0.000042806136,0.0012421026,0.000031833762,0.00020274073,0.0004951329,0.00008943169,0.0013711326],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973552,0.0003186431,0.0005732332,0.0005955323,0.00045333113,0.00070402445],"domain_scores_gemma":[0.99870807,0.00008793369,0.00039750006,0.00057121547,0.0001646505,0.00007060446],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003454604,0.000428293,0.000897155,0.00032097657,0.00019477535,0.00001633626,0.00021485535,0.00021387386,0.0009881231],"category_scores_gemma":[0.000017357943,0.00030362397,0.00010929452,0.0008305841,0.0003468244,0.000116191884,0.0001218677,0.00079644803,0.000011603583],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0624514,0.0015043572,0.9266497,0.000013291346,0.0015887765,0.00028082944,0.0009617348,0.000013786953,0.00468368,0.000011843407,0.00017412094,0.0016665112],"study_design_scores_gemma":[0.03508413,0.013303496,0.94310784,0.00011037086,0.00016357414,0.00010996915,0.00037367534,0.0000065715067,0.0015666201,0.0000050800195,0.0057613594,0.00040733663],"about_ca_topic_score_codex":0.0021377604,"about_ca_topic_score_gemma":0.00086587266,"teacher_disagreement_score":0.02736727,"about_ca_system_score_codex":0.0008905554,"about_ca_system_score_gemma":0.0003354607,"threshold_uncertainty_score":0.9999416},"labels":[],"label_agreement":null},{"id":"W4289223990","doi":"10.1080/2162402x.2022.2104070","title":"Targeting 3D chromosomal architecture at the RANK loci to suppress myeloma-driven osteoclastogenesis","year":2022,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Worldwide Cancer Research; Versus Arthritis; Medical Research Scotland","keywords":"Osteoclast; RANKL; Cancer research; Multiple myeloma; Immune system; Epigenetics; Regulator; Biology; Bone marrow; Cell biology; Signal transduction; Receptor; Immunology; Genetics; Gene; Activator (genetics)","score_opus":0.014935925523961703,"score_gpt":0.2768729583328667,"score_spread":0.26193703280890496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4289223990","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98610693,0.0019490897,0.00008093119,0.0075513828,0.0002966931,0.0011186567,0.00013880555,0.00010274473,0.0026547827],"genre_scores_gemma":[0.98974365,0.000044196106,0.0010480807,0.0009634672,0.00017095222,0.0006509125,0.00037591442,0.00005618729,0.006946634],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99754083,0.0004432547,0.00027976953,0.0004879206,0.00048823628,0.0007599655],"domain_scores_gemma":[0.99875015,0.00026348798,0.00008245787,0.00066564436,0.000070208065,0.00016803158],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00022643051,0.00024661564,0.0004168236,0.00017626733,0.0009025157,0.0000163696,0.0004050787,0.00009078317,0.0058506145],"category_scores_gemma":[0.00018628057,0.00017504922,0.00015480992,0.00036398254,0.00020017092,0.00002669387,0.0011788914,0.0005570512,0.00046875316],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008719921,0.0008115268,0.04630608,0.00009538402,0.0016182436,0.002566173,0.0046046143,0.0045959977,0.7597667,0.000072378614,0.018842787,0.15200016],"study_design_scores_gemma":[0.011087447,0.004851082,0.15074569,0.00003844455,0.00025561015,0.0029902551,0.001813015,0.0006969993,0.023143394,0.0000341147,0.8037715,0.0005724675],"about_ca_topic_score_codex":0.0002233408,"about_ca_topic_score_gemma":0.00008659309,"teacher_disagreement_score":0.7849287,"about_ca_system_score_codex":0.00056435046,"about_ca_system_score_gemma":0.00018137465,"threshold_uncertainty_score":0.9950582},"labels":[],"label_agreement":null},{"id":"W4300960076","doi":"10.1080/2162402x.2022.2127284","title":"Influencing tumor-associated macrophages in malignant melanoma with monoclonal antibodies","year":2022,"lang":"en","type":"review","venue":"OncoImmunology","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"Guy's and St Thomas' NHS Foundation Trust; King's Health Partners; King's College London; Cancer Research UK; Medical Research Council; Barts Charity; National Institute for Health and Care Research; NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research; Breast Cancer Now; King’s College London","keywords":"Melanoma; Monoclonal antibody; Cancer research; Tumor microenvironment; Medicine; Immunotherapy; Immune system; Immune checkpoint; Cancer immunotherapy; Immunology; Antibody","score_opus":0.028218293026081913,"score_gpt":0.2865933822820599,"score_spread":0.25837508925597796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4300960076","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007055988,0.9871757,0.0000010331655,0.000017878143,0.0020716481,0.0008949698,0.00014089904,0.00017106456,0.0024708074],"genre_scores_gemma":[0.0008287194,0.99267787,0.00006064682,0.00010674431,0.00002982443,0.0006470402,0.0010036236,0.00018079384,0.0044647474],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.994387,0.0017084612,0.0013728266,0.0010936905,0.00010662609,0.0013314376],"domain_scores_gemma":[0.9968808,0.0008780093,0.0011699795,0.0009862119,0.00006405549,0.000020892441],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00059692806,0.0010164699,0.003798048,0.0008448786,0.00038308307,0.000029741383,0.0013078245,0.001037188,0.0044250255],"category_scores_gemma":[0.00016755846,0.0008392028,0.00045268843,0.0008326607,0.0007944466,0.00011653019,0.00088006246,0.0029252474,0.0008054368],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000420287,0.0008073444,0.0020244692,0.0039360244,0.0053291214,0.0026530027,0.0012419736,0.000013796919,0.0015466111,0.00041365303,0.0019690346,0.97964466],"study_design_scores_gemma":[0.001525136,0.0006457063,0.00056040805,0.00401476,0.000550792,0.0018399109,0.00034468825,1.400042e-7,0.00015300328,0.00002470467,0.9894127,0.00092804554],"about_ca_topic_score_codex":0.00080827944,"about_ca_topic_score_gemma":0.0002915356,"teacher_disagreement_score":0.9874437,"about_ca_system_score_codex":0.0015032528,"about_ca_system_score_gemma":0.0012930272,"threshold_uncertainty_score":0.9999725},"labels":[],"label_agreement":null},{"id":"W4317721404","doi":"10.1080/2162402x.2023.2168233","title":"The inhibitory NKR-P1B receptor regulates NK cell-mediated mammary tumor immunosurveillance in mice","year":2023,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; University of Toronto; University of Windsor","funders":"Natural Sciences and Engineering Research Council of Canada; Universities Space Research Association; Cancer Research Society; University of Windsor","keywords":"Immunosurveillance; Biology; Granzyme B; Cancer research; Mammary tumor; TIGIT; Immune system; Downregulation and upregulation; Cell biology; Immunology; Cancer; T cell; Breast cancer; Gene","score_opus":0.007104199108676819,"score_gpt":0.21263986557963016,"score_spread":0.20553566647095334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4317721404","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9431241,0.022977784,0.000012823953,0.0028551535,0.020417716,0.0005018803,0.00001307942,0.00070169,0.009395782],"genre_scores_gemma":[0.91209924,0.005796112,0.000019868923,0.00049396564,0.000082550476,0.00015954411,0.00066583476,0.00005828278,0.08062461],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99711215,0.0007960276,0.0007209776,0.00048967724,0.00005832004,0.0008228237],"domain_scores_gemma":[0.9978346,0.0010767282,0.00030006876,0.0006474055,0.00012252567,0.000018645354],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00083258754,0.00031534364,0.00041915508,0.0003542816,0.0005166442,0.000044806806,0.0006168465,0.0004408543,0.00062260614],"category_scores_gemma":[0.00034770148,0.00025773302,0.00015036366,0.0007726164,0.00042282077,0.00022081143,0.00028430473,0.0009836277,0.014063324],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005276316,0.00010084902,0.0007743065,0.000014922255,0.000094756586,0.000018951694,0.00039729668,0.0000066553316,0.8998417,0.0002810449,0.09438222,0.003559639],"study_design_scores_gemma":[0.0021958295,0.00032245208,0.025916977,0.00005316605,0.000009271931,0.00012474223,0.0015417332,0.000030515632,0.17831948,0.00009946056,0.79101944,0.0003669205],"about_ca_topic_score_codex":0.0003000602,"about_ca_topic_score_gemma":0.000088537025,"teacher_disagreement_score":0.7215223,"about_ca_system_score_codex":0.0002038137,"about_ca_system_score_gemma":0.0001514291,"threshold_uncertainty_score":0.9999875},"labels":[],"label_agreement":null},{"id":"W4365515216","doi":"10.1080/2162402x.2023.2201147","title":"Neoadjuvant immune checkpoint blockade triggers persistent and systemic T <sub>reg</sub> activation which blunts therapeutic efficacy against metastatic spread of breast tumors","year":2023,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Ministry of Health, British Columbia; Ministerie van Volksgezondheid, Welzijn en Sport; Nederlandse Organisatie voor Wetenschappelijk Onderzoek; F. Hoffmann-La Roche; Oncode Institute; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; National Science Foundation","keywords":"Medicine; Immune checkpoint; Breast cancer; Immune system; Cancer research; Metastatic breast cancer; Metastasis; Primary tumor; Cancer; Immunotherapy; Blockade; Oncology; CD8; Internal medicine; Immunology; Receptor","score_opus":0.02013765047830695,"score_gpt":0.2661501953040062,"score_spread":0.24601254482569923,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4365515216","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9891769,0.007185785,0.000022688884,0.0019088073,0.00034466994,0.0009146265,0.000028429178,0.00015583697,0.00026223075],"genre_scores_gemma":[0.9961804,0.0031421406,0.000026433936,0.00012804523,0.000048142876,0.00007207392,0.0001282792,0.000060720417,0.00021375521],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975622,0.00022760562,0.000878944,0.00047972353,0.00032142128,0.00053009496],"domain_scores_gemma":[0.9984309,0.00023084204,0.00047824063,0.00058023445,0.00019464434,0.00008511307],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00064542686,0.00035812886,0.00094040483,0.0004897968,0.0001388966,0.00002017904,0.00019109185,0.00019500084,0.000030658168],"category_scores_gemma":[0.00009390046,0.00030396236,0.000339093,0.0010024159,0.00034183293,0.000102205,0.00008634012,0.0003574033,0.00004390863],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003248546,0.0002595123,0.00050235115,0.00025680315,0.0014655981,0.000030120435,0.0014633464,0.000043017626,0.91959184,0.000015120052,0.000031752126,0.073092],"study_design_scores_gemma":[0.019145088,0.0023958352,0.32190484,0.0022450539,0.00093510497,0.0024062085,0.0076822108,0.0012765015,0.640695,0.000034741657,0.0006007339,0.000678702],"about_ca_topic_score_codex":0.00023050356,"about_ca_topic_score_gemma":0.000013216959,"teacher_disagreement_score":0.3214025,"about_ca_system_score_codex":0.00031024875,"about_ca_system_score_gemma":0.0003216944,"threshold_uncertainty_score":0.99994123},"labels":[],"label_agreement":null},{"id":"W4367184214","doi":"10.1080/2162402x.2023.2204745","title":"Early response evaluation of PD-1 blockade in NSCLC patients through FDG-PET-CT and T cell profiling of tumor-draining lymph nodes","year":2023,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Bristol-Myers Squibb","keywords":"Medicine; Blockade; CD8; Lymph; Positron emission tomography; Pathological; Oncology; Imaging biomarker; Pathology; Internal medicine; Cancer research; Immune system; Nuclear medicine; Receptor; Immunology; Radiology; Magnetic resonance imaging","score_opus":0.03555770407278394,"score_gpt":0.3185617188335017,"score_spread":0.2830040147607178,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4367184214","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996747,0.0015035137,0.0000027313913,0.00019291026,0.00016862259,0.00041858913,0.000012609178,0.000027602575,0.0009264024],"genre_scores_gemma":[0.9992529,0.00017591089,0.0003241278,0.000056022865,0.000012439184,0.000036110687,0.000026872816,0.000019702535,0.00009589782],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9984347,0.00034441976,0.0004746208,0.00022941316,0.00028621938,0.00023063278],"domain_scores_gemma":[0.9990632,0.00025737268,0.00023869266,0.0002504312,0.00017364194,0.000016679673],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013941005,0.00012592312,0.00036888625,0.00027006652,0.00003591083,0.000003859334,0.00008279738,0.00003844729,0.0000400195],"category_scores_gemma":[0.0003240488,0.00011752833,0.00006072106,0.00050045317,0.00021885215,0.000072091076,0.000055069995,0.00011921086,0.0000060305983],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014174269,0.00026688376,0.19902815,0.00014226405,0.00013471741,0.000050728548,0.003601551,0.0000224984,0.76686805,0.000016944672,0.000019246494,0.015674688],"study_design_scores_gemma":[0.011495461,0.00076488004,0.8625375,0.000318842,0.00008260691,0.000041245537,0.0015719982,0.00035227658,0.12249367,0.000108154396,0.00011957693,0.00011377882],"about_ca_topic_score_codex":0.0005152295,"about_ca_topic_score_gemma":0.000008092737,"teacher_disagreement_score":0.66350937,"about_ca_system_score_codex":0.00014428906,"about_ca_system_score_gemma":0.0003311799,"threshold_uncertainty_score":0.4792666},"labels":[],"label_agreement":null},{"id":"W4378627997","doi":"10.1080/2162402x.2023.2218782","title":"Eribulin mesylate exerts antitumor effects via CD103","year":2023,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Tsukuba; Eisai Canada; Eisai","keywords":"Cancer research; Cytotoxic T cell; Granzyme B; Tumor microenvironment; TIGIT; CD8; Chemistry; T cell; Downregulation and upregulation; Immune system; Biology; Immunology; In vitro","score_opus":0.011743955864055916,"score_gpt":0.31917743913521274,"score_spread":0.3074334832711568,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4378627997","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9820567,0.0017560255,0.000027465287,0.0030743459,0.0019306993,0.00047310122,0.0000053750614,0.00044168744,0.01023465],"genre_scores_gemma":[0.98134714,0.00095350156,0.00011139793,0.000857187,0.00023054625,0.00011958335,0.00012977024,0.00003460073,0.016216286],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9989169,0.00007105475,0.00019112088,0.00028712137,0.000093419185,0.00044035754],"domain_scores_gemma":[0.99941117,0.00013508157,0.000059590995,0.00027500011,0.000044189685,0.0000750015],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00011121602,0.00017458384,0.00043616636,0.00019812825,0.0000843746,0.0000064131978,0.00009238236,0.00015441704,0.00086602167],"category_scores_gemma":[0.0000369158,0.00015161514,0.00010737432,0.0003910489,0.00012901443,0.000045031073,0.00007974994,0.00021495212,0.0033505596],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020320232,0.0007818204,0.029813651,0.0002815815,0.0011269435,0.0056666345,0.00079997233,0.000008060495,0.7695388,0.00056562654,0.071183436,0.11820145],"study_design_scores_gemma":[0.01224441,0.004191351,0.4504195,0.000117945136,0.0005919895,0.000951697,0.00004286198,0.00022054913,0.09123728,0.001062372,0.43847856,0.00044149425],"about_ca_topic_score_codex":0.00010714497,"about_ca_topic_score_gemma":0.000017275874,"teacher_disagreement_score":0.6783015,"about_ca_system_score_codex":0.00010943881,"about_ca_system_score_gemma":0.000098050354,"threshold_uncertainty_score":0.99742544},"labels":[],"label_agreement":null},{"id":"W4379365035","doi":"10.1080/2162402x.2023.2214478","title":"Trial watch: immunotherapeutic strategies on the horizon for hepatocellular carcinoma","year":2023,"lang":"en","type":"review","venue":"OncoImmunology","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovation Cluster (Canada)","funders":"National Medical Research Council; Medical Research Council; Eisai","keywords":"Medicine; Oncology; Durvalumab; Internal medicine; Hepatocellular carcinoma; Liver transplantation; Bevacizumab; Tremelimumab; Brentuximab vedotin; Nivolumab; Regimen; Atezolizumab; Immunotherapy; Intensive care medicine; Cancer; Transplantation; Ipilimumab; Lymphoma; Chemotherapy","score_opus":0.2962444592995445,"score_gpt":0.36719836804497147,"score_spread":0.07095390874542695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379365035","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0046407287,0.98157847,0.000018276007,0.0009639954,0.0013764428,0.009813729,0.000091286674,0.00027134758,0.0012457074],"genre_scores_gemma":[0.0046213106,0.98281485,0.000040808372,0.00011105224,0.00078063825,0.0059955497,0.0008983468,0.0002978159,0.0044396147],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99649185,0.0005510917,0.0010384398,0.0008019156,0.00030242215,0.00081426336],"domain_scores_gemma":[0.9962443,0.0017051627,0.00047719997,0.0013819678,0.00010980907,0.00008152041],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00070522504,0.0008973671,0.0030216617,0.00028882487,0.00030971426,0.000095314266,0.00054401765,0.0010794413,0.00019107],"category_scores_gemma":[0.00011842279,0.0005294002,0.0019882885,0.00052421197,0.00025921737,0.000050159164,0.00010321302,0.00091559865,0.0011062801],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0088443,0.00060209347,0.00012839217,0.00932451,0.0047411188,0.0004510256,0.00024315376,2.6479135e-8,0.000022745773,0.008797365,0.0019593714,0.9648859],"study_design_scores_gemma":[0.012453996,0.007982694,0.0000067063374,0.0030153987,0.0042842887,0.00010252923,0.00016217623,0.000023689081,0.000029127885,0.00039738565,0.97108144,0.00046059638],"about_ca_topic_score_codex":0.000093401955,"about_ca_topic_score_gemma":0.000005490221,"teacher_disagreement_score":0.96912205,"about_ca_system_score_codex":0.0003643738,"about_ca_system_score_gemma":0.0012798693,"threshold_uncertainty_score":0.99971575},"labels":[],"label_agreement":null},{"id":"W4381486868","doi":"10.1080/2162402x.2023.2222560","title":"Updates on radiotherapy-immunotherapy combinations: Proceedings of 6 <sup>th</sup> annual ImmunoRad conference","year":2023,"lang":"en","type":"review","venue":"OncoImmunology","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Institute of Cancer Research","funders":"National Cancer Institute; University of California, San Francisco; EMD Serono; Genentech; European Society for Medical Oncology; Eli Lilly and Company; Associazione Italiana per la Ricerca sul Cancro; Ono Pharmaceutical; Eisai; National Institute for Health and Care Research; Seagen; F-star Therapeutics; Accuray; Mersana Therapeutics; Break Through Cancer; RefleXion Medical; Regeneron Pharmaceuticals; Parker Institute for Cancer Immunotherapy; Ipsen; Varian Medical Systems; Pfizer; Prostate Cancer Foundation; Bristol-Myers Squibb; AstraZeneca; Novocure; Cancer Research UK; Boston Scientific Corporation","keywords":"Medical physics; Medicine; Radiation therapy; Immunotherapy; Cancer; Internal medicine","score_opus":0.03747778903876445,"score_gpt":0.3168971474978056,"score_spread":0.2794193584590412,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4381486868","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001193152,0.99199927,0.000014631418,0.00020217609,0.0014428233,0.0021893787,0.0007650037,0.000612023,0.0015815671],"genre_scores_gemma":[0.00024523446,0.9730892,0.000115365765,0.00014352436,0.000078313984,0.00074273837,0.0010772044,0.00041160488,0.024096796],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9931288,0.0010033462,0.00278996,0.0013684927,0.0002158495,0.0014936009],"domain_scores_gemma":[0.9938965,0.0018494583,0.0021650444,0.0013744336,0.0006736007,0.000040961277],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"category_scores_codex":[0.0012449234,0.0016607018,0.005565774,0.0019606121,0.0005928637,0.00009833243,0.0027197222,0.0028591533,0.0016304244],"category_scores_gemma":[0.00031128226,0.0014900219,0.0015224712,0.0015592957,0.0019134894,0.0003871544,0.00034776193,0.002507063,0.0030355998],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016292217,0.0015479688,0.000004945513,0.0032661706,0.008698654,0.000016632124,0.0025844767,0.0000023684852,0.0060739093,0.014387075,0.009025953,0.9527626],"study_design_scores_gemma":[0.0039989827,0.0027170829,0.00003974592,0.008167968,0.00047578028,0.0004240831,0.0011209421,0.0000016824396,0.000994151,0.00033942822,0.9804331,0.0012870404],"about_ca_topic_score_codex":0.00015457984,"about_ca_topic_score_gemma":0.000002875817,"teacher_disagreement_score":0.9714072,"about_ca_system_score_codex":0.0004638087,"about_ca_system_score_gemma":0.0009837637,"threshold_uncertainty_score":0.9997942},"labels":[],"label_agreement":null},{"id":"W4384499645","doi":"10.1080/2162402x.2023.2233403","title":"Longitudinal immune monitoring of patients with resectable esophageal adenocarcinoma treated with Neoadjuvant PD-L1 checkpoint inhibition","year":2023,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Esophageal Cancer Research and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Medicine; Peripheral blood mononuclear cell; CD8; Biomarker; Oncology; Immune system; Internal medicine; Neoadjuvant therapy; Flow cytometry; Gastroenterology; Cancer; Cancer research; Immunology; Breast cancer; Biology","score_opus":0.021816981490046516,"score_gpt":0.2832220520964986,"score_spread":0.2614050706064521,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4384499645","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943706,0.0040480476,0.00001163148,0.00016980794,0.00006258732,0.0006940589,0.000032001495,0.00013451125,0.00047676035],"genre_scores_gemma":[0.9979511,0.0001782998,0.00032626596,0.000006027714,0.00006506124,0.00014870528,0.00032541755,0.000049228107,0.00094990927],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980532,0.00007582205,0.00035417997,0.0004292115,0.00047375576,0.0006138517],"domain_scores_gemma":[0.99882364,0.00006526735,0.00016297428,0.00049519254,0.00032885082,0.00012407092],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016424462,0.00025207165,0.0005683435,0.00035041128,0.0001298304,0.000013132025,0.00009718929,0.00012243883,0.00012834182],"category_scores_gemma":[0.00003674375,0.0001734289,0.000080189544,0.0008071432,0.00025820493,0.0001312589,0.000093968476,0.00034438903,0.000088257206],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008172885,0.0004925909,0.98415804,0.00011491633,0.00045610397,0.0013932149,0.00020962783,0.000015751051,0.002421146,0.000032571974,0.000028524748,0.0025046323],"study_design_scores_gemma":[0.009171809,0.009760463,0.92720085,0.00029307252,0.000124966,0.00007157761,0.0001817657,0.000012617516,0.053025372,0.000016389895,0.00001768708,0.00012343508],"about_ca_topic_score_codex":0.0008932546,"about_ca_topic_score_gemma":0.000029256786,"teacher_disagreement_score":0.056957193,"about_ca_system_score_codex":0.00035661674,"about_ca_system_score_gemma":0.0002318596,"threshold_uncertainty_score":0.70722246},"labels":[],"label_agreement":null},{"id":"W4386741883","doi":"10.1080/2162402x.2023.2253644","title":"Immune checkpoint blockade therapy mitigates systemic inflammation and affects cellular FLIP-expressing monocytic myeloid-derived suppressor cells in non-progressor non-small cell lung cancer patients","year":2023,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"Fondazione Italiana per la Ricerca sul Cancro; Fondazione Cassa di Risparmio di Verona Vicenza Belluno e Ancona; Università Cattolica del Sacro Cuore; Associazione Italiana per la Ricerca sul Cancro; Università degli Studi di Verona; China Scholarship Council; European Commission; Cancer Research Institute","keywords":"Immune checkpoint; Blockade; Immune system; Medicine; Myeloid; Inflammation; Cancer research; Myeloid-derived Suppressor Cell; Systemic inflammation; Monocyte; Cancer; Immunology; Immunotherapy; Suppressor; Internal medicine; Receptor","score_opus":0.00811540187893353,"score_gpt":0.23181351436910871,"score_spread":0.22369811249017518,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386741883","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.955286,0.039059717,0.000024114117,0.00013865167,0.0030762432,0.0019443884,0.000047089867,0.00023050996,0.00019327883],"genre_scores_gemma":[0.99033636,0.0067518833,0.000092641385,0.00003466206,0.000084778774,0.0009233242,0.00031979932,0.00013788017,0.0013186572],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99593556,0.00059250614,0.0010550981,0.000963854,0.000107198,0.0013457907],"domain_scores_gemma":[0.99787897,0.000418548,0.0006942287,0.0007993229,0.00016176025,0.00004719606],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005131542,0.00070250366,0.0011003918,0.0006135518,0.00036694919,0.00007418662,0.00069308496,0.0010078008,0.00018202013],"category_scores_gemma":[0.000051952975,0.00069187535,0.00019472736,0.0005650477,0.00054410205,0.00024840797,0.00052419305,0.0009857806,0.00031983596],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042407814,0.00016958461,0.009631848,0.00040338817,0.00029025183,0.000034236367,0.0049421936,0.0002984801,0.97817874,0.0000018754129,0.00015826033,0.005467079],"study_design_scores_gemma":[0.008464628,0.00032274897,0.03456612,0.00075988285,0.000084382875,0.000014831991,0.0008054789,0.00052434957,0.9529817,0.000015485924,0.00078848185,0.0006719284],"about_ca_topic_score_codex":0.0007847498,"about_ca_topic_score_gemma":0.00004462007,"teacher_disagreement_score":0.035050366,"about_ca_system_score_codex":0.00045835093,"about_ca_system_score_gemma":0.00022772941,"threshold_uncertainty_score":0.99955326},"labels":[],"label_agreement":null},{"id":"W4386742019","doi":"10.1080/2162402x.2023.2253642","title":"Homogeneity in immune features between colorectal liver metastases better identifies patients with good prognosis compared to pathological response to preoperative chemotherapy","year":2023,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"Fonds de Recherche du Québec - Santé; Institute of Cancer Research; Institut Du Cancer de Montréal; International Hepato-Pancreato-Biliary Association; Ethicon; Université de Montréal","keywords":"Medicine; Chemotherapy; Colorectal cancer; Pathological; Immune system; Grading (engineering); Oncology; Internal medicine; Pathology; Gastroenterology; Cancer; Immunology; Biology","score_opus":0.01867915437774884,"score_gpt":0.2863768383331473,"score_spread":0.26769768395539845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386742019","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99308836,0.00040950783,0.000013238741,0.0040255357,0.00014034285,0.0019222101,0.0001776501,0.00015077542,0.000072371295],"genre_scores_gemma":[0.9966962,0.00005963193,0.0007435935,0.0011845884,0.00004554102,0.00048126758,0.00024427142,0.000040853472,0.0005040927],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976563,0.00049564784,0.00043958132,0.0005713695,0.00029007002,0.000547058],"domain_scores_gemma":[0.998947,0.00031947502,0.00009765025,0.00037132256,0.00016515923,0.00009939167],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060013356,0.0003225263,0.00077141146,0.0004863153,0.00013372794,0.000041113948,0.00024870128,0.00020276291,0.00017169511],"category_scores_gemma":[0.000148214,0.00023702774,0.00012893774,0.0011990586,0.0002421404,0.00009246875,0.00015344277,0.0003037537,0.00012651233],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0631884,0.0006702171,0.79260147,0.000025990455,0.0006905006,0.00020090342,0.0046372814,0.0000064389274,0.12039538,0.000003969018,0.0014703071,0.016109142],"study_design_scores_gemma":[0.0056273253,0.004328321,0.9446874,0.000121024976,0.00006933721,0.000018266459,0.00044959597,0.0000010282131,0.04162133,0.0000050727886,0.0027930783,0.00027818323],"about_ca_topic_score_codex":0.00033377545,"about_ca_topic_score_gemma":0.00031522906,"teacher_disagreement_score":0.15208596,"about_ca_system_score_codex":0.00023882242,"about_ca_system_score_gemma":0.000116494804,"threshold_uncertainty_score":0.96657103},"labels":[],"label_agreement":null},{"id":"W4387907317","doi":"10.1080/2162402x.2023.2261278","title":"Driver mutations in <i>GNAQ</i> and <i>GNA11</i> genes as potential targets for precision immunotherapy in uveal melanoma patients","year":2023,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"Agencia Estatal de Investigación; Instituto de Salud Carlos III; Generalitat de Catalunya; Centres de Recerca de Catalunya","keywords":"GNAQ; Melanoma; Population; Cancer; Malignancy; Cancer research; Medicine; Biology; Genetics; Mutation; Gene","score_opus":0.007912358496235821,"score_gpt":0.2520083694141703,"score_spread":0.2440960109179345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387907317","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9755095,0.02102812,0.000084833235,0.00046299415,0.0014171842,0.0010197035,0.0000759063,0.00012201229,0.00027974407],"genre_scores_gemma":[0.9897897,0.0054844576,0.00014119843,0.00030114644,0.00002240498,0.0003787071,0.0006781275,0.00006495723,0.003139252],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9972736,0.0005449119,0.00072666677,0.00056952826,0.00006262355,0.0008226359],"domain_scores_gemma":[0.99867964,0.0006157713,0.00019137724,0.00039320134,0.00010226953,0.000017737088],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005334027,0.0003544734,0.00060831604,0.00079455285,0.00029070876,0.000028496883,0.00037163383,0.00060282595,0.00023847367],"category_scores_gemma":[0.00015410602,0.0003477893,0.0001445397,0.0005401025,0.0004028621,0.0002461172,0.00015551024,0.0004116588,0.0004384853],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0058674146,0.0006159833,0.021872718,0.000023948352,0.0002658083,0.00003256064,0.0029964524,0.000061363986,0.73960894,0.00058296806,0.0009157468,0.22715609],"study_design_scores_gemma":[0.029232696,0.0030958836,0.7007421,0.00014412079,0.000043229764,0.00014063178,0.0015601852,0.000066404464,0.06685509,0.0035788359,0.19357926,0.0009615536],"about_ca_topic_score_codex":0.0004880084,"about_ca_topic_score_gemma":0.00013113805,"teacher_disagreement_score":0.6788694,"about_ca_system_score_codex":0.00010927518,"about_ca_system_score_gemma":0.00014196277,"threshold_uncertainty_score":0.9998974},"labels":[],"label_agreement":null},{"id":"W4390004386","doi":"10.1080/2162402x.2023.2290787","title":"A phase 2, multicenter, open-label study of anti-LAG-3 ieramilimab in combination with anti-PD-1 spartalizumab in patients with advanced solid malignancies","year":2023,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"National Cancer Institute; University of Texas MD Anderson Cancer Center; Society for Immunotherapy of Cancer; Novartis Pharmaceuticals Corporation","keywords":"Medicine; Rash; Internal medicine; Renal cell carcinoma; Oncology; Melanoma; Nausea; Response Evaluation Criteria in Solid Tumors; Clinical endpoint; Adverse effect; Cancer; Phases of clinical research; Nivolumab; Immunotherapy; Clinical trial; Cancer research","score_opus":0.026400031308302294,"score_gpt":0.3339655591300359,"score_spread":0.3075655278217336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390004386","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99701554,0.00022177862,0.000004788697,0.00017260421,0.00014382982,0.0022555098,0.000017595998,0.000043583375,0.00012475018],"genre_scores_gemma":[0.9991635,0.00020207338,0.00012553656,0.000090076486,0.000004027186,0.00015040296,0.00012956122,0.000034683417,0.00010010735],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99833107,0.00012800739,0.00052020326,0.00038932322,0.00024716463,0.00038420403],"domain_scores_gemma":[0.9990967,0.00005564822,0.00024697985,0.0004154146,0.00015687509,0.00002840451],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023664934,0.00022330348,0.00071483426,0.00046762335,0.000052426585,0.000015380381,0.00023179679,0.00009804901,0.00002300198],"category_scores_gemma":[0.000034532673,0.00017459324,0.000021208589,0.0010966468,0.00017981022,0.00022098687,0.00010398266,0.00019745436,0.000006925121],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07100174,0.07569356,0.76251525,0.00015571131,0.0004970232,0.00033361078,0.0067287465,0.000043223346,0.046871196,0.000021798129,0.00005934128,0.03607878],"study_design_scores_gemma":[0.24966434,0.02199722,0.72253674,0.0004286047,0.00004240246,0.0000072938074,0.003096535,0.00014865039,0.0017661012,0.000003820307,0.00013374341,0.00017457388],"about_ca_topic_score_codex":0.0007923762,"about_ca_topic_score_gemma":0.0009356296,"teacher_disagreement_score":0.1786626,"about_ca_system_score_codex":0.00017331797,"about_ca_system_score_gemma":0.00014767653,"threshold_uncertainty_score":0.71197057},"labels":[],"label_agreement":null},{"id":"W4396812747","doi":"10.1080/2162402x.2024.2349347","title":"Characterization of innate lymphoid cell subsets infiltrating melanoma and epithelial ovarian tumors","year":2024,"lang":"en","type":"article","venue":"OncoImmunology","topic":"IL-33, ST2, and ILC Pathways","field":"Immunology and Microbiology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"Alberta Cancer Foundation","keywords":"Innate lymphoid cell; Tumor microenvironment; Innate immune system; Biology; Ovarian cancer; Melanoma; Immune system; Phenotype; Cytotoxic T cell; Cancer research; Immunology; Cancer; In vitro; Gene","score_opus":0.0074328781120161155,"score_gpt":0.20576455707811206,"score_spread":0.19833167896609594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396812747","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898458,0.0020107657,0.00017533686,0.00013001129,0.0016342415,0.00017953815,0.0012108258,0.00013562346,0.0046778577],"genre_scores_gemma":[0.99729097,0.00044991952,0.00006859219,0.00010252429,0.00007029675,0.000018706696,0.000541343,0.000030771418,0.0014268833],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99852806,0.00022595386,0.00046389332,0.00036591128,0.000031620537,0.00038455144],"domain_scores_gemma":[0.99936044,0.00012349096,0.00015908387,0.00024944503,0.000090065194,0.000017468856],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025065392,0.0002282198,0.00040641378,0.00022967353,0.0001504595,0.00002370946,0.00018239996,0.00039733868,0.00020391526],"category_scores_gemma":[0.00007177976,0.00021153521,0.000066905304,0.00024166633,0.0003442929,0.00017293918,0.00011017045,0.00030997762,0.00033656578],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010417121,0.000061003917,0.0012601897,0.00010909156,0.00011113996,0.000026103266,0.0021201272,2.8158445e-7,0.9835352,0.0032964295,0.0000651514,0.009311148],"study_design_scores_gemma":[0.0013027596,0.00050401594,0.022763873,0.00013187224,0.000060281367,0.0006415784,0.00031876014,0.000020001886,0.9067547,0.0002943556,0.06690785,0.00029995808],"about_ca_topic_score_codex":0.0001855293,"about_ca_topic_score_gemma":0.000021486609,"teacher_disagreement_score":0.07678047,"about_ca_system_score_codex":0.0000419021,"about_ca_system_score_gemma":0.00022299887,"threshold_uncertainty_score":0.8626156},"labels":[],"label_agreement":null},{"id":"W4400205565","doi":"10.1080/2162402x.2024.2374954","title":"<i>Faecalibacterium prausnitzii</i> strain EXL01 boosts efficacy of immune checkpoint inhibitors","year":2024,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Ligue Contre le Cancer; Agence Nationale de la Recherche; Institut National Du Cancer; European Commission; Sorbonne Université; Seerave Foundation","keywords":"Faecalibacterium prausnitzii; Immune system; Medicine; Gut flora; Immunology; Cancer research; Immune checkpoint; Adjuvant; Immunotherapy","score_opus":0.008579587314305014,"score_gpt":0.26658473935113786,"score_spread":0.25800515203683283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400205565","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98371476,0.011464153,0.00012620717,0.00086836156,0.0011192919,0.00026143447,0.00009394367,0.000057237747,0.0022945942],"genre_scores_gemma":[0.9964392,0.00080040836,0.00029715418,0.00016622333,0.00027698113,0.000015780266,0.0003463075,0.00004806352,0.0016098628],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983475,0.00011185078,0.0005939151,0.0004440594,0.00007974354,0.0004228825],"domain_scores_gemma":[0.9992166,0.000031281277,0.00012851434,0.0004966154,0.00006631791,0.00006065949],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003125586,0.0002274661,0.00032018812,0.000105936044,0.00005880845,0.000023124894,0.00025459877,0.0003645049,0.000113838876],"category_scores_gemma":[0.00006710293,0.00021389627,0.0002308937,0.00016689538,0.0002508777,0.000006114974,0.00019921527,0.000270739,0.00009190217],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000116188305,0.00013226754,0.00012834491,0.00012761797,0.00012250678,0.000015095703,0.00019749717,0.000002032723,0.9887966,0.00033041864,0.0012733701,0.008758072],"study_design_scores_gemma":[0.0009626365,0.0009789857,0.025392974,0.00013491327,0.000038687995,0.00015458874,0.00013943935,0.0000057509387,0.7232281,0.00006563267,0.24860041,0.00029788795],"about_ca_topic_score_codex":0.000084024075,"about_ca_topic_score_gemma":0.000021418626,"teacher_disagreement_score":0.2655685,"about_ca_system_score_codex":0.000039277114,"about_ca_system_score_gemma":0.0003231495,"threshold_uncertainty_score":0.8722437},"labels":[],"label_agreement":null},{"id":"W4400687481","doi":"10.1080/2162402x.2024.2378520","title":"Human NK cells and cancer","year":2024,"lang":"en","type":"review","venue":"OncoImmunology","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Associazione Italiana per la Ricerca sul Cancro; Ministry of Health, British Columbia; Ministero della Salute; Fondazione AIRC per la ricerca sul cancro ETS","keywords":"Cytotoxic T cell; Immune system; Biology; Cancer immunotherapy; Immunology; Cancer cell; Myeloid-derived Suppressor Cell; NK-92; Immunotherapy; Cell biology; Effector; Function (biology); Cancer; Cancer research; Suppressor; Interleukin 21; Neuroscience; T cell; Genetics; In vitro","score_opus":0.03591132773530244,"score_gpt":0.3372357243338374,"score_spread":0.301324396598535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400687481","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000012733916,0.9781058,0.00000190807,0.000045545275,0.01679017,0.0003560852,0.000065184104,0.00019373419,0.0044288496],"genre_scores_gemma":[0.000009351185,0.84489465,0.0000032114867,0.00007852272,0.000098712124,0.00017752913,0.00035870116,0.00007139365,0.15430793],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99797946,0.00033251237,0.0006341017,0.00061192265,0.00002202704,0.0004199878],"domain_scores_gemma":[0.99916637,0.00007869011,0.0002763757,0.00042102157,0.000041927335,0.000015590433],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00014602774,0.0005240628,0.0014960626,0.00040056388,0.00022119611,0.00004216278,0.0002637514,0.0012601989,0.0042081764],"category_scores_gemma":[0.000012295344,0.0004051475,0.0003850285,0.0001848539,0.0003135389,0.00007143272,0.00025842752,0.0015427612,0.009800621],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000008646518,0.000049675335,2.769525e-7,0.0037621546,0.0012052148,0.000012483571,0.00009206671,2.4807088e-8,0.0071595134,0.0008164489,0.07771736,0.9091761],"study_design_scores_gemma":[0.00022763915,0.00015607913,0.000001419269,0.003888937,0.0015534832,0.0003720739,0.000047413425,7.114416e-8,0.00012751894,0.00002701176,0.993228,0.00037032095],"about_ca_topic_score_codex":0.00021770706,"about_ca_topic_score_gemma":0.000017169883,"teacher_disagreement_score":0.91551065,"about_ca_system_score_codex":0.00018774367,"about_ca_system_score_gemma":0.00016326435,"threshold_uncertainty_score":0.99984},"labels":[],"label_agreement":null},{"id":"W4401340322","doi":"10.1080/2162402x.2024.2384667","title":"DNA mismatch repair defect and intratumor heterogeneous deficiency differently impact immune responses in diffuse large B-cell lymphoma","year":2024,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Cancer Institute; National Institutes of Health","keywords":"PMS2; MSH6; MSH2; Cancer research; Biology; Diffuse large B-cell lymphoma; MLH1; Immune checkpoint; Tumor microenvironment; Immunotherapy; DNA mismatch repair; Lymphoma; Immune system; Immunology; Gene; DNA repair; Genetics","score_opus":0.010397270822970772,"score_gpt":0.28179853891762097,"score_spread":0.2714012680946502,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401340322","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9389995,0.058636844,0.000017987104,0.0002190672,0.00072469737,0.00045840474,0.00003761205,0.00028218812,0.0006237457],"genre_scores_gemma":[0.99770045,0.0009466997,0.00013405905,0.000121986835,0.000053608277,0.000079020065,0.000022500017,0.000070531714,0.0008711154],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9976611,0.00025561938,0.0005055335,0.00065096805,0.00019958812,0.00072715565],"domain_scores_gemma":[0.99875736,0.0004178384,0.00006865602,0.00059739273,0.00004517141,0.00011358172],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003365277,0.00037044054,0.00064365333,0.0004042561,0.00007813935,0.00004620143,0.00017119653,0.0003085427,0.00018676763],"category_scores_gemma":[0.0002295429,0.00029769537,0.00031583477,0.0004099538,0.00022618864,0.0000549564,0.00020082487,0.00037193086,0.00008114862],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009331658,0.009970184,0.068396166,0.0011661326,0.0007367667,0.0052388227,0.006522702,0.000012288344,0.8638935,0.00023673783,0.0010103002,0.033484753],"study_design_scores_gemma":[0.026780525,0.008880571,0.8847355,0.00079505675,0.0004682588,0.007825849,0.00074880314,0.0017624288,0.061338145,0.00060926157,0.0049087876,0.0011468031],"about_ca_topic_score_codex":0.00023392525,"about_ca_topic_score_gemma":0.00011735563,"teacher_disagreement_score":0.8163393,"about_ca_system_score_codex":0.00056613766,"about_ca_system_score_gemma":0.0004248153,"threshold_uncertainty_score":0.9999475},"labels":[],"label_agreement":null},{"id":"W4402527544","doi":"10.1080/2162402x.2024.2400429","title":"Multiprong CD38 targeting to enhance anti-PD1 immune checkpoint blockade efficacy","year":2024,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Beatrice Hunter Cancer Research Institute; Dalhousie University","funders":"Canadian Institutes of Health Research; Beatrice Hunter Cancer Research Institute; Research Nova Scotia; Cancer Research Institute","keywords":"Blockade; Immune checkpoint; Medicine; Cancer research; PD-L1; Nivolumab; CD38; Immunotherapy; Immune system; Immunology; Internal medicine; Receptor; Biology","score_opus":0.006891819566299605,"score_gpt":0.2831083397043341,"score_spread":0.2762165201380345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402527544","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95024526,0.042793434,0.0032187586,0.0010784781,0.0007845473,0.0002232356,0.000008040972,0.00009880835,0.0015494288],"genre_scores_gemma":[0.99346757,0.00043551243,0.0018102373,0.00014769397,0.0006939175,0.00003777815,0.00010752291,0.00005534213,0.0032444533],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983329,0.000074610405,0.000401957,0.0006054176,0.00009922246,0.0004859022],"domain_scores_gemma":[0.9993445,0.000043530606,0.00006186192,0.0004187311,0.00006102244,0.000070318856],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026941297,0.00024924052,0.0002709544,0.000095118485,0.00011731262,0.00004616768,0.0003272797,0.00025521408,0.00014157558],"category_scores_gemma":[0.0001851592,0.0002374732,0.00016481617,0.00021556142,0.000083232786,0.0000061851124,0.00030585172,0.00027014245,0.00032250246],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005789459,0.000060463728,0.00009049866,0.000027857755,0.00012726503,0.0000451361,0.00021596007,0.00025990154,0.9890699,0.000050228795,0.0030783599,0.006916553],"study_design_scores_gemma":[0.00023539546,0.0002626061,0.0008346887,0.00006694322,0.000022211994,0.000054634693,0.000100773264,0.00010648523,0.7853005,0.000018798357,0.21271893,0.00027801318],"about_ca_topic_score_codex":0.000084006075,"about_ca_topic_score_gemma":0.0000026605599,"teacher_disagreement_score":0.20964056,"about_ca_system_score_codex":0.000030877578,"about_ca_system_score_gemma":0.00010158397,"threshold_uncertainty_score":0.9683876},"labels":[],"label_agreement":null},{"id":"W4403190877","doi":"10.1080/2162402x.2024.2413719","title":"Benzodiazepines compromise the outcome of cancer immunotherapy","year":2024,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Tryptophan and brain disorders","field":"Neuroscience","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"HORIZON EUROPE European Research Council; Agence Nationale de la Recherche; HORIZON EUROPE Framework Programme; Cancéropôle Ile de France; Institut National Du Cancer; Institut Universitaire de France; Ligue Contre le Cancer; Fondation pour la Recherche Médicale; Labex Immuno-Oncology; Association pour la Recherche sur le Cancer; Seerave Foundation; European Commission","keywords":"Medicine; Cancer immunotherapy; Immunotherapy; Compromise; Cancer; Internal medicine; Political science","score_opus":0.042816880718713604,"score_gpt":0.34140930155500787,"score_spread":0.2985924208362943,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403190877","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9694555,0.019036474,0.000062905325,0.0063217375,0.0016338595,0.00023657389,0.000025583095,0.0002849512,0.0029424652],"genre_scores_gemma":[0.99586993,0.0014034295,0.000027064701,0.0011375136,0.000048313555,0.000046996483,8.33909e-7,0.000029773943,0.0014361135],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99909055,0.0001046398,0.00024483565,0.000240388,0.0001035788,0.00021601589],"domain_scores_gemma":[0.99924177,0.00036313856,0.00005559111,0.0003130744,0.0000137030665,0.000012744715],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009581073,0.00011837153,0.0001894687,0.00007696782,0.000067379515,0.000028386257,0.00043277725,0.000070578375,0.00042414985],"category_scores_gemma":[0.00007755335,0.00007373468,0.00010745366,0.00029259906,0.0004294341,0.00006739989,0.00006281583,0.00020129842,0.00008448564],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000058253627,0.000062434636,0.0011867774,0.00003597316,0.000037202717,0.000011687958,0.00080711796,0.000020713425,0.90505844,0.02028224,0.0009911574,0.071448006],"study_design_scores_gemma":[0.0012695303,0.00025524368,0.04592364,0.000084719126,0.0000205078,0.000046845867,0.00036343807,0.0007018383,0.38189787,0.0052896887,0.56378937,0.00035733133],"about_ca_topic_score_codex":0.00023787345,"about_ca_topic_score_gemma":0.000047540532,"teacher_disagreement_score":0.5627982,"about_ca_system_score_codex":0.000024605917,"about_ca_system_score_gemma":0.000047857862,"threshold_uncertainty_score":0.46441433},"labels":[],"label_agreement":null},{"id":"W4403214873","doi":"10.1080/2162402x.2024.2412869","title":"The landscape of T-cell engagers for the treatment of follicular lymphoma","year":2024,"lang":"en","type":"review","venue":"OncoImmunology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"National Cancer Institute; National Institutes of Health; Fundación Española de Hematología y Hemoterapia","keywords":"Medicine; Follicular lymphoma; Lymphoma; Cancer research; Oncology; Internal medicine","score_opus":0.03959889579960756,"score_gpt":0.3349351575010171,"score_spread":0.29533626170140953,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403214873","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002815667,0.9953292,0.0000018020676,0.00023183793,0.00062216015,0.0020645498,0.00011192218,0.000016615038,0.0013403618],"genre_scores_gemma":[0.0006812824,0.9955825,0.0000577825,0.000012684491,0.000108351094,0.0014917696,0.0001605024,0.000048980688,0.001856141],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99854475,0.0001296479,0.0006359833,0.0002919185,0.00013011678,0.00026755553],"domain_scores_gemma":[0.9965975,0.0020853989,0.00037298768,0.0008454078,0.00006851291,0.000030146597],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020321051,0.00037044648,0.001775506,0.000097591284,0.00012251629,0.000011027411,0.00022325684,0.0002866999,0.00003370716],"category_scores_gemma":[0.000039520204,0.0001405089,0.0015053574,0.00019305594,0.00020955557,0.000007733656,0.000040821193,0.00007324963,0.00003829805],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007310103,0.0009520501,0.000014545104,0.0035330402,0.004217359,0.000035583413,0.0001937464,1.0399745e-7,0.000004597535,0.00059446326,0.0019214815,0.98845994],"study_design_scores_gemma":[0.002283383,0.0025710554,0.000040080395,0.0018183944,0.013244381,0.00010020705,0.00016697978,0.0000038504495,0.0001379694,0.000023690898,0.97950965,0.00010033805],"about_ca_topic_score_codex":0.000081758786,"about_ca_topic_score_gemma":0.00001107074,"teacher_disagreement_score":0.9883596,"about_ca_system_score_codex":0.00031502717,"about_ca_system_score_gemma":0.0006243713,"threshold_uncertainty_score":0.5729787},"labels":[],"label_agreement":null},{"id":"W4404473852","doi":"10.1080/2162402x.2024.2429846","title":"Systemic administration of a viral nanoparticle neoadjuvant prevents lung metastasis development through emergency myelopoiesis","year":2024,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Institut National de la Recherche Scientifique","funders":"Canadian Institutes of Health Research; Fondation Jean-Louis Lévesque; Health Research","keywords":"Medicine; Metastasis; Myelopoiesis; Tumor microenvironment; Cancer research; Context (archaeology); Immune system; Tumor progression; Cancer; Immunology; Primary tumor; Bone marrow; Internal medicine; Biology; Stem cell; Progenitor cell","score_opus":0.016083435193827936,"score_gpt":0.27704574483883915,"score_spread":0.2609623096450112,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404473852","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95488507,0.030638088,0.0017850546,0.00021660521,0.009851423,0.00032195033,0.000008840486,0.00019134046,0.0021016307],"genre_scores_gemma":[0.98475903,0.00057580887,0.00019029995,0.000028215043,0.000023339788,0.00008575514,0.00014549965,0.000024161827,0.014167894],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981621,0.0002710461,0.0008180449,0.00035161083,0.000054861805,0.00034232507],"domain_scores_gemma":[0.99935204,0.00006655403,0.00019100957,0.0002880891,0.00009063781,0.000011673227],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0002604664,0.00021842799,0.00036563573,0.00015422421,0.0001597703,0.000014757127,0.00018904927,0.0002455902,0.0034541856],"category_scores_gemma":[0.000049974286,0.00019772077,0.000150248,0.00023881848,0.00010480054,0.00030547613,0.000084110085,0.0002748782,0.0012046379],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003895079,0.00020808635,0.00027451298,0.00017032064,0.00086131284,0.000011043464,0.0023896713,0.0000044254466,0.9704025,0.0018665522,0.006196536,0.017225523],"study_design_scores_gemma":[0.0006513202,0.00047207047,0.0017359265,0.0002210072,0.00016770598,0.00048649096,0.001092907,0.00003005521,0.83189964,0.00010490923,0.16288249,0.0002554924],"about_ca_topic_score_codex":0.00007145401,"about_ca_topic_score_gemma":0.0000116171,"teacher_disagreement_score":0.15668596,"about_ca_system_score_codex":0.00016302492,"about_ca_system_score_gemma":0.00022379111,"threshold_uncertainty_score":0.99957305},"labels":[],"label_agreement":null},{"id":"W4408037006","doi":"10.1080/2162402x.2025.2473163","title":"Humanized mouse models of <i>KRAS</i> -mutated colorectal and pancreatic cancers with HLA-class-I match for pre-clinical evaluation of cancer immunotherapies","year":2025,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Canadian Institutes of Health Research; Ontario Institute for Cancer Research","keywords":"KRAS; Colorectal cancer; Medicine; Pancreatic cancer; Human leukocyte antigen; Cancer; Immunotherapy; Cancer research; Immunology; Immune system; Oncology; Internal medicine; Antigen","score_opus":0.03291333261453035,"score_gpt":0.37823464790956546,"score_spread":0.3453213152950351,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408037006","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97596055,0.020774523,0.00027991142,0.00043751372,0.00020645598,0.0016243717,0.000063136344,0.000033486638,0.0006200677],"genre_scores_gemma":[0.99278635,0.0048154388,0.000657436,0.00022446936,0.000020354119,0.00048878475,0.000042215583,0.000029003562,0.00093594677],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983247,0.00018181924,0.00071882823,0.00031340355,0.00022715407,0.00023407437],"domain_scores_gemma":[0.99835366,0.0002974501,0.00039763298,0.000313616,0.00061306654,0.000024553156],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008105724,0.00020045567,0.0008464422,0.00015995245,0.00006671198,0.000007307189,0.000118299824,0.00021798663,0.00011137492],"category_scores_gemma":[0.000064340566,0.00015838075,0.00013206486,0.00026947632,0.00070221204,0.00007613442,0.00002887138,0.0001545522,2.4245404e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10577389,0.0006366377,0.02524934,0.0008470558,0.009540235,0.0000019141844,0.0033480756,0.00038149464,0.73865324,0.0006667444,0.0007334099,0.11416798],"study_design_scores_gemma":[0.17323525,0.017830212,0.3258291,0.003835606,0.009666099,0.000069284644,0.0048079346,0.03669015,0.41851276,0.0035628972,0.0047661774,0.001194552],"about_ca_topic_score_codex":0.0040264972,"about_ca_topic_score_gemma":0.0012797153,"teacher_disagreement_score":0.32014048,"about_ca_system_score_codex":0.00031944757,"about_ca_system_score_gemma":0.0013519678,"threshold_uncertainty_score":0.64585793},"labels":[],"label_agreement":null},{"id":"W4409204557","doi":"10.1080/2162402x.2025.2484880","title":"Surrogate markers of intestinal dysfunction associated with survival in advanced cancers","year":2025,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Diet and metabolism studies","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"H2020 European Research Council; Bristol-Myers Squibb; Samsung; Institut Gustave-Roussy; Genentech; Ipsen; Daiichi Sankyo Europe; National Cancer Institute; Servier; Nordic Pharma Group; Eisai; F. Hoffmann-La Roche; Agence Nationale de la Recherche; Seagen; Seerave Foundation; Les Laboratories Pierre Fabre; AstraZeneca; Novocure; Taiho Pharmaceutical; Regeneron Pharmaceuticals; European Commission; Sanofi; Amgen; Pfizer; Celgene; Ignyta; Eli Lilly and Company","keywords":"Medicine; Oncology; Internal medicine; Surrogate endpoint; Cancer research","score_opus":0.01095478614241044,"score_gpt":0.26912126049815727,"score_spread":0.2581664743557468,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409204557","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9622673,0.0011584422,0.000042305925,0.0004463479,0.00067065674,0.00017201147,0.0000026342157,0.000033485354,0.035206832],"genre_scores_gemma":[0.99644274,0.0002785165,0.00015634303,0.000076614466,0.000009025312,0.000025627278,0.000014571834,0.000007664988,0.0029888893],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992791,0.0000643198,0.00021297592,0.00015867919,0.00008255673,0.0002023949],"domain_scores_gemma":[0.99946976,0.00014726457,0.00009626927,0.00013331692,0.00013868723,0.000014716632],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020808469,0.00010451282,0.0004417111,0.0001796894,0.000025362608,0.0000011194742,0.000049693,0.00006971138,0.000027969982],"category_scores_gemma":[0.00044225392,0.00008515163,0.000036881313,0.00045598875,0.0001905583,0.000034861514,0.000034958906,0.00017986208,0.0000023309342],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007988694,0.0002878846,0.9228751,0.00009176448,0.00075142144,0.00004440073,0.00044227604,0.00006516202,0.017520733,0.0014430037,0.0003360447,0.0481535],"study_design_scores_gemma":[0.0044984287,0.0006386666,0.9898698,0.0004024655,0.00011008238,0.000002008201,0.0013287452,0.000018243221,0.00058453577,0.00007118936,0.0024072218,0.000068624904],"about_ca_topic_score_codex":0.00057844515,"about_ca_topic_score_gemma":0.001815857,"teacher_disagreement_score":0.066994675,"about_ca_system_score_codex":0.00020472589,"about_ca_system_score_gemma":0.0002848586,"threshold_uncertainty_score":0.34723827},"labels":[],"label_agreement":null},{"id":"W4410599138","doi":"10.1080/2162402x.2025.2507856","title":"Updates on radiotherapy-immunotherapy combinations: Proceedings of 8th Annual ImmunoRad Conference","year":2025,"lang":"en","type":"review","venue":"OncoImmunology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"Weill Cornell Medical College; Pfizer","keywords":"Immunotherapy; Medicine; Radiation therapy; Medical physics; Cancer; Internal medicine","score_opus":0.02578443872472441,"score_gpt":0.34544427869642474,"score_spread":0.31965983997170033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410599138","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013563986,0.98652434,0.00001392623,0.00049670885,0.000780562,0.0019965076,0.0002528664,0.00014905045,0.009650393],"genre_scores_gemma":[0.00007497328,0.98768216,0.000447792,0.00040243473,0.000086213935,0.00036919213,0.00030941074,0.00010326137,0.0105245495],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967608,0.00012534049,0.001481279,0.00074359955,0.00034660782,0.0005423802],"domain_scores_gemma":[0.99717426,0.00040652198,0.0010827375,0.0007350506,0.0005472351,0.00005416892],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00046088645,0.0008341712,0.0037728588,0.0010895089,0.00014402253,0.000043276552,0.00076920545,0.0010219592,0.0006298465],"category_scores_gemma":[0.00009059602,0.0006766186,0.0010572274,0.0011144971,0.0006895122,0.00012916322,0.000090430316,0.0009781533,0.000040913823],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015300532,0.00095845584,0.000010873176,0.009508616,0.0031471737,0.000009072125,0.00032727278,2.5885557e-8,0.0005561991,0.004893555,0.005060408,0.9739983],"study_design_scores_gemma":[0.004353836,0.0024485025,0.00008216921,0.025552219,0.0006409159,0.00018594149,0.0002403525,7.212959e-7,0.00015917663,0.00013232842,0.9657026,0.00050122297],"about_ca_topic_score_codex":0.0000799743,"about_ca_topic_score_gemma":0.000002804218,"teacher_disagreement_score":0.9734971,"about_ca_system_score_codex":0.00060144585,"about_ca_system_score_gemma":0.0015449859,"threshold_uncertainty_score":0.9995685},"labels":[],"label_agreement":null},{"id":"W4411977696","doi":"10.1080/2162402x.2025.2521396","title":"Uncovering common transcriptional features shared by mature peripheral blood PMN-MDSCs and tumor-infiltrating neutrophils in humans","year":2025,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Neutrophil, Myeloperoxidase and Oxidative Mechanisms","field":"Immunology and Microbiology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"Associazione Italiana per la Ricerca sul Cancro; Deutsche Forschungsgemeinschaft; Ministero dell’Istruzione, dell’Università e della Ricerca; European Cooperation in Science and Technology; Ministry of Health","keywords":"Peripheral blood; Peripheral; Medicine; Immunology; Cancer research; Biology; Internal medicine","score_opus":0.006370808758004077,"score_gpt":0.23273141373820855,"score_spread":0.22636060498020447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411977696","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9746153,0.02010816,0.000053151416,0.0011252215,0.00071073434,0.00034591623,0.00015437558,0.00011251407,0.0027746535],"genre_scores_gemma":[0.9948622,0.0003420718,0.0001966861,0.0013417347,0.000031379263,0.000080224134,0.00035643112,0.000030374862,0.002758901],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99785453,0.00035502217,0.0004922795,0.0006212393,0.000047242287,0.00062967406],"domain_scores_gemma":[0.99931365,0.00014108344,0.00012716836,0.00034278797,0.000051688192,0.00002362242],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00019352218,0.00040033215,0.0006562978,0.00025985242,0.00035561764,0.00005583399,0.00036328842,0.0004878746,0.00037468493],"category_scores_gemma":[0.000031991127,0.00038731628,0.00010689074,0.00028649764,0.0003451928,0.00021136172,0.00014504386,0.0011075835,0.000026479876],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003166305,0.00020860146,0.004269853,0.000043627242,0.00024571188,0.00005815156,0.00057395396,0.00001315169,0.97606754,0.01579531,0.0011759748,0.0012314768],"study_design_scores_gemma":[0.014538257,0.0015531509,0.29424006,0.0006582365,0.00029568735,0.00069953816,0.002496789,0.0000049160644,0.59608674,0.0076917633,0.08028679,0.0014480833],"about_ca_topic_score_codex":0.00039966975,"about_ca_topic_score_gemma":0.00042426647,"teacher_disagreement_score":0.37998083,"about_ca_system_score_codex":0.000095058494,"about_ca_system_score_gemma":0.000091354,"threshold_uncertainty_score":0.9998579},"labels":[],"label_agreement":null},{"id":"W4412034547","doi":"10.1080/2162402x.2025.2528955","title":"Benzodiazepines interfere with the efficacy of pembrolizumab-based cancer immunotherapy. Results of a nationwide cohort study including over 50,000 participants with advanced lung cancer","year":2025,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Cancer, Stress, Anesthesia, and Immune Response","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"H2020 European Research Council; Labex Immuno-Oncology; Institut Gustave-Roussy; Cancéropôle Ile de France; Institut National Du Cancer; Fondation Gustave Roussy; Institut Universitaire de France; Ligue Contre le Cancer; Fondation pour la Recherche Médicale; Agence Nationale de la Recherche; Association pour la Recherche sur le Cancer; Seerave Foundation; European Commission","keywords":"Pembrolizumab; Medicine; Lung cancer; Immunotherapy; Oncology; Cancer immunotherapy; Cohort; Internal medicine; Cancer","score_opus":0.016426121830857558,"score_gpt":0.3410293854833371,"score_spread":0.32460326365247955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412034547","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9814205,0.014277387,0.000059287213,0.0017189978,0.00020340778,0.001746998,0.00004348273,0.000065066044,0.00046483238],"genre_scores_gemma":[0.99651486,0.001424151,0.000048082566,0.00030795386,0.00005563906,0.00070236134,0.000015162936,0.000053915628,0.0008778509],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99778605,0.00028200133,0.0007051385,0.00044343955,0.00034438545,0.00043898638],"domain_scores_gemma":[0.9974213,0.000696346,0.0005684488,0.000838879,0.00043757196,0.000037434733],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040541586,0.00032611328,0.0009950448,0.00031020588,0.00013535917,0.000013028064,0.00032018908,0.00012147181,0.00011209462],"category_scores_gemma":[0.00017029079,0.00020283961,0.00011391412,0.00067530415,0.00054324564,0.00009097756,0.000066685985,0.00033132246,4.720254e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14944527,0.0016402624,0.78868866,0.00031211908,0.0035726759,0.000025823134,0.0045041884,0.0024561603,0.027823742,0.000041525393,0.00060831365,0.020881243],"study_design_scores_gemma":[0.025029944,0.0023363656,0.95232904,0.0016598814,0.0007411409,0.000009911087,0.001241727,0.00027140472,0.010341408,0.0000015088638,0.0058267037,0.00021095341],"about_ca_topic_score_codex":0.005828038,"about_ca_topic_score_gemma":0.0036465856,"teacher_disagreement_score":0.16364038,"about_ca_system_score_codex":0.00028935604,"about_ca_system_score_gemma":0.0012558529,"threshold_uncertainty_score":0.88102883},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"}],"label_agreement":"agree"},{"id":"W4412578767","doi":"10.1080/2162402x.2025.2534912","title":"The human STING agonist E7766 induces immunogenic tumor clearance, independent of tumor-intrinsic STING expression in the <i> KRAS <sup>G12D/+</sup> Trp53 <sup>−/−</sup> </i> murine model of sarcoma","year":2025,"lang":"en","type":"article","venue":"OncoImmunology","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; Alberta Bone and Joint Health Institute; University of Calgary","funders":"Canadian Institutes of Health Research","keywords":"Sting; Cancer research; Agonist; KRAS; Sarcoma; Medicine; Cancer; Pathology; Internal medicine; Receptor; Physics","score_opus":0.017011622663489517,"score_gpt":0.2660783263580014,"score_spread":0.24906670369451187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412578767","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97663724,0.018092418,0.00007572306,0.00036794817,0.0003234513,0.0007350106,0.000042271575,0.000074493684,0.0036514618],"genre_scores_gemma":[0.99700576,0.0004756666,0.000083728555,0.00033386587,0.000030995303,0.00012968625,0.000050084105,0.00004970482,0.0018404844],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9940929,0.0021356628,0.0018617257,0.0006692007,0.00017989818,0.001060617],"domain_scores_gemma":[0.99592805,0.0015490162,0.000869643,0.0013775096,0.00025519554,0.000020560923],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0019510181,0.0005765682,0.0011715681,0.0005241514,0.001008557,0.00005453375,0.0020939722,0.00045458056,0.00011231326],"category_scores_gemma":[0.00066833064,0.00040047333,0.00037904576,0.0006397345,0.0015670611,0.00018918978,0.0009265832,0.0018463134,0.00005668436],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028321904,0.0006598018,0.0015078683,0.00012169998,0.000422451,0.00002485225,0.004275672,0.0015178839,0.9752423,0.003294672,0.000497056,0.009603536],"study_design_scores_gemma":[0.011859744,0.0021298148,0.03245969,0.002024414,0.00029410323,0.00061076233,0.030226424,0.0018299804,0.9029255,0.001613972,0.012966987,0.001058619],"about_ca_topic_score_codex":0.00074004557,"about_ca_topic_score_gemma":0.000075634525,"teacher_disagreement_score":0.072316825,"about_ca_system_score_codex":0.00017472134,"about_ca_system_score_gemma":0.00047020544,"threshold_uncertainty_score":0.99984473},"labels":[],"label_agreement":null},{"id":"W4414508324","doi":"10.1080/2162402x.2025.2562210","title":"IL-21-reprogrammed Vδ1 T cells exert killing against solid tumors which is enhanced by CAR arming for off-the-shelf immunotherapy","year":2025,"lang":"en","type":"article","venue":"OncoImmunology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Discovery Centre","funders":"Canadian Institutes of Health Research; Ontario Ministry of Health and Long-Term Care","keywords":"Chimeric antigen receptor; Immunotherapy; Cancer immunotherapy; T cell; Ovarian cancer; Tumor microenvironment; Cell therapy; Antigen; Cancer","score_opus":0.01529819831688233,"score_gpt":0.32126101308457927,"score_spread":0.30596281476769693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414508324","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9517187,0.019283997,0.004289195,0.009208886,0.0015440088,0.0038868904,0.00007006763,0.0003271735,0.009671088],"genre_scores_gemma":[0.891757,0.01273727,0.0015822335,0.005242776,0.00036903934,0.001555572,0.00022809448,0.00023631235,0.086291686],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9964743,0.00019799611,0.0008303996,0.00086895877,0.0003701087,0.0012582327],"domain_scores_gemma":[0.9970073,0.0007045821,0.00023079602,0.0014146043,0.00053590216,0.00010681042],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00097951,0.00046153838,0.0010500976,0.0003273629,0.00043916027,0.00007515052,0.0006886699,0.00044230462,0.00061190856],"category_scores_gemma":[0.00019237219,0.00038783276,0.00039531387,0.00087927683,0.0004161361,0.00008383631,0.00016685623,0.00090920314,0.0000749672],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001294934,0.00022058493,0.00007407863,0.000072797055,0.00055354275,0.0000071010704,0.0012560483,0.0000048662014,0.6996263,0.00004715084,0.0035658071,0.2932768],"study_design_scores_gemma":[0.004004264,0.0006445776,0.00009508045,0.000161978,0.00006404407,0.0000119561455,0.000986268,0.000364969,0.6471291,0.00017845523,0.34610602,0.00025326316],"about_ca_topic_score_codex":0.00021384489,"about_ca_topic_score_gemma":0.000040241746,"teacher_disagreement_score":0.3425402,"about_ca_system_score_codex":0.00045500507,"about_ca_system_score_gemma":0.00062450254,"threshold_uncertainty_score":0.99985737},"labels":[],"label_agreement":null},{"id":"W4417071864","doi":"10.1080/2162402x.2025.2590245","title":"Deubiquitinating enzyme JOSD2 modulates cGAS to facilitate immune evasion in colorectal cancer","year":2025,"lang":"en","type":"article","venue":"OncoImmunology","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Artificial Intelligence in Medicine (Canada)","funders":"National Natural Science Foundation of China","keywords":"Deubiquitinating enzyme; Evasion (ethics); Colorectal cancer; Immune system; Microsatellite instability; Immunotherapy; Immunosuppression; Cancer","score_opus":0.020903676722866197,"score_gpt":0.28467255722174806,"score_spread":0.26376888049888186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417071864","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97075206,0.018923283,0.00014413627,0.0019653786,0.0019756723,0.00048641628,0.000032157193,0.0001356352,0.005585285],"genre_scores_gemma":[0.98429245,0.00036340722,0.00008086156,0.0005442531,0.000012596415,0.00024407895,0.000048722042,0.000023569904,0.014390054],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99728644,0.0006057961,0.0007113862,0.00053321704,0.00003870336,0.00082444935],"domain_scores_gemma":[0.9989315,0.0004349639,0.00012119531,0.00035610987,0.00013696609,0.000019224686],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00049182615,0.00033416567,0.0006645551,0.0006972029,0.0002358281,0.00002254481,0.0005179452,0.00048679364,0.0011327047],"category_scores_gemma":[0.00047017387,0.0003213694,0.00014458355,0.00054432824,0.00028798933,0.00011303943,0.00044203,0.0006705781,0.0011506325],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017216633,0.00016071252,0.0019879013,0.00002396938,0.00019202687,0.000012572985,0.0021828574,0.000073571726,0.96392035,0.0014790854,0.00080701255,0.02743829],"study_design_scores_gemma":[0.0026254598,0.0006826996,0.0912296,0.00034801883,0.000029535368,0.00005113213,0.0013708766,0.00003251043,0.8227717,0.00026488362,0.08021191,0.00038164473],"about_ca_topic_score_codex":0.002572258,"about_ca_topic_score_gemma":0.00073559803,"teacher_disagreement_score":0.14114861,"about_ca_system_score_codex":0.00037559055,"about_ca_system_score_gemma":0.00027268723,"threshold_uncertainty_score":0.9999238},"labels":[],"label_agreement":null},{"id":"W7117357993","doi":"10.1080/2162402x.2025.2604877","title":"IL-37/IL-1R8 axis: a novel major mechanism of control at the interface between tumor and immune cells","year":2025,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"Associazione Italiana per la Ricerca sul Cancro; Fondazione Umberto Veronesi; Ministero della Salute","keywords":"Inflammasome; Immune system; Tumor microenvironment; Regulator; Cytokine; Inflammation; Mechanism (biology); Transcription factor; Signal transduction; Innate immune system","score_opus":0.009705949025675373,"score_gpt":0.23826926724224454,"score_spread":0.22856331821656917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7117357993","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96568197,0.02692895,0.0012666357,0.0012229492,0.0015872561,0.000667043,0.0007076249,0.00007988275,0.0018576925],"genre_scores_gemma":[0.98571754,0.00033884982,0.00009068677,0.00018118811,0.000024406352,0.00009477167,0.00006914387,0.000023882692,0.013459549],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980594,0.00036449364,0.0005835074,0.00045104325,0.000037503953,0.0005040851],"domain_scores_gemma":[0.9981988,0.00074619905,0.000305947,0.0006477786,0.00008397332,0.00001728268],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00039513168,0.00034730133,0.000831481,0.00015163187,0.00032675735,0.000011928396,0.00048385715,0.00041563815,0.00034939527],"category_scores_gemma":[0.00006320366,0.0002520419,0.00018861027,0.00020561695,0.0006304077,0.000055872468,0.00040282492,0.00031816453,0.00028826192],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00067689636,0.00017285191,0.0011094785,0.000029141009,0.0020097825,0.0000052242267,0.0003791389,9.883762e-7,0.97860783,0.0057010124,0.00039766057,0.010910009],"study_design_scores_gemma":[0.008300054,0.0006591913,0.021319844,0.000088119166,0.0008907865,0.00008390852,0.0005729052,0.0000020282434,0.9341816,0.0009329905,0.032686252,0.0002823788],"about_ca_topic_score_codex":0.00035743215,"about_ca_topic_score_gemma":0.00007740295,"teacher_disagreement_score":0.044426274,"about_ca_system_score_codex":0.000098096665,"about_ca_system_score_gemma":0.00010197099,"threshold_uncertainty_score":0.9999932},"labels":[],"label_agreement":null}]}